0001683168-24-002236.txt : 20240409 0001683168-24-002236.hdr.sgml : 20240409 20240409145608 ACCESSION NUMBER: 0001683168-24-002236 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 62 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240409 DATE AS OF CHANGE: 20240409 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QS Energy, Inc. CENTRAL INDEX KEY: 0001103795 STANDARD INDUSTRIAL CLASSIFICATION: OIL & GAS FILED MACHINERY & EQUIPMENT [3533] ORGANIZATION NAME: 06 Technology IRS NUMBER: 522088326 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29185 FILM NUMBER: 24832265 BUSINESS ADDRESS: STREET 1: 23902 FM 2978 CITY: TOMBALL STATE: TX ZIP: 77375 BUSINESS PHONE: 775-300-7647 MAIL ADDRESS: STREET 1: 23902 FM 2978 CITY: TOMBALL STATE: TX ZIP: 77375 FORMER COMPANY: FORMER CONFORMED NAME: SAVE THE WORLD AIR INC DATE OF NAME CHANGE: 20000120 10-K 1 qsenergy_i10k-123123.htm FORM 10-K QS ENERGY, INC. 10-K
false 2023 FY 0001103795 0001103795 2023-01-01 2023-12-31 0001103795 2023-12-31 0001103795 2024-04-01 0001103795 2023-10-01 2023-12-31 0001103795 2022-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2023-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2022-12-31 0001103795 2022-01-01 2022-12-31 0001103795 us-gaap:CommonStockMember 2021-12-31 0001103795 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001103795 us-gaap:RetainedEarningsMember 2021-12-31 0001103795 2021-12-31 0001103795 us-gaap:CommonStockMember 2022-12-31 0001103795 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001103795 us-gaap:RetainedEarningsMember 2022-12-31 0001103795 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001103795 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001103795 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001103795 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001103795 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001103795 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001103795 us-gaap:CommonStockMember 2023-12-31 0001103795 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001103795 us-gaap:RetainedEarningsMember 2023-12-31 0001103795 qsep:PatentCostsMember 2023-01-01 2023-12-31 0001103795 qsep:PatentCostsMember 2022-01-01 2022-12-31 0001103795 qsep:StockOptionsMember 2023-01-01 2023-12-31 0001103795 qsep:StockOptionsMember 2022-01-01 2022-12-31 0001103795 qsep:WarrantsMember 2023-01-01 2023-12-31 0001103795 qsep:WarrantsMember 2022-01-01 2022-12-31 0001103795 qsep:ConvertibleNotesMember 2023-01-01 2023-12-31 0001103795 qsep:ConvertibleNotesMember 2022-01-01 2022-12-31 0001103795 us-gaap:OfficeEquipmentMember 2023-12-31 0001103795 us-gaap:OfficeEquipmentMember 2022-12-31 0001103795 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001103795 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001103795 qsep:TestingEquipmentMember 2023-12-31 0001103795 qsep:TestingEquipmentMember 2022-12-31 0001103795 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001103795 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001103795 qsep:CorporateOfficeSpaceMember 2021-06-30 0001103795 qsep:CorporateOfficeSpaceMember 2021-12-31 0001103795 qsep:CorporateOfficeSpaceMember 2022-12-31 0001103795 qsep:CorporateOfficeSpaceMember 2022-01-01 2022-12-31 0001103795 2022-11-01 2022-12-31 0001103795 qsep:TomballTexasOfficesMember 2023-12-31 0001103795 qsep:ConvertibleNotesMember 2021-12-31 0001103795 qsep:ConvertibleNotesMember 2022-01-01 2022-12-31 0001103795 qsep:ConvertibleNotesMember 2022-12-31 0001103795 qsep:ConvertibleNotesMember 2023-01-01 2023-12-31 0001103795 qsep:ConvertibleNotesMember 2023-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2021-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-12-31 0001103795 qsep:DebtDiscountMember 2021-12-31 0001103795 qsep:DebtDiscountMember 2022-01-01 2022-12-31 0001103795 qsep:DebtDiscountMember qsep:FairValueOfWarrantsMember 2022-01-01 2022-12-31 0001103795 qsep:DebtDiscountMember qsep:OriginalIssueDiscountMember 2022-01-01 2022-12-31 0001103795 qsep:DebtDiscountMember qsep:DiscountConvertedMember 2022-01-01 2022-12-31 0001103795 qsep:DebtDiscountMember 2022-12-31 0001103795 qsep:DebtDiscountMember 2023-01-01 2023-12-31 0001103795 qsep:DebtDiscountMember qsep:FairValueOfWarrantsMember 2023-01-01 2023-12-31 0001103795 qsep:DebtDiscountMember qsep:OriginalIssueDiscountMember 2023-01-01 2023-12-31 0001103795 qsep:DebtDiscountMember qsep:DiscountConvertedMember 2023-01-01 2023-12-31 0001103795 qsep:DebtDiscountMember 2023-12-31 0001103795 qsep:PPPLoanMember 2020-06-01 2020-06-30 0001103795 qsep:PPPLoanMember 2020-06-30 0001103795 qsep:PPPLoanMember 2021-12-31 0001103795 qsep:PPPLoanMember 2022-01-01 2022-12-31 0001103795 qsep:PPPLoanMember 2022-12-31 0001103795 qsep:PPPLoanMember 2023-01-01 2023-12-31 0001103795 qsep:PPPLoanMember 2023-12-31 0001103795 qsep:AOTPrototysMember 2023-01-01 2023-12-31 0001103795 qsep:AOTPrototysMember 2022-01-01 2022-12-31 0001103795 qsep:TempleUniversityLicenseAgreementsMember 2023-01-01 2023-12-31 0001103795 qsep:TempleUniversityLicenseAgreementsMember 2022-01-01 2022-12-31 0001103795 qsep:TempleUniversityLicenseAgreementsMember 2023-12-31 0001103795 qsep:TempleUniversityLicenseAgreementsMember 2022-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-12-31 0001103795 srt:MinimumMember us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-12-31 0001103795 srt:MaximumMember us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2023-12-31 0001103795 qsep:ExerciseOfWarrantsMember 2023-01-01 2023-12-31 0001103795 srt:MinimumMember qsep:ExerciseOfWarrantsMember 2023-01-01 2023-12-31 0001103795 srt:MaximumMember qsep:ExerciseOfWarrantsMember 2023-01-01 2023-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001103795 srt:MinimumMember us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001103795 srt:MaximumMember us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2022-12-31 0001103795 qsep:ExerciseOfWarrantsMember 2022-01-01 2022-12-31 0001103795 srt:MinimumMember qsep:ExerciseOfWarrantsMember 2022-01-01 2022-12-31 0001103795 srt:MaximumMember qsep:ExerciseOfWarrantsMember 2022-01-01 2022-12-31 0001103795 qsep:ExerciseOfOptionsMember 2022-01-01 2022-12-31 0001103795 us-gaap:StockOptionMember 2021-12-31 0001103795 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001103795 us-gaap:StockOptionMember 2022-12-31 0001103795 us-gaap:StockOptionMember 2023-01-01 2023-12-31 0001103795 us-gaap:StockOptionMember 2023-12-31 0001103795 us-gaap:WarrantMember 2023-12-31 0001103795 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001103795 us-gaap:WarrantMember us-gaap:ConvertibleDebtMember 2023-03-01 2023-09-30 0001103795 us-gaap:WarrantMember us-gaap:ConvertibleDebtMember 2023-09-30 0001103795 us-gaap:WarrantMember qsep:ConsultingAgreementMember 2023-01-01 2023-12-31 0001103795 us-gaap:WarrantMember qsep:ConsultingAgreementMember srt:MinimumMember 2023-01-01 2023-12-31 0001103795 us-gaap:WarrantMember qsep:ConsultingAgreementMember srt:MaximumMember 2023-01-01 2023-12-31 0001103795 us-gaap:WarrantMember us-gaap:ConvertibleDebtMember 2022-09-01 2022-09-30 0001103795 us-gaap:WarrantMember qsep:ConsultingAgreementMember 2022-01-01 2022-12-31 0001103795 us-gaap:WarrantMember srt:MinimumMember qsep:ConsultingAgreementMember 2022-12-31 0001103795 us-gaap:WarrantMember srt:MaximumMember qsep:ConsultingAgreementMember 2022-12-31 0001103795 us-gaap:WarrantMember qsep:ConsultingAgreementMember srt:MinimumMember 2022-01-01 2022-12-31 0001103795 us-gaap:WarrantMember qsep:ConsultingAgreementMember srt:MaximumMember 2022-01-01 2022-12-31 0001103795 us-gaap:StockOptionMember qsep:OptionPrice1Member 2023-12-31 0001103795 us-gaap:StockOptionMember qsep:OptionPrice1Member 2023-01-01 2023-12-31 0001103795 us-gaap:StockOptionMember qsep:OptionPrice2Member 2023-12-31 0001103795 us-gaap:StockOptionMember qsep:OptionPrice2Member 2023-01-01 2023-12-31 0001103795 us-gaap:StockOptionMember qsep:OptionPrice3Member 2023-12-31 0001103795 us-gaap:StockOptionMember qsep:OptionPrice3Member 2023-01-01 2023-12-31 0001103795 us-gaap:WarrantMember 2021-12-31 0001103795 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001103795 us-gaap:WarrantMember 2022-12-31 0001103795 us-gaap:WarrantMember qsep:Warrant1Member 2023-12-31 0001103795 us-gaap:WarrantMember qsep:Warrant1Member 2023-01-01 2023-12-31 0001103795 us-gaap:WarrantMember qsep:Warrant2Member 2023-12-31 0001103795 us-gaap:WarrantMember qsep:Warrant3Member 2023-12-31 0001103795 us-gaap:WarrantMember qsep:Warrant3Member 2023-01-01 2023-12-31 0001103795 qsep:LicenseAgreementsMember 2023-12-31 0001103795 qsep:CompensationAgreementsMember 2023-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

Table of Contents

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2023

 

or

 

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

Commission File Number 0-29185

 

QS ENERGY, INC.

(Exact name of registrant as specified in its charter)

 

Nevada 52-2088326
(State or other jurisdiction
of incorporation or organization)		 (I.R.S. Employer
Identification No.)

 

23902 FM 2978

Tomball, TX 77375

(Address, including zip code, of principal executive offices)

 

(775) 300-7647

(Registrant’s telephone number, including area code)

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Name of each exchange on which registered
None N/A

 

Securities registered pursuant to Section 12(g) of the Exchange Act: Common Stock, $0.001 par value.

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes ☐ No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes ☐ No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one)

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
  Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive- based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes ☐ No ☒

 

The aggregate market value of the voting and non-voting common equity held by non-affiliates (excluding voting shares held by officers and directors) as of December 31, 2023 was $21,268,000.

 

The number of shares of the Registrant’s Common Stock outstanding as of April 1, 2024 was 397,931,803.

 

DOCUMENTS INCORPORATED BY REFERENCE - None

 

Transitional Small Business Disclosure Format (Check one)

Yes ☐ No ☒

 

 

 

   

 

 

QS ENERGY, INC.

FORM 10-K

INDEX

 

PART I  
   
Item 1. Business 2
   
Item 1A. Risk Factors 17
   
Item 1B. Unresolved Staff Comments 23
   
Item 1C. Cybersecurity 23
   
Item 2. Properties 23
   
Item 3. Legal Proceedings 23
   
Item 4. Mine Safety Disclosures 23
   
PART II  
   
Item 5. Market for Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 24
   
Item 6. Selected Financial Data 25
   
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operation 25
   
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 29
   
Item 8. Financial Statements and Supplementary Data 29
   
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 29
   
Item 9A. Controls and Procedures 30
   
Item 9B. Other Information 31
   
PART III  
   
Item 10. Directors, Executive Officers and Corporate Governance 32
   
Item 11. Executive Compensation 36
   
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 38
   
Item 13. Certain Relationships and Related Transactions, and Director Independence 39
   
Item 14. Principal Accounting Fees and Services 39
   
PART IV  
   
Item 15. Exhibits, Financial Statement Schedules 40
   
Item 16. Form 10-K Summary 41
   
SIGNATURES 42

 

 

 

 i 

 

 

PART I

 

Forward-Looking Statements

 

This Annual Report on Form 10-K contains forward-looking statements. These forward-looking statements include predictions and statements regarding our future:

 

  · revenues and profits;
  · customers;
  · research and development expenses and efforts;
  · scientific and other third-party test results;
  · sales and marketing expenses and efforts;
  · liquidity and sufficiency of existing cash;
  · technology and products; and
  · the effect of recent accounting pronouncements on our financial condition and results of operations.

 

You can identify these and other forward-looking statements by the use of words such as “may,” “will,” “expects,” “anticipates,” “believes,” “estimates,” “intends,” “project,” “potential,” “forecast” “continues,” “strategies,” or the negative of such terms, or other comparable terminology, and also include statements concerning plans, objectives, goals, strategies and future events or performance.

 

Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth below under the heading “Risk Factors.” We cannot assure you that we will achieve or accomplish our expectations, beliefs or projections. All forward-looking statements included in this document are based on information available to us on the date hereof. We assume no obligation to update any forward-looking statements.

 

 

 

 

 

 

 

 

 

 

 1 

 

 

Item 1. Business

 

The discussion of our business is as of the date of filing this report, unless otherwise indicated.

 

Overview

 

QS Energy, Inc. (“QS Energy” or “Company” or “we” or “us” or “our”) develops and seeks to commercialize energy efficiency technologies that assist in meeting increasing global energy demands, improving the economics of oil transport, and reducing greenhouse gas emissions. The Company's intellectual properties include a portfolio of domestic and international patents, a substantial portion of which have been developed in conjunction with and exclusively licensed by us from Temple University of Philadelphia, PA (“Temple”). QS Energy's primary technology (and for now only technology) is called Applied Oil Technology (AOT), a commercial-grade crude oil pipeline transportation flow-assurance product. Engineered specifically to reduce pipeline pressure loss, increase pipeline flow rate and capacity, and reduce shippers’ reliance on diluents and drag reducing agents to meet pipeline maximum viscosity requirements, AOT is a 100% solid-state system that in lab and other tests has shown to reduce crude oil viscosity by applying a high intensity electrical field to crude oil while in transit. AOT technology has shown to deliver reductions in crude oil viscosity and pipeline pressure loss as demonstrated in independent third-party tests performed by the U.S. Department of Energy, the PetroChina Pipeline R&D Center, and ATS RheoSystems, a division of CANNON™, at full-scale test facilities in the U.S. and China, and under commercial operating conditions on one of North America’s largest high-volume crude oil pipelines. Prior testing on a commercial crude oil condensate pipeline demonstrated high correlation between laboratory analysis and full-scale AOT operations under commercial operating conditions with onsite measurements and data collected by the pipeline operator on its supervisory control and data acquisition (“SCADA”) system. The AOT product is still in development and testing and has transitioned from laboratory testing to initial demonstration and continued testing in advance of our goal of seeking commercial acceptance and adoption by the upstream and midstream pipeline marketplace. Such commercial acceptance and adoption have not been achieved. We continue to devote the bulk of our efforts to the promotion, design, testing and the commercial manufacturing and test operations of our crude oil pipeline products in the upstream and midstream energy sector. Our efforts in the foregoing regard have been substantially hampered by our lack of capital. We should be able to continue our efforts to commercialize our AOT product during 2024 only if we are able to raise sufficient capital to do so. We can provide no assurances that we will be able to raise the capital we need to continue our efforts in 2024, or that any such capital will be available to us on acceptable terms and conditions.

 

Our Company was incorporated on February 18, 1998, as a Nevada Corporation under the name Mandalay Capital Corporation. The Company changed its name to Save the World Air, Inc. on February 11, 1999. Effective August 11, 2015, the Company changed its name to QS Energy, Inc. The name change was affected through a short-form merger pursuant to Section 92A.180 of the Nevada Revised Statutes. Additionally, QS Energy Pool, Inc., a California corporation, was formed as a wholly owned subsidiary of the Company on July 6, 2015 to serve as a vehicle for the Company to explore, review and consider acquisition opportunities. To date, QS Energy Pool has not entered into any acquisition transaction. However, the Company will still consider entering into potential beneficial acquisitions. The Company is considering dissolving QS Energy Pool to reduce costs associated with operating this subsidiary. The Company’s common stock is quoted under the symbol “QSEP” on the Over-the-Counter Bulletin Board (Pink Sheets).

 

More information including the Company’s updates, fact sheet, logos and media articles are available at our corporate website, www.qsenergy.com.

 

A history of important events associated with our efforts to develop and commercialize our AOT technology is as follows: Between 2011 and 2012, the Company transitioned from prototype testing of its AOT technology at the U.S. Department of Energy Rocky Mountain Oilfield Testing Center, Midwest, Wyoming (“RMOTC”), to the design and production of full-scale commercial prototype units. The Company worked in a collaborative engineering environment with multiple energy industry companies to refine the AOT Midstream commercial design to comply with the stringent standards and qualification processes as dictated by independent engineering audit groups and North American industry regulatory bodies. In May 2013, the Company’s first commercial prototype unit known as AOT Midstream, was completed.

 

 

 

 2 

 

 

In 2013, the Company entered into an Equipment Lease/Option to Purchase Agreement (“TransCanada Lease”) with TransCanada Keystone Pipeline, L.P. by its agent TC Oil Pipeline Operations, Inc. ("TransCanada") which agreed to lease and test the effectiveness of the Company’s AOT technology and equipment on one of TransCanada’s operating pipelines. As previously reported in our 10-K report filed with the SEC on March 16, 2015, in June 2014, the equipment was accepted by TransCanada and the lease commenced and the first full test of the AOT equipment on the Keystone pipeline was performed in July 2014 by Dr. Rongjia Tao of Temple University, with subsequent testing performed by an independent laboratory, ATS RheoSystems, a division of CANNON™ (“ATS”) in September 2014. Upon review of the July 2014 test results and preliminary report by Dr. Tao, QS Energy and TransCanada mutually agreed that this initial test was flawed due to, among other factors, the short-term nature of the test, the inability to isolate certain independent pipeline operating factors such as fluctuations in upstream pump station pressures, and limitations of the AOT device to produce a sufficient electric field to optimize viscosity reduction. Subsequent testing by ATS in September 2014 demonstrated viscosity reductions of 8% to 23% depending on flow rates and crude oil types in transit. In its summary report, ATS concluded that i) data indicated a decrease in viscosity of crude oil flowing through the TransCanada pipeline due to AOT treatment of the crude oil; and ii) the power supply installed on our equipment would need to be increased to maximize reduction in viscosity and take full advantage of the AOT technology. We determined more testing would be required to establish the commercial efficacy of our AOT technology. The TransCanada Lease was terminated by TransCanada, effective October 15, 2014. Upon termination of the TransCanada Lease, all equipment was uninstalled, returned, inspected and configured for re-deployment.

 

On July 15, 2014, the Company entered into an Equipment Lease/Option to Purchase Agreement (“Kinder Morgan Lease”) with Kinder Morgan Crude & Condensate, LLC (“Kinder Morgan”) under which Kinder Morgan agreed to lease and test the effectiveness of the Company’s AOT technology and equipment on one of Kinder Morgan’s operating crude oil condensate pipelines. Equipment provided under the Lease included a single AOT Midstream pressure vessel with a maximum flow capacity of 5,000 gallons per minute. The equipment was delivered to Kinder Morgan in December 2014 and installed in March 2015. In April 2015, during pre-start testing, low electrical impedance was measured in the unit, indicating an electrical short. A replacement unit was installed in May 2015. The second unit also presented with low impedance when flooded with crude condensate from Kinder Morgan’s pipeline. Subsequent to design modifications, a remanufactured AOT unit was installed and tested at Kinder Morgan’s pipeline facility in August 2015. Initial results were promising, with the unit operating generally as expected. However, voltage dropped as preliminary tests continued, indicating decreased impedance within the AOT pressure vessel. QS Energy personnel and outside consultants performed a series of troubleshooting assessments and determined that, despite modifications made to the AOT, conductive materials present in the crude oil condensate appeared to be the root cause of the decreased impedance. Based on these results, QS Energy and Kinder Morgan personnel mutually agreed to put a hold on final acceptance of equipment under the lease and suspended in-field testing to provide time to re-test crude oil condensate in a laboratory setting, and thoroughly review and test selected AOT component design and fabrication. Subsequent analysis and testing led to changes in electrical insulation, inlet flow improvements and other component modifications. These design changes were implemented and tested by Industrial Screen and Maintenance (ISM), one of QS Energy's supply chain partners in Casper, Wyoming. Tests performed by ISM at its Wyoming facility indicated significant improvements to system impedance and efficiency of electric field generation.

 

In February 2016, the modified AOT equipment was installed at Kinder Morgan’s facility. Pre-acceptance testing was performed in April 2016, culminating in more than 24 hours of continuous operations. In-field viscosity measurements and pipeline data collected during this test indicated the AOT equipment operated as expected, demonstrating viscosity reductions equivalent to those measured under laboratory conditions. Supervisory Control And Data Acquisition (“SCADA”) pipeline operating data collected by Kinder Morgan during this test indicated a pipeline pressure drop reduction consistent with expectations. Results of this test were promising; however, due to the short duration of the test and limited data collection, definitive conclusions regarding the AOT performance and its impact on pipeline operations could not be reached. Based on final analysis of in-field test results, SCADA operating data and subsequent analysis of crude oil condensate samples at Temple University, it became unlikely Kinder Morgan would use the AOT at the original test location or other condensate pipeline. Kinder Morgan expressed interest in AOT operations at one of their heavy crude pipeline locations subject to results of other AOT demonstration projects and provided the Company with additional crude oil samples which have been tested at Temple University for future test correlation and operational planning purposes. The Kinder Morgan Lease is currently in suspension and there are no current plans to resume the lease or reinstall an AOT device at a Kinder Morgan facility.

 

 

 

 3 

 

 

Southern Research Institute (SRI) was engaged by QS Energy in 2015 to investigate the root cause of the crude oil condensate impedance issue by replicating conditions experienced in the field utilizing a laboratory-scaled version of the AOT and crude oil condensate samples provided by Kinder Morgan. In addition, QS Energy retained an industry expert petroleum pipeline engineer to review the AOT design and suggest design modifications to resolve the crude oil condensate impedance issue. This engineer has studied design details, staff reports and forensic photographs of each relevant AOT installation and test. Based on these investigations, specific modifications were proposed to resolve the impedance issue, and improve the overall efficiency of the AOT device, resulting in a new value-engineered design of certain AOT internal components.

 

During the third quarter of 2016, the Company developed an onsite testing program to demonstrate AOT viscosity reduction at prospective customer sites. This program utilized a laboratory-scale AOT device designed and developed by the Company and tested at the Southern Research Institute. Under this program, Company engineers set up a temporary lab at the customer’s site to test a full range of crude oils. Fees charged for providing this service were dependent on scope of services, crude oil sample to be tested, and onsite time requirements. In the fourth quarter 2016, the Company entered a contract to provide these onsite testing services to a North American oil producer and pipeline operator over a one-week period in early 2017 at a fixed price of $50,000. This test was performed in January 2017; data analysis and final report was completed in March 2017. Test results demonstrated viscosity reduction under limited laboratory conditions. The oil producer requested access to observe a full-scale demonstration facility and view operating data when they become available.

 

In 2014, the Company began development of a new suite of products based around the new electrical heat system which reduces oil viscosity through a process known as joule heat (“Joule Heat”). The Company built and tested its first Joule Heat prototype in June 2015. The system was operational; however, changes to the prototype configuration would be required to determine commercial effectiveness of this unit. In December 2015, we suspended Joule Heat development activities to focus Company resources on finalizing commercial development of the AOT. We may resume Joule Heat development in the future depending on the availability of sufficient capital and other resources.

 

In July 2017, the Company filed for trademark protection for the word “eDiluent” in advance of rolling out a new marketing and revenue strategy based on the concept of using AOT to reduce pipeline dependence upon diluent to reduce viscosity of crude oils. A primary function of AOT is to reduce viscosity by means of its solid-state electronics technology, in essence providing an electronic form of diluent, or “eDiluent”. Subject to successful testing of our AOT technology and sufficient the availability of operating capital, the Company plans to market and sell a value-added service under the name eDiluent, designed to be upsold by the Company’s midstream pipeline customers in an effort to provide the Company with long-term recurring revenues.

 

During the third quarter 2017, the Company built a dedicated laboratory space at its then Tomball, Texas facility, providing onsite testing utilizing our laboratory-scale AOT device, among other equipment. Development of an AOT unit for use in crude oil upstream and gathering operations was restarted in September 2017, utilizing resources at the Tomball, Texas facility. Also, during the third quarter 2017, the Company built an outdoor facility at the Tomball, Texas site for onsite storage of AOT inventory and other large equipment.

 

Throughout 2018 our primary strategic goal was focused on installing and operating a demonstration AOT project on a commercial crude oil pipeline. Much of our time was spent meeting with industry executives and engineers in North and South America and working with local representatives in the Asian and the Middle Eastern markets. In December 2018, we reached mutual agreement with a major U.S.-based pipeline operator on a demonstration project under which we would install and operate our AOT equipment on a crude oil pipeline located in the Southern United States. We believed at the time that the selected project site would be ideal for demonstration purposes, delivering heavy crudes which, based on samples tested at Temple University, and, subject to the discussion below, would experience significant viscosity reduction when treated with our AOT technology.

 

While management focused on finding a partner and finalizing terms of the demonstration project, and in our continuing efforts to commercialize our AOT technology, our engineering team worked throughout 2018 to prepare one of our inventoried AOT units for deployment. All system upgrade, inspections and testing protocols were completed in December 2018. The pipeline operator finalized site selection and began site design and engineering in January 2019, completing site preparation and equipment installation in June 2019. The project was installed within budget, quality compliant, and without safety incidents. The system passed the pre-start safety review, data acquisition signal verifications, and mechanical inspections. Under full crude oil flow, the system was confirmed to have no leaks and no environmental issues were noted. Data collected during the full-flow startup phase confirmed internal differential pressures to be negligible and consistent with design specifications. However, when the system was energized, and the unit was run-up to high-voltage operations, the primary power supply began to operate erratically and had to be taken offline. Subsequent inspection determined the primary power supply had failed.

 

 

 

 4 

 

 

After removing the primary power supply, our engineers reconfigured the system to run off a smaller secondary power supply. Although this unit was not capable of achieving target treatment voltage, we performed limited testing and troubleshooting measures, after which the damaged power supply was shipped to the manufacturer for expedited repair and reconditioning. Inspections performed during the repair process indicated internal power supply components had been physically damaged. Though not definitive, it appears that damage may have occurred during transit prior to initial installation at the demonstration site. While the demonstration project was offline for power supply repairs, our engineering team worked with oil samples pulled from the operating pipeline for testing at our then Tomball laboratory facility. These tests were designed to confirm our target power requirements as accurately as possible and help us fine-tune enhancements planned for a new optimized AOT internal grid pack design we had planned to test at the demonstration site as part of our continuing value engineering effort.

 

During initial testing with the small power supply, current draw was greater than prior field deployments. While it was expected that the small power supply would not achieve treatment voltage, as voltage was increased, actual current draw experienced under test conditions exceeded the operating limit of the power supply. Subsequent laboratory and in-field testing performed at our then Tomball facility showed the electrical conductivity of the oil to be quite high and in line with field observations. Although these tests indicated the unit was generally functioning properly, results further indicated the damaged power supply, once repaired, would not be capable of providing sufficient power to fully treat the crude oil due to the oil’s high electrical conductivity. In anticipation of this result, the Company initiated in advance of testing parallel tasks of: i) installation of the repaired power supply to perform limited testing to confirm laboratory and in-field test results; and ii) procurement of a new power supply capable of providing significantly more power and a modified AOT grid pack assembly reconfigured and generally optimized based on the latest laboratory and in-field test results.

 

When the repaired power supply was installed in late August 2019, the system operated as expected, and limited testing was performed at that time. Results of this limited testing were consistent with laboratory tests performed to date. As expected, the repaired power supply was not capable of providing sufficient power to fully treat the crude oil under commercial operating conditions. Based on results of this limited testing, Company engineers completed designs and began implementation of modifications to the AOT internal grid pack assembly.

 

The new high capacity power supply and modified grid pack were installed in December 2019. However, prior to flooding the system with crude oil, early-phase startup testing indicated an electrical short circuit. Subsequent inspection revealed damage to the internal grid pack which likely occurred during installation. The grid pack was shipped offsite for repairs with reinstallation scheduled for January 2020.

 

The AOT demonstration project continued to experience setbacks during the first quarter of 2020. After repairing and re-installing the modified grid pack, the system shut down again during commissioning presenting with error conditions similar to the December 2019 failure. At that time, based on external inspections and on-site testing, our engineers suspected the grid pack had again been damaged during re-installation and that such suspected damage was the most likely cause of the electrical short circuit. It was determined at that time the best course of action would be to remove the modified grid pack and re-install the original grid pack which had previously been installed multiple times without sustaining damage, and perform a detailed inspection of the modified grid pack in an effort to determine the cause of the electrical short circuit.

 

Executing this plan, our team removed the modified grid pack and re-installed the original grid pack assembly in the AOT in January 2020. After removal, our engineers performed a detailed inspection of the modified grid pack. Inconsistent with expectations, no damage to the modified grid pack was found during this inspection, leaving the cause of the electrical short circuit undiagnosed.

 

In January and February 2020, our engineers tested and attempted to operate the AOT under a variety of conditions. In these tests, the system could be run at high voltage, but not high enough for treatment with the installed grid pack, under static “shut-in” conditions; however, the system continued to shut down due to an electrical short circuit when operated under pressure. In simple terms, this means the system could be flooded with crude oil and powered up in excess of 10,000 volts when the system was shut-in by closing the intake and outtake valves which isolates the system from the pipeline’s operating pressure. However, once the valves were opened and the system was subjected to the pipeline’s operating pressure, the system developed an electrical short circuit and shut down.

 

 

 

 5 

 

 

As the presence of high pressure appears to trigger the short circuit, it was the belief of our engineers that it is unlikely the fault is in the grid pack assembly as this component is fully submerged in crude oil and is generally subjected to equal pressure on all components. The electrical short is more likely developing in the electrical connection assembly built into the blind flange at the top of the pressure vessel, which is subjected to high pressure under normal operating conditions. Unfortunately, this electrical connection assembly could not be inspected without destroying the assembly itself. Instead, our engineers developed a plan to replace the installed blind flange and electrical connection assembly with components from inventory which would be rebuilt prior to installation.

 

As part of an ongoing reliability-engineering effort, our engineers at that time worked on incremental modifications to improve electrical isolation within the blind flange and electrical connection assembly. These previously developed plans allowed us to move quickly with vendors and present an expedited plan to the pipeline operator. In March 2020, our engineers designed modifications to the blind flange, electrical connections and related housing intended to minimize the effects of high pressure and likelihood of internal electrical short circuits. Concurrently, a blind flange with high voltage assembly was shipped from inventory to a shop with specialized equipment used to strip the flange of all electrical insulation materials. Once the stripping process was complete, castings were made to complete the internal assembly. Our engineers believed at the time that this modification could solve the electrical short issue we have experienced in prior tests.

 

While the blind flange assembly was being remanufactured, we took the opportunity to implement a number of relatively minor modifications to other system configurations which had been planned for future units based on results of our engineering team’s reliability engineering work over the past two years. These modifications were designed to improve the reliability of internal electrical connections, increase the structural support of the internal grid pack, and maintain higher quality control over internal component positioning and alignment during vertical installation.

 

Notwithstanding our efforts, the AOT system continues to be non-operational under normal operating conditions. As reported in previous updates on our website at https://qsenergy.com/updates and in our Form 8-K filed with the SEC on March 4, 2020, the AOT system experienced shutdowns during the commissioning process. In December 2019, after installing a modified grid pack and new high-capacity power supply, the system shut down presenting with an electrical short which was determined to be due to damage to the system’s internal grid pack likely incurred during installation. After repairing and re-installing the modified grid pack in January 2020, the system shut down again during commissioning presenting with error conditions similar to the December 2019 failure. At that time, based on external inspections and on-site testing, our engineers suspected the grid pack had again been damaged during re-installation and that such suspected damage was the most likely cause of the electrical short circuit. As reported in our January 24, 2020 website update page, it was determined at that time the best course of action would be to remove the modified grid pack and re-install the original grid pack which had previously been installed multiple times without sustaining damage, and perform a detailed inspection of the modified grid pack in an effort to determine the cause of the electrical short circuit.

 

Executing on this plan, our team removed the modified grid pack and re-installed the original grid pack assembly in the AOT. After removal, our engineers performed a detailed inspection of the modified grid pack. Inconsistent with our expectations, no damage to the modified grid pack was found during this inspection, leaving the cause of the most recent electrical short circuit undiagnosed.

 

We have tested and attempted to operate the AOT under a variety of conditions. We have been able to bring the system up to high voltage under static “shut-in” conditions; however, as reported above, the system continued to shut down due to an electrical short circuit when operated under pressure. In simple terms, as also reported above, this means we can flood the system with crude oil, shut-in the system by closing the intake and outtake valves isolating the system from the pipeline’s operating pressure, and power up the system in excess of 10,000 volts. Once the valves are opened and the system is subjected to the pipeline’s operating pressure, the system develops an electrical short circuit and shuts down. Because of our inability to fully diagnose the cause of our current electrical problems, we can provide no assurances that we will not face other operational issues after completing a full diagnosis and evaluation of our technology.

 

As previously reported, in December 2018, we entered into an agreement with a major U.S.-based pipeline operator under which the Company installed its AOT equipment on a crude oil pipeline located in the Southern United States for testing and demonstration purposes. Based on laboratory tests and operations of prototype equipment at other locations, we had a reasonable expectation that the equipment would operate successfully and that test results would demonstrate quantifiable benefits to pipeline operators. This has not occurred.

 

 

 6 

 

 

As reported in the Company’s Form 10-K and Form 10-Q filed with the SEC on March 31, 2020 and June 29, 2020, respectively, and in website updates published on the Company’s website at https://qsenergy.com/updates, the Company experienced a number of difficulties and delays at the demonstration site. Despite identifying and implementing numerous design modifications over several months, the Company was unable to successfully operate its AOT equipment.

 

In late June 2020, equipment modifications intended to mitigate electrical short circuit issues identified in earlier tests were completed. During startup testing, the system experienced a new failure mode in which the system could be operated at a baseline high voltage (well below operational voltage required to treat heavy crude), but after a period of time, the system would drop to very low voltage indicating a reduction in electrical resistance in the AOT. This voltage drop was both dynamic, developing over time as electrical current was applied; and transient, in that the power supply could be shut-down and re-started with this voltage drop characteristic repeating. After reviewing these results and running subsequent in-field tests at the direction of the power supply manufacturer, they recommended a configuration modification to the control module of the system’s high-voltage power supply which, in their experience, could resolve the system’s ability to maintain constant voltage under our unique operating conditions in which the AOT essentially acts as a very large capacitor. During the first week of July 2020, we modified the power supply control module at the direction of the power supply manufacturer. Though this modification did appear to solve the voltage drop issue, the AOT could not achieve operational voltage as the system control module indicated arc-faults when high voltage was applied above the baseline voltage levels. After many attempts to bring the system up to operating voltage, arc-faults continued until the AOT demonstrated symptoms of what appeared to be a dead short (electrical short-to-ground; voltage dropped to zero) and the system could no longer be re-started.

 

After discussions with our demonstration pipeline partner, it was mutually agreed that the best course of action was to move the equipment from the demonstration site to another location where our engineers could disassemble and inspect the equipment. Our AOT equipment was moved to storage, inspection, and testing site in the state of Mississippi. Our former demonstration partner indicated their continued interest in our AOT technology and may consider installation and operation of a new AOT demonstration project if our operational issues can be resolved.

 

We shut down all testing of our AOT product in July 2020, due to a lack of operating capital; we received limited capital in 2021, allowing us to commence some additional testing of our AOT product.

 

In 2021, following our receipt of limited capital, our engineer commenced re-testing and completed a troubleshooting sequence. Lab test fixtures were designed and built, and testing results supported the redesign of the AOT internals. The results of the electrical testing of the insulating material showed that the material of constructions was functioning as designed. However, during the testing it was discovered that the material swells when exposed to crude oil. The current design does not accommodate a change in size of the parts.

 

We validated a new design concept for the grid pack will reduce arcing and allowed us to apply full voltage during a recent test. A 3rd party engineering firm with proper experience and three-dimensional modeling software was engaged. A design review was completed, final drawings were sent to our vendors, and prototype parts, for fit and electrical testing, were ordered.

 

In August 2022 we completed the testing of the new components. The assembly did not suffer the arcing problems we saw when testing an assembly made from parts of the full size AOT. It appeared that we accomplished the goal of eliminating the sources of arcing that prevented us from achieving treatment voltages with this new design.

  

The lessons learned during the stack assembly test have been applied and the results incorporated into the designs for the spacer rings and the screens. This change to the isolator ring design resulted in some iterative designs to optimize the casting tooling or molds. The time spent on this redesign created a delay in our goal for testing in September 2022.

 

Since reporting our findings on October 7, 2021, we have been able to positively confirm and correct 80% of what we have determined thus far to be the necessary improvements for a reliable and field worthy AOT. Based on the results of the recent component testing, we were able to rework the original grid pack, achieve high voltage in air and oil to verify that the individual components worked when assembled.

 

 

 

 7 

 

 

Once all the parts were delivered for a full AOT, we assembled the stack and installed the stack into the vessel. The vessel was filled with oil and tested. We were able to apply full voltage of 40.1kV to the AOT. We believe the AOT is now ready to test with customer oil and be deployed back into the field. Having achieved a positive hydrostatic test, we were able to have our final engineering call with a potential development partner. We are currently in pursuit of an LOI to include financial metrics for a commercially viable contract.

 

We reopened discussions with our original development partner as well as reaching out to others. While we have tested with a representative oil sample, we have not yet reached an agreement with a development partner allowing us to test a development partner's pipeline oil as a prelude to another field test. Our efforts continue to reach agreement with a suitable development partner as our next step to develop and commercialize our AOT technology.

 

Our team has diligently pursued the formalization of a new initiative, aligning it with the strategic priorities of potential development partners. As we endeavor to seamlessly incorporate state-of-the-art technologies into a novel operational framework, we acknowledge that comprehensive planning and meticulous execution invariably require more time than initially anticipated.

 

A noteworthy milestone has been achieved, demonstrating significant viscosity reduction for the specified oil target. Our collaboration with Temple University continues as we meticulously define the operational parameters of the AOT system, essential for effective field deployment. Concurrently, we are actively exploring other promising opportunities in parallel.

 

Our expenses to date have been funded through the sale of shares of common stock and convertible debt, as well as proceeds from the exercise of stock purchase warrants and options. We will need to raise substantial additional capital through 2024, and beyond, to fund work on our AOT, our sales and marketing efforts, continuing research and development, and certain other expenses, including without limitation, legal and accounting expenses, until we achieve, if at all, a revenue base. We can provide no assurances that additional capital will be available to us, or if it is, that such additional capital will be offered at acceptable terms. Please see note 12 (Subsequent Events) of our Consolidated Financial Statements, attached hereto.

 

There are significant risks associated with our business, our Company and our stock. See “Risk Factors,” below.

 

Our Business Strategy

 

Assuming we are able to raise sufficient capital, we intend to continue to seek commercialization and marketing of our current technologies. Our current and primary product portfolio is dedicated to the crude oil production and transportation marketplace, with a specifically targeted product offering for enhancing the flow-assurance parameters of new and existing pipeline gathering and transmission systems.

 

Our primary goal is to provide the oil industry with a cost-effective method by which to increase the number of barrels of oil able to be transported per day through the industry’s existing and newly built pipelines. The greatest impact on oil transport volume may be realized through reductions in pipeline operator reliance on diluent for viscosity reduction utilizing AOT technology; a process the Company refers to as electronic diluent, or “eDiluent”. The Company filed for trademark protection of the term eDiluent in 2017. We also seek to provide the oil industry with a way to reduce emissions from operating equipment. We believe our goals are realizable via viscosity reduction using our AOT product line.

 

We believe QS Energy’s technologies will enable the petroleum industry to gain key value advantages boosting profit, while satisfying the needs of regulatory bodies at the same time. Key players in the pipeline industry continue to demonstrate interest in our technologies.

 

Our manufacturing strategy is to contract with third-party vendors and suppliers, each with a strong reputation and proven track record in the pipeline industry. These vendors are broken up by product component subcategory, enabling multiple manufacturing capacity redundancies and safeguards to be utilized. In addition, this strategy allows the Company to eliminate the prohibitively high capital expenditures such as costs of building, operating and maintaining its own manufacturing facilities, ratings, personnel and licenses, thereby eliminating unnecessary capital intensity and risk.

 

 

 

 8 

 

 

Our identified market strategy is to continue meeting with oil and gas industry executives in the upstream, gathering, and midstream sectors from both domestic and foreign companies. Our goal is to introduce our technology to oil and gas companies and to demonstrate potential value for the purposes of negotiating commercial implementation of our AOT technology to their existing infrastructures.

 

Our strategy includes:

 

  1. Continue optimization and value engineering of our AOT Midstream commercial product line.
  2. Install and operate AOT equipment on a commercial midstream pipeline.
  3. Directly market AOT technology to midstream pipeline operators based on results and analysis of data from the AOT demonstration project.
  5. Present demonstration project results and analysis at various trade conferences.
  6. Continue to make inroads and meet with key strategic potential customers in the following geographic regions:

 

  a. United States
  b. Canada
  c. South and Central America
  d. Middle East
  e. Asia

 

  7. Continue to make inroads and strategic alliances with additional supply chain and logistics support to rapidly expand our production capacity beyond its current physical limitations, adding capacity, reach and stability with pre-approved supply chain members that meet the criteria of the customers’ procurement divisions.
  8. Develop new AOT technologies crude oil technologies with the potential to expand our market reach upstream and gathering pipeline, offshore pipelines, rail and trucking containers, and crude oil container ships.
  9. Continue to collaborate on scientific and technical whitepaper reports, product development enhancements, and additional products with our engineering support, consultants and relationships.
  10. Seek long-term recurring revenues by directly offering or licensing electronic viscosity reduction (electronic diluent, or “eDiluent”) as a service to reduce reliance on physical diluent.

 

Market Analysis Overview

 

QS Energy’s AOT crude oil viscosity reduction technology directly targets the heavy crude oil transportation industry, initially targeting the midstream crude oil pipeline operations which deliver high volumes of heavy crude oil to market. The U.S. Energy Information Administration (EIA) forecasts U.S. crude oil production will average 13.0 million barrels per day in 2020, up 0.8 million barrels per day from 2019, but then fall to 12.7 million barrels per day in 2021. The forecast decline in 2021 is in response to lower oil prices and would mark the first annual U.S. crude oil production decline since 2016. Worldwide, EIA forecasts crude oil prices averaging $43.30 per barrel in 2020, increasing to $55.36 per barrel in 2021. In recent months, oil prices have been driven to local lows due to a number of external factors. In March 2020, combined factors of the coronavirus pandemic and increase OPEC output drove Brent Crude prices as low as $20 per barrel compared to an average $64 per barrel for Brent Crude in 2019. Despite this quick drop in crude prices, long-term forecasts remain strong. The EIA forecasts that, by 2025, the average price of a barrel of Brent crude oil will rise to $82 per barrel, growing to $93 per barrel (quoted in 2018 dollars to remove the effects of inflation). Prices are expected to continue to increase as cheap sources of oil are exhausted, making it more expensive to extract oil.

 

In 2019, demand for crude oil averaged 101 million barrels per day. The EIA forecasts demand will remain flat, averaging 102 million barrels per day by the end of 2021. Long-term, EIA forecasting demand to grow at an average of 0.4% annually. Commitments to stop climate change introduced more uncertainty into future oil demand. Barclays predicted that oil demand could peak by 2025, falling by as much as 30% by 2050 if countries kept their Paris Climate Accord commitments.

 

 

 

 9 

 

 

2018 worldwide crude oil production at 82 million barrels per day. North American production (U.S. and Canada) is estimated at 16 million barrels per day. At $50 per barrel, this represents annual worldwide and North American sales of $1.5 trillion and $292 billion, respectively. The EIA estimates 71% worldwide crude oil production is transported by midstream pipelines, with 90% of North American production transported by midstream pipelines. In 2014, the Congressional Research Service estimated the average cost of midstream pipeline transportation at $5 per barrel. Assuming a $5 per barrel transportation cost and 2018 crude oil production rates, annual worldwide and North American midstream crude oil transportation costs are approximately $83 billion and $22 billion, respectively.

 

The energy sector continues to operate in a period of both rapid change and expansion. Due to the relatively recent and widespread adoption of advanced oilfield drilling and completion technologies, known as enhanced oil recovery (EOR) techniques, enormous reserves of “tight” oil and gas are now recoverable from shale formations throughout North America and the world. This historic surge in upstream crude oil production has resulted in costly and persistent transportation bottlenecks when moving upstream production to downstream storage, offloading facilities and refineries. This persistent and severe industrywide problem is stimulating investments in new and existing pipeline infrastructure and a reliance on less desirable alternate forms of transport, including rail and freight truck.

 

Since the initial use of EOR or tertiary recovery techniques in the 1970s, oil and gas producers have progressively relied more heavily on the application of gas and chemical injection as well as thermal recovery. These extraction techniques, coupled with a much greater number of new wells in active oilfields, has raised the output of reservoirs by 30 to 60 percent above traditional primary and secondary recovery practices. Due to the rapid adoption of advanced extraction technologies throughout the U.S. energy industry, a 34-year decline in domestic oil and gas production was reversed in 2006. Historically high output from massive shale formations such as North Dakota’s Bakken, Texas’ Eagle Ford and Permian Basin, Colorado’s Green River and Utah’s Uintah Basin continues to the present day.

 

Other nations with significant exploitable shale formations include Russia, China, Argentina, Colombia, Ecuador, Libya, Australia, Venezuela, Mexico and dozens of others, providing a ready market for crude oil pipeline optimization technologies as production comes online. All told, the U.S. Energy Information Administration estimates there to be 345 billion barrels of identified and recoverable shale oil worldwide.

 

Consequently, oil production exceeds the capacity of existing pipelines in the U.S., Canada, South and Central America, and many other regions of the world, often resulting in delivery delays to refineries and increased reliance on more costly rail and tanker truck transport.

 

Recently, the softening of oil prices worldwide has incentivized producers and transporters to reduce costs and seek technologies that can provide greater operational efficiencies. AOT is specifically designed to increase pipeline capacity, while reducing reliance on diluent, pipeline operating costs and overhead, thereby increasing margins and delivering measurable competitive advantages.

 

Projected Pipeline Infrastructure Investment

 

Among the challenges facing the global crude oil production and transportation sectors, few are as intransigent or detrimental to the industry as the transportation bottlenecks and well-to-market delivery delays that are endemic here in North America and overseas. While new pipeline infrastructure projects are underway here in the U.S., Canada and in foreign markets, gaining legislative approval is a lengthy process and their construction is highly capital-intensive.

 

Although pipelines are by far the safest and most economical transportation method, outmoded pipeline infrastructure constructed primarily in the 1950s and 1960s cannot provide the capacity necessary to move production downstream to storage, refinery and offloading facilities. Consequently, delivery delays to refineries and reliance on less desirable rail and tanker truck transport have increased exponentially since 2008 when the shale boom began in earnest. Data compiled by the U.S. Energy Information Administration, IHS Global and the American Petroleum Institute identify billions in lost revenue opportunities for E&P companies and tax collection agencies in leading oil producing states such as Texas, North Dakota, Alaska, California, Colorado, Wyoming and Utah directly attributable to production takeaway constraints.

 

 

 

 10 

 

 

Despite the recently depressed price level of global oil benchmarks, experts forecast continued growth in crude oil pipeline capital expenditures. In June 2018, the Interstate National Gas Association of America published a study titled “North America Midstream Infrastructure through 2035.” Among its key findings, this report estimates $321 billion will be invested in midstream crude oil infrastructure between 2018 and 2035. This demand is largely due to capacity constraints coupled with the high cost of delivering crude oil by truck or rail.

 

We believe QS Energy’s AOT technology is strategically aligned with the major requirements and challenges facing the petroleum pipeline economy. The AOT is designed to increase pipeline flowrate while relaxing pipeline viscosity requirements, effectively increasing pipeline capacity and reducing or eliminating bottlenecks. This has the ancillary benefit of reducing the need to add diluent or heat to reduce viscosity while reducing reliance on more costly truck and rail transport to meet increasing capacity demands. Our AOT technology may also mitigate costly operating factors such as vapor pressure, pigging (pipeline cleaning) frequency, power consumption, and onset of turbulent flow. Of these factors, vapor pressure, which may be mitigated by AOT through reduced reliance on diluent and a reduction in heat buildup in transit, is of high importance to many pipeline operators as vapor pressure is tightly controlled by the EPA and is very expensive to mitigate by other means. We are now seeking to commercialize AOT as a cost-efficient solution for both new and existing pipeline operations.

 

Target Markets

 

The oil and gas sector market can be segmented into three primary categories: Upstream Producers, Midstream Transporters and Downstream Refiners:

 

  · The Upstream segment is involved in the exploration and production (E&P) of oil and gas.

 

  · Midstream companies and partnerships transport oil and gas to markets via pipelines, rail and shipping, and provide storage in the field and at the destination location.

 

  · The Downstream sector refines oil and gas into finished products and, in cooperation with manufacturers and retailers, markets and distributes fuels and other refined petroleum products.

 

Upstream Producers

 

The Upstream segment has the greatest exposure to commodity prices. When prices fall as has been the case recently, they feel the brunt of this realignment. They also have the most to gain from additional flow throughput capacity and therefore would see immediate benefit from QS Energy’s AOT.

 

This sector is typically nimble and faces few barriers to entry. With clear financial upside for every additional barrel of crude oil that they are able to transport, these companies are often open to new and innovative technology capable of providing greater efficiencies, lower costs and improved cash flow. Upstream producers physically move the most volume of product. They are customers to the Midstream transporters and enter into long-term contractual shipping obligations (tariff-based transportation contracts) with Midstream transporters to secure the movement of product from their fields to the refiners and markets downstream.

 

Producers make the spot market price for every barrel delivered to refinery, minus the transport costs, tariffs, and marketing discounts associated with bringing the product to market. A rough rule of thumb for this market is that the further away they are from the refinery, the higher the transport costs to deliver the product. Discussions with Upstream entities has uncovered strong interest in solutions that unlock chokepoints from their field equipment to the transmission line loading terminals through viscosity reduction (AOT). In addition, this group would also benefit from transporters implementing our AOT transmission-line series due to its ability to increase the overall flow capacity of pipelines transporting product from loading terminals to market.

 

 

 

 11 

 

 

Midstream Gathering Transporters

 

A subset of the Midstream transporters sector is the gathering line operators. This group often functions as a part of the Upstream producers’ operations, or within the Midstream transporter’s operations. Midstream gathering lines are the regional transportation infrastructure that connect Upstream oilfield gathering lines to Midstream long-distance main trunk lines. Typically, these pipelines are of a relatively short length (20-100 miles) and have diameters between 6” and 12”, and could benefit from our smaller, lower cost AOT technology.

 

Midstream entities transport the bulk of the world’s crude oil output via the 400,000 miles of crude oil pipelines globally. Domestically, they deliver a large percentage of the U.S. daily production of 9.2 million barrels per day through 160,000 miles of crude pipelines. Midstream operators represent a strong and ready market for AOT, and field test deployments for both solutions are underway.

 

The pipeline transport operators’ business model is to charge a tariff to transport each barrel of oil through their pipeline. Due to the high daily volume of oil being transported and its value as a commodity, even incremental performance efficiencies can drive significant reductions in overhead reduction and increases in toll revenues. AOT may also provide pipeline operators the opportunity to offer on-demand electronic diluent as a service at a premium fee to customers highly dependent on diluent to meet viscosity requirements.

 

The potential benefits of AOT includes increased flow, reduced pipeline operating pressure and reduced friction losses and friction-induced heat build-up, providing economic benefits through increased capacity and toll rate income, and regulatory benefits through reductions in BTU per ton-mile, off-gassing and reduced carbon emissions (CO2).

 

Other heavy crude oil transporters

 

Truck, rail and marine crude oil carriers rely on heat and other costly and potentially hazardous measures to address the difficulties of onloading and offloading thick, heavy crudes. The Company is investigating AOT equipment designs specifically targeting this market’s viscosity and vapor pressure requirements and related evaporation mitigation practices mandated by the U.S. Environmental Protection Agency.

 

Our Products and Technology

 

AOT Commercial Products

 

As discussed in Item 1., above, (Business) under the section Overview, beginning in the second quarter of 2012, the Company began the design and engineering efforts required to transition from laboratory and prototype testing to AOT units designed for full-scale commercial testing. The Company established its supply chain, designs, drawings, engineering, certifications and specifications to comply with the engineering audit processes as dictated by the energy industry regulation processes and North American regulatory bodies. We have built, delivered and tested, under limited duration and conditions, AOT equipment on a high-volume commercial pipeline. We have not proven the commercial viability of this product. Please see “ITEM 1A, Risk Factors”, for a discussion associated with the commercial viability of our products.

 

The first commercial deployment of AOT occurred on the Keystone Pipeline in Udall, Kansas in May 2014, utilizing four AOT pressure vessels in a parallel “4-Pack” configuration for a cumulative capacity of 600,000 barrels per day. This system was operated under normal pipeline operating conditions as reported in the ATS RheoSystems field test summary report dated February 5, 2015. See section titled “Laboratory and Scientific Testing” below for more information on test procedures and results. Subsequent to testing and termination of the TransCanada lease, the AOT 4-Pack was uninstalled and reconfigured for deployment as four individual AOT units.

 

 

 

 12 

 

 

Our second AOT commercial installation was a single AOT deployment initially installed in March 2015 on the Kinder Morgan Crude & Condensate pipeline, which provides takeaway capacity for the Eagle Ford Shale in South Texas, primarily delivering light crude oil. As discussed in the Overview section above, equipment was installed limited operations and tests were performed in 2015 and 2016. Based on final analysis of in-field test results, SCADA operating data and subsequent analysis of crude oil samples at Temple University, it is unlikely Kinder Morgan would use the AOT at the original test location or other condensate pipeline. Kinder Morgan may consider AOT operations at one of their heavy crude pipeline locations subject to results of other AOT demonstration projects.

 

The Company continues to optimize and value engineer its AOT product line, targeting both midstream and upstream markets. The Company has installed an AOT demonstration project in cooperation with a major U.S. pipeline operator. As described in the Overview section above, this project has experienced numerous failures during initial testing which the Company is working to correct. As reported above, the project was removed from the demonstration site.

 

Joule Heat Product Development

 

The Company began development of its Joule Heat product in 2014, based around the new electrical heat system which reduces oil viscosity through a process known as joule heat, specifically targeting the upstream crude oil transportation market. The Company’s first Joule Heat prototype was installed for testing purposes under a joint development agreement with Newfield Exploration Company in June 2015 and the system was operational; however, changes to the prototype configuration will be required to determine commercial effectiveness of this unit. In December 2015, we suspended Joule Heat development activities to focus Company resources on finalizing commercial development of the AOT. We may resume Joule Heat development in the future depending on the availability of sufficient capital and other resources.

 

AOT Commercial Supply Chain

 

The Company has developed a supply chain for fabrication of the commercial AOT. The supply chain consists of multiple component suppliers and manufacturing companies engaged under Independent Contractor Agreements according to their respective fields of expertise. The supply chain entities have been chosen for their ability to work collaboratively with QS Energy and for their existing relationships with current and potential future customers of QS Energy technologies. The external components such as pressure vessels, inlet and outlet piping header systems, personnel and equipment shelters have been manufactured under contract with Power Service Inc. with offices in Wyoming, Utah, Colorado, Montana, North Dakota, and Texas. Internal components such as grid packs, electrical connections and other machined parts have been manufactured by Industrial Screen and Maintenance, with offices in Wyoming and Colorado. All equipment is manufactured in the United States of America, using only approved raw materials and vendors for quality control and import/export compliance purposes and meet the certifications and specifications as dictated by our customers and their independent oversight and auditing authorities.

 

Other components such as power systems, electrical junction boxes, cabling, hardware, switches, circuit breakers, computer equipment, sensors, SCADA/PLC, software and other power and integration equipment are purchased as complete units from various suppliers with operations based throughout North America. All component vendors are required to meet or exceed the same specifications as the parts manufacturers to maintain compliance as dictated by our customers and their independent oversight and auditing authorities.

 

AOT Intellectual Property

 

The Company began its own independent audit process for the updating of its intellectual property portfolio in 2012. The goal of this process was to streamline unnecessary legacy items left over from prior management, consolidate efforts to countries and regions of interest and retire items that were no longer valid or had been replaced with new intellectual property developments. In 2013, the Company retained the law firm of Jones Walker LLP, with operations based in Houston, Texas and began consolidation and streamlining efforts to manage intellectual properties.

 

 

 

 13 

 

 

QS Energy is currently maintaining and licensing from Temple University a portfolio of domestic and international patents, which have either been granted or have been published and are pending subject to final approval by the respective patent agency. Each of these intellectual properties are related to QS Energy’s AOT, Joule Heat and Fuel Injector technologies. Subject to additional capital funding, we intend actively to continue to develop and market our AOT technology. Development of QS Energy’s Fuel Injector and Joule Heat technologies have been suspended. The Company continues to maintain a license agreement with Temple University with respect to the underlying Fuel Injector patents, and is considering its options to re-start commercialization, sublicense the technology, or terminate the fuel injector license agreement with Temple. For details of the licensing agreements with Temple University, see Financial Statements attached hereto, Note 6. Please see ITEM 1A, Risk Factors below for a discussion of risks associated with these intellectual properties.

 

Current Business Status

 

As reported above, our AOT technology had design and operational flaws, and continues to require substantial testing and development, requiring a substantial infusion of capital in the Company. We can provide no assurances that we will be able to raise additional capital required to continue our efforts to commercialize our AOT technology. With limited capital, reported above, the Company is currently seeking to correct the failures associated with its AOT technology. Once operational, the Company plans to analyze and use AOT performance data to re-engage current and new prospective customers in our primary target North American and South American midstream crude oil markets. See the Overview section above for details.

 

Throughout 2023, our efforts have been tightly focused on executing our AOT demonstration project strategy. A number of companies in North America, South America and the Middle East have expressed interest in our technology and a desire to review demonstration project test results and visit the demonstration site. Assuming successful operations, we believe our AOT project should provide data requested by prospective customers such as real-time changes in viscosity, pipeline pressure drop reduction and increases in pipeline operating flowrates. All collected data will be normalized such that it can be used to evaluate the financial and operational benefits across a wide range of commercial operating scenarios without disclosing confidential details of our operations. We believe that real-world data from our AOT project could be used to accelerate our desire to achieve commercial adoption of our AOT technology, positioning us to re-engage with industry executives.

 

Laboratory and Scientific Testing

 

From 2010 through 2013, the Company worked with the U.S. Department of Energy (“US DOE”) to test its technology at the Department of Energy’s Rocky Mountain Oilfield Testing Center (“RMOTC”), near Casper, Wyoming. This third-party testing independently verified the efficacy of the Company’s technology operating in a controlled facility, using commercial-scale prototype of our AOT equipment. These tests were summarized in the US DOE Rocky Mountain Oilfield Test Center report dated April 4, 2012 (“ROMRC Report”), which reported AOT measured pressure loss reduction of 40% and viscosity reduction of 40%; and reported observed reductions in line-loss and gains in pump operation efficiency across the entire length of the 4.4-mile test pipeline. A subsequent long-duration (24-hour) test at the RMOTC facility tested the effectiveness of AOT in treating oil overnight, as pipeline oil temperatures and viscosities drop. In its report dated May 3, 2012 to May 4, 2012, US DOE engineers recorded 56% reduction in viscosity of the AOT-treated oil versus untreated oil, with AOT effectively stabilizing oil viscosity throughout the overnight run despite dropping temperatures.

 

Laboratory testing of our AOT technology has been conducted by Dr. Rongjia Tao. Testing of the technology as applied to crude oil transmission has been conducted at Temple University in their Physics Department, in addition to the US DOE, at their Rocky Mountain Oilfield Testing Center, located on the Naval Petroleum Reserve #3 Teapot Dome Oilfield, north of Casper, Wyoming. In addition, a group led by Dr. Rongjia Tao, Chairman, Department of Physics of Temple University conducted experiments, using the laboratory-scale Applied Oil Technology apparatus at the National Institute of Standards and Technology (NIST) Center for Neutron Research (CNR). NIST is an agency of the U.S. Department of Commerce, founded in 1901 in Gaithersburg, Maryland.

 

Independent laboratory testing was also conducted as a collaborative effort by Temple University and PetroChina Pipeline R&D Center (“PetroChina”) in 2012. In its report dated June 26, 2012 (“PetroChina Report”), PetroChina concluded, “The above series of tests show that it is very effective to use AOT to reduce the viscosity of crude oil. We can see that AOT has significantly reduced the viscosity of Daqing crude oil, Changqing crude oil, and Venezuela crude oil, and greatly improved its flow rate.”

 

 

 

 14 

 

 

As previously reported in 2014, QS Energy installed and tested its commercial AOT equipment, leased and operated by TransCanada on TransCanada’s high-volume Keystone pipeline operation. The first full test of the AOT equipment on the Keystone pipeline was performed in July 2014, with preliminary data analyzed and reported by Dr. Rongjia Tao of Temple University. Upon review of the July 2014 test results and preliminary report by Dr. Tao, QS Energy and TransCanada mutually agreed that this initial test was flawed due to, among other factors, the short-term nature of the test, the inability to isolate certain independent pipeline operating factors such as fluctuations in upstream pump station pressures, and limitations of the AOT device to produce a sufficient electric field to optimize viscosity reduction. Although Dr. Tao’s preliminary report indicated promising results, QS Energy and TransCanada mutually agreed that no conclusions could be reliably reached from the July 2014 test or from Dr. Tao’s preliminary report. As a result of this test, the Company modified its testing protocols and contracted with an independent laboratory, ATS RheoSystems, a division of CANNON (“ATS”), to perform follow-up tests at the TransCanada facility. This independent laboratory performed viscosity measurements at the TransCanada facility during subsequent testing in September 2014. As detailed in its field test report dated October 6, 2014, ATS measured AOT viscosity reductions of 8% to 23% depending on flow rates and crude oil types in transit. Over the duration of a 24-hour test intended to measure the recovery of the AOT treated oil from its reduced-viscosity treated state to its original pre-treated viscosity, ATS measured viscosity reductions of 23% three hours after treatment and 11% thirteen hours after treatment, with the crude oil returning to its untreated state approximately twenty-two hours after treatment. In its summary report dated February 5, 2015, ATS concluded that i) data indicated a decrease in viscosity of crude oil flowing through the TransCanada pipeline due to AOT treatment of the crude oil; and ii) the power supply installed on our equipment would need to be increased to maximize reduction in viscosity and take full advantage of the AOT technology.

 

Although, as reported by ATS, the efficacy of the AOT technology operated in the TransCanada field test was constrained due to limitations of the electric field applied by that unit’s power supply, subsequent analysis by QS Energy personnel of ATS test results compared against laboratory tests performed at Temple University on oil samples provided by TransCanada revealed a single test run in which the electric field generated by the AOT was sufficient to fully treat the oil given operating conditions at the time of the test. In this test run, ATS measured a 23% reduction in viscosity three hours after AOT treatment. Laboratory tests at Temple University performed on a sample of crude oil provided by TransCanada of the same type treated in that specific field test measured a 27% reduction in viscosity in the laboratory immediately following treatment. Allowing for the actual three-hour of recovery time of the field test measurement, the resulting field test viscosity reduction of 23% correlates very well to the 27% viscosity reduction achieved in the laboratory setting.

 

Due to the small sample size of tests performed during the TransCanada field test, results reported by ATS are statistically inconclusive and cannot be relied upon to provide proof of AOT efficacy. While more testing is required to establish the efficacy of our AOT technology, we are encouraged by the findings of our independent research laboratory and the results of subsequent comparative analysis of data collected under laboratory and commercial operating conditions. We look forward to further development and commercialization of our technology. The TransCanada Lease was terminated by TransCanada, effective October 15, 2014. The Company has modified the design of the AOT power supply such that future installations of the AOT device are expected to achieve sufficient electric field to optimize viscosity reduction.

 

The Company contracted Southern Research Company (“SRI”) in 2015 to perform independent laboratory tests on its prototype Joule Heat units AOT Upstream units. SRI performed tests on a prototype Joule Heat unit in September 2015, which showed promising results in which the Joule Heat prototype was observed to increase crude oil temperatures. In December 2015, we suspended Joule Heat and AOT Upstream development activities to focus Company resources on finalizing commercial development of the AOT Midstream.

 

See also our discussion above in Item 1., under the section labeled Overview.

 

 

 

 

 15 

 

 

Competition

 

The oil transportation industry is highly competitive. We are aware of only three currently available competitive technologies in widespread use for reducing the viscosity of oil throughout the world. Many of our competitors have greater financial, research, marketing and staff resources than we do. For instance, oil pipeline operators use heat, diluents such as naphtha and/or natural gasoline, and/or chemical viscosity reduction additives, or chemical drag-reducing agents to improve flow in pipelines. Our research indicates that these methods are either very energy-intensive, or costly to implement on a day-to-day basis. Management believes that the Company’s AOT technology presents advantages over traditional methods, yet the industry’s willingness to experiment with new technology may pose some challenges in acceptance.

 

We are not aware of any other technology using uniform electrical field crude oil viscosity reduction technology which is designed to significantly improve pipeline operation efficiency. Although we are unaware of any technologies that compete directly with our technologies, there can be no assurance that any unknown existing or future technology will not be superior to products incorporating our AOT technology. Major domestic and international manufacturers and distributors of pipeline flow-improvement chemical solutions include Pemex, Petrotrin, Pluspetrol, Repsol, Glencore, Conoco-Philips, and Baker-Hughes. According to our research, heater skid manufacturers are generally local to the oilfield and pipeline regions, and are comprised of a large number of relatively small businesses in a fragmented industry. Major heater skid manufacturers are Parker, KW International, Thermotech Systems, LTD.

 

Government Regulation and Environmental Matters

 

Our research and development activities are not subject to any governmental regulations that would have a significant impact on our business and we believe that we are in compliance with all applicable regulations that apply to our business as it is presently conducted. Our products, as such, are not subject to certification or approval by the EPA or other governmental agencies domestically or internationally. Depending upon whether we manufacture or license our products in the future and in which countries such products are manufactured or sold, we may be subject to regulations, including environmental regulations, at such time.

 

Non-Disclosure Agreements

 

To protect our intellectual property, we have entered into agreements with certain employees and consultants, which limit access to, and disclosure or use of, our technology. There can be no assurance, however, that the steps we have taken to deter misappropriation of our intellectual property or third-party development of our technology and/or processes will be adequate, that others will not independently develop similar technologies and/or processes or that secrecy will not be breached. In addition, although management believes that our technology has been independently developed and does not infringe on the proprietary rights of others, there can be no assurance that our technology does not and will not so infringe or that third parties will not assert infringement claims against us in the future. Management believes that the steps they have taken to date will provide some degree of protection; however, no assurance can be given that this will be the case.

 

Employees

 

As of December 31, 2023, the Company had one full-time employee. We also utilized the services of part-time consultants on an as-needed basis to assist us with various matters, including engineering, logistics, investor relations, public relations, accounting and sales and marketing. We intend to hire additional personnel to provide services when they are needed on a full-time basis. We recognize that our efficiency largely depends, in part, on our ability to hire and retain additional qualified personnel as and when needed and we have adopted procedures to assure our ability to do so.

 

 

 

 16 

 

 

Item 1A. Risk Factors

 

We have a history of losses, and we cannot assure you that we will ever become or remain profitable. As a result, you may lose your entire investment.

 

We generated insignificant revenues from operations in late 2006 and subsequently did not generate any revenues until 2014 and we have incurred recurring net losses every year since our inception in 1998. For the fiscal years ended December 31, 2023 and 2022, we had net losses of $1,224,000 and $1,548,000 respectively. To date, we have dedicated most of our financial resources to research and development, general and administrative expenses and initial sales and marketing activities. We have funded all of our activities through sales of our debt and equity securities for cash. We anticipate net losses and negative cash flow to continue until such time as our products are brought to market in sufficient amounts to offset operating losses. Our ability to achieve profitability is dependent upon our continuing research and development, product development, and sales and marketing efforts, to deliver viable products and the Company’s ability to successfully bring them to market. Although our management is optimistic that we will succeed in marketing products incorporating our technologies, there can be no assurance that we will ever generate significant revenues or that any revenues that may be generated will be sufficient for us to become profitable or thereafter maintain profitability. If we cannot generate sufficient revenues or become or remain profitable, we may have to cease our operations and liquidate our business.

 

Our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern, which may hinder our ability to obtain future financing.

 

During the year ended December 31, 2023, we incurred a net loss of $1,224,000 and used cash in operations of $629,000 and had a stockholders’ deficit of $5,244,000 as of December 31, 2023. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that its financial statements are issued. As a result, our independent registered public accounting firm included an explanatory paragraph in its report on our financial statements as of and for the year ended December 31, 2023, with respect to this uncertainty. This going concern opinion could materially limit our ability to raise additional funds through the issuance of new debt or equity securities and subsequent reports by our independent registered public accounting firm on our financial statements may also include an explanatory paragraph with respect to our ability to continue as a going concern. Our ability to continue as a going concern is subject to our ability to obtain significant additional capital to fund our operations and to generate revenue from sales, of which there is no assurance. If we fail to raise sufficient capital, we may have to liquidate our business and you may lose your investment.

 

Since we have not yet begun to generate positive cash flow from operations, our ability to continue operations is dependent on our ability to either begin to generate positive cash flow from operations or our ability to raise capital from outside sources.

 

We have not generated cash flow from operations since our inception in February 1998 and have relied on external sources of capital to fund operations. We had $70,000 in cash at December 31, 2023 and used cash in operations of $629,000 for the year ended December 31, 2023.

 

We currently do not have credit facilities available with financial institutions or other third parties, and historically have relied upon best efforts third-party funding. Though we have been successful at raising capital on a best-efforts basis in the past, we can provide no assurance that we will be successful in any future best-efforts financing endeavors. We will need to continue to rely upon financing from external sources to fund our operations for the foreseeable future. If we are unable to raise sufficient capital from external sources to fund our operations, we may need to curtail operations.

 

 

 

 

 17 

 

 

We will need substantial additional capital to meet our operating needs, and we cannot be sure that additional financing will be available.

 

During fiscal 2023, our cash burn rate amounted to approximately $53,000 per month and could increase during the remainder of fiscal 2024. In order to fund our capital needs, we conducted private offerings of our securities in 2022 and 2023. While discussion regarding additional interim and permanent financings are being actively conducted, management cannot predict with certainty that an equity line of credit will be available to provide adequate funds, or any funds at all, or whether any additional interim or permanent financings will be available at all or, if it is available, if it will be available on favorable terms. If we cannot obtain needed capital, our research and development, and sales and marketing plans, business and financial condition and our ability to reduce losses and generate profits will be materially and adversely affected.

 

Our business prospects are difficult to predict because of our limited operating history, early stage of development and unproven business strategy. Since our incorporation in 1998, we have been and continue to be involved in development of products using our technology, establishing manufacturing and marketing of these products to consumers and industry partners. Although we believe our technology and products in development have significant profit potential, we may not attain profitable operations and our management may not succeed in realizing our business objectives.

 

If we are not able to devote adequate resources to product development and commercialization, we may not be able to develop our products.

 

Our business strategy is to develop, manufacture and market products incorporating our AOT technology. We believe that our revenue growth and profitability, if any, will substantially depend upon our ability to raise additional necessary capital for research and development, complete development of our products in development and successfully introduce and commercialize our products.

 

If we are not able to devote adequate resources to product development and commercialization, we may not be able to develop our products.

 

Our business strategy is to develop, manufacture and market products incorporating our AOT technology. We believe that our revenue growth and profitability, if any, will substantially depend upon our ability to raise additional necessary capital for research and development, complete development of our products in development and successfully introduce and commercialize our products.

 

Certain of our products are still under various stages of development. Because we have limited resources to devote to product development and commercialization, any delay in the development of one product or reallocation of resources to product development efforts that prove unsuccessful may delay or jeopardize the development of other product candidates. Although our management believes that it may finance our product development through private placements and other capital sources, if we do not develop new products and bring them to market, our ability to generate revenues will be adversely affected.

 

The commercial viability of QS Energy’s technologies remains largely unproven and we may not be able to attract customers.

 

Despite the fact that we leased AOT equipment in 2014 to a major oil pipeline operator and tested the equipment on their high-volume pipeline under normal operating conditions, entered into a lease agreement with a second major oil pipeline operator to operate and test AOT equipment in 2015, and have initiated a project to demonstrate our AOT technology on a commercial pipeline in 2019, the commercial viability of our devices is not known at this time. If commercial opportunities are not realized from the use of products incorporating the AOT technology, our ability to generate revenue would be adversely affected. There can be no assurances that we will be successful in marketing our products, or that customers will ultimately purchase our products. Failure to have commercial success from the sale of our products will significantly and negatively impact our financial condition. There can be no assurances that we will be successful in marketing our products, or that customers will ultimately purchase our products. Failure to have commercial success from the sale of our products will significantly and negatively impact our financial condition.

 

 

 

 18 

 

 

If our products and services do not gain market acceptance, it is unlikely that we will become profitable and it is unlikely that we will be able to stay in business.

 

At this time, our technology is commercially unproven, and the use of our technology by others is limited. Specific examples of use to date include:

 

  · Temple University, testing, research and joint development;
     
  · U.S. Department of Energy Rocky Mountain Oilfield Testing Center, testing and research;
     
  · PetroChina Pipeline R&D Center, testing and research;
     
  · TransCanada, short-term testing;
     
  · Kinder Morgan Crude and Condensate, short-term testing;
     
  · On-site short-term testing of a laboratory-scale AOT at a Canadian oil producer’s facility in Alberta Canada.
     
  · A demonstration project in cooperation with a commercial pipeline operator in the Southern United States

 

The commercial success of our products will depend upon the adoption of our technology by the oil industry. Market acceptance will depend on many factors, including:

 

  · the willingness and ability of consumers and industry partners to adopt new technologies;

 

  · our ability to convince potential industry partners and consumers that our technology is an attractive alternative to other technologies;

 

  · our ability to manufacture products and provide services in sufficient quantities with acceptable quality and at an acceptable cost; and,

 

  · our ability to place and service sufficient quantities of our products.

 

If our products do not achieve a significant level of market acceptance, demand for our products will not develop as expected and it is unlikely that we will become profitable, and unlikely that we will be able to stay in business.

 

We outsource and rely on third parties for the manufacture of our products.

 

Our business model calls for the outsourcing of the manufacture of our products in order to reduce our capital and infrastructure costs, capital expenditure and personnel. Accordingly, we must enter into agreements with other companies that can assist us and provide certain capabilities that we do not possess, and to increase our manufacturing capacity as necessary. We can provide no assurances that any such outsourcing will be at commercially acceptable rates or profitable. Moreover, we do not have the required financial and human resources or capability to manufacture, market and sell our products. Our business model calls for the outsourcing of the manufacture, and sales and marketing of our products in order to reduce our capital and infrastructure costs as a means of potentially improving our financial position and the profitability of our business. Accordingly, we must enter into agreements with other companies that can assist us and provide certain capabilities that we do not possess. We may not be successful in entering into additional such alliances on favorable terms or at all. Furthermore, any delay in entering into agreements could delay the development and commercialization of our products and reduce their competitiveness even if they reach the market. Any such delay related to our existing or future agreements could adversely affect our business.

 

 

 

 19 

 

 

If any party to which we have outsourced certain functions fails to perform its obligations under agreements with us, the development and commercialization of our products could be delayed or curtailed.

 

To the extent that we rely on other companies to manufacture, sell or market our products, we will be dependent on the timeliness and effectiveness of their efforts. If any of these parties do not perform its obligations in a timely and effective manner, the commercialization of our products could be delayed or curtailed because we may not have sufficient financial resources or capabilities to continue such development and commercialization on our own.

 

Any revenues that we may earn in the future are unpredictable, and our operating results are likely to fluctuate from quarter to quarter.

 

We believe that our future operating results will fluctuate due to a variety of factors, including delays in product development, market acceptance of our new products, changes in the demand for and pricing of our products, competition and pricing pressure from competitive products, manufacturing delays and expenses related to and the results of proceedings relating to our intellectual property.

 

A large portion of our expenses, including expenses for our facilities, equipment and personnel, is relatively fixed and not subject to further significant reduction. In addition, we expect our operating expenses will increase in the future as we continue our commercialization efforts and increase our production and marketing activities, among other activities. Although we expect to generate revenues from sales of our products, revenues may decline or not grow as anticipated and our operating results could be substantially harmed for a particular fiscal period. Moreover, our operating results in some quarters may not meet the expectations of stock market analysts and investors. In that case, our stock price most likely would decline.

 

Nondisclosure agreements with employees and others may not adequately prevent disclosure of trade secrets and other proprietary information.

 

In order to protect our proprietary technology and processes, we rely in part on nondisclosure agreements with our employees, licensing partners, customers, consultants, agents and other organizations to which we disclose our proprietary information. These agreements may not effectively prevent disclosure of confidential information and may not provide an adequate remedy in the event of unauthorized disclosure of confidential information. In addition, others may independently discover trade secrets and proprietary information, and in such cases, we could not assert any trade secret rights against such parties. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain trade secret protection could adversely affect our competitive business position. Since we rely on trade secrets and nondisclosure agreements, in addition to patents, to protect some of our intellectual property, there is a risk that third parties may obtain and improperly utilize our proprietary information to our competitive disadvantage. We may not be able to detect unauthorized use or take appropriate and timely steps to enforce our intellectual property rights.

 

The manufacture, use or sale of our current and proposed products may infringe on the patent rights of others, and we may be forced to litigate if an intellectual property dispute arises.

 

We have taken measures to protect ourselves from infringing on the patent rights of others; however, if we infringe or are alleged to have infringed another party’s patent rights, we may be required to seek a license, defend an infringement action or challenge the validity of the patents in court. Patent litigation is costly and time consuming. We may not have sufficient resources to bring these actions to a successful conclusion. In addition, if we do not obtain a license, do not successfully defend an infringement action or are unable to have infringed patents declared invalid, we may incur substantial monetary damages ,encounter significant delays in marketing our current and proposed product candidates, be unable to conduct or participate in the manufacture, use or sale of product, candidates or methods of treatment requiring licenses, lose patent protection for our inventions and products; or find our patents are unenforceable, invalid, or have a reduced scope of protection.

 

Parties making such claims may be able to obtain injunctive relief that could effectively block our ability to further develop or commercialize our current and proposed product candidates in the United States and abroad and could result in the award of substantial damages. Defense of any lawsuit or failure to obtain any such license could substantially harm the company. Litigation, regardless of outcome, could result in substantial cost to and a diversion of efforts by the Company to operate its business.

 

 

 

 20 

 

 

We may face costly intellectual property/ license agreements disputes.

 

Our ability to compete effectively will depend in part on our ability to develop and maintain proprietary aspects of our technologies and either to operate without infringing the proprietary rights of others or to obtain rights to technology owned by third parties. Our pending patent applications, specifically patent rights of the AOT technology and Joule Heating process may not result in the issuance of any patents or any issued patents that will offer protection against competitors with similar technology. Patents we have licensed for our technologies, and which we may receive, may be challenged, invalidated or circumvented in the future or the rights created by those patents may not provide a competitive advantage. We also rely on trade secrets, technical know-how and continuing invention to develop and maintain our competitive position. Others may independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets. See Note 6 of our financial statements attached hereto for a discussion and status of our license agreements with Temple University.

 

Changes in governmental regulations and policies may affect export of our technologies.

 

The Company recognizes domestic and foreign governmental actions, including but not limited to trade restrictions and tariffs, may adversely affect our ability to export our technologies, or may adversely affect the economics of cross-border transactions.

 

We may not be able to attract or retain qualified senior personnel.

 

We believe we are currently able to manage our current business with our existing management team. However, as we expand the scope of our operations, we will need to obtain the full-time services of additional senior management and other personnel. Competition for highly skilled personnel is intense, and there can be no assurance that we will be able to attract or retain qualified senior personnel. Our failure to do so could have an adverse effect on our ability to implement our business plan. As we add full-time senior personnel, our overhead expenses for salaries and related items will increase compensation packages, these increases could be substantial.

 

If we lose our key personnel or are unable to attract and retain additional personnel, we may be unable to achieve profitability.

 

Our future success is substantially dependent on the efforts of our senior management. The loss of the services of members of our senior management may significantly delay or prevent the achievement of product development and other business objectives. Because of the scientific nature of our business, we depend substantially on our ability to attract and retain qualified marketing, scientific and technical personnel, including consultants. There is intense competition among specialized automotive companies for qualified personnel in the areas of our activities. If we lose the services of, or do not successfully recruit key marketing, scientific and technical personnel, the growth of our business could be substantially impaired. We do not maintain key man insurance for any of these individuals.

 

Currently, there is only very limited trading in our stock, so you may be unable to sell your shares at or near the quoted bid prices if you need to sell your shares.

 

The shares of our common stock are thinly traded on the OTC Bulletin Board (pink sheets), meaning that the number of persons interested in purchasing our common shares at or near bid prices at any given time may be relatively small or non-existent. This situation is attributable to a number of factors, including the fact that we are a small company engaged in a high-risk business which is relatively unknown to stock analysts, stock brokers, institutional investors and others in the investment community that can generate or influence daily trading volume and valuation. Should we even come to the attention of such persons, they tend to be risk-averse and would be reluctant to follow an unproven, early stage company such as ours or purchase or recommend the purchase of our shares until such time as we became more seasoned and viable. As a consequence, there may be periods of several days or more when trading activity in our shares is minimal or non-existent, as compared to a seasoned issuer which has a large and steady volume of trading activity that will generally support continuous trading without negatively impacting share price. We cannot provide any assurance that a broader or more active public trading market for shares of our common stock will develop or be sustained. Due to these conditions, we cannot give any assurance that shareholders will be able to sell their shares at or near bid prices or at all.

 

 

 

 21 

 

 

The market price of our stock is volatile.

 

The market price for our common stock has been volatile during the last year, ranging from a closing price of $0.03 on December 31, 2023 to a closing price of $0.15 on January 24, 2023, and a closing price of $0.06 on March 28, 2024. See Part II, item 5, below. Additionally, the price of our stock has been both higher and lower than those amounts on an intra-day basis in the last year. Because our stock is thinly traded, its price can change dramatically over short periods, even in a single day. The market price of our common stock could fluctuate widely in response to many factors, including, developments with respect to patents or proprietary rights, announcements of technological innovations by us or our competitors, announcements of new products or new contracts by us or our competitors, actual or anticipated variations in our operating results due to the level of development expenses and other factors, changes in financial estimates by securities analysts and whether any future earnings of ours meet or exceed such estimates, conditions and trends in our industry, new accounting standards, general economic, political and market conditions and other factors.

 

Substantial sales of common stock could cause our stock price to fall.

 

In the past year, there have been times when average daily trading volume of our common stock has been extremely low, and there have been many days in which no shares were traded at all. At other times, the average daily trading volume of our common stock has been high. Nevertheless, the possibility that substantial amounts of common stock may be sold in the public market may adversely affect prevailing market prices for our common stock and could impair a shareholder’s ability to sell our stock or our ability to raise capital through the sale of our equity securities.

 

Potential issuance of additional shares of our common stock could dilute existing stockholders.

 

We are authorized to issue up to 500,000,000 shares of common stock and up to 100,000,000 of preferred stock. To the extent of such authorization, our Board of Directors has the ability, without seeking stockholder approval, to issue additional shares of common stock or preferred stock in the future for such consideration as the Board of Directors may consider sufficient. The issuance of additional common stock or preferred stock in the future may reduce the proportionate ownership and voting power of shareholders.

 

We may not be successful in identifying, making, financing and integrating acquisitions.

 

A component of our business strategy is to make selective acquisitions that will strengthen our core services or presence in selected markets. The success of this strategy will depend, among other things, on our ability to identify suitable acquisition candidates, to obtain acceptable financing, to timely and successfully integrate acquired businesses or assets and to retain the key personnel and the customer base of acquired businesses. Any future acquisitions could present a number of risks, including but not limited to:

 

  · incorrect assumptions regarding the future results of acquired operations or assets or expected cost reductions or other synergies expected to be realized as a result of acquiring operations or assets;

 

  · failure to integrate successfully the operations or management of any acquired operations or assets in a timely manner;

 

  · failure to retain or attract key employees; and

 

  · diversion of management’s attention from existing operations or other priorities.

 

If we are unable to identify, make and successfully integrate acquired businesses, it could have a material adverse effect on our business, financial condition, results of operations and cash flows.

 

 

 

 22 

 

 

Our common stock is subject to penny stock regulation, which may make it more difficult for us to raise capital.

 

Our common stock is considered penny stock under SEC regulations. It is subject to rules that impose additional sales practice requirements on broker-dealers who sell our securities. For example, broker-dealers must make a suitability determination for the purchaser, receive the purchaser’s written consent to the transaction prior to sale, and make special disclosures regarding sales commissions, current stock price quotations, recent price information and information on the limited market in penny stock. Because of these additional obligations, some broker-dealers may not affect transactions in penny stocks, which may adversely affect the liquidity of our common stock and shareholders’ ability to sell our common stock in the secondary market. This lack of liquidity may make it difficult for us to raise capital in the future.

 

Item 1B. Unresolved Staff Comments

 

None.

 

Item 1C. Cybersecurity

 

None.

 

Item 2. Properties

 

As of June 1, 2021, our executive offices were moved to 3606 Challenger Way, Unit 1, Carson City, Nevada 89706, under a lease providing for a four year term at approximately $4,100 per month. Effective October 31, 2022, the Company terminated the lease and has no further obligation. 

 

The Company’s former executive offices were located in Tomball, Texas (“Tomball Facility”) and leased from JBL Energy Partners, an entity owned by Jason Lane, former Director and Chairman of the Board of the Company who resigned in April 2021. The Tomball Facility was under a month-to-month lease at a lease rate of $5,000 per month, as amended. Total rent expense under this lease during the year ended December 31, 2021 was $8,000. The Tomball Facility lease with Lane was terminated in connection with the resignation of Mr. Lane. At May 1, 2021, the Company agreed to continue to lease a portion of the Tomball facility from the landlord on a month to month basis at $1,000 per month. The Company also rents a storage facility in Tomball on a month-to-month basis for $250 per month, and a small office and storage facility in Carson City, Nevada on a month to month basis for a monthly rental of $1,000.

  

We believe our facilities are adequate to meet our current and near-term needs.

    

Item 3. Legal Proceedings

 

There is no litigation of any significance with the exception of the matters that have arisen under, and are being handled in, the normal course of business.

 

Item 4. Mine Safety Disclosures.

 

None.

 

 

 

 23 

 

 

PART II

 

Item 5. Market for Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

Effective August 11, 2015, the Company changed its name to QS Energy, Inc., and changed its trading symbol to “QSEP”. The following table sets forth the high and low bid prices of the Company’s common stock for the quarters indicated as quoted in the Pink Sheets as reported by Yahoo Finance. These quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission, and may not represent actual transactions.

 

   2023   2022 
   High   Low   High   Low 
First Quarter  $0.17   $0.06   $0.05   $0.03 
Second Quarter  $0.09   $0.04   $0.04   $0.02 
Third Quarter  $0.09   $0.05   $0.13   $0.02 
Fourth Quarter  $0.07   $0.03   $0.09   $0.04 

 

According to the records of our transfer agent, we had approximately 1,000 stockholders of record of our common stock at April 1, 2024. The Company believes that the number of beneficial owners is substantially higher than this amount.

 

We do not pay a dividend on our common stock and we currently intend to retain future cash flows to finance our operations and fund the growth of our business. Any payment of future dividends will be at the discretion of our Board of Directors and will depend upon, among other things, our earnings, financial condition, capital requirements, level of indebtedness, contractual restrictions in respect to the payment of dividends and other factors that our Board of Directors deems relevant.

 

All of the shares issued by the Company discussed below were issued in non-public offerings without SEC registration in reliance on exemptions from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended (“Securities Act”) and other applicable exemptions under the Securities Act.

 

Issuances of Unregistered Securities in Current Fiscal Year

 

During the year ended December 31, 2023, the Company issued an aggregate of 16,512,375 shares of its common stock as follows: 

 

  · The Company issued 15,129,048 shares of its common stock upon the conversion of $646,000 in convertible notes, net of unamortized discount of $296,000, pursuant to convertible notes conversion prices of $0.03 to $0.05 per share.
     
  · The Company issued 1,383,327 shares of its common stock upon the exercise of warrants of $52,000, at $0.02 to $0.04 per share.

 

  · The Company issued convertible notes in aggregate value of $585,000 for net proceeds of $532,000, convertible into 11,715,748 shares in common stock of the Company at a conversion price of $0.05 per share, and in connection with these notes, issued warrants to purchase 11,715,748 shares of common stock of the Company at an exercise price of $0.07 per share and expiring one year from the date of issuance, summarized by month as follows:

 

Shares of Common Stock Issuable upon conversion of Notes Issued in 2023

 

Month of Issuance  Principal amount of convertible notes   Conversion
Price		  Shares of common
Stock issuable upon
Conversion of Principal		 
March 2023  $99,000   $0.05 per share   1,980,000 
April 2023   42,000   $0.05 per share   843,700 
May 2023   90,000   $0.05 per share   1,797,664 
July 2023   79,000   $0.05 per share   1,570,184 
September 2023   275,000   $0.05 per share   5,524,200 
   $585,000       11,715,748 

 

 

 

 24 

 

 


Issuances of Unregistered Securities in Prior Fiscal Year

 

During the year ended December 31, 2022, the Company issued an aggregate of 20,773,874 shares of its common stock as follows: 

 

  · The Company issued 6,040,049 shares of its common stock upon the conversion of $178,000 in convertible notes, net of unamortized discount of $119,000, pursuant to convertible notes conversion prices of $0.02 to $0.03 per share.
     
  · The Company issued 14,483,825 shares of its common stock upon the exercise of warrants of $542,000, at $0.03 to $0.04 per share.
     
  · The Company issued 250,000 shares of its common stock upon the exercise of options of $20,000, at $0.08 per share.

 

  · The Company issued convertible notes in aggregate value of $432,000 for net proceeds of $393,000, convertible into 14,409,995 shares in common stock of the Company at a conversion price of 0.03 per share, and in connection with these notes, issued warrants to purchase 14,409,995 shares of common stock of the Company at an exercise price of $0.04 per share and expiring one year from the date of issuance, summarized by month as follows:

 

Shares of Common Stock Issuable upon conversion of Notes Issued in 2022

 

Month of Issuance  Principal amount of convertible notes   Conversion
Price		  Shares of common
Stock issuable upon
Conversion of Principal		 
September 2022  $432,000   $0.03 per share   14,409,995 
   $432,000       14,409,995 

 

Item 6. Selected Financial Data

 

None.

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operation

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the Consolidated Financial Statements and supplementary data referred to in this Item 7 of this Form 10-K.

 

This discussion contains forward-looking statements that involve risks and uncertainties. Such statements, which include statements concerning future revenue sources and concentration, selling, general and administrative expenses, research and development expenses, capital resources, additional financings and additional losses, are subject to risks and uncertainties, including, but not limited to, those discussed above in Item 1 and elsewhere in this Form 10-K, particularly in “Risk Factors,” that could cause actual results to differ materially from those projected. Unless otherwise expressly indicated, the information set forth in this Form 10-K is as of December 31, 2022, and we undertake no duty to update this information.

 

 

 

 25 

 

 

Overview

 

The Company has not generated significant revenues since its inception in February 1998. We continue to devote the bulk of our efforts to the promotion, design, testing and the commercial manufacturing and operations of our crude oil pipeline products in the upstream and midstream energy sector. We anticipate that these efforts will continue during 2024.

 

Our expenses to date have been funded primarily through the sale of shares of common stock and convertible debt, as well as proceeds from the exercise of stock purchase warrants and options. We raised capital in 2023 and also need to raise substantial additional capital in 2024, and possibly beyond, to fund our sales and marketing efforts, continuing research and development, and certain other expenses, until our revenue base grows sufficiently.

 

Results of Operation

 

QS ENERGY, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

   Year ended 
   2023   2022   Change   % Change 
Revenues  $–   $–   $–    – 
                     
Operating expenses   688,000    765,000    (77,000)   (10%)
Research and development expenses   203,000    486,000    (283,000)   (58%)
Loss from operations   (891,000)   (1,251,000)   (360,000)   (29%)
                     
Forgiveness of PPP loan payable   –    63,000    63,000    100% 
Interest and financing expense   (333,000)   (360,000)   (27,000)   (7%)
Net Loss  $(1,224,000)  $(1,548,000)  $(324,000)   (21%)

 

Revenue Comparison, 2023 and 2022

 

The Company recognized no revenues during the twelve-month periods ended December 31, 2023 and December 31, 2022.

 

Operating Expense Comparison, 2023 and 2022

 

Operating expenses were $688,000 for the fiscal year ended December 31, 2023, compared to $765,000 for the fiscal year ended December 31, 2022, a decrease of $77,000. This decrease was attributable to a decrease in non-cash expenses of $90,000, offset by an increase in cash expenses of $13,000. Specifically, the decrease in non-cash expenses is attributable a decrease in stock-based compensation related to consultants of $90,000. The increase in cash expenses is attributable to increases in patent maintenance expenses of $17,000, office expenses of $13,000, insurance of $5,000, rent expenses of $5,000, legal and accounting fees of $5,000, consulting fees of $3,000, offset by decreases in travel expenses of $17,000, bank fees of $8,000, auto expenses of $7,000, salaries and benefits of $2,000, and mail and freight of $1,000.

 

Research and development expenses were $203,000 for the fiscal year ended December 31, 2023, compared to $486,000 for the fiscal year ended December 31, 2022, a decrease of $283,000. This decrease is attributable to AOT prototype and demonstration project development costs.

 

 

 

 26 

 

 

Interest expenses were $333,000 for the fiscal year ended December 31, 2023, compared to $360,000 for the fiscal year ended December 31, 2022, a decrease of $27,000. This decrease is attributable to a decrease in interest and financing expense of $27,000 to account the relative fair value of the warrants issued with our convertible notes and the notes’ beneficial conversion feature that were recorded as note discounts.

 

We had a net loss of $1,224,000 or $0.00 loss per share for the fiscal year ended December 31, 2023 compared to a net loss of $1,548,000 or $0.00 loss per share for the fiscal year ended December 31, 2022.

 

Liquidity and Capital Resources

 

General

 

We have incurred negative cash flow from operations since our inception in 1998. As of December 31, 2023, we had cash of $70,000 and a stockholders’ deficit of $5,244,000. Our operating cash flow in 2023 was funded primarily through cash reserves, the exercise of stock purchase warrants and options for cash, and the issuance of convertible notes for cash.

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, the Company had a net loss of $1,224,000 and used cash in operations of $629,000 for the year ended December 31, 2023. In addition, as of December 31, 2023, thirty-eight notes payable with an aggregate balance of $2,022,000 and certain obligation to a former officer are past due. These factors raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued. Our ability to continue as a going concern is dependent upon our ability to raise additional funds and implement our business plan. The consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

 

Summary

 

At December 31, 2023, the Company had cash on hand in the amount of $70,000. Management estimates that the current funds on hand will be sufficient to continue operations through January 2024. Management is currently seeking additional funds, primarily through the issuance of debt and equity securities for cash to operate our business, including without limitation the expenses it will incur in connection with the license agreements with Temple; costs associated with product development and commercialization of the AOT technology; costs to manufacture and ship the products; costs to maintain an effective system of internal controls and disclosure controls and procedures; costs of maintaining our status as a public company by filing periodic reports with the SEC and costs required to protect our intellectual property. In addition, as discussed below, the Company has substantial contractual commitments, including without limitation certain payments to a former officer, during the remainder of 2024 and beyond. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stock holders, in case of equity financing.

 

 

 

 

 

 27 

 

 

Contractual Obligations

 

The Company’s contractual commitments for future periods, including minimum guaranteed compensation payments and other agreements as described in the following table and associated footnotes:

 

Year ending
December 31,		  License
Agreements (1)		   Compensation
Agreements		   Total
Obligations		 
2024  $187,500   $197,000   $384,500 
2025   187,500    –    187,500 
2026   187,500    –    187,500 
2027   187,500    –    187,500 
2028   187,500    –    187,500 
Total  $937,500   $197,000   $1,134,500 

___________________

  (1) Consists of license maintenance fees to Temple University in the amount of $187,500 paid annually through the life of the underlying patents or until otherwise terminated by either party. For details of the Temple Licensing Agreements, see Note 6 of the Financial Statements, attached hereto.
     
  (2) Consists of certain contractually provided benefits to a former executive officer pursuant to a severance agreement and amendments thereto. The balance due as of December 31, 2023, of $197,000 is included as part of Accounts payable and accrued expenses in the accompanying consolidated balance sheets, of which the total amount is in arrears.  The former executive officer disputes the amount identified in the above table, claiming the above amount is less than the amount to which he believes he is owed. Absent an agreement to settle the dispute, and in the event the former executive officer elects to initiate litigation regarding the dispute, including claims for interest and penalties to which the former executive officer believes he is entitled, the Company has reserved, and if necessary and appropriate will assert, all factual and legal defenses, counter-claims, rights, and remedies it may have in any such suit.

 

Licensing Fees to Temple University

 

For details of the licensing agreements with Temple University, see Financial Statements attached hereto, Note 6.

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, expenses, and related disclosure of contingent assets and liabilities. We evaluate, on an on-going basis, our estimates and judgments, including those related to the useful life of the assets. We base our estimates on historical experience and assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

 

The methods, estimates and judgments we use in applying our most critical accounting policies have a significant impact on the results that we report in our consolidated financial statements. The SEC considers an entity’s most critical accounting policies to be those policies that are both most important to the portrayal of a company’s financial condition and results of operations and those that require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about matters that are inherently uncertain at the time of estimation. For a more detailed discussion of the accounting policies of the Company, see Note 1 of the Notes to the Consolidated Financial Statements, “Summary of Significant Accounting Policies”.

 

 

 

 28 

 

 

We believe the following critical accounting policies, among others, require significant judgments and estimates used in the preparation of our consolidated financial statements.

 

Estimates

 

The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Certain significant estimates were made in connection with preparing our consolidated financial statements as described in Note 1 to Notes to Consolidated Financial Statements. Actual results could differ from those estimates.

 

Stock-Based Compensation

 

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock-based payments to officers, directors, employees, and consultants by measuring the cost of services received in exchange for equity awards utilizing the grant date fair value of the awards, with the cost recognized as compensation expense on the straight-line basis in the Company’s financial statements over the vesting period of the awards. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services.

 

The fair value of the Company's stock options and warrants grant is estimated using the Black-Scholes Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or warrants, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes Option Pricing model could materially affect compensation expense recorded in future periods.

 

Recent Accounting Pronouncements

 

See Note 1 of the financial statements for discussion of recent accounting pronouncements.

 

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

 

We issue from time to time fixed rate discounted convertible notes. Our convertible notes and our equity securities are exposed to risk as set forth above, in Item 1A, “Risk Factors.” Please also see Item 7, above, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

 

Item 8. Financial Statements and Supplementary Data

 

Our consolidated financial statements as of and for the years ended December 31, 2023 and 2022 are presented in a separate section of this report following Item 15 and begin with the index on page F-1.

 

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

None.

 

 

 

 29 

 

 

Item 9A. Controls and Procedures

 

1. Disclosure Controls and Procedures

 

The Company's management, with the participation of the Company's Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of disclosure controls and procedures, pursuant to Exchange Act Rule 13a-15(b), as of December 31, 2023. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of December 31, 2023 due to the material weaknesses discussed below.

 

2. Internal Control over Financial Reporting

 

  (a) Management's Annual Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Internal control over financial reporting is defined in Rule 13a-15(f) or 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, the company’s principal executive and principal financial officers and effected by the company’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

 

Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;

 

Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the Company; and

 

Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.

 

Management assessed the effectiveness of our internal control over financial reporting as of December 31, 2023, at the reasonable assurance level described above. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control – Integrated Framework (2013). Based on this assessment, our Chief Executive Officer and Chief Financial Officer concluded, that our internal controls over financial reporting was not effective as of December 31, 2023 due to material weaknesses. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the registrant’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

The material weaknesses identified include (i) the Company had inadequate segregation of duties consistent with control objectives; and (ii) the Company had an insufficient number of personnel with an appropriate level of U.S. GAAP knowledge and experience and ongoing training in the application of U.S. GAAP and SEC disclosure requirements commensurate with the Company’s financial reporting requirements.

 

Notwithstanding the identified material weaknesses, management has concluded that the Financial Statements included in this Annual Report on Form 10-K present fairly, in all material respects, the Company’s financial position, results of operations and cash flows for the periods disclosed in conformity with U.S. GAAP.

 

 

 

 30 

 

 

This Annual Report on Form 10-K does not include an attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit us to provide only management’s report in this Annual Report on Form 10-K.

 

  (b) Changes in Internal Control over Financial Reporting

 

No change in the Company's internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the fourth quarter ended December 31, 2023 that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

 

Item 9B. Other Information

 

During the quarter ended December 31, 2023, no director or officer adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408(a) of Regulation S-K.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 31 

 

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance

 

Composition of Board of Directors

 

Our bylaws provide that the Board shall consist of between one and eight directors, as determined by the Board from time to time. The number of directors is currently fixed at seven (7) members. Each board member serves a term of three years and will serve until their successors are elected and qualified, or until their earlier resignation or removal. Currently, the Board consists of three (3) members.

 

In 2016, the Board of Directors of the Company amended the Bylaws of the Company to divide Directors into three classes: Class I, Class II, and Class III. To implement this classified board structure, the initial term of the Class I, Class II, and Class III Directors was one (1), two (2), and three (3) years respectively, with subsequent three-year terms for all classes of Directors.

 

Officers are appointed by our Board of Directors and their terms of office are, except to the extent governed by an employment contract, at the discretion of our Board of Directors. There are no family relationships among any of our current directors or our executive officers.

 

The following constitutes the Board of Directors as of December 31, 2023:

 

Name   Age   Position   Director Class   Director Since   Term Expires
Cecil Bond Kyte   52   Chief Executive Officer, Director (Non-Independent)   Class I   2021   2024
Donald Dickson   68   Director (Independent)   Class II   2013   2024
Eric Bunting   55   Director (Independent)   Class I   2017   2024

 

Biographical Information Regarding Directors

 

Cecil Bond Kyte, Chief Executive Officer (Non-Independent Director) was elected to serve as Chairman of the Board of the Company in December 2007, then known as Save The World Air, Inc. (“STWA”). In January 2010, he was appointed to serve as CEO of STWA. In November 2013, Mr. Kyte voluntarily resigned as a director, Chairman of the Board, and CEO of STWA. Since then, Mr. Kyte has held positions with the following public companies: MassRoots, Inc., where he served as a board member from late 2017, through July 2019. Massroots, Inc. was a technology platform for the cannabis industry during the time Mr. Kyte served as a director of the company; Rightscorp, Inc., where, since 2015, Mr. Kyte has served and continues to serve as the company’s CEO, and since 2016, has served and continues to serve as the company’s CFO. Mr. Kyte is also a member of the board of Rightscorp. Rightscorp’s mission is to support copyright holders’ abilities to litigate and monetize their music and other copyrights against piracy and peer to peer infringement on the internet. Mr. Kyte has mainly been associated with “start overs” rather than “start ups,” using his abilities to restructure and develop a company’s management, financial condition, compliance, and product commercialization. In addition to his current roles as CEO, CFO, and board member of Rightscorp, Mr. Kyte is currently supporting the funding and business development for Bye Aerospace’s suite of products including the development and manufacturing of advanced civilian/military aerospace technologies. Mr. Kyte has been a pilot for 35 years. He received a B.S. Degree in accounting from Long Beach State University.

 

Prior to his appointment as CEO, CFO, and Chairman of the Company, effective July 31, 2020, Mr. Kyte entered into an agreement (“Agreement”) with the Company whereby he agreed to purchase 10,560,000 shares of common stock of the Company for $0.015 per share for a total purchase price of $158,000, $10,000 of which was due and payable on August 7, 2020, $40,000 on August 31, 2020, and $108,000 on September 14, 2020. Mr. Kyte did not meet this funding schedule; instead, during the period August 2020, through October 2020, he purchased 2,000,000 shares of common stock of the Company for a total purchase price of $30,000 or $0.015 per share.

 

 

 

 32 

 

 

Beginning January 14, 2021, through June 7, 2021, Mr. Kyte purchased an additional 8,533,333 shares of common stock of the Company for a total purchase price of $128,000 or $0.015 per share. During this time, Mr. Kyte also provided the Company additional capital in the amount of $117,000 in exchange for a convertible promissory note (“Note”), together with a related Warrant. The Note does not bear any interest; however, the implied interest rate used was 10% since the Note was issued for 10% less than its face value of $128,700. The Note is unsecured, matures in twelve months from issuance and is convertible into 6,435,000 shares of common stock of the Company at $0.02 per share. As part of the issuance of the Note, the Company granted Mr. Kyte a Warrant to purchase 3,217,500 shares of the Company’s common stock. The Warrant is fully vested, exercisable at $0.03 per share and expires one year from the date of issuance.

 

During the period August 2020, through June 2021 (the “Relevant Period”), Mr. Kyte provided the Company with $275,000 in working capital. During this Relevant Period, Mr. Kyte also introduced capital to the Company in the sum of $150,000 from third-party sources. This capital was received by the Company in exchange for convertible promissory notes and related warrants. With this additional third-party capital infusion, during this Relevant Period, Mr. Kyte was responsible, directly and indirectly, for providing the Company with working capital in the amount of $425,000.

 

The Agreement also provided that subject to the Company’s receipt of working capital directly and indirectly from Mr. Kyte in the amount of no less than $500,000 by a date no later than September 29, 2020, Mr. Kyte would be appointed to the Company’s Board and to serve as the Company’s Chairman, CEO, and CFO, without compensation through the balance of calendar year 2020. Neither of the foregoing conditions was satisfied; thus Mr. Kyte was not appointed to the Company’s Board or management in calendar year 2020. Nonetheless, given the resignations of Messrs. Mann and Green from the Board, effective April 9, 2021, and the resignations of Messrs. Lane and Bundros from the Board, effective April 15, 2021, and the resignation of Mr. Dickson as CEO of the Company, effective April 15, 2021, and the resignation of Mike McMullen as CFO of the Company, effective April 15, 2021, the remaining two directors of the Company, namely, Mr. Dickson and Dr. Bunting, appointed Mr. Kyte, and Mr. Kyte agreed, to serve on the Company’s Board as a Class I Director and to serve as the Company’s CEO, CFO, and Chairman, effective April 15, 2021, with compensation to be determined at a later time subject to the Company’s financial condition and viability.

 

Don Dickson (Independent Director), appointed to Board of Directors on August 6, 2013, and currently is employed with Cherokee, Inc. which allows him to consult on different energy projects around the nation in the oil and gas industry. Don retired from Kinder Morgan in 2017, during his time there he worked on projects such as the Northeast Energy Direct Project and the Cortez Expansion project as project manager / engineering principal / construction support. The NED project will serve the Northeast United States delivering natural gas to the region, while the Cortez expansion project will increase the volume of CO2 being shipped from Southwest Colorado to West Texas for oil recovery. Prior to rejoining Kinder Morgan Mr. Dickson served as Chief Executive Officer for Advanced Pipeline Services (APS). APS was established for the purpose of providing a full range of services to the oil and gas industry. Core business areas are in new construction of pipeline and facilities, horizontal directional drilling and pipeline integrity/rehabilitation. Prior to APS, Mr. Dickson worked for Kinder Morgan in their natural gas operations, retiring after twenty-six years. During his time at Kinder Morgan served in different engineering capacities including as Director of Operations on two major pipeline projects, the 42” (REX) Rockies Mountain Express through the state of Illinois, and the 42” (MEP) Midcontinent Express Pipeline through the state of Louisiana. He also was Director of Operations with Tetra Resources completing various onshore and offshore oil and gas wells and a Senior Engineer with Halliburton Services. Mr. Dickson earned his B.S. in Engineering from Oklahoma State University.

 

Eric Bunting M.D. (Independent Director) was appointed to the Board effective April 1, 2017. Dr. Bunting is a board-certified Ear, Nose, and Throat physician, and he is an owner and partner in an independent specialty group. This group has partnered with Wichita Surgical Specialist (“WSS”), which remains one of the country’s largest surgical multispecialty groups. Dr. Bunting has been on the board of directors of WSS for the last 10 years. Dr. Bunting graduated from Kansas University School of Medicine and subsequently received specialty training at Kansas University Medical Center. Dr. Bunting has many diverse business and entrepreneurial interests. Dr. Bunting has an interest in early startup companies and franchising opportunities. He is an owner and partner in approximately 40 fast-casual restaurant franchises in 10 states. He has board of director experience in the health care industry with multiple ambulatory surgical centers and a radiation center. Dr. Bunting has been an integral part of these boards through merger and acquisition periods. Other interests are in the wine and spirits industry where Dr. Bunting has been involved in a successful spirit start-up, which is poised for an acquisition opportunity. Dr. Bunting has other ongoing active business investments in the evolving internet artificial intelligence industry, as it relates to marketing and advertising. Dr. Bunting has been an investor in the Company, acquiring a significant number of shares over the last four years. During this period, he has been and will remain an unbiased shareholder advocate looking forward to commercialization, deployment, and eventual profitability for the Company.

 

 

 

 33 

 

 

Director Compensation Policy

 

Effective January 1, 2014, the Board passed a resolution suspending the July 1, 2013 Board compensation policy. Effective May 6, 2014, the Board approved a compensation policy which includes two annual grants of options, including i) an option to purchase a number of shares of common stock equal to $25,000 divided by the per share closing price on the date of grant with an exercise price equal to the stock closing price on the date of grant, a one year vesting period and an expiration date 10 years from the date of grant; and ii) an option to purchase a number of shares of common stock equal to $25,000 divided by the per share fair market value of the option calculated using the Black-Scholes Option Pricing Model based on market conditions, including stock closing price, risk free interest rate and stock volatility, on the date of grant with an exercise price equal to the stock closing price on the date of grant, vesting immediately and an expiration date 10 years from the date of grant. Also, effective July 1, 2013, the Board approved an annual grant of options to purchase 25,000 shares of common stock at a price equal to the stock’s closing price on the date of grant, vesting immediately and expiring 10 years from the date of grant as compensation to the chairman of the Board’s Audit Committee. Effective January 1, 2015, the Board amended the policy such that there is only one annual grant as follows: i) all options granted would vest over one year; and ii) options granted mid-year due to appointment to the Board or appointment to Chairman of the Audit Committee would be adjusted such that the number of shares would be calculated on a pro rata basis depending on the number of day remaining in the calendar year, and the options would vest December 31 of the year of grant. Board compensation for the calendar year 2023, payable to members of the Board was suspended.

 

Executive Officers

 

The following table sets forth certain information regarding our executive officers as of December 31, 2023:

 

Name   Age   Position
Cecil Bond Kyte   52   Chief Executive Officer and Chief Financial Officer

 

Cecil Bond Kyte, Chief Executive Officer and Chief Financial Officer. Please see above under “Biographical Information Regarding Directors.”

  

CORPORATE GOVERNANCE

 

We maintain a corporate governance page on our corporate website at www.qsenergy.com, which includes information regarding the Company’s corporate governance practices. Our codes of business conduct and ethics, Board committee charters and certain other corporate governance documents and policies are posted on our website. In addition, we will provide a copy of any of these documents without charge to any stockholder upon written request made to Corporate Secretary, QS Energy, Inc., P.O. Box 946, Carson City, Nevada 89702. The information on our website is not, and shall not be deemed to be, a part of this Form 10-K or incorporated by reference into this or any other filing we make with the Securities and Exchange Commission (the “SEC”).

 

Board of Directors

 

Director Independence

 

Our Board of Directors as of December 31, 2023, consisted of three (3) members. As of that date, the Board has affirmatively determined that Mr. Dickson and Dr. Bunting are independent directors. Mr. Kyte, our Chief Executive Officer is not considered independent.

 

Meetings of the Board

 

The Board held four (4) meetings in 2023. A majority of the members attended all 4 board meetings held in 2023. One meeting was held in 2024.

 

 

 

 34 

 

 

Communications with the Board

 

The following procedures have been established by the Board in order to facilitate communications between our stockholders and the Board:

 

Stockholders may send correspondence, which should indicate that the sender is a stockholder, to the Board or to any individual director, by mail to Corporate Secretary, QS Energy, Inc. P.O. Box 946, Carson City, Nevada 89702 or by e-mail to info@qsenergy.com.

 

Our Secretary will be responsible for the first review and logging of this correspondence and will forward the communication to the director or directors to whom it is addressed unless it is a type of correspondence which the Board has identified as correspondence which may be retained in our files and not sent to directors. The Board has authorized the Secretary to retain and not send to directors communications that: (a) are advertising or promotional in nature (offering goods or services), (b) solely relate to complaints by customers with respect to ordinary course of business customer service and satisfaction issues or (c) clearly are unrelated to our business, industry, management or Board or committee matters. These types of communications will be logged and filed but not circulated to directors. Except as set forth in the preceding sentence, the Secretary will not screen communications sent to directors.

 

The log of stockholder correspondence will be available to members of the Board for inspection. At least once each year, the Secretary will provide to the Board a summary of the communications received from stockholders, including the communications not sent to directors in accordance with the procedures set forth above.

 

Our shareholders may also communicate directly with the non-management directors, individually or as a group, by mail c/o Corporate Secretary, QS Energy, Inc. P.O. Box 946, Carson City, Nevada 89702, or by e-mail to info@qsenergy.com.

 

The Audit Committee has established procedures, as outlined in the Company’s policy for “Procedures for Accounting and Auditing Matters”, for the receipt, retention and treatment of complaints regarding questionable accounting, internal controls, and financial improprieties or auditing matters. Any of the Company’s employees may confidentially communicate concerns about any of these matters by calling our toll-free number, +1 (844) 645-7737. Upon receipt of a complaint or concern, a determination will be made whether it pertains to accounting, internal controls or auditing matters and if it does, it will be handled in accordance with the procedures established by the Audit Committee.

 

Committees of the Board

 

Effective July 21, 2021, the Board dissolved the Company’s Audit Committee, and the functions thereof were assumed by the full Board.

 

 

 

 

 

 35 

 

 

Item 11. Executive Compensation

 

EXECUTIVE COMPENSATION DISCUSSION AND ANALYSIS

 

The following table sets forth certain information regarding the compensation earned during the last three fiscal years by the Named Executive Officers:

 

Summary Compensation Table

 

    Long-Term Compensation Awards  
Name and Principal Position   Fiscal
Year		    

Annual
Compensation
Salary

($)

     Stock
Awards
($)		     Securities
Underlying
Options
(#)		     Full Value
of Options
($)		     All Other
Compensation
($)		     Total
($)		  
Cecil Bond Kyte (1)   2023     –     –     –     –     –     –  
Chief Executive Officer   2022     –     –     –     –     –     –  
    2021     –     –     –     –     –     –  
                                           
Don Dickson (2)   2023     –     –     –     –     –     –  
Former Chief Executive Officer   2022     –     –     –     –     –     –  
    2021     –     –     300,000     9,000     –     9,000  
                                           
Michael McMullen (3)   2023     –     –     –     –     –      –  
Former Chief Financial Officer   2022     –     –     –     –     –     –  
    2021     46,200     –     –     –     –     46,200  

_________________

(1) Mr. Kyte was appointed Chief Executive Officer (“CEO”) effective April 15, 2021.
   
(2) Mr. Dickson will not receive any cash compensation for his role as interim CEO; rather, his compensation will be in the form of options that will be granted (“Grant”) to Mr. Dickson to purchase 100,000 shares of restricted common stock of the Company (the “Options”), each month of his employment as interim CEO during the Term. The Options will vest on the 30th day following the date of Grant, provided that Mr. Dickson remains in his role as interim CEO on the vesting date. All of the Options shall be priced as of the closing market price of the Company’s common stock as reported by the OTCBB (Pink Sheets) on the date of Grant. The Options issued to Mr. Dickson in exchange for serving as the Company’s interim CEO shall expire ten (10) years from the date of Grant. Mr. Dickson resigned as interim CEO, effective April 15, 2021.
   
(3) Mr. McMullen was appointed Chief Financial Officer (“CFO”) effective April 1, 2017. Mr. McMullen’s annual base salary under his employment agreement as CFO is $158,400, for a two-year term. Effective March 31, 2019, the Company amended Mr. McMullen’s employment agreement. As amended, the contract was extended by 90 days with no other change in terms. Effective July 1, 2019 through November 15, 2019, Mr. McMullen was employed on a month-to-month basis with no other changes in terms. Effective November 15, 2019, Mr. McMullen’s employment agreement was amended extending the term of the agreement to February 15, 2020 with no other changes in terms.
   
  Mr. McMullen’s Employment Agreement was amended and restated effective February 15, 2020. As amended, Mr. McMullen’s employment agreement was extended on a month-to-month basis with no other terms modified. Mr. McMullen resigned as CFO, effective April 15, 2021.

 

 

 

 36 

 

 

OPTION GRANTS IN LAST FISCAL YEAR

 

During the year ended December 31, 2023, the Company granted no options to Named Executive Officers.

 

AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR AND YEAR-END OPTION VALUES

 

No options were exercised by any of the Named Executive Officers during the 2023 fiscal year. The following table sets forth the number of shares of our common stock subject to exercisable and unexercisable stock options which the Named Executive Officers held at the end of the 2023 fiscal year.

 

  

Shares

Acquired on Exercise

  

Value

Realized

  

Number of Securities

Underlying Unexercised

Options at

Fiscal Year-End (#)

  

Value of Unexercised

In-the-Money Options ($)(1)

 
Name  (#)   ($)   Exercisable   Unexercisable   Exercisable   Unexercisable 
Don Dickson  –   –   3,877,694   –   –   – 
Michael McMullen  –   –   800,000   –   –   – 

_________________

(1) Market value of our common stock at fiscal year-end minus the exercise price. The closing price of our common stock on December 29, 2023 the last trading day of the year was $0.06 per share.

  

EMPLOYMENT AGREEMENTS

 

Employment Agreement with Don Dickson

 

Mr. Dickson’s acceptance of the appointment as interim CEO of the Company for a term of 90 days became effective April 15, 2020 under terms as follows:

 

Compensation will be in the form of options that will be granted (“Grant”) to Mr. Dickson to purchase 100,000 shares of restricted common stock of the Company (the “Options”), each month of his employment as interim CEO during the Term. The Options will vest on the 30th day following the date of Grant, provided that Mr. Dickson remains in his role as interim CEO on the vesting date. All of the Options shall be priced as of the closing market price of the Company’s common stock as reported by the OTCBB (Pink Sheets) on the date of Grant. The Options issued to Mr. Dickson in exchange for serving as the Company’s interim CEO shall expire ten (10) years from the date of Grant. Mr. Dickson resigned as the Company’s CEO effective April 15, 2021.

 

Employment Agreement with Michael McMullen

 

Mr. McMullen’s employment agreement (“McMullen Employment Agreement”) with the Company became effective April 1, 2017, pursuant to which he is serving as the Company’s Chief Financial Officer. The term (“Term”) of the McMullen Employment Agreement is two years. Annual base salary under the McMullen Employment Agreement for the full Term is $158,400. The Company will also issue options (“Options”) to Mr. McMullen to purchase 250,000 shares of restricted shares of common stock of the Company at a per share exercise price equal to the stock price listed on the OTCBB market at market close on April 3, 2017. The 125,000 of the Options vested on April 1, 2017, and 125,000 Options vested on April 1, 2018. The Options shall expire 10 years from the date of grant of the Options.

 

Effective March 31, 2019, the Company amended the McMullen Employment Agreement. As amended, the contract was extended by 90 days with no other change in terms. Effective July 1, 2019 through November 15, 2019, Mr. McMullen was employed on a month-to-month basis with no other changes in terms. Effective November 15, 2019, the McMullen Employment Agreement was amended extending the term of the agreement to February 15, 2020 with no other changes in terms.

 

 

 37 

 

 

Mr. McMullen’s Employment Agreement was amended and restated effective February 15, 2020. Mr. McMullen’s Employment Agreement had been scheduled to terminate February 15, 2019. As amended, his employment agreement was extended on a month-to-month basis. As of July 16, 2020, the Company deferred Mr. McMullen’s salary. As of December 31, 2020 deferred salary due to Mr. McMullen had accrued to $72,600. Deferred salaries were reported in operating expenses and related party payable. Mr. McMullen resigned as the Company’s CFO, effective April 15, 2021.

 

DIRECTORS COMPENSATION

 

Board compensation for calendar year 2023, payable to members of the Board under the Company’s May 6, 2014, Board compensation policy, as amended January 1, 2015, was suspended.

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

 

The following table sets forth certain information regarding the beneficial ownership of our common stock as of December 31, 2023.

 

  · each person, or group of affiliated persons, known by us to be the beneficial owner of more than 5% of the outstanding shares of our common stock;
  · each of our directors;
  · the Company’s Chief Executive Officer and President, and Chief Financial Officer, are the only persons serving as a Named Executive as of December 31, 2023 for services rendered in all capacities to the Company (such individuals are hereafter referred to as the “Named Executive Officers”); and all of our directors and executive officers serving as a group.

 

Named Executive Officers and Director  Number of Shares
of Common Stock
Beneficially		   Percentage of
Shares
Beneficially		 
Name and Address of Beneficial Owner (1)  Owned (2)   Owned (2) 
Kyte, Cecil Bond, Chief Executive Officer, Chief Financial Officer   20,185,833    4.89% 
Dickson, Donald, Director   6,714,453    1.70% 
Bunting, Eric – Director   14,432,621    3.55% 
All directors and executive officers as a group   38,115,407    8.85% 

_________________

(1) Unless otherwise indicated, the address of each listed person is c/o QS Energy, Inc., 23902 FM 2978, Tomball, Texas 77375.
   
(2)

Percentage of beneficial ownership is based upon 392,586,471 shares of the Company’s common stock outstanding as of December 31, 2023. Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of common stock subject to options and warrants currently exercisable or convertible, or exercisable or convertible within 60 days, are deemed outstanding for determining the number of shares beneficially owned and for computing the percentage ownership of the person holding such options, but are not deemed outstanding for computing the percentage ownership of any other person. Except as indicated by footnote, and subject to community property laws where applicable, the persons named in the table have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them.

 

As of the date of this report Mr. Kyte beneficially owns 16,968,333 shares of common stock of the Company, and a Warrant to purchase 3,217,500 shares of common stock of the Company.

 

 

 

 38 

 

 

Item 13. Certain Relationships and Related Transactions, and Director Independence

 

Accrued Expenses - Related Parties

 

As of December 31, 2023 and 2022, total accrued expenses – related parties amounted to $6,000 and $6,000, respectively. Included in the December 31, 2023 accrued amount are $6,000 in unpaid directors fees owed to members of the Board of Directors.

 

Director Independence

 

The Company believes Mr. Dickson and Dr. Bunting are independent, and Mr. Kyte is not independent.

 

Item 14. Principal Accounting Fees and Services

 

The Board has selected Weinberg & Company, P.A. to audit our financial statements for the fiscal year ended December 31, 2023.

 

Weinberg & Company, P.A. was first appointed in fiscal year 2002, and has audited our financial statements for fiscal years 2002 through 2023.

 

Audit and Other Fees

 

The following table summarizes the fees charged by Weinberg & Company, P.A. for certain services rendered to the Company during 2023 and 2022.

  

   Amount 
   Fiscal   Fiscal 
Type of Fee  Year 2023   Year 2022 
Audit (1)  $81,000   $66,000 
Audit Related (2)   –    – 
Taxes (3)   

13,000

    19,000 
All Other (4)   –    – 
Total  $94,000   $85,000 

_________________

(1) This category consists of fees for the audit of our annual financial statements included in the Company’s annual report on Form 10-K and review of the financial statements included in the Company’s quarterly reports on Form 10-Q. This category also includes advice on audit and accounting matters that arose during, or as a result of, the audit or the review of interim financial statements, statutory audits required by non-U.S. jurisdictions and the preparation of an annual “management letter” on internal control matters.
(2) Represents services that are normally provided by the independent auditors in connection with statutory and regulatory filings or engagements for those fiscal years, aggregate fees charged for assurance and related services that are reasonably related to the performance of the audit and are not reported as audit fees. These services include consultations regarding Sarbanes-Oxley Act requirements, various SEC filings and the implementation of new accounting requirements.
(3) Represents aggregate fees charged for professional services for tax compliance and preparation, tax consulting and advice, and tax planning.
(4) Represents aggregate fees charged for products and services other than those services previously reported.

 

 

 

 39 

 

 

PART IV

 

Item 15. Exhibits, Financial Statement Schedules

 

(a)     The following documents are filed as part of this Form 10-K.

 

Financial Statements:

 

Reference is made to the contents to the consolidated financial statements of QS Energy, Inc. under Item 7 of this Form 10-K.

 

(b)     Exhibits:

 

The exhibits listed below are required by Item 601 of Regulation S-K.

 

Exhibit No.   Description
3.1(1)   Articles of Incorporation, as amended, of the Registrant
3.1(6)   Articles of Merger
3.1(5)   Amendment to Articles of Incorporation (12/20/13)
3.1(15)   Second amendment to Articles of Incorporation (10/12/17)
3.2(4)   Amended and Restated Bylaws of the Registrant
3.2(8)   Amendment to the Amended and Restated Bylaws
10.1(2)   License Agreement between the Registrant and Temple University dated February 2, 2007
10.2(3)   License Agreement between the Registrant and Temple University dated August 9, 2011
10.4(7)   Registrant’s Business Plan
10.8(9)   Jason Lane Employment Agreement effective April 1, 2017
10.9(10)   Michael McMullen Employment Agreement effective April 1, 2017
10.10(11)   Bigger Separation Agreement effective April 1, 2017
10.13(12)   Forms of Convertible Note, Warrant, and Securities Purchase Agreement in 2017 Spring Offering
10.11(13)   Amendment to the License Agreement between the Registrant and Temple University
10.12(14)   Submission of Matters to a Vote of Security Holders
10.13(16)   Amendment to Jason Lane employment agreement
10.14(17)   Form of Spring 2018 Securities Purchase Agreement
10.15(18)   Form of Winter 2018-2019 Offering Securities Purchase Agreement
10.16(18)   Amendment to Jason Lane employment agreement effective April 1, 2019
10.17(18)   Amendment to Michael McMullen employment agreement effective April 1, 2019
10.18(19)   Fourth Amendment to Jason Lane employment agreement effective February 15, 2020
10.19(19)   Third Amendment to Michael McMullen employment agreement effective February 15, 2020
21(17)   List of Subsidiaries
24*   Power of Attorney (included on Signature Page)
31.1*   Certification of Chief Executive Officer of Annual Report Pursuant to Rule 13(a)—15(e) or Rule 15(d)—15(e)
31.2*   Certification of Chief Financial Officer of Annual Report Pursuant to 18 U.S.C. Section 1350
32.1*   Certification of Chief Executive Officer and Chief Financial Officer of Annual Report pursuant to Rule 13(a)—15(e) or Rule 15(d)—15(e)
     
101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Schema Document
101.CAL*   Inline XBRL Calculation Linkbase Document
101.DEF*   Inline XBRL Definition Linkbase Document
101.LAB*   Inline XBRL Label Linkbase Document
101.PRE*   Inline XBRL Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted in iXBRL, and included in exhibit 101)

 

 

 

 40 

 

 

*   Filed herewith.
**   Confidential treatment previously requested.
†   Management contract or compensatory plan or arrangement.

 

(1)   Incorporated by reference from Registrant’s Registration Statement on Form 10-SB (Registration Number 000-29185), as amended, filed on March 2, 2000
(2)    Incorporated by reference from Registrant’s Form 8-K filed on February 8, 2007
(3)   Incorporated by reference from Registrant’s Form 8-K filed on August 11, 2011
(4)   Incorporated by reference from Registrant’s Form 8-K filed on July 8, 2013
(5)   Incorporated by reference from Registrant’s Form 8-K filed on December 20, 2013
(6)   Incorporated by reference from Registrant’s Form 8-K filed on August 11, 2015
(7)   Incorporated by reference from Registrant’s Form 8-K filed on December 1, 2015
(8)   Incorporated by reference from Registrant’s Form 8-K filed on November 14, 2016
(9)   Incorporated by reference from Registrant’s Form 10-K filed March 31, 2017
(10)   Incorporated by reference from Registrant’s Form 10-K filed March 31, 2017
(11)   Incorporated by reference from Registrant’s Form 10-K filed March 31, 2017
(12)   Incorporated by reference from Registrant’s Form 8-K filed June 6, 2017
(13)   Incorporated by reference from Registrant’s Form 8-K filed July 14, 2017
(14)   Incorporated by reference from Registrant’s Form 8-K filed July 19, 2017
(15)   Incorporated by reference from Registrant’s Form 8-K filed October 12, 2017
(16)   Incorporated by reference from Registrant’s Form 10-Q filed November 14, 2017
(17)   Incorporated by reference from Registrant’s Form 10-K filed April 2, 2018
(18)   Incorporated by reference from Registrant’s Form 10-K filed April 1, 2019
(19)   Incorporated by reference from Registrant’s Form 10-K filed March 30, 2020

  

Item 16. Form 10-K Summary

 

None.

 

 

 

 41 

 

 

SIGNATURES

 

In accordance with Section 13 or 15(d) of the Exchange Act, the Registrant has caused this report to be signed on its behalf by the undersigned, hereunto duly authorize.

 

  QS Energy, Inc.  
       
Date: April 9, 2024 By: /s/ Cecil Bond Kyte  
    Cecil Bond Kyte  
    Chief Executive Officer  
       

 

POWER OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Cecil Bond Kyte as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Exchange Act of 1934 this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

NAME   TITLE   DATE
         
/s/ Cecil Bond Kyte   Chief Executive Officer, Chief Financial Officer, and Chairman of the Board of Directors   April 9, 2024
Cecil Bond Kyte        
         
/s/ Donald Dickson   Director   April 9, 2024
Donald Dickson        
         
/s/ Eric Bunting, M.D.   Director   April 9, 2024
Eric Bunting, M.D.        

  

 

 

 42 

 

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

QS ENERGY, INC. AND SUBSIDIARIES

DECEMBER 31, 2023 AND 2022

 

  Page
   
Report of Independent Registered Public Accounting Firm (PCAOB ID 572) F-2
   
Consolidated Balance Sheets F-4
   
Consolidated Statements of Operations F-5
   
Consolidated Statements of Stockholders’ Deficit F-6
   
Consolidated Statements of Cash Flows F-7
   
Notes to Consolidated Financial Statements F-8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 F-1 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Stockholders and Board of Directors of QS Energy, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of QS Energy, Inc. and subsidiaries (the “Company”) as of December 31, 2023 and 2022, the related consolidated statements of operations, shareholders’ deficit, and cash flows for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has experienced recurring operating losses and negative operating cash flows since inception, has a stockholders’ deficit, and has financed its working capital requirements through the recurring sale of its debt and equity securities. In addition, as of December 31, 2023, notes payable with an aggregate balance of $2,022,000 and certain obligations to a former officer are past due. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1 to the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

  

Critical Audit Matter

 

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

 

 

 

 F-2 

 

 

Convertible note transactions

 

As described in Note 4 to the financial statements, during 2023 the Company issued convertible notes in the aggregate of $585,000, and warrants to acquire shares of the Company’s common stock. The Company allocated the proceeds received from the issuance of the convertible notes and warrants based upon their relative fair values.

 

We identified the accounting for the issuance of the convertible notes and warrants as a critical audit matter because of the significance of the account balances, and due to the complexity involved in assessing the classification and presentation of the convertible notes and warrants. The auditing for these transactions required a high degree of auditor judgement including evaluating the reasonableness of the significant judgements made by management in determining the appropriate accounting.

 

The primary audit procedures we performed to address this critical audit matter included the following, among others:

 

·We read the convertible note and warrant agreements, and relevant documentation.

 

·We evaluated the reasonableness of the Company’s methodology for allocation of proceeds including the Company’s consideration of relevant accounting standards.

 

·We developed independent estimates for the fair value of the warrants issued based on the assumptions and data used by management.

 

We have served as the Company’s auditor since 2002.

 

/s/Weinberg & Company, P.A.

Los Angeles, California

April 9, 2024

 

 

 

 F-3 

 

 

QS ENERGY, INC.

CONSOLIDATED BALANCE SHEETS

 

         
   December 31   December 31 
   2023   2022 
ASSETS          
Current assets:          
Cash  $70,000   $133,000 
Prepaid expenses and other current assets   12,000    19,000 
Total current assets   82,000    152,000 
Property and equipment, net   2,000    6,000 
Total assets  $84,000   $158,000 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current liabilities:          
Accounts payable-license agreements-past due  $2,198,000   $1,962,000 
Accounts payable and accrued expenses   972,000    946,000 
Convertible notes payable, net of discounts of $25,000 and $140,000, respectively: including $2,022,000 and $1,730,000, respectively, in default   2,101,000    1,865,000 
PPP Loan payable   57,000    75,000 
Total current liabilities   5,328,000    4,848,000 
Total liabilities   5,328,000    4,848,000 
           
Commitments and contingencies   –    – 
           
Stockholders’ deficit          
Common stock, $0.001 par value: 500,000,000 shares authorized, 392,586,471 and 376,074,096 shares issued and outstanding at December 31, 2023 and 2022, respectively   392,587    376,075 
Additional paid-in capital   119,729,413    119,075,925 
Accumulated deficit   (125,366,000)   (124,142,000)
Total stockholders’ deficit   (5,244,000)   (4,690,000)
Total liabilities and stockholders’ deficit  $84,000   $158,000 

 

  

The accompanying notes are an integral part of these consolidated financial statements.

 

 

 

 F-4 

 

 

QS ENERGY, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

         
   Year ended 
   December 31 
   2023   2022 
Revenues  $–   $– 
           
Operating expenses   688,000    765,000 
Research and development expenses   203,000    486,000 
Loss from operations   (891,000)   (1,251,000)
           
PPP loan debt forgiveness   –    63,000 
Interest and financing expense   (333,000)   (360,000)
Net Loss  $(1,224,000)  $(1,548,000)
           
Net loss per common share, basic and diluted  $(0.00)  $(0.00)
Weighted average common shares outstanding, basic and diluted   385,561,786    361,790,243 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

 

 

 

 

 

 F-5 

 

 

QS ENERGY, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

                     
           Additional       Total 
   Common Stock   Paid-in   Accumulated   Stockholders’ 
   Shares   Amount   Capital   Deficit   Deficit 
Balance, December 31, 2021   355,300,222   $355,301   $118,065,699   $(122,594,000)  $(4,173,000)
                          
Common stock issued on conversion of notes payable   6,040,049    6,040    52,960    –    59,000 
Warrants issued with convertible notes   –    –    283,000    –    283,000 
Common stock issued on exercise of warrants   14,483,825    14,484    527,516    –    542,000 
Fair value of options and warrants issued as compensation   –    –    127,000    –    127,000 
Common stock issued on exercise of options   250,000    250    19,750    –    20,000 
Net loss   –    –    –    (1,548,000)   (1,548,000)
Balance, December 31, 2022   376,074,096   $376,075   $119,075,925   $(124,142,000)  $(4,690,000)
                          
Common stock issued on conversion of notes payable   15,129,048    15,129    334,871    –    350,000 
Warrants issued with convertible notes   –    –    231,000    –    231,000 
Common stock issued on exercise of warrants   1,383,327    1,383    50,617    –    52,000 
Fair value of warrants issued as compensation   –    –    37,000    –    37,000 
Net loss   –    –    –    (1,224,000)   (1,224,000)
Balance, December 31, 2023   392,586,471   $392,587   $119,729,413   $(125,366,000)  $(5,244,000)

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

 

 

 

 F-6 

 

 

QS ENERGY, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

         
   Year ended 
   December 31 
   2023   2022 
Cash flows from Operating Activities          
Net loss  $(1,224,000)  $(1,548,000)
Adjustments to reconcile net loss to net cash used in operating activities:          
Fair value of warrants issued as compensation   37,000    127,000 
Amortization of debt discount   103,000    149,000 
Accrued interest expense   182,000    162,000 
Depreciation   4,000    4,000 
Gain on partial forgiveness of PPP note payable   –    (63,000)
Changes in operating assets and liabilities:          
Operating lease right of use asset   –    143,000 
Prepaid expenses and other current assets   7,000    (5,000)
Accounts payable and accrued expenses   26,000    16,000 
Accounts payable – license agreements   236,000    236,000 
Operating lease liabilities   –    (144,000)
Net cash used in operating activities   (629,000)   (923,000)
Cash flows from investing activities          
Purchase of property and equipment   –    (1,000)
Net cash used in investing activities   –    (1,000)
Cash flows from financing activities          
Net proceeds from issuance of convertible notes and warrants   532,000    393,000 
Net proceeds from exercise of warrants and options   52,000    562,000 
Principal payment on PPP loan payable   (18,000)   (12,000)
Net cash provided by financing activities   566,000    943,000 
Net increase (decrease) in cash   (63,000)   19,000 
Cash, beginning of period   133,000    114,000 
Cash, end of period  $70,000   $133,000 
           
Supplemental disclosures of cash flow information          
Cash paid during the year for:          
Interest  $–   $– 
Income Taxes  $1,600   $1,600 
Non-cash investing and financing activities          
Conversion of convertible notes to common stock, net  $350,000   $59,000 
Relative fair value of warrants associated with issued convertible notes  $231,000   $283,000 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

 

 F-7 

 

 

QS ENERGY, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

 

1. Business and Summary of Significant Accounting Policies

 

QS Energy, Inc. (“QS Energy”, “Company”) was incorporated on February 18, 1998, as a Nevada Corporation under the name Mandalay Capital Corporation. The Company changed its name to Save the World Air, Inc. on February 11, 1999. Effective August 11, 2015, the Company changed its name to QS Energy, Inc.

 

QS Energy develops and seeks to commercialize energy efficiency technologies that assist in meeting increasing global energy demands, improving the economics of oil transport, and reducing greenhouse gas emissions. The Company’s intellectual properties include a portfolio of domestic and international patents, a substantial portion of which have been developed in conjunction with and exclusively licensed from Temple University of Philadelphia, PA (“Temple”). QS Energy’s primary technology is called Applied Oil Technology (AOT), a commercial-grade crude oil pipeline transportation flow-assurance product.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the twelve-months ended December 31, 2023, the Company incurred a net loss of $1,224,000, used cash in operations of $629,000 and had a stockholders’ deficit of $5,244,000 as of December 31, 2023. In addition, as of December 31, 2023, thirty-eight notes payable with an aggregate balance of $2,022,000 and certain obligations to a former officer are past due. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

At December 31, 2023, the Company had cash on hand in the amount of $70,000. Management estimates that the current cash on hand will be sufficient to continue operations through April 2024. The AOT product is still in development and testing and has transitioned from laboratory testing to initial demonstration and continued testing in advance of our goal of seeking commercial acceptance and adoption by the upstream and midstream pipeline marketplace. QS Energy’s efforts in the foregoing regard have been substantially hampered by a lack of capital. The Company should be able to continue its efforts to commercialize its AOT product during 2024 only if sufficient capital is raised to do so. The Company can provide no assurances in its ability to raise the capital needed to continue efforts in 2024, or that any such capital will be available to it on acceptable terms and conditions.

 

Management is currently seeking additional funds, primarily through the issuance of debt and equity securities for cash to operate our business, including without limitation the expenses it will incur in connection with the license agreements with Temple; costs associated with product development and commercialization of the AOT technologies; costs to manufacture and ship the products; costs to design and implement an effective system of internal controls and disclosure controls and procedures; costs of maintaining our status as a public company by filing periodic reports with the SEC and costs required to protect our intellectual property. In addition, as discussed below, the Company has substantial contractual commitments, including without limitation salaries to our executive officers pursuant to employment agreements, and certain payments to a former officer and consulting fees, during the remainder of 2024 and beyond.

 

 

 

 F-8 

 

 

No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders in case of equity financing.

 

Inflation

 

Macroeconomic factors such as inflation, rising interest rates, governmental responses there to and possible recession caused thereby also add significant uncertainty to our operations and possible effects to the amount and type of financing available to the Company in the future.

 

Basis of Presentation

 

The accompanying consolidated financial statements and related notes include activities of the Company and have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).

 

The consolidated financial statements include the accounts of QS Energy Inc. and its wholly owned subsidiaries, QS Energy Pool, Inc. and STWA Asia Pte. Limited. Intercompany transactions and balances have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates include those related to assumptions used in valuing the issuance of convertible notes and the corresponding debt discount, assumptions used in valuing equity instruments issued for services, the realizability of deferred tax assets and the related valuation allowance, accruals for potential liabilities, and assumptions used in the determination of the Company’s liquidity. Actual results could differ from these estimates.

 

Revenue Recognition

 

Under its business plan, the Company anticipates the leasing of its primary technology. The Company will recognize lease revenue ratably over the life of the lease upon commencement of the lease. Revenue on future product sales will be recognized in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers.

 

Cash

 

Cash consists of demand deposits with banks. The Company holds no cash equivalents as of December 31, 2023 and 2022, respectively. The Company maintains its cash with domestic financial institutions. At times, cash balances may exceed federally insured limits of $250,000 per depositor at each financial institution. The Company believes that no significant concentration of credit risk exists with respect to these cash balances because of its assessment of the creditworthiness and financial viability of the financial institutions.

 

 

 

 F-9 

 

 

Property and Equipment

 

Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method based on the estimated useful lives of the assets, generally ranging from three to ten years. Expenditures for major renewals and improvements that extend the useful lives of property and equipment are capitalized. Expenditures for repairs and maintenance are charged to expense as incurred. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the lease term.

 

Impairment of Long-lived Assets

 

Our long-lived assets, such as property and equipment, are reviewed for impairment at least annually, or when events and circumstances indicate that depreciable or amortizable long-lived assets might be impaired and the undiscounted cash flows estimated to be generated by those assets are less than the carrying amount of those assets. When specific assets are determined to be unrecoverable, the cost basis of the asset is reduced to reflect the current value.

  

We use various assumptions in determining the current fair value of these assets, including future expected cash flows and discount rates, as well as other fair value measures. Our impairment loss calculations require us to apply judgment in estimating future cash flows, including forecasting useful lives of the assets and selecting the discount rate that reflects the risk inherent in future cash flows.

 

If actual results are not consistent with our assumptions and judgments used in estimating future cash flows and asset fair values, we may be exposed to future impairment losses that could be material to our results. Based upon management’s annual review, no impairments were recorded for the years ended December 31, 2023 and 2022.

 

Leases

 

The Company accounts for its leases in accordance with the guidance of ASC 842, Leases. The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments (see Note 3).

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes. The Company recognizes deferred tax assets and liabilities to reflect the estimated future tax effects, calculated at anticipated future tax rates, of future deductible or taxable amounts attributable to events that have been recognized on a cumulative basis in the financial statements. A valuation allowance related to a deferred tax asset is recorded when it is more likely than not that some portion of the deferred tax asset will not be realized.

 

Research and Development Costs

 

Research and development expenses relate primarily to the development, design, testing of preproduction prototypes and models, compensation, and consulting fees, and are expensed as incurred. Total research and development costs recorded during the years ended December 31, 2023 and 2022, amounted to $203,000 and $486,000, respectively.

 

 

 

 F-10 

 

 

Patent Costs

 

Patent costs consist of patent-related legal and filing fees. Due to the uncertainty associated with the successful development of our AOT product, all patent costs are expensed as incurred. During the years ended December 31, 2023 and 2022, patent costs were $30,000 and $13,000, respectively, and were included as part of operating expenses in the accompanying consolidated statements of operations. 

 

Stock-Based Compensation

 

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock-based payments to officers, directors, employees, and consultants by measuring the cost of services received in exchange for equity awards utilizing the grant date fair value of the awards, with the cost recognized as compensation expense on the straight-line basis in the Company’s financial statements over the vesting period of the awards.  Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services.

 

The fair value of the Company's stock options and warrants grant is estimated using the Black-Scholes Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or warrants, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes Option Pricing model could materially affect compensation expense recorded in future periods.

 

Fair Value of Financial Instruments

 

Accounting standards require certain assets and liabilities to be reported at fair value in the financial statements and provide a framework for establishing that fair value. Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, the Company considers the principal or most advantageous market in which it transacts and considers assumptions that market participants would use when pricing the asset or liability. The framework for determining fair value is based on a hierarchy that prioritizes the inputs and valuation techniques used to measure fair value:

 

Level 1—Quoted prices in active markets for identical assets or liabilities.

 

Level 2—Inputs, other than the quoted prices in active markets, are observable either directly or indirectly.

 

Level 3—Unobservable inputs based on the Company’s assumptions.

 

The Company is required to use observable market data if such data is available without undue cost and effort.

 

The carrying amounts for cash, accounts payable, accrued expenses and convertible notes payable approximate their fair value due to the short-term nature of such instruments.

  

 

 

 F-11 

 

 

Loss per Share

 

Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution, using the treasury stock method that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the loss of the Company. In computing diluted loss per share, the treasury stock method assumes that outstanding options and warrants are exercised, and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants.

 

For the years ended December 31, 2023 and 2022, the dilutive impact of outstanding stock options of 25,757,155 shares and 26,057,601 shares; outstanding warrants of 17,953,239 shares and 20,314,153 shares; and notes convertible into approximately 34,716,235 and 35,138,466 shares of our common stock, respectively, have been excluded because their impact on the loss per share is anti-dilutive.

 

Recent Accounting Pronouncements

 

Recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statement presentation or disclosures.

 

In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06). ASU 2020-06 simplifies the accounting for convertible debt by eliminating the beneficial conversion and cash conversion accounting models. Upon adoption of ASU 2020-06, convertible debt proceeds, unless issued with a substantial premium or an embedded conversion feature that is not clearly and closely related to the host contract, will no longer be allocated between debt and equity components. This modification will reduce the issue discount and result in less non-cash interest expense in financial statements. ASU 2020-06 also updates the earnings per share calculation and requires entities to assume share settlement when the convertible debt can be settled in cash or shares. ASU 2020-06 will be effective January 1, 2024, and a cumulative-effect adjustment to the opening balance of retained earnings is required upon adoption. Early adoption is permitted, but no earlier than January 1, 2021, including interim periods within that year. The adoption of ASU 2020-06 is not expected to have any impact on the Company’s consolidated financial statement presentation or disclosures subsequent to its adoption, with any effect being largely dependent on the composition and terms of outstanding financial instruments at the time of adoption.

 

 

2. Property and Equipment

 

At December 31, 2023 and 2022, property and equipment consists of the following:

          
   December 31, 
   2023   2022 
         
Office equipment  $35,000   $35,000 
Furniture and fixtures   5,000    5,000 
Testing equipment   37,000    37,000 
Leasehold Improvements   25,000    25,000 
Subtotal   102,000    102,000 
Less accumulated depreciation   (100,000)   (96,000)
Total  $2,000   $6,000 

 

Depreciation expense for the years ended December 31, 2023 and 2022 was $4,000 and $4,000, respectively.

 

 

 

 F-12 

 

 

 

3. Leases

 

In June 2021, the Company commenced a lease for its corporate office space under an operating lease agreement, and recorded an operating lease right-of-use asset and the related operating lease liability of $165,000. At December 31, 2021, the balance of right-of-use asset was $143,000 and the balance of the lease liability was $144,000. During 2022, the Company amortized $33,000 of the right-of-use asset and paid $32,000 of the lease liability. On October 31, 2022, the Company entered into a lease amendment with the lessor of the space to terminate the lease and be released from lease obligation. The Company accounted for the cancellation of the lease by writing off the right-of-use asset of $110,000 and cancelling the operating lease liability of $112,000, which resulted in the gain on lease cancellation of $2,000 which is recorded in operating expense on the accompany consolidated statements of operations for the year ended December 31, 2022.

 

Lease with former related party

 

The Company’s former executive offices were formally located in Tomball, Texas and was leased for $5,000 per month under a month-to-month lease from JBL Energy Partners (“JBL”). JBL was an entity owned by Jason Lane, former Director and Chairman of the Board of the Company who resigned in April 2021, and the lease was terminated in April 2021 in connection with the resignation of Mr. Lane. As of December 31, 2023, the balance payable to JBL Energy Partners was $19,000 and is included as part of accounts payable and accrued expenses in the accompanying consolidated balance sheets. Commencing May 1, 2021, the Company agreed to continue to lease a portion of the Tomball facility from the new landlord on a month-to-month basis at $1,000 per month. The Company also rents a storage facility on a month-to-month basis for $250 per month.

 

4. Convertible Notes Payable

          
   December 31, 
   2023   2022 
         
Convertible notes  $1,332,000   $1,393,000 
Accrued interest   794,000    612,000 
Total outstanding debt, including $2,022,000 and $1,730,000 in default at December 31, 2023 and 2022, respectively   2,126,000    2,005,000 
Less: Unamortized debt discount   (25,000)   (140,000)
Total outstanding debt, net of unamortized debt discount  $2,101,000   $1,865,000 

 

Convertible notes

 

At December 31, 2021, convertible notes payable totaled $1,137,000. During the year ended December 31, 2022, the Company issued convertible promissory notes in the aggregate of $432,000 for cash proceeds of $393,000, net of OID of $39,000. The notes are unsecured, with a 10% original issue discount, mature in twelve months from issuance, and are convertible into 14,409,995 shares of the Company’s common stock at $0.03 per share. In addition, the Company granted the note holders warrants to purchase 14,409,995 shares of the Company’s common stock with a relative value of $283,000. The warrants are fully vested, and expire one year from the date of issuance. The Company determined the fair value of the warrants by using a Black-Scholes option pricing model, with the following assumptions: expected term of 1.0 year, stock price of $0.09, exercise price of $0.04, volatility of 212%, risk-free rate of 4.05%, and no forfeiture rate. Also during 2022, convertible notes of $176,000 and accrued interest of $2,000, net of unamortized discount of $119,000, were converted into 6,040,049 shares of common stock. At December 31, 2022, total outstanding convertible notes payable totaled $1,393,000.

 

 

 

 F-13 

 

 

During the year ended December 31, 2023, the Company issued convertible promissory notes in the aggregate of $585,000 for cash proceeds of $532,000, net of OID of $53,000. The notes are unsecured, with a 10% original issue discount, mature in twelve months from issuance, and are convertible into 11,715,748 shares of the Company’s common stock at $0.05 per share. In addition, the Company granted the note holders warrants to purchase 11,715,748 shares of the Company’s common stock with a relative fair value of $231,000. The warrants are fully vested and expire one year from the date of issuance. The Company determined the fair value of the warrants by using a Black-Scholes option pricing model, with the following assumptions: expected term of 1.0 year, stock price of $0.06 to $0.07, exercise price of $0.07, volatility of 169% to 206%, risk-free rate of 4.64% to 5.46%, and no forfeiture rate. Also during 2023, convertible notes of $646,000, net of unamortized discount of $296,000, were converted into 15,129,048 shares of common stock. At December 31, 2023, total outstanding convertible notes payable totaled $1,332,000. As of December 31, 2023, convertible notes payable and accrued interest are convertible into 34,716,235 shares of common stock at conversion rates ranging from $0.02 to $0.48 per share. As of December 31, 2023, a total of 38 convertible notes and accrued interest in the aggregate of $2,022,000 have reached maturity and are past due. The Company is currently in negotiations with these noteholders to settle these past due notes payable.

 

Accrued interest

 

At December 31, 2021, accrued interest on convertible notes payable totaled $435,000. During the year ended December 31, 2022, accrued interest of $162,000 was recorded, and accrued interest of $2,000 was converted into shares of common stock. At December 31, 2022, accrued interest on convertible notes payable totaled $612,000.

 

During the year ended December 31, 2023, accrued interest of $182,000 was recorded. At December 31, 2023, accrued interest on convertible notes payable totaled $794,000.

 

Debt discount

 

At December 31, 2021, the unamortized debt discount was $86,000. During the year ended December 31, 2022, debt discount of $322,000 was recorded for the relative fair value of warrants of $283,000 and OID of $39,000, debt discount amortization of $149,000 was recorded, and $119,000 of debt discount was removed and included in the carrying amount of related convertible notes payable that were converted into shares of common stock. At December 31, 2022, the unamortized debt discount was $140,000.

 

During the year ended December 31, 2023, debt discount of $284,000 was recorded for the relative fair value of warrants of $231,000 and OID of $53,000, debt discount amortization of $103,000 was recorded, and $296,000 of debt discount was removed and included in the carrying amount of related convertible notes payable that were converted into shares of common stock. At December 31, 2023, the unamortized debt discount was $25,000.

 

 

5. PPP Loan Payable

 

In June 2020, the Company was granted a loan (the “PPP loan”) from Cadence Bank in the aggregate amount of $151,000, pursuant to the Paycheck Protection Program (the “PPP”) under the CARES Act.

 

The PPP loan agreement matures on June 18, 2025, bears interest at a rate of 1% per annum, and is unsecured and guaranteed by the U.S. Small Business Administration (“SBA”). The Company applied ASC 470, Debt, to account for the PPP loan. The PPP loan may be prepaid at any time prior to maturity with no prepayment penalties. Funds from the PPP loan may only be used for qualifying expenses as described in the CARES Act, including qualifying payroll costs, qualifying group health care benefits, qualifying rent and debt obligations, and qualifying utilities. Management believes the entire loan amount has been used for qualifying expenses and all of the conditions outlined in the PPP loan program were adhered to by the Company. Under the terms of the PPP, certain amounts of the loan may be forgiven if they are used for qualifying expenses.

 

 

 

 F-14 

 

 

At December 31, 2021, the balance of the PPP loan was $151,000. During the year ended December 31, 2022, the Company received notice that $63,000 of the loan was forgiven, and recognized a gain on forgiveness of PPP loan of $63,000. During 2022, the Company paid $12,000 of principal, and at December 31, 2022, the balance of the PPP loan was $75,000. During the year ended December 31, 2023, the Company paid $18,000 of principal on the PPP loan, and at December 31, 2023, the balance of the PPP loan was $57,000. The terms of the PPP loan provide for customary events of default including, among other things, payment defaults, breach of representations and warranties, and insolvency events. The Company was in compliance with the terms of the PPP loan as of December 31, 2023.

 

 

6. Research and Development

 

The Company constructs, develops and tests the AOT technology with internal resources and through the assistance of various third-party entities. Costs incurred and expensed include fees such as license fees, purchase of test equipment, viscometers, SCADA systems, computer equipment, direct costs related to AOT equipment manufacture and installation, payroll and other related equipment and various logistical expenses for the purposes of evaluating and testing the Company’s AOT prototypes.

 

Costs incurred for research and development are expensed as incurred. Purchased materials that do not have an alternative future use are also expensed. Furthermore, costs incurred in the construction of prototypes with no certainty of any alternative future use and established commercial uses are also expensed.

 

For the years ended December 31, 2023 and 2022, our research and development expenses were $203,000 and $486,000, respectively.

 

AOT Prototypes

 

During the years ended December 31, 2023 and 2022, the Company incurred total expenses of $14,000 and $298,000, respectively, in the manufacture and testing of the AOT prototype equipment. These expenses have been reflected as part of Research and Development expenses on the accompanying consolidated statements of operations.

 

Temple University Licensing Agreement-amount past due

 

On August 1, 2011, the Company and Temple University (“Temple”) entered into two (2) Exclusive License Agreements (collectively, the “License Agreements”) relating to Temple’s patent applications, patents and technical information pertaining to technology associated with an electric and/or magnetic field assisted fuel injector system (the “First Temple License”), and to technology to reduce crude oil viscosity (the “Second Temple License”). The License Agreements are exclusive, and the territory licensed to the Company is worldwide and replace previously issued License Agreements.

 

Pursuant to the two licensing agreements, the Company paid Temple a non-refundable license maintenance fee of $300,000, and agreed to pay (i) annual maintenance fees of $187,500; (ii) royalty fee ranging from 4% up to 7% from revenues generated from the licensing agreements; and (iii) 25% of all revenues generated from sub-licensees to secure or maintain the sub-license or option thereon. The term of the licenses commenced in August 2011 and will expire upon expiration of the patents. The agreements can also be terminated by either party upon notification under terms of the licensing agreements or if the Company ceases the development of the patent or fails to commercialize the patent rights.

 

Total expenses recognized during each twelve-month period ended December 31, 2023 and 2022 pursuant to these two License Agreements amounted to $188,000 and has been reflected in Research and Development expenses on the accompanying consolidated statements of operations. In the twelve-month periods ended December 31, 2023 and 2022, the Company also recognized penalty interest on past-due balances of $48,000 and $48,000, respectively, which is included as part of interest and financing expense in the accompanying consolidated statements of operations.

 

 

 

 F-15 

 

 

As of December 31, 2023 and 2022, total unpaid fees due to Temple pursuant to these agreements are $2,198,000 and $1,962,000, respectively, which are included as part of Accounts Payable – license agreements in the accompanying consolidated balance sheets. With regards to the unpaid fees to Temple, a total of $135,000 are deferred until such time the Company achieves a revenue milestone of $835,000 or upon termination of the licensing agreements and the remaining $2,063,000 are deemed past due. The Company is currently in discussions with Temple to settle or cure the past due balance.

 

No revenues were earned from the two License Agreements during the year ended December 31, 2023 and 2022.

 

  

7. Income Taxes

 

The Company did not provide for any Federal and State income tax for the years ended December 31, 2023 and 2022 due to the Company’s net losses. A reconciliation of income taxes with the amounts computed at the statutory federal rate follows:

         
   December 31, 
   2023   2022 
Computed tax provision (benefit) at federal statutory rate (21%)  $(70,000)  $(167,000)
Valuation allowance   70,000    167,000 
Income tax provision  $–   $– 

 

The deferred tax assets and deferred tax liabilities recorded on the balance sheet are as follows:

         
   December 31, 
   2023   2022 
Net operating loss carry forwards  $12,698,000   $13,124,000 
Stock based compensation   (8,000)   (27,000)
Other temporary differences   (57,000)   35,000 
Valuation allowance   (12,633,000)   (13,132,000)
Total deferred taxes net of valuation allowance  $–   $– 

 

As of December 31, 2023, the Company had net operating losses available for carry forward for state and federal tax purposes of approximately $60 million expiring through 2044. These carry forward benefits will be subject to annual limitations due to the ownership change limitations imposed by the Internal Revenue Code and similar state provisions. The annual limitation, if imposed, may result in the expiration of net operating losses before utilization.

 

As of December 31, 2023, the Company recorded a valuation allowance of $12,633,000 for its deferred tax assets since the Company believes that such assets did not meet the more likely than not criteria to be recoverable through projected future profitable operations in the foreseeable future. This valuation is based on the federal corporate tax rate of 21%.

 

 

 

 F-16 

 

 

Effective January 1, 2007, the Company adopted FASB guidance that addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under this guidance, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The FASB also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. As of December 31, 2023 and 2022, the Company does not have a liability for unrecognized tax benefits.

 

The Company files income tax returns in the U.S. federal jurisdiction and the State of Texas. The Company is subject to U.S. federal or state income tax examinations by tax authorities for years after 2002. During the periods open to examination, the Company has net operating loss and tax credit carry forwards for U.S. federal and state tax purposes that have attributes from closed periods. Since these net operating losses and tax credit carry forwards may be utilized in future periods, they remain subject to examination. The Company’s policy is to record interest and penalties on uncertain tax provisions as income tax expense. As of December 31, 2023, the Company has no accrued interest or penalties related to uncertain tax positions. The Company believes that it has not taken any uncertain tax positions that would impact its consolidated financial statements as of December 31, 2023 and 2022. 

 

 

8. Common Stock

 

Year Ending December 31, 2023

 

During the year ended December 31, 2023, the Company issued an aggregate of 16,512,375 shares of its common stock as follows:

 

  · The Company issued 15,129,048 shares of its common stock upon the conversion of $646,000 in convertible notes at $0.03 to $0.05 per share, net of unamortized discount of $296,000.

 

  · The Company issued 1,383,327 shares of its common stock upon the exercise of warrants of $52,000, at $0.02 to $0.04 per share.

 

Year Ending December 31, 2022

 

During the year ended December 31, 2022, the Company issued an aggregate of 20,773,874 shares of its common stock as follows:

 

  · The Company issued 6,040,049 shares of its common stock upon the conversion of $178,000 in convertible notes at $0.02 to $0.03 per share, net of unamortized discount of $119,000.

 

  · The Company issued 14,483,825 shares of its common stock upon the exercise of warrants of $542,000, at $$0.03 to $0.04 per share.

 

  · The Company issued 250,000 shares of its common stock upon the exercise of options of $20,000, at $0.08 per share.

 

 

9. Stock Options and Warrants

 

The Company periodically issues stock options and warrants to employees and non-employees in capital raising transactions, for services and for financing costs. Options and warrants vest and expire according to terms established at the grant date.

 

 

 

 F-17 

 

 

Options

 

Employee options vest according to the terms of the specific grant and expire from 5 to 10 years from date of grant. The weighted average, remaining contractual life of employee and non-employee options outstanding at December 31, 2023 was 3.9 years. Stock option activity for the period January 1, 2022 to December 31, 2023, was as follows:

          
   Options  

Weighted Avg.

Exercise Price

 
Options outstanding, December 31, 2021   31,080,601   $0.17 
Options granted   –    – 
Options exercised   (250,000)   0.08 
Options cancelled   (4,773,000)   0.26 
Options outstanding, December 31, 2022   26,057,601   $0.15 
Options granted   –    – 
Options exercised   –    – 
Options cancelled   (300,446)   0.72 
Options outstanding, December 31, 2023   25,757,155   $0.14 

 

The weighted average exercise prices, remaining contractual lives for options granted, exercisable, and expected to vest as of December 31, 2023, were as follows:

 

As of December 31, 2023, the market price of the Company’s stock was $0.06 per share. At December 31, 2023 the aggregate intrinsic value of the options outstanding was $115,000. Future unamortized compensation expense on the unvested outstanding options at December 31, 2023 is $0.

                       
   Outstanding Options   Exercisable Options 
Option
Exercise Price
Per Share		  Shares   Life
(Years)		 

Weighted

Average

Exercise Price

   Shares  

Weighted

Average

Exercise Price

 
$0.02 - $0.24   22,055,551   4.1  $0.10    22,055,551   $0.10 
$0.25 - $0.49   3,238,552   2.7   0.36    3,238,552    0.36 
$0.50 - $0.99   463,052   0.4   0.85    463,052    0.85 
    25,757,155   3.9  $0.14    25,757,155   $0.14 

 

Year Ending December 31, 2023

 

During the year ended December 31, 2023 did not issue options to employees, officers or members of the Board of Directors.

 

Year Ending December 31, 2022

 

During the year ended December 31, 2022, the Company did not issue options to employees, officers or members of the Board of Directors.

 

 

 

 F-18 

 

 

Warrants

 

The following table summarizes certain information about the Company’s stock purchase warrants.

          
   Warrants  

Weighted Avg.

Exercise Price

 
Warrants outstanding, December 31, 2021   19,977,149   $0.04 
Warrants granted   16,426,657    0.04 
Warrants exercised   (14,483,825)   0.04 
Warrants expired   (1,605,828)   0.04 
Warrants outstanding, December 31, 2022   20,314,153   $0.04 
Warrants granted   12,482,410    0.07 
Warrants exercised   (1,383,327)   0.04 
Warrants expired   (13,459,997)   0.04 
Warrants outstanding, December 31, 2023   17,953,239   $0.06 

 

 At December 31, 2023 the price of the Company’s common stock was $0.06 per share and the aggregate intrinsic value of the warrants outstanding was $145,000. As of December 31, 2023, 17,919,906 warrants were fully vested and 33,333 warrants vest in January 2024.

                       
   Outstanding Warrants   Exercisable Warrants 
Warrant
Exercise Price
Per Share		  Shares   Life
(Years)		 

Weighted

Average

Exercise Price

   Shares  

Weighted

Average

Exercise Price

 
$0.02 - $0.24   17,883,239   0.6  $0.06    17,849,906   $0.06 
$0.25 - $0.49   –   –   –    –    – 
$0.50 - $1.00   70,000   0.3   0.80    70,000    0.80 
    17,953,239   0.6  $0.06    17,919,906   $0.06 

 

Year Ending December 31, 2023

 

  · In March through September 2023, pursuant to terms of convertible notes issued, the Company granted warrants to purchase 11,715,748 shares of common stock with an exercise price of $0.07 per share, vesting immediately upon grant and expiring one year from the date of grant.
     
  · In January through December 2023, pursuant to terms of consulting agreements, the Company granted warrants to purchase 766,662 shares of common stock with an exercise price of $0.03 to $0.13 per share, vesting up to one month from the date of grant and expiring one to two years from the date of grant. Total fair value of these options at grant date was approximately $35,000 determined using the Black-Scholes Option Pricing model with the following assumptions: life of 1 to 2 years; risk free interest rate of 0.73% to 5.07%; volatility of 182% to 245%; and dividend yield of 0%. During the year ended December 31, 2023, the Company recognized compensation expense of $37,000 based on the fair value of the warrants that vested.

 

 

 

 F-19 

 

 

Year Ending December 31, 2022

  

  · In September 2022, pursuant to terms of convertible notes issued, the Company granted warrants to purchase 14,409,995 shares of common stock with an exercise price of $0.04 per share, vesting immediately upon grant and expiring one year from the date of grant.
     
  · In January through December 2022, pursuant to terms of consulting agreements, the Company granted warrants to purchase 2,016,662 shares of common stock with an exercise price of $0.02 to $0.09 per share, vesting up to one month from the date of grant and expiring two to five years from the date of grant. Total fair value of these options at grant date was approximately $127,000 determined using the Black-Scholes Option Pricing model with the following assumptions: life of 2 to 5 years; risk free interest rate of 0.13% to 4.49%; volatility of 193% to 245%; and dividend yield of 0%. During the year ended December 31, 2022, the Company recognized compensation expense of $127,000 based on the fair value of the warrants that vested.

 

 

10. Related Party Transactions

 

Accrued Expenses – Related Party

 

As of December 31, 2023 and 2022, total accrued expenses – related parties amounted to $6,000 and $6,000 and are included in accrued expense on the accompany consolidated balance sheet. The accrued expenses – related parties consisted of unused vacation of officers, unreimbursed out-of-pocket expenses incurred by officers, and unpaid board and committee fees to members of the Company’s Board of Directors.

 

 

11. Commitments and Contingencies

 

We are involved in certain legal proceedings that arise from time to time in the ordinary course of our business. Except for income tax contingencies, we record accruals for contingencies to the extent that our management concludes that the occurrence is probable and that the related amounts of loss can be reasonably estimated. Legal expenses associated with the contingency are expensed as incurred. There is no current or pending litigation of any significance with the exception of the matters that have arisen under, and are being handled in, the normal course of business.

 

 

 

 

 

 F-20 

 

 

Contractual Commitments

 

The Company’s contractual commitments for future periods, licensing agreements and minimum guaranteed compensation payments as described in the following table and associated footnotes:

               
Year ending
December 31,		  License
Agreements (1)		   Compensation
Agreements (2)		   Total
Obligations		 
2024  $187,500   $197,000   $384,500 
2025   187,500    –    187,500 
2026   187,500    –    187,500 
2027   187,500    –    187,500 
2028   187,500    –    187,500 
Total  $937,500   $197,000   $1,134,500 

 

  (1)

Consists of license maintenance fees to Temple University in the amount of $187,500 paid annually through the life of the underlying patents or until otherwise terminated by either party (see Note 6).

     
  (2) Consists of certain contractually provided benefits to a former executive officer pursuant to a severance agreement and amendments thereto. The balance due as of December 31, 2023, of $197,000 is included as part of Accounts payable and accrued expenses in the accompanying consolidated balance sheets, of which the total amount is in arrears. The former executive officer disputes the amount identified in the above table, claiming the above amount is less than the amount to which he believes he is owed. Absent an agreement to settle the dispute, and in the event the former executive officer elects to initiate litigation regarding the dispute, including claims for interest and penalties to which the former executive officer believes he is entitled, the Company has reserved, and if necessary and appropriate will assert, all factual and legal defenses, counter-claims, rights, and remedies it may have in any such suit.

 

 

12. Subsequent Events

 

In January through March 2024, pursuant to terms of a consulting agreement, the Company granted warrants to purchase 99,999 shares of common stock with an exercise price of $0.05 to $0.07 per share, vesting one month from grant and expiring two years from the date of grant.

 

In January through March 2024, the Company issued convertible promissory notes in the aggregate of $199,000 for cash proceeds of $181,000, net of OID $18,000. The notes are unsecured, have an implied interest rate of 10%, mature in twelve months from issuance, and are convertible into 3,980,900 shares of the Company’s common stock at $0.05 per share. In addition, the Company granted the note holders warrants to purchase 3,980,900 shares of the Company’s common stock at $0.07 per share. The warrants are fully vested and expire one year from the date of issuance.

 

In February 2024, the Company issued 133,333 shares of its common stock upon the exercise of warrants for proceeds of $4,000 at an exercise price of $0.03 to $0.04 per share.

 

In February through March 2024, the Company issued 3,212,000 shares of its common stock upon the conversion of notes payable at a conversion price of $0.05 per share.

 

In March 2024, pursuant to terms of a consulting agreement, the Company issued 2,000,000 shares of its common stock.

 

 

 

 

 F-21 

 EX-31.1 2 qsenergy_ex3101.htm CERTIFICATION OF CHIEF EXECUTIVE OFFICER

EXHIBIT 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

AND RULES 13A-14 AND 15D-14 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

I, Cecil Bond Kyte, certify that:

 

1.     I have reviewed this Annual Report on Form 10-K of QS Energy, Inc.;

 

2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.     The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) or 15d-15(e) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(d)-15(f) for the registrant and have:

 

(a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its condensed consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)     Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)     Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.     The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)     All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: April 9, 2024 /s/ CECIL BOND KYTE  
Cecil Bond Kyte  
Chief Executive Officer  

 

 

 EX-31.2 3 qsenergy_ex3102.htm CERTIFICATION OF CHIEF FINANCIAL OFFICER

EXHIBIT 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

AND RULES 13A-14 AND 15D-14 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

I, Cecil Bond Kyte, certify that:

 

1.     I have reviewed this Annual Report on Form 10-K of QS Energy, Inc.; 

 

2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.     The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) or 15d-15(e) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(d)-15(f) for the registrant and have:

 

(a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its condensed consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)     Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)     Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.     The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)     All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: April 9, 2024 /s/ CECIL BOND KYTE  
Cecil Bond Kyte  
Chief Financial Officer  

 

 

 EX-32.1 4 qsenergy_ex3201.htm CERTIFICATION

EXHIBIT 32.1

 

CERTIFICATION OF PERIODIC FINANCIAL REPORT BY THE

CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Solely for the purposes of complying with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, we, the undersigned Chief Executive Officer and the Chief Financial Officer of QS Energy, Inc. (the “Company”), hereby certify, based on our knowledge, that the Annual Report on Form 10-K of the Company for the year ended December 31, 2023 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: April 9, 2024 /s/ Cecil Bond Kyte
Cecil Bond Kyte
Interim Chief Executive Officer
 
Date: April 9, 2024 /s/ Cecil Bond Kyte
Cecil Bond Kyte
Chief Financial Officer 

 

 

 EX-101.SCH 5 qsep-20231231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 995512 - Disclosure - Business and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995513 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 995514 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Convertible Notes Payable link:presentationLink link:calculationLink link:definitionLink 995516 - Disclosure - PPP Loan Payable link:presentationLink link:calculationLink link:definitionLink 995517 - Disclosure - Research and Development link:presentationLink link:calculationLink link:definitionLink 995518 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995519 - Disclosure - Common Stock link:presentationLink link:calculationLink link:definitionLink 995520 - Disclosure - Stock Options and Warrants link:presentationLink link:calculationLink link:definitionLink 995521 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995522 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995523 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995524 - Disclosure - Business and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 995526 - Disclosure - Convertible Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 995527 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 995528 - Disclosure - Stock Options and Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 995529 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 995530 - Disclosure - Business and Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995531 - Disclosure - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 995532 - Disclosure - Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995533 - Disclosure - Leases (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995534 - Disclosure - Convertible Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Convertible Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995536 - Disclosure - PPP Loan Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995537 - Disclosure - Research and Development (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995538 - Disclosure - Income Taxes (Details - Income tax reconciliation) link:presentationLink link:calculationLink link:definitionLink 995539 - Disclosure - Income Taxes (Details - Deferred taxes) link:presentationLink link:calculationLink link:definitionLink 995540 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995541 - Disclosure - Common Stock (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995542 - Disclosure - Stock Options and Warrants (Details - Options outstanding) link:presentationLink link:calculationLink link:definitionLink 995543 - Disclosure - Stock Options and Warrants (Details - Options by exercise price per share) link:presentationLink link:calculationLink link:definitionLink 995544 - Disclosure - Stock Options and Warrants (Details - Warrant exercise price per share) link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Stock Options and Warrants (Details - Warrant exercise price per share) link:presentationLink link:calculationLink link:definitionLink 995546 - Disclosure - Stock Options and Warrants (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995547 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995548 - Disclosure - Commitments and Contingencies (Details - Commitments) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 qsep-20231231_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 qsep-20231231_def.xml XBRL DEFINITION FILE EX-101.LAB 8 qsep-20231231_lab.xml XBRL LABEL FILE Long-Term Debt, Type [Axis] Convertible Notes Payable [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Finite-Lived Intangible Assets by Major Class [Axis] Patent Costs [Member] Antidilutive Securities [Axis] Stock Options [Member] Warrants [Member] Convertible Notes [Member] Long-Lived Tangible Asset [Axis] Office Equipment [Member] Furniture and Fixtures [Member] Testing Equipment [Member] Leasehold Improvements [Member] Property Subject to or Available for Operating Lease [Axis] Corporate Office Space [Member] Tomball Texas Offices [Member] Debt Instrument [Axis] Debt Discount [Member] Transaction Type [Axis] Fair Value Of Warrants [Member] Original Issue Discount [Member] Discount Converted [Member] PPP Loan [Member] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] A O T Prototys [Member] Temple University License Agreements [Member] Stock Conversion Description [Axis] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Exercise Of Warrants [Member] Exercise Of Options [Member] Award Type [Axis] Equity Option [Member] Warrant [Member] Convertible Debt [Member] Consulting Agreement [Member] Exercise Price Range [Axis] $0.02 - $0.24 [Member] $0.25 - $0.49 [Member] $0.50 - $0.99 [Member] $0.02 - $0.24 [Member] $0.25 - $0.49 [Member] $0.50 - $1.00 [Member] Other Commitments [Axis] License Agreements [Member] Compensation Agreements [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Firm ID Auditor Name Auditor Location Statement of Financial Position [Abstract] ASSETS Current assets: Cash Prepaid expenses and other current assets Total current assets Property and equipment, net Total assets LIABILITIES AND STOCKHOLDERS’ DEFICIT Current liabilities: Accounts payable-license agreements-past due Accounts payable and accrued expenses Convertible notes payable, net of discounts of $25,000 and $140,000, respectively: including $2,022,000 and $1,730,000, respectively, in default PPP Loan payable Total current liabilities Total liabilities Commitments and contingencies Stockholders’ deficit Common stock, $0.001 par value: 500,000,000 shares authorized, 392,586,471 and 376,074,096 shares issued and outstanding at December 31, 2023 and 2022, respectively Additional paid-in capital Accumulated deficit Total stockholders’ deficit Total liabilities and stockholders’ deficit Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Discounts on convertible notes payable Convertible notes in default Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Operating expenses Research and development expenses Loss from operations PPP loan debt forgiveness Interest and financing expense Net Loss Net loss per common share, basic Net loss per common share, diluted Weighted average common shares outstanding, basic Weighted average common shares outstanding, diluted Statement [Table] Statement [Line Items] Beginning balance, value Beginning balance, shares Common stock issued on conversion of notes payable Common stock issued on conversion of notes payable, shares Warrants issued with convertible notes Common stock issued on exercise of warrants Common stock issued on exercise of warrants, shares Fair value of warrants issued as compensation Fair value of options and warrants issued as compensation Common stock issued on exercise of options Common stock issued on exercise of options, shares Net loss Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Cash flows from Operating Activities Adjustments to reconcile net loss to net cash used in operating activities: Fair value of warrants issued as compensation Amortization of debt discount Accrued interest expense Depreciation Gain on partial forgiveness of PPP note payable Changes in operating assets and liabilities: Operating lease right of use asset Prepaid expenses and other current assets Accounts payable and accrued expenses Accounts payable – license agreements Operating lease liabilities Net cash used in operating activities Cash flows from investing activities Purchase of property and equipment Net cash used in investing activities Cash flows from financing activities Net proceeds from issuance of convertible notes and warrants Net proceeds from exercise of warrants and options Principal payment on PPP loan payable Net cash provided by financing activities Net increase (decrease) in cash Cash, beginning of period Cash, end of period Supplemental disclosures of cash flow information Cash paid during the year for: Interest Income Taxes Non-cash investing and financing activities Conversion of convertible notes to common stock, net Relative fair value of warrants associated with issued convertible notes Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance [Table Text Block] Company Selected Measure Name Named Executive Officers, Footnote [Text Block] Peer Group Issuers, Footnote [Text Block] Changed Peer Group, Footnote [Text Block] PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote [Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Equity Valuation Assumption Difference, Footnote [Text Block] Compensation Actually Paid vs. Total Shareholder Return [Text Block] Compensation Actually Paid vs. Net Income [Text Block] Compensation Actually Paid vs. Company Selected Measure [Text Block] Total Shareholder Return Vs Peer Group [Text Block] Compensation Actually Paid vs. Other Measure [Text Block] Tabular List [Table Text Block] Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Attributable to Parent Company Selected Measure Amount Other Performance Measure Amount Adjustment to Compensation Amount PEO Name Measure Name Non-GAAP Measure Description [Text Block] Additional 402(v) Disclosure [Text Block] Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis [Text Block] Stock Price or TSR Estimation Method [Text Block] Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined [Text Block] Forgone Recovery, Individual Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability [Text Block] Outstanding Recovery, Individual Name Outstanding Recovery Compensation Amount Restatement Does Not Require Recovery [Text Block] Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure [Text Block] Award Timing Method [Text Block] Award Timing Predetermined [Flag] Award Timing MNPI Considered [Flag] Award Timing, How MNPI Considered [Text Block] MNPI Disclosure Timed for Compensation Value [Flag] Awards Close in Time to MNPI Disclosures [Table Text Block] Awards Close in Time to MNPI Disclosures, Individual Name Award Underlying Securities Amount Award Exercise Price Award Grant Date Fair Value Underlying Security Market Price Change, Percent Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted [Flag] Insider Trading Policies and Procedures Not Adopted [Text Block] Accounting Policies [Abstract] Business and Summary of Significant Accounting Policies Property, Plant and Equipment [Abstract] Property and Equipment Leases Leases Debt Disclosure [Abstract] Convertible Notes Payable Ppp Loan Payable PPP Loan Payable Research and Development [Abstract] Research and Development Income Tax Disclosure [Abstract] Income Taxes Equity [Abstract] Common Stock Share-Based Payment Arrangement [Abstract] Stock Options and Warrants Related Party Transactions [Abstract] Related Party Transactions Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Going Concern Inflation Basis of Presentation Use of Estimates Revenue Recognition Cash Property and Equipment Impairment of Long-lived Assets Leases Income Taxes Research and Development Costs Patent Costs Stock-Based Compensation Fair Value of Financial Instruments Loss per Share Recent Accounting Pronouncements Schedule of property and equipment Schedule of convertible notes payable Schedule of reconciliation of income taxes Schedule of deferred income taxes Stock options outstanding Schedule of options outstanding by per share price Schedule of warrants activity Schedule of warrants outstanding by per share price Schedule of contractual commitments Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Net loss Cash flow from operations Stockholders' deficit Notes payable Cash on Hand Asset impairment Research and development costs Operating expenses Antidilutive shares Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, gross Accumulated depreciation Depreciation expense Operating lease right-of-use asset Operating lease liability Amortization of right-of-use asset Payments of lease liability Right-of-use asset write off Operating lease liability cancelled Gain on lease cancellation Accounts Payable Convertible notes Accrued interest Total outstanding debt, including $2,022,000 and $1,730,000 in default at December 31, 2023 and 2022, respectively Debt default amount Less: Unamortized debt discount Total outstanding debt, net of unamortized debt discount Convertible notes payable Increase in convertible notes Proceeds from convertible debt Original issue discount Warrants issued, shares Warrants issued, value Debt converted, amount converted Debt converted, interest converted Unamortized debt discount Debt converted, shares issued Convertible notes terms Accrued interest on convertible notes payable Accrued interest Increase in debt discount Debt discount amortization Decrease in debt discount Aggregate amount Maturity date Debt interest rate PPP loan payable Debt instrument, decrease, forgiveness Gain on forgiveness of PPP loan PPP loan paid Schedule of Research and Development Arrangement, Contract to Perform for Others [Table] Research and Development Arrangement, Contract to Perform for Others [Line Items] Interest and financing expense Accounts payable - licensing agreement Temple licensing agreement terms Computed tax provision (benefit) at federal statutory rate (21%) Valuation allowance Income tax provision Net operating loss carry forwards Stock based compensation Other temporary differences Valuation allowance Total deferred taxes net of valuation allowance Net operating loss carryforward Federal corporate tax rate Conversion of Stock [Table] Conversion of Stock [Line Items] Debt converted, amount converted Conversion price Unamortized discount Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Options, Outstanding beginning balance Weighted Average Exercise Price, Outstanding Beginning Balance Options, Granted Weighted Average Exercise Price, Granted Options, Exercised Weighted Average Exercise Price, Exercised Options, Cancelled Weighted Average Exercise Price, Cancelled Options, Outstanding ending balance Weighted Average Exercise Price, Outstanding Ending Balance Shares, options outstanding Life (Years), options outstanding Weighted average exercise price, options outstanding Shares, options exercisable Weighted average exercise price, options exercisable Warrants outstanding, beginning balance Warrants outstanding, beginning balance Warrants granted Weighted average exercise price, Granted Warrants exercised Weighted average exercise price, Exercised Warrants Expired Weighted average exercise price, Expired Warrants outstanding, ending balance Weighted average exercise price, Outstanding ending balance Warrants outstanding Life (Years), warrants outstanding Weighted average exercise price, warrants outstanding Warrants exercisable Weighted average exercise price, warrants exercisable Stock price Aggregate intrinsic value of options outstanding Unamortized compensation expense Aggregate intrinsic value of options outstanding Warrants vested outstanding Warrants expected to vest Weighted Average Exercise Price, warrants outstanding Fair value of warrants granted Expected life Risk free interest rate - minimum Risk free interest rate - maximum Volatility - minimum Volatility - maximum Expected dividend yield Share based compensation expense Warrants granted Accrued expenses related parties Other Commitments [Table] Other Commitments [Line Items] 2024 2025 2026 2027 2028 Total Annual maintenance fee Severance payable Temple university license agreements. Accounts Payable - deferred [Member] Accounts payable - past due [Member] $0.02 - $0.24 [Member] [Default Label] $0.25 - $0.49 [Member] [Default Label] Assets, Current Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Operating Income (Loss) Shares, Outstanding Issuance of Stock and Warrants for Services or Claims Increase (Decrease) in Other Operating Assets Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Notes Payable Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Lessee, Operating Leases [Text Block] Income Tax Disclosure [Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Property, Plant and Equipment, Policy [Policy Text Block] Lessee, Leases [Policy Text Block] Income Tax, Policy [Policy Text Block] Operating Expenses Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Long-Term Debt, Gross Interest Expense, Debt Income Tax Expense (Benefit) Deferred Tax Liabilities, Deferred Expense Deferred Tax Assets, Valuation Allowance Debt Conversion, Converted Instrument, Amount Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Class of Warrant or Right, Exercise Price of Warrants or Rights Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding WarrantsIssuedShares Other Commitment EX-101.PRE 9 qsep-20231231_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2023
Apr. 01, 2024
Cover [Abstract]    
Document Type 10-K  
Amendment Flag false  
Document Annual Report true  
Document Transition Report false  
Document Period End Date Dec. 31, 2023  
Document Fiscal Period Focus FY  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 0-29185  
Entity Registrant Name QS ENERGY, INC.  
Entity Central Index Key 0001103795  
Entity Tax Identification Number 52-2088326  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 23902 FM 2978  
Entity Address, City or Town Tomball  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 77375  
City Area Code 775  
Local Phone Number 300-7647  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Public Float $ 21,268,000  
Entity Common Stock, Shares Outstanding   397,931,803
ICFR Auditor Attestation Flag false  
Document Financial Statement Error Correction [Flag] false  
Auditor Firm ID 572  
Auditor Name Weinberg & Company, P.A.  
Auditor Location Los Angeles, California  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash $ 70,000 $ 133,000
Prepaid expenses and other current assets 12,000 19,000
Total current assets 82,000 152,000
Property and equipment, net 2,000 6,000
Total assets 84,000 158,000
Current liabilities:    
Accounts payable-license agreements-past due 2,198,000 1,962,000
Accounts payable and accrued expenses 972,000 946,000
Convertible notes payable, net of discounts of $25,000 and $140,000, respectively: including $2,022,000 and $1,730,000, respectively, in default 2,101,000 1,865,000
PPP Loan payable 57,000 75,000
Total current liabilities 5,328,000 4,848,000
Total liabilities 5,328,000 4,848,000
Commitments and contingencies
Stockholders’ deficit    
Common stock, $0.001 par value: 500,000,000 shares authorized, 392,586,471 and 376,074,096 shares issued and outstanding at December 31, 2023 and 2022, respectively 392,587 376,075
Additional paid-in capital 119,729,413 119,075,925
Accumulated deficit (125,366,000) (124,142,000)
Total stockholders’ deficit (5,244,000) (4,690,000)
Total liabilities and stockholders’ deficit $ 84,000 $ 158,000
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 500,000,000 500,000,000
Common stock, shares issued 392,586,471 376,074,096
Common stock, shares outstanding 392,586,471 376,074,096
Convertible Notes Payable [Member]    
Debt Instrument [Line Items]    
Discounts on convertible notes payable $ 25,000 $ 140,000
Convertible notes in default $ 2,022,000 $ 1,730,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenues $ 0 $ 0
Operating expenses 688,000 765,000
Research and development expenses 203,000 486,000
Loss from operations (891,000) (1,251,000)
PPP loan debt forgiveness 0 63,000
Interest and financing expense (333,000) (360,000)
Net Loss $ (1,224,000) $ (1,548,000)
Net loss per common share, basic $ (0.00) $ (0.00)
Net loss per common share, diluted $ (0.00) $ (0.00)
Weighted average common shares outstanding, basic 385,561,786 361,790,243
Weighted average common shares outstanding, diluted 385,561,786 361,790,243
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 355,301 $ 118,065,699 $ (122,594,000) $ (4,173,000)
Beginning balance, shares at Dec. 31, 2021 355,300,222      
Common stock issued on conversion of notes payable $ 6,040 52,960 59,000
Common stock issued on conversion of notes payable, shares 6,040,049      
Warrants issued with convertible notes 283,000 283,000
Common stock issued on exercise of warrants $ 14,484 527,516 542,000
Common stock issued on exercise of warrants, shares 14,483,825      
Fair value of options and warrants issued as compensation 127,000 127,000
Common stock issued on exercise of options $ 250 19,750 20,000
Common stock issued on exercise of options, shares 250,000      
Net loss (1,548,000) (1,548,000)
Ending balance, value at Dec. 31, 2022 $ 376,075 119,075,925 (124,142,000) (4,690,000)
Ending balance, shares at Dec. 31, 2022 376,074,096      
Common stock issued on conversion of notes payable $ 15,129 334,871 350,000
Common stock issued on conversion of notes payable, shares 15,129,048      
Warrants issued with convertible notes 231,000 231,000
Common stock issued on exercise of warrants $ 1,383 50,617 52,000
Common stock issued on exercise of warrants, shares 1,383,327      
Fair value of warrants issued as compensation 37,000 37,000
Net loss (1,224,000) (1,224,000)
Ending balance, value at Dec. 31, 2023 $ 392,587 $ 119,729,413 $ (125,366,000) $ (5,244,000)
Ending balance, shares at Dec. 31, 2023 392,586,471      
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from Operating Activities    
Net loss $ (1,224,000) $ (1,548,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Fair value of warrants issued as compensation 37,000 127,000
Amortization of debt discount 103,000 149,000
Accrued interest expense 182,000 162,000
Depreciation 4,000 4,000
Gain on partial forgiveness of PPP note payable 0 (63,000)
Changes in operating assets and liabilities:    
Operating lease right of use asset 0 143,000
Prepaid expenses and other current assets 7,000 (5,000)
Accounts payable and accrued expenses 26,000 16,000
Accounts payable – license agreements 236,000 236,000
Operating lease liabilities 0 (144,000)
Net cash used in operating activities (629,000) (923,000)
Cash flows from investing activities    
Purchase of property and equipment 0 (1,000)
Net cash used in investing activities 0 (1,000)
Cash flows from financing activities    
Net proceeds from issuance of convertible notes and warrants 532,000 393,000
Net proceeds from exercise of warrants and options 52,000 562,000
Principal payment on PPP loan payable (18,000) (12,000)
Net cash provided by financing activities 566,000 943,000
Net increase (decrease) in cash (63,000) 19,000
Cash, beginning of period 133,000 114,000
Cash, end of period 70,000 133,000
Cash paid during the year for:    
Interest 0 0
Income Taxes 1,600 1,600
Non-cash investing and financing activities    
Conversion of convertible notes to common stock, net 350,000 59,000
Relative fair value of warrants associated with issued convertible notes $ 231,000 $ 283,000
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure [Table]    
Net Income (Loss) Attributable to Parent $ (1,224,000) $ (1,548,000)
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Insider Trading Arrangements
 3 Months Ended
Dec. 31, 2023
Insider Trading Arrangements [Line Items]  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Business and Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Business and Summary of Significant Accounting Policies

 

1. Business and Summary of Significant Accounting Policies

 

QS Energy, Inc. (“QS Energy”, “Company”) was incorporated on February 18, 1998, as a Nevada Corporation under the name Mandalay Capital Corporation. The Company changed its name to Save the World Air, Inc. on February 11, 1999. Effective August 11, 2015, the Company changed its name to QS Energy, Inc.

 

QS Energy develops and seeks to commercialize energy efficiency technologies that assist in meeting increasing global energy demands, improving the economics of oil transport, and reducing greenhouse gas emissions. The Company’s intellectual properties include a portfolio of domestic and international patents, a substantial portion of which have been developed in conjunction with and exclusively licensed from Temple University of Philadelphia, PA (“Temple”). QS Energy’s primary technology is called Applied Oil Technology (AOT), a commercial-grade crude oil pipeline transportation flow-assurance product.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the twelve-months ended December 31, 2023, the Company incurred a net loss of $1,224,000, used cash in operations of $629,000 and had a stockholders’ deficit of $5,244,000 as of December 31, 2023. In addition, as of December 31, 2023, thirty-eight notes payable with an aggregate balance of $2,022,000 and certain obligations to a former officer are past due. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

At December 31, 2023, the Company had cash on hand in the amount of $70,000. Management estimates that the current cash on hand will be sufficient to continue operations through April 2024. The AOT product is still in development and testing and has transitioned from laboratory testing to initial demonstration and continued testing in advance of our goal of seeking commercial acceptance and adoption by the upstream and midstream pipeline marketplace. QS Energy’s efforts in the foregoing regard have been substantially hampered by a lack of capital. The Company should be able to continue its efforts to commercialize its AOT product during 2024 only if sufficient capital is raised to do so. The Company can provide no assurances in its ability to raise the capital needed to continue efforts in 2024, or that any such capital will be available to it on acceptable terms and conditions.

 

Management is currently seeking additional funds, primarily through the issuance of debt and equity securities for cash to operate our business, including without limitation the expenses it will incur in connection with the license agreements with Temple; costs associated with product development and commercialization of the AOT technologies; costs to manufacture and ship the products; costs to design and implement an effective system of internal controls and disclosure controls and procedures; costs of maintaining our status as a public company by filing periodic reports with the SEC and costs required to protect our intellectual property. In addition, as discussed below, the Company has substantial contractual commitments, including without limitation salaries to our executive officers pursuant to employment agreements, and certain payments to a former officer and consulting fees, during the remainder of 2024 and beyond.

 

No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders in case of equity financing.

 

Inflation

 

Macroeconomic factors such as inflation, rising interest rates, governmental responses there to and possible recession caused thereby also add significant uncertainty to our operations and possible effects to the amount and type of financing available to the Company in the future.

 

Basis of Presentation

 

The accompanying consolidated financial statements and related notes include activities of the Company and have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).

 

The consolidated financial statements include the accounts of QS Energy Inc. and its wholly owned subsidiaries, QS Energy Pool, Inc. and STWA Asia Pte. Limited. Intercompany transactions and balances have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates include those related to assumptions used in valuing the issuance of convertible notes and the corresponding debt discount, assumptions used in valuing equity instruments issued for services, the realizability of deferred tax assets and the related valuation allowance, accruals for potential liabilities, and assumptions used in the determination of the Company’s liquidity. Actual results could differ from these estimates.

 

Revenue Recognition

 

Under its business plan, the Company anticipates the leasing of its primary technology. The Company will recognize lease revenue ratably over the life of the lease upon commencement of the lease. Revenue on future product sales will be recognized in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers.

 

Cash

 

Cash consists of demand deposits with banks. The Company holds no cash equivalents as of December 31, 2023 and 2022, respectively. The Company maintains its cash with domestic financial institutions. At times, cash balances may exceed federally insured limits of $250,000 per depositor at each financial institution. The Company believes that no significant concentration of credit risk exists with respect to these cash balances because of its assessment of the creditworthiness and financial viability of the financial institutions.

 

Property and Equipment

 

Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method based on the estimated useful lives of the assets, generally ranging from three to ten years. Expenditures for major renewals and improvements that extend the useful lives of property and equipment are capitalized. Expenditures for repairs and maintenance are charged to expense as incurred. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the lease term.

 

Impairment of Long-lived Assets

 

Our long-lived assets, such as property and equipment, are reviewed for impairment at least annually, or when events and circumstances indicate that depreciable or amortizable long-lived assets might be impaired and the undiscounted cash flows estimated to be generated by those assets are less than the carrying amount of those assets. When specific assets are determined to be unrecoverable, the cost basis of the asset is reduced to reflect the current value.

  

We use various assumptions in determining the current fair value of these assets, including future expected cash flows and discount rates, as well as other fair value measures. Our impairment loss calculations require us to apply judgment in estimating future cash flows, including forecasting useful lives of the assets and selecting the discount rate that reflects the risk inherent in future cash flows.

 

If actual results are not consistent with our assumptions and judgments used in estimating future cash flows and asset fair values, we may be exposed to future impairment losses that could be material to our results. Based upon management’s annual review, no impairments were recorded for the years ended December 31, 2023 and 2022.

 

Leases

 

The Company accounts for its leases in accordance with the guidance of ASC 842, Leases. The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments (see Note 3).

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes. The Company recognizes deferred tax assets and liabilities to reflect the estimated future tax effects, calculated at anticipated future tax rates, of future deductible or taxable amounts attributable to events that have been recognized on a cumulative basis in the financial statements. A valuation allowance related to a deferred tax asset is recorded when it is more likely than not that some portion of the deferred tax asset will not be realized.

 

Research and Development Costs

 

Research and development expenses relate primarily to the development, design, testing of preproduction prototypes and models, compensation, and consulting fees, and are expensed as incurred. Total research and development costs recorded during the years ended December 31, 2023 and 2022, amounted to $203,000 and $486,000, respectively.

 

Patent Costs

 

Patent costs consist of patent-related legal and filing fees. Due to the uncertainty associated with the successful development of our AOT product, all patent costs are expensed as incurred. During the years ended December 31, 2023 and 2022, patent costs were $30,000 and $13,000, respectively, and were included as part of operating expenses in the accompanying consolidated statements of operations. 

 

Stock-Based Compensation

 

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock-based payments to officers, directors, employees, and consultants by measuring the cost of services received in exchange for equity awards utilizing the grant date fair value of the awards, with the cost recognized as compensation expense on the straight-line basis in the Company’s financial statements over the vesting period of the awards.  Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services.

 

The fair value of the Company's stock options and warrants grant is estimated using the Black-Scholes Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or warrants, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes Option Pricing model could materially affect compensation expense recorded in future periods.

 

Fair Value of Financial Instruments

 

Accounting standards require certain assets and liabilities to be reported at fair value in the financial statements and provide a framework for establishing that fair value. Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, the Company considers the principal or most advantageous market in which it transacts and considers assumptions that market participants would use when pricing the asset or liability. The framework for determining fair value is based on a hierarchy that prioritizes the inputs and valuation techniques used to measure fair value:

 

Level 1—Quoted prices in active markets for identical assets or liabilities.

 

Level 2—Inputs, other than the quoted prices in active markets, are observable either directly or indirectly.

 

Level 3—Unobservable inputs based on the Company’s assumptions.

 

The Company is required to use observable market data if such data is available without undue cost and effort.

 

The carrying amounts for cash, accounts payable, accrued expenses and convertible notes payable approximate their fair value due to the short-term nature of such instruments.

  

Loss per Share

 

Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution, using the treasury stock method that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the loss of the Company. In computing diluted loss per share, the treasury stock method assumes that outstanding options and warrants are exercised, and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants.

 

For the years ended December 31, 2023 and 2022, the dilutive impact of outstanding stock options of 25,757,155 shares and 26,057,601 shares; outstanding warrants of 17,953,239 shares and 20,314,153 shares; and notes convertible into approximately 34,716,235 and 35,138,466 shares of our common stock, respectively, have been excluded because their impact on the loss per share is anti-dilutive.

 

Recent Accounting Pronouncements

 

Recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statement presentation or disclosures.

 

In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06). ASU 2020-06 simplifies the accounting for convertible debt by eliminating the beneficial conversion and cash conversion accounting models. Upon adoption of ASU 2020-06, convertible debt proceeds, unless issued with a substantial premium or an embedded conversion feature that is not clearly and closely related to the host contract, will no longer be allocated between debt and equity components. This modification will reduce the issue discount and result in less non-cash interest expense in financial statements. ASU 2020-06 also updates the earnings per share calculation and requires entities to assume share settlement when the convertible debt can be settled in cash or shares. ASU 2020-06 will be effective January 1, 2024, and a cumulative-effect adjustment to the opening balance of retained earnings is required upon adoption. Early adoption is permitted, but no earlier than January 1, 2021, including interim periods within that year. The adoption of ASU 2020-06 is not expected to have any impact on the Company’s consolidated financial statement presentation or disclosures subsequent to its adoption, with any effect being largely dependent on the composition and terms of outstanding financial instruments at the time of adoption.

 
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property and Equipment
 12 Months Ended
Dec. 31, 2023
Property, Plant and Equipment [Abstract]  
Property and Equipment

 

2. Property and Equipment

 

At December 31, 2023 and 2022, property and equipment consists of the following:

          
   December 31, 
   2023   2022 
         
Office equipment  $35,000   $35,000 
Furniture and fixtures   5,000    5,000 
Testing equipment   37,000    37,000 
Leasehold Improvements   25,000    25,000 
Subtotal   102,000    102,000 
Less accumulated depreciation   (100,000)   (96,000)
Total  $2,000   $6,000 

 

Depreciation expense for the years ended December 31, 2023 and 2022 was $4,000 and $4,000, respectively.

 
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases
 12 Months Ended
Dec. 31, 2023
Leases  
Leases

 

3. Leases

 

In June 2021, the Company commenced a lease for its corporate office space under an operating lease agreement, and recorded an operating lease right-of-use asset and the related operating lease liability of $165,000. At December 31, 2021, the balance of right-of-use asset was $143,000 and the balance of the lease liability was $144,000. During 2022, the Company amortized $33,000 of the right-of-use asset and paid $32,000 of the lease liability. On October 31, 2022, the Company entered into a lease amendment with the lessor of the space to terminate the lease and be released from lease obligation. The Company accounted for the cancellation of the lease by writing off the right-of-use asset of $110,000 and cancelling the operating lease liability of $112,000, which resulted in the gain on lease cancellation of $2,000 which is recorded in operating expense on the accompany consolidated statements of operations for the year ended December 31, 2022.

 

Lease with former related party

 

The Company’s former executive offices were formally located in Tomball, Texas and was leased for $5,000 per month under a month-to-month lease from JBL Energy Partners (“JBL”). JBL was an entity owned by Jason Lane, former Director and Chairman of the Board of the Company who resigned in April 2021, and the lease was terminated in April 2021 in connection with the resignation of Mr. Lane. As of December 31, 2023, the balance payable to JBL Energy Partners was $19,000 and is included as part of accounts payable and accrued expenses in the accompanying consolidated balance sheets. Commencing May 1, 2021, the Company agreed to continue to lease a portion of the Tomball facility from the new landlord on a month-to-month basis at $1,000 per month. The Company also rents a storage facility on a month-to-month basis for $250 per month.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Convertible Notes Payable
 12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Convertible Notes Payable

 

4. Convertible Notes Payable

          
   December 31, 
   2023   2022 
         
Convertible notes  $1,332,000   $1,393,000 
Accrued interest   794,000    612,000 
Total outstanding debt, including $2,022,000 and $1,730,000 in default at December 31, 2023 and 2022, respectively   2,126,000    2,005,000 
Less: Unamortized debt discount   (25,000)   (140,000)
Total outstanding debt, net of unamortized debt discount  $2,101,000   $1,865,000 

 

Convertible notes

 

At December 31, 2021, convertible notes payable totaled $1,137,000. During the year ended December 31, 2022, the Company issued convertible promissory notes in the aggregate of $432,000 for cash proceeds of $393,000, net of OID of $39,000. The notes are unsecured, with a 10% original issue discount, mature in twelve months from issuance, and are convertible into 14,409,995 shares of the Company’s common stock at $0.03 per share. In addition, the Company granted the note holders warrants to purchase 14,409,995 shares of the Company’s common stock with a relative value of $283,000. The warrants are fully vested, and expire one year from the date of issuance. The Company determined the fair value of the warrants by using a Black-Scholes option pricing model, with the following assumptions: expected term of 1.0 year, stock price of $0.09, exercise price of $0.04, volatility of 212%, risk-free rate of 4.05%, and no forfeiture rate. Also during 2022, convertible notes of $176,000 and accrued interest of $2,000, net of unamortized discount of $119,000, were converted into 6,040,049 shares of common stock. At December 31, 2022, total outstanding convertible notes payable totaled $1,393,000.

 

During the year ended December 31, 2023, the Company issued convertible promissory notes in the aggregate of $585,000 for cash proceeds of $532,000, net of OID of $53,000. The notes are unsecured, with a 10% original issue discount, mature in twelve months from issuance, and are convertible into 11,715,748 shares of the Company’s common stock at $0.05 per share. In addition, the Company granted the note holders warrants to purchase 11,715,748 shares of the Company’s common stock with a relative fair value of $231,000. The warrants are fully vested and expire one year from the date of issuance. The Company determined the fair value of the warrants by using a Black-Scholes option pricing model, with the following assumptions: expected term of 1.0 year, stock price of $0.06 to $0.07, exercise price of $0.07, volatility of 169% to 206%, risk-free rate of 4.64% to 5.46%, and no forfeiture rate. Also during 2023, convertible notes of $646,000, net of unamortized discount of $296,000, were converted into 15,129,048 shares of common stock. At December 31, 2023, total outstanding convertible notes payable totaled $1,332,000. As of December 31, 2023, convertible notes payable and accrued interest are convertible into 34,716,235 shares of common stock at conversion rates ranging from $0.02 to $0.48 per share. As of December 31, 2023, a total of 38 convertible notes and accrued interest in the aggregate of $2,022,000 have reached maturity and are past due. The Company is currently in negotiations with these noteholders to settle these past due notes payable.

 

Accrued interest

 

At December 31, 2021, accrued interest on convertible notes payable totaled $435,000. During the year ended December 31, 2022, accrued interest of $162,000 was recorded, and accrued interest of $2,000 was converted into shares of common stock. At December 31, 2022, accrued interest on convertible notes payable totaled $612,000.

 

During the year ended December 31, 2023, accrued interest of $182,000 was recorded. At December 31, 2023, accrued interest on convertible notes payable totaled $794,000.

 

Debt discount

 

At December 31, 2021, the unamortized debt discount was $86,000. During the year ended December 31, 2022, debt discount of $322,000 was recorded for the relative fair value of warrants of $283,000 and OID of $39,000, debt discount amortization of $149,000 was recorded, and $119,000 of debt discount was removed and included in the carrying amount of related convertible notes payable that were converted into shares of common stock. At December 31, 2022, the unamortized debt discount was $140,000.

 

During the year ended December 31, 2023, debt discount of $284,000 was recorded for the relative fair value of warrants of $231,000 and OID of $53,000, debt discount amortization of $103,000 was recorded, and $296,000 of debt discount was removed and included in the carrying amount of related convertible notes payable that were converted into shares of common stock. At December 31, 2023, the unamortized debt discount was $25,000.

 
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
PPP Loan Payable
 12 Months Ended
Dec. 31, 2023
Ppp Loan Payable  
PPP Loan Payable

 

5. PPP Loan Payable

 

In June 2020, the Company was granted a loan (the “PPP loan”) from Cadence Bank in the aggregate amount of $151,000, pursuant to the Paycheck Protection Program (the “PPP”) under the CARES Act.

 

The PPP loan agreement matures on June 18, 2025, bears interest at a rate of 1% per annum, and is unsecured and guaranteed by the U.S. Small Business Administration (“SBA”). The Company applied ASC 470, Debt, to account for the PPP loan. The PPP loan may be prepaid at any time prior to maturity with no prepayment penalties. Funds from the PPP loan may only be used for qualifying expenses as described in the CARES Act, including qualifying payroll costs, qualifying group health care benefits, qualifying rent and debt obligations, and qualifying utilities. Management believes the entire loan amount has been used for qualifying expenses and all of the conditions outlined in the PPP loan program were adhered to by the Company. Under the terms of the PPP, certain amounts of the loan may be forgiven if they are used for qualifying expenses.

 

At December 31, 2021, the balance of the PPP loan was $151,000. During the year ended December 31, 2022, the Company received notice that $63,000 of the loan was forgiven, and recognized a gain on forgiveness of PPP loan of $63,000. During 2022, the Company paid $12,000 of principal, and at December 31, 2022, the balance of the PPP loan was $75,000. During the year ended December 31, 2023, the Company paid $18,000 of principal on the PPP loan, and at December 31, 2023, the balance of the PPP loan was $57,000. The terms of the PPP loan provide for customary events of default including, among other things, payment defaults, breach of representations and warranties, and insolvency events. The Company was in compliance with the terms of the PPP loan as of December 31, 2023.

 
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Research and Development
 12 Months Ended
Dec. 31, 2023
Research and Development [Abstract]  
Research and Development

 

6. Research and Development

 

The Company constructs, develops and tests the AOT technology with internal resources and through the assistance of various third-party entities. Costs incurred and expensed include fees such as license fees, purchase of test equipment, viscometers, SCADA systems, computer equipment, direct costs related to AOT equipment manufacture and installation, payroll and other related equipment and various logistical expenses for the purposes of evaluating and testing the Company’s AOT prototypes.

 

Costs incurred for research and development are expensed as incurred. Purchased materials that do not have an alternative future use are also expensed. Furthermore, costs incurred in the construction of prototypes with no certainty of any alternative future use and established commercial uses are also expensed.

 

For the years ended December 31, 2023 and 2022, our research and development expenses were $203,000 and $486,000, respectively.

 

AOT Prototypes

 

During the years ended December 31, 2023 and 2022, the Company incurred total expenses of $14,000 and $298,000, respectively, in the manufacture and testing of the AOT prototype equipment. These expenses have been reflected as part of Research and Development expenses on the accompanying consolidated statements of operations.

 

Temple University Licensing Agreement-amount past due

 

On August 1, 2011, the Company and Temple University (“Temple”) entered into two (2) Exclusive License Agreements (collectively, the “License Agreements”) relating to Temple’s patent applications, patents and technical information pertaining to technology associated with an electric and/or magnetic field assisted fuel injector system (the “First Temple License”), and to technology to reduce crude oil viscosity (the “Second Temple License”). The License Agreements are exclusive, and the territory licensed to the Company is worldwide and replace previously issued License Agreements.

 

Pursuant to the two licensing agreements, the Company paid Temple a non-refundable license maintenance fee of $300,000, and agreed to pay (i) annual maintenance fees of $187,500; (ii) royalty fee ranging from 4% up to 7% from revenues generated from the licensing agreements; and (iii) 25% of all revenues generated from sub-licensees to secure or maintain the sub-license or option thereon. The term of the licenses commenced in August 2011 and will expire upon expiration of the patents. The agreements can also be terminated by either party upon notification under terms of the licensing agreements or if the Company ceases the development of the patent or fails to commercialize the patent rights.

 

Total expenses recognized during each twelve-month period ended December 31, 2023 and 2022 pursuant to these two License Agreements amounted to $188,000 and has been reflected in Research and Development expenses on the accompanying consolidated statements of operations. In the twelve-month periods ended December 31, 2023 and 2022, the Company also recognized penalty interest on past-due balances of $48,000 and $48,000, respectively, which is included as part of interest and financing expense in the accompanying consolidated statements of operations.

 

As of December 31, 2023 and 2022, total unpaid fees due to Temple pursuant to these agreements are $2,198,000 and $1,962,000, respectively, which are included as part of Accounts Payable – license agreements in the accompanying consolidated balance sheets. With regards to the unpaid fees to Temple, a total of $135,000 are deferred until such time the Company achieves a revenue milestone of $835,000 or upon termination of the licensing agreements and the remaining $2,063,000 are deemed past due. The Company is currently in discussions with Temple to settle or cure the past due balance.

 

No revenues were earned from the two License Agreements during the year ended December 31, 2023 and 2022.

 
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes

  

7. Income Taxes

 

The Company did not provide for any Federal and State income tax for the years ended December 31, 2023 and 2022 due to the Company’s net losses. A reconciliation of income taxes with the amounts computed at the statutory federal rate follows:

         
   December 31, 
   2023   2022 
Computed tax provision (benefit) at federal statutory rate (21%)  $(70,000)  $(167,000)
Valuation allowance   70,000    167,000 
Income tax provision  $–   $– 

 

The deferred tax assets and deferred tax liabilities recorded on the balance sheet are as follows:

         
   December 31, 
   2023   2022 
Net operating loss carry forwards  $12,698,000   $13,124,000 
Stock based compensation   (8,000)   (27,000)
Other temporary differences   (57,000)   35,000 
Valuation allowance   (12,633,000)   (13,132,000)
Total deferred taxes net of valuation allowance  $–   $– 

 

As of December 31, 2023, the Company had net operating losses available for carry forward for state and federal tax purposes of approximately $60 million expiring through 2044. These carry forward benefits will be subject to annual limitations due to the ownership change limitations imposed by the Internal Revenue Code and similar state provisions. The annual limitation, if imposed, may result in the expiration of net operating losses before utilization.

 

As of December 31, 2023, the Company recorded a valuation allowance of $12,633,000 for its deferred tax assets since the Company believes that such assets did not meet the more likely than not criteria to be recoverable through projected future profitable operations in the foreseeable future. This valuation is based on the federal corporate tax rate of 21%.

 

Effective January 1, 2007, the Company adopted FASB guidance that addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under this guidance, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The FASB also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. As of December 31, 2023 and 2022, the Company does not have a liability for unrecognized tax benefits.

 

The Company files income tax returns in the U.S. federal jurisdiction and the State of Texas. The Company is subject to U.S. federal or state income tax examinations by tax authorities for years after 2002. During the periods open to examination, the Company has net operating loss and tax credit carry forwards for U.S. federal and state tax purposes that have attributes from closed periods. Since these net operating losses and tax credit carry forwards may be utilized in future periods, they remain subject to examination. The Company’s policy is to record interest and penalties on uncertain tax provisions as income tax expense. As of December 31, 2023, the Company has no accrued interest or penalties related to uncertain tax positions. The Company believes that it has not taken any uncertain tax positions that would impact its consolidated financial statements as of December 31, 2023 and 2022. 

 
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Common Stock
 12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Common Stock

 

8. Common Stock

 

Year Ending December 31, 2023

 

During the year ended December 31, 2023, the Company issued an aggregate of 16,512,375 shares of its common stock as follows:

 

  · The Company issued 15,129,048 shares of its common stock upon the conversion of $646,000 in convertible notes at $0.03 to $0.05 per share, net of unamortized discount of $296,000.

 

  · The Company issued 1,383,327 shares of its common stock upon the exercise of warrants of $52,000, at $0.02 to $0.04 per share.

 

Year Ending December 31, 2022

 

During the year ended December 31, 2022, the Company issued an aggregate of 20,773,874 shares of its common stock as follows:

 

  · The Company issued 6,040,049 shares of its common stock upon the conversion of $178,000 in convertible notes at $0.02 to $0.03 per share, net of unamortized discount of $119,000.

 

  · The Company issued 14,483,825 shares of its common stock upon the exercise of warrants of $542,000, at $$0.03 to $0.04 per share.

 

  · The Company issued 250,000 shares of its common stock upon the exercise of options of $20,000, at $0.08 per share.

 
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Options and Warrants
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Stock Options and Warrants

 

9. Stock Options and Warrants

 

The Company periodically issues stock options and warrants to employees and non-employees in capital raising transactions, for services and for financing costs. Options and warrants vest and expire according to terms established at the grant date.

 

Options

 

Employee options vest according to the terms of the specific grant and expire from 5 to 10 years from date of grant. The weighted average, remaining contractual life of employee and non-employee options outstanding at December 31, 2023 was 3.9 years. Stock option activity for the period January 1, 2022 to December 31, 2023, was as follows:

          
   Options  

Weighted Avg.

Exercise Price

 
Options outstanding, December 31, 2021   31,080,601   $0.17 
Options granted   –    – 
Options exercised   (250,000)   0.08 
Options cancelled   (4,773,000)   0.26 
Options outstanding, December 31, 2022   26,057,601   $0.15 
Options granted   –    – 
Options exercised   –    – 
Options cancelled   (300,446)   0.72 
Options outstanding, December 31, 2023   25,757,155   $0.14 

 

The weighted average exercise prices, remaining contractual lives for options granted, exercisable, and expected to vest as of December 31, 2023, were as follows:

 

As of December 31, 2023, the market price of the Company’s stock was $0.06 per share. At December 31, 2023 the aggregate intrinsic value of the options outstanding was $115,000. Future unamortized compensation expense on the unvested outstanding options at December 31, 2023 is $0.

                       
   Outstanding Options   Exercisable Options 
Option
Exercise Price
Per Share		  Shares   Life
(Years)		 

Weighted

Average

Exercise Price

   Shares  

Weighted

Average

Exercise Price

 
$0.02 - $0.24   22,055,551   4.1  $0.10    22,055,551   $0.10 
$0.25 - $0.49   3,238,552   2.7   0.36    3,238,552    0.36 
$0.50 - $0.99   463,052   0.4   0.85    463,052    0.85 
    25,757,155   3.9  $0.14    25,757,155   $0.14 

 

Year Ending December 31, 2023

 

During the year ended December 31, 2023 did not issue options to employees, officers or members of the Board of Directors.

 

Year Ending December 31, 2022

 

During the year ended December 31, 2022, the Company did not issue options to employees, officers or members of the Board of Directors.

 

Warrants

 

The following table summarizes certain information about the Company’s stock purchase warrants.

          
   Warrants  

Weighted Avg.

Exercise Price

 
Warrants outstanding, December 31, 2021   19,977,149   $0.04 
Warrants granted   16,426,657    0.04 
Warrants exercised   (14,483,825)   0.04 
Warrants expired   (1,605,828)   0.04 
Warrants outstanding, December 31, 2022   20,314,153   $0.04 
Warrants granted   12,482,410    0.07 
Warrants exercised   (1,383,327)   0.04 
Warrants expired   (13,459,997)   0.04 
Warrants outstanding, December 31, 2023   17,953,239   $0.06 

 

 At December 31, 2023 the price of the Company’s common stock was $0.06 per share and the aggregate intrinsic value of the warrants outstanding was $145,000. As of December 31, 2023, 17,919,906 warrants were fully vested and 33,333 warrants vest in January 2024.

                       
   Outstanding Warrants   Exercisable Warrants 
Warrant
Exercise Price
Per Share		  Shares   Life
(Years)		 

Weighted

Average

Exercise Price

   Shares  

Weighted

Average

Exercise Price

 
$0.02 - $0.24   17,883,239   0.6  $0.06    17,849,906   $0.06 
$0.25 - $0.49   –   –   –    –    – 
$0.50 - $1.00   70,000   0.3   0.80    70,000    0.80 
    17,953,239   0.6  $0.06    17,919,906   $0.06 

 

Year Ending December 31, 2023

 

  · In March through September 2023, pursuant to terms of convertible notes issued, the Company granted warrants to purchase 11,715,748 shares of common stock with an exercise price of $0.07 per share, vesting immediately upon grant and expiring one year from the date of grant.
     
  · In January through December 2023, pursuant to terms of consulting agreements, the Company granted warrants to purchase 766,662 shares of common stock with an exercise price of $0.03 to $0.13 per share, vesting up to one month from the date of grant and expiring one to two years from the date of grant. Total fair value of these options at grant date was approximately $35,000 determined using the Black-Scholes Option Pricing model with the following assumptions: life of 1 to 2 years; risk free interest rate of 0.73% to 5.07%; volatility of 182% to 245%; and dividend yield of 0%. During the year ended December 31, 2023, the Company recognized compensation expense of $37,000 based on the fair value of the warrants that vested.

 

Year Ending December 31, 2022

  

  · In September 2022, pursuant to terms of convertible notes issued, the Company granted warrants to purchase 14,409,995 shares of common stock with an exercise price of $0.04 per share, vesting immediately upon grant and expiring one year from the date of grant.
     
  · In January through December 2022, pursuant to terms of consulting agreements, the Company granted warrants to purchase 2,016,662 shares of common stock with an exercise price of $0.02 to $0.09 per share, vesting up to one month from the date of grant and expiring two to five years from the date of grant. Total fair value of these options at grant date was approximately $127,000 determined using the Black-Scholes Option Pricing model with the following assumptions: life of 2 to 5 years; risk free interest rate of 0.13% to 4.49%; volatility of 193% to 245%; and dividend yield of 0%. During the year ended December 31, 2022, the Company recognized compensation expense of $127,000 based on the fair value of the warrants that vested.

 
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Party Transactions
 12 Months Ended
Dec. 31, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

 

10. Related Party Transactions

 

Accrued Expenses – Related Party

 

As of December 31, 2023 and 2022, total accrued expenses – related parties amounted to $6,000 and $6,000 and are included in accrued expense on the accompany consolidated balance sheet. The accrued expenses – related parties consisted of unused vacation of officers, unreimbursed out-of-pocket expenses incurred by officers, and unpaid board and committee fees to members of the Company’s Board of Directors.

 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies
 12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

 

11. Commitments and Contingencies

 

We are involved in certain legal proceedings that arise from time to time in the ordinary course of our business. Except for income tax contingencies, we record accruals for contingencies to the extent that our management concludes that the occurrence is probable and that the related amounts of loss can be reasonably estimated. Legal expenses associated with the contingency are expensed as incurred. There is no current or pending litigation of any significance with the exception of the matters that have arisen under, and are being handled in, the normal course of business.

 

Contractual Commitments

 

The Company’s contractual commitments for future periods, licensing agreements and minimum guaranteed compensation payments as described in the following table and associated footnotes:

               
Year ending
December 31,		  License
Agreements (1)		   Compensation
Agreements (2)		   Total
Obligations		 
2024  $187,500   $197,000   $384,500 
2025   187,500    –    187,500 
2026   187,500    –    187,500 
2027   187,500    –    187,500 
2028   187,500    –    187,500 
Total  $937,500   $197,000   $1,134,500 

 

  (1)

Consists of license maintenance fees to Temple University in the amount of $187,500 paid annually through the life of the underlying patents or until otherwise terminated by either party (see Note 6).

     
  (2) Consists of certain contractually provided benefits to a former executive officer pursuant to a severance agreement and amendments thereto. The balance due as of December 31, 2023, of $197,000 is included as part of Accounts payable and accrued expenses in the accompanying consolidated balance sheets, of which the total amount is in arrears. The former executive officer disputes the amount identified in the above table, claiming the above amount is less than the amount to which he believes he is owed. Absent an agreement to settle the dispute, and in the event the former executive officer elects to initiate litigation regarding the dispute, including claims for interest and penalties to which the former executive officer believes he is entitled, the Company has reserved, and if necessary and appropriate will assert, all factual and legal defenses, counter-claims, rights, and remedies it may have in any such suit.

 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Subsequent Events
 12 Months Ended
Dec. 31, 2023
Subsequent Events [Abstract]  
Subsequent Events

 

12. Subsequent Events

 

In January through March 2024, pursuant to terms of a consulting agreement, the Company granted warrants to purchase 99,999 shares of common stock with an exercise price of $0.05 to $0.07 per share, vesting one month from grant and expiring two years from the date of grant.

 

In January through March 2024, the Company issued convertible promissory notes in the aggregate of $199,000 for cash proceeds of $181,000, net of OID $18,000. The notes are unsecured, have an implied interest rate of 10%, mature in twelve months from issuance, and are convertible into 3,980,900 shares of the Company’s common stock at $0.05 per share. In addition, the Company granted the note holders warrants to purchase 3,980,900 shares of the Company’s common stock at $0.07 per share. The warrants are fully vested and expire one year from the date of issuance.

 

In February 2024, the Company issued 133,333 shares of its common stock upon the exercise of warrants for proceeds of $4,000 at an exercise price of $0.03 to $0.04 per share.

 

In February through March 2024, the Company issued 3,212,000 shares of its common stock upon the conversion of notes payable at a conversion price of $0.05 per share.

 

In March 2024, pursuant to terms of a consulting agreement, the Company issued 2,000,000 shares of its common stock.

 

 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Business and Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Going Concern

Going Concern

 

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the twelve-months ended December 31, 2023, the Company incurred a net loss of $1,224,000, used cash in operations of $629,000 and had a stockholders’ deficit of $5,244,000 as of December 31, 2023. In addition, as of December 31, 2023, thirty-eight notes payable with an aggregate balance of $2,022,000 and certain obligations to a former officer are past due. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

At December 31, 2023, the Company had cash on hand in the amount of $70,000. Management estimates that the current cash on hand will be sufficient to continue operations through April 2024. The AOT product is still in development and testing and has transitioned from laboratory testing to initial demonstration and continued testing in advance of our goal of seeking commercial acceptance and adoption by the upstream and midstream pipeline marketplace. QS Energy’s efforts in the foregoing regard have been substantially hampered by a lack of capital. The Company should be able to continue its efforts to commercialize its AOT product during 2024 only if sufficient capital is raised to do so. The Company can provide no assurances in its ability to raise the capital needed to continue efforts in 2024, or that any such capital will be available to it on acceptable terms and conditions.

 

Management is currently seeking additional funds, primarily through the issuance of debt and equity securities for cash to operate our business, including without limitation the expenses it will incur in connection with the license agreements with Temple; costs associated with product development and commercialization of the AOT technologies; costs to manufacture and ship the products; costs to design and implement an effective system of internal controls and disclosure controls and procedures; costs of maintaining our status as a public company by filing periodic reports with the SEC and costs required to protect our intellectual property. In addition, as discussed below, the Company has substantial contractual commitments, including without limitation salaries to our executive officers pursuant to employment agreements, and certain payments to a former officer and consulting fees, during the remainder of 2024 and beyond.

 

No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders in case of equity financing.

 
Inflation

Inflation

 

Macroeconomic factors such as inflation, rising interest rates, governmental responses there to and possible recession caused thereby also add significant uncertainty to our operations and possible effects to the amount and type of financing available to the Company in the future.

 
Basis of Presentation

Basis of Presentation

 

The accompanying consolidated financial statements and related notes include activities of the Company and have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).

 

The consolidated financial statements include the accounts of QS Energy Inc. and its wholly owned subsidiaries, QS Energy Pool, Inc. and STWA Asia Pte. Limited. Intercompany transactions and balances have been eliminated in consolidation.

 
Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates include those related to assumptions used in valuing the issuance of convertible notes and the corresponding debt discount, assumptions used in valuing equity instruments issued for services, the realizability of deferred tax assets and the related valuation allowance, accruals for potential liabilities, and assumptions used in the determination of the Company’s liquidity. Actual results could differ from these estimates.

 
Revenue Recognition

Revenue Recognition

 

Under its business plan, the Company anticipates the leasing of its primary technology. The Company will recognize lease revenue ratably over the life of the lease upon commencement of the lease. Revenue on future product sales will be recognized in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers.

 
Cash

Cash

 

Cash consists of demand deposits with banks. The Company holds no cash equivalents as of December 31, 2023 and 2022, respectively. The Company maintains its cash with domestic financial institutions. At times, cash balances may exceed federally insured limits of $250,000 per depositor at each financial institution. The Company believes that no significant concentration of credit risk exists with respect to these cash balances because of its assessment of the creditworthiness and financial viability of the financial institutions.

 
Property and Equipment

Property and Equipment

 

Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method based on the estimated useful lives of the assets, generally ranging from three to ten years. Expenditures for major renewals and improvements that extend the useful lives of property and equipment are capitalized. Expenditures for repairs and maintenance are charged to expense as incurred. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the lease term.

 
Impairment of Long-lived Assets

Impairment of Long-lived Assets

 

Our long-lived assets, such as property and equipment, are reviewed for impairment at least annually, or when events and circumstances indicate that depreciable or amortizable long-lived assets might be impaired and the undiscounted cash flows estimated to be generated by those assets are less than the carrying amount of those assets. When specific assets are determined to be unrecoverable, the cost basis of the asset is reduced to reflect the current value.

  

We use various assumptions in determining the current fair value of these assets, including future expected cash flows and discount rates, as well as other fair value measures. Our impairment loss calculations require us to apply judgment in estimating future cash flows, including forecasting useful lives of the assets and selecting the discount rate that reflects the risk inherent in future cash flows.

 

If actual results are not consistent with our assumptions and judgments used in estimating future cash flows and asset fair values, we may be exposed to future impairment losses that could be material to our results. Based upon management’s annual review, no impairments were recorded for the years ended December 31, 2023 and 2022.

 
Leases

Leases

 

The Company accounts for its leases in accordance with the guidance of ASC 842, Leases. The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments (see Note 3).

 
Income Taxes

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes. The Company recognizes deferred tax assets and liabilities to reflect the estimated future tax effects, calculated at anticipated future tax rates, of future deductible or taxable amounts attributable to events that have been recognized on a cumulative basis in the financial statements. A valuation allowance related to a deferred tax asset is recorded when it is more likely than not that some portion of the deferred tax asset will not be realized.

 
Research and Development Costs

Research and Development Costs

 

Research and development expenses relate primarily to the development, design, testing of preproduction prototypes and models, compensation, and consulting fees, and are expensed as incurred. Total research and development costs recorded during the years ended December 31, 2023 and 2022, amounted to $203,000 and $486,000, respectively.

 
Patent Costs

Patent Costs

 

Patent costs consist of patent-related legal and filing fees. Due to the uncertainty associated with the successful development of our AOT product, all patent costs are expensed as incurred. During the years ended December 31, 2023 and 2022, patent costs were $30,000 and $13,000, respectively, and were included as part of operating expenses in the accompanying consolidated statements of operations. 

 
Stock-Based Compensation

Stock-Based Compensation

 

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock-based payments to officers, directors, employees, and consultants by measuring the cost of services received in exchange for equity awards utilizing the grant date fair value of the awards, with the cost recognized as compensation expense on the straight-line basis in the Company’s financial statements over the vesting period of the awards.  Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services.

 

The fair value of the Company's stock options and warrants grant is estimated using the Black-Scholes Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or warrants, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes Option Pricing model could materially affect compensation expense recorded in future periods.

 
Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

Accounting standards require certain assets and liabilities to be reported at fair value in the financial statements and provide a framework for establishing that fair value. Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, the Company considers the principal or most advantageous market in which it transacts and considers assumptions that market participants would use when pricing the asset or liability. The framework for determining fair value is based on a hierarchy that prioritizes the inputs and valuation techniques used to measure fair value:

 

Level 1—Quoted prices in active markets for identical assets or liabilities.

 

Level 2—Inputs, other than the quoted prices in active markets, are observable either directly or indirectly.

 

Level 3—Unobservable inputs based on the Company’s assumptions.

 

The Company is required to use observable market data if such data is available without undue cost and effort.

 

The carrying amounts for cash, accounts payable, accrued expenses and convertible notes payable approximate their fair value due to the short-term nature of such instruments.

  
Loss per Share

Loss per Share

 

Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution, using the treasury stock method that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the loss of the Company. In computing diluted loss per share, the treasury stock method assumes that outstanding options and warrants are exercised, and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants.

 

For the years ended December 31, 2023 and 2022, the dilutive impact of outstanding stock options of 25,757,155 shares and 26,057,601 shares; outstanding warrants of 17,953,239 shares and 20,314,153 shares; and notes convertible into approximately 34,716,235 and 35,138,466 shares of our common stock, respectively, have been excluded because their impact on the loss per share is anti-dilutive.

 
Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

Recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statement presentation or disclosures.

 

In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06). ASU 2020-06 simplifies the accounting for convertible debt by eliminating the beneficial conversion and cash conversion accounting models. Upon adoption of ASU 2020-06, convertible debt proceeds, unless issued with a substantial premium or an embedded conversion feature that is not clearly and closely related to the host contract, will no longer be allocated between debt and equity components. This modification will reduce the issue discount and result in less non-cash interest expense in financial statements. ASU 2020-06 also updates the earnings per share calculation and requires entities to assume share settlement when the convertible debt can be settled in cash or shares. ASU 2020-06 will be effective January 1, 2024, and a cumulative-effect adjustment to the opening balance of retained earnings is required upon adoption. Early adoption is permitted, but no earlier than January 1, 2021, including interim periods within that year. The adoption of ASU 2020-06 is not expected to have any impact on the Company’s consolidated financial statement presentation or disclosures subsequent to its adoption, with any effect being largely dependent on the composition and terms of outstanding financial instruments at the time of adoption.

 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property and Equipment (Tables)
 12 Months Ended
Dec. 31, 2023
Property, Plant and Equipment [Abstract]  
Schedule of property and equipment
          
   December 31, 
   2023   2022 
         
Office equipment  $35,000   $35,000 
Furniture and fixtures   5,000    5,000 
Testing equipment   37,000    37,000 
Leasehold Improvements   25,000    25,000 
Subtotal   102,000    102,000 
Less accumulated depreciation   (100,000)   (96,000)
Total  $2,000   $6,000 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Convertible Notes Payable (Tables)
 12 Months Ended
Dec. 31, 2023
Debt Disclosure [Abstract]  
Schedule of convertible notes payable
          
   December 31, 
   2023   2022 
         
Convertible notes  $1,332,000   $1,393,000 
Accrued interest   794,000    612,000 
Total outstanding debt, including $2,022,000 and $1,730,000 in default at December 31, 2023 and 2022, respectively   2,126,000    2,005,000 
Less: Unamortized debt discount   (25,000)   (140,000)
Total outstanding debt, net of unamortized debt discount  $2,101,000   $1,865,000 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of reconciliation of income taxes
         
   December 31, 
   2023   2022 
Computed tax provision (benefit) at federal statutory rate (21%)  $(70,000)  $(167,000)
Valuation allowance   70,000    167,000 
Income tax provision  $–   $– 
Schedule of deferred income taxes
         
   December 31, 
   2023   2022 
Net operating loss carry forwards  $12,698,000   $13,124,000 
Stock based compensation   (8,000)   (27,000)
Other temporary differences   (57,000)   35,000 
Valuation allowance   (12,633,000)   (13,132,000)
Total deferred taxes net of valuation allowance  $–   $– 
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Options and Warrants (Tables)
 12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Stock options outstanding
          
   Options  

Weighted Avg.

Exercise Price

 
Options outstanding, December 31, 2021   31,080,601   $0.17 
Options granted   –    – 
Options exercised   (250,000)   0.08 
Options cancelled   (4,773,000)   0.26 
Options outstanding, December 31, 2022   26,057,601   $0.15 
Options granted   –    – 
Options exercised   –    – 
Options cancelled   (300,446)   0.72 
Options outstanding, December 31, 2023   25,757,155   $0.14 
Schedule of options outstanding by per share price
                       
   Outstanding Options   Exercisable Options 
Option
Exercise Price
Per Share		  Shares   Life
(Years)		 

Weighted

Average

Exercise Price

   Shares  

Weighted

Average

Exercise Price

 
$0.02 - $0.24   22,055,551   4.1  $0.10    22,055,551   $0.10 
$0.25 - $0.49   3,238,552   2.7   0.36    3,238,552    0.36 
$0.50 - $0.99   463,052   0.4   0.85    463,052    0.85 
    25,757,155   3.9  $0.14    25,757,155   $0.14 
Schedule of warrants activity
          
   Warrants  

Weighted Avg.

Exercise Price

 
Warrants outstanding, December 31, 2021   19,977,149   $0.04 
Warrants granted   16,426,657    0.04 
Warrants exercised   (14,483,825)   0.04 
Warrants expired   (1,605,828)   0.04 
Warrants outstanding, December 31, 2022   20,314,153   $0.04 
Warrants granted   12,482,410    0.07 
Warrants exercised   (1,383,327)   0.04 
Warrants expired   (13,459,997)   0.04 
Warrants outstanding, December 31, 2023   17,953,239   $0.06 
Schedule of warrants outstanding by per share price
                       
   Outstanding Warrants   Exercisable Warrants 
Warrant
Exercise Price
Per Share		  Shares   Life
(Years)		 

Weighted

Average

Exercise Price

   Shares  

Weighted

Average

Exercise Price

 
$0.02 - $0.24   17,883,239   0.6  $0.06    17,849,906   $0.06 
$0.25 - $0.49   –   –   –    –    – 
$0.50 - $1.00   70,000   0.3   0.80    70,000    0.80 
    17,953,239   0.6  $0.06    17,919,906   $0.06 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies (Tables)
 12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Schedule of contractual commitments
               
Year ending
December 31,		  License
Agreements (1)		   Compensation
Agreements (2)		   Total
Obligations		 
2024  $187,500   $197,000   $384,500 
2025   187,500    –    187,500 
2026   187,500    –    187,500 
2027   187,500    –    187,500 
2028   187,500    –    187,500 
Total  $937,500   $197,000   $1,134,500 

 

  (1)

Consists of license maintenance fees to Temple University in the amount of $187,500 paid annually through the life of the underlying patents or until otherwise terminated by either party (see Note 6).

     
  (2) Consists of certain contractually provided benefits to a former executive officer pursuant to a severance agreement and amendments thereto. The balance due as of December 31, 2023, of $197,000 is included as part of Accounts payable and accrued expenses in the accompanying consolidated balance sheets, of which the total amount is in arrears. The former executive officer disputes the amount identified in the above table, claiming the above amount is less than the amount to which he believes he is owed. Absent an agreement to settle the dispute, and in the event the former executive officer elects to initiate litigation regarding the dispute, including claims for interest and penalties to which the former executive officer believes he is entitled, the Company has reserved, and if necessary and appropriate will assert, all factual and legal defenses, counter-claims, rights, and remedies it may have in any such suit.
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Business and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]      
Net loss $ 1,224,000 $ 1,548,000  
Cash flow from operations 629,000 923,000  
Stockholders' deficit 5,244,000 4,690,000 $ 4,173,000
Notes payable 2,022,000    
Cash on Hand 70,000 133,000  
Asset impairment 0 0  
Research and development costs $ 203,000 $ 486,000  
Stock Options [Member]      
Finite-Lived Intangible Assets [Line Items]      
Antidilutive shares 25,757,155 26,057,601  
Warrants [Member]      
Finite-Lived Intangible Assets [Line Items]      
Antidilutive shares 17,953,239 20,314,153  
Convertible Notes [Member]      
Finite-Lived Intangible Assets [Line Items]      
Antidilutive shares 34,716,235 35,138,466  
Patent Costs [Member]      
Finite-Lived Intangible Assets [Line Items]      
Operating expenses $ 30,000 $ 13,000  
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property and Equipment (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 102,000 $ 102,000
Accumulated depreciation (100,000) (96,000)
Property and equipment, net 2,000 6,000
Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 35,000 35,000
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 5,000 5,000
Testing Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 37,000 37,000
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 25,000 $ 25,000
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property and Equipment (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Abstract]    
Depreciation expense $ 4,000 $ 4,000
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases (Details Narrative) - USD ($)
 2 Months Ended 12 Months Ended
Dec. 31, 2022
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2021
Jun. 30, 2021
Right-of-use asset write off $ 110,000        
Operating lease liability cancelled 112,000        
Corporate Office Space [Member]          
Operating lease right-of-use asset       $ 143,000 $ 165,000
Operating lease liability $ 144,000 $ 144,000     $ 165,000
Amortization of right-of-use asset   33,000      
Payments of lease liability   32,000      
Gain on lease cancellation   $ 2,000      
Tomball Texas Offices [Member]          
Accounts Payable     $ 19,000    
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Convertible Notes Payable (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Convertible notes $ 1,332,000 $ 1,393,000
Accrued interest 794,000 612,000
Total outstanding debt, including $2,022,000 and $1,730,000 in default at December 31, 2023 and 2022, respectively 2,126,000 2,005,000
Less: Unamortized debt discount (25,000) (140,000)
Total outstanding debt, net of unamortized debt discount 2,101,000 1,865,000
Convertible Notes Payable [Member]    
Debt Instrument [Line Items]    
Debt default amount $ 2,022,000 $ 1,730,000
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Convertible Notes Payable (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Debt Instrument [Line Items]      
Convertible notes payable $ 2,126,000 $ 2,005,000  
Proceeds from convertible debt $ 532,000 393,000  
Convertible notes terms As of December 31, 2023, convertible notes payable and accrued interest are convertible into 34,716,235 shares of common stock at conversion rates ranging from $0.02 to $0.48 per share.    
Debt discount amortization $ 103,000 149,000  
Debt Discount [Member]      
Debt Instrument [Line Items]      
Unamortized debt discount 25,000 140,000 $ 86,000
Increase in debt discount 284,000 322,000  
Debt Discount [Member] | Fair Value Of Warrants [Member]      
Debt Instrument [Line Items]      
Increase in debt discount 231,000 283,000  
Debt Discount [Member] | Original Issue Discount [Member]      
Debt Instrument [Line Items]      
Increase in debt discount 53,000 39,000  
Debt Discount [Member] | Discount Converted [Member]      
Debt Instrument [Line Items]      
Decrease in debt discount 296,000 119,000  
Convertible Notes [Member]      
Debt Instrument [Line Items]      
Convertible notes payable 1,332,000 1,393,000 1,137,000
Increase in convertible notes 585,000 432,000  
Proceeds from convertible debt 532,000 393,000  
Original issue discount $ 53,000 $ 39,000  
Warrants issued, shares 11,715,748 14,409,995  
Warrants issued, value $ 231,000 $ 283,000  
Debt converted, amount converted 646,000 176,000  
Debt converted, interest converted   2,000  
Unamortized debt discount $ 296,000 $ 119,000  
Debt converted, shares issued 15,129,048 6,040,049  
Convertible Notes Payable [Member]      
Debt Instrument [Line Items]      
Unamortized debt discount $ 25,000 $ 140,000  
Accrued interest on convertible notes payable 794,000 612,000 $ 435,000
Accrued interest $ 182,000 $ 162,000  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
PPP Loan Payable (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Jun. 30, 2020
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Debt Instrument [Line Items]        
PPP loan payable   $ 57,000 $ 75,000  
PPP Loan [Member]        
Debt Instrument [Line Items]        
Aggregate amount $ 151,000      
Maturity date Jun. 18, 2025      
Debt interest rate 1.00%      
PPP loan payable   57,000 75,000 $ 151,000
Debt instrument, decrease, forgiveness     63,000  
Gain on forgiveness of PPP loan     63,000  
PPP loan paid   $ 18,000 $ 12,000  
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Research and Development (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Research and Development Arrangement, Contract to Perform for Others [Line Items]    
Research and development expenses $ 203,000 $ 486,000
Interest and financing expense 333,000 360,000
Accounts payable - licensing agreement 2,198,000 1,962,000
Revenues 0 0
A O T Prototys [Member]    
Research and Development Arrangement, Contract to Perform for Others [Line Items]    
Research and development expenses 14,000 298,000
Temple University License Agreements [Member]    
Research and Development Arrangement, Contract to Perform for Others [Line Items]    
Research and development expenses 188,000 188,000
Interest and financing expense 48,000 48,000
Accounts payable - licensing agreement $ 2,198,000 $ 1,962,000
Temple licensing agreement terms With regards to the unpaid fees to Temple, a total of $135,000 are deferred until such time the Company achieves a revenue milestone of $835,000 or upon termination of the licensing agreements and the remaining $2,063,000 are deemed past due. The Company is currently in discussions with Temple to settle or cure the past due balance.  
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Details - Income tax reconciliation) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Computed tax provision (benefit) at federal statutory rate (21%) $ (70,000) $ (167,000)
Valuation allowance 70,000 167,000
Income tax provision $ 0 $ 0
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Details - Deferred taxes) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Net operating loss carry forwards $ 12,698,000 $ 13,124,000
Stock based compensation (8,000) (27,000)
Other temporary differences (57,000) 35,000
Valuation allowance (12,633,000) (13,132,000)
Total deferred taxes net of valuation allowance $ 0 $ 0
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Details Narrative)
$ in Millions
 12 Months Ended
Dec. 31, 2023
USD ($)
Income Tax Disclosure [Abstract]  
Net operating loss carryforward $ 60
Federal corporate tax rate 21.00%
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Common Stock (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Convertible Notes Payable [Member]    
Conversion of Stock [Line Items]    
Debt converted, shares issued 15,129,048 6,040,049
Debt converted, amount converted $ 646,000 $ 178,000
Unamortized discount $ 296,000 $ 119,000
Convertible Notes Payable [Member] | Minimum [Member]    
Conversion of Stock [Line Items]    
Conversion price $ 0.03 $ 0.02
Convertible Notes Payable [Member] | Maximum [Member]    
Conversion of Stock [Line Items]    
Conversion price $ 0.05 $ 0.03
Exercise Of Warrants [Member]    
Conversion of Stock [Line Items]    
Debt converted, shares issued 1,383,327 14,483,825
Debt converted, amount converted $ 52,000 $ 542,000
Exercise Of Warrants [Member] | Minimum [Member]    
Conversion of Stock [Line Items]    
Conversion price $ 0.02 $ 0.03
Exercise Of Warrants [Member] | Maximum [Member]    
Conversion of Stock [Line Items]    
Conversion price $ 0.04 $ 0.04
Exercise Of Options [Member]    
Conversion of Stock [Line Items]    
Debt converted, shares issued   250,000
Debt converted, amount converted   $ 20,000
Conversion price   $ 0.08
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Options and Warrants (Details - Options outstanding) - Equity Option [Member] - $ / shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Options, Outstanding beginning balance 26,057,601 31,080,601
Weighted Average Exercise Price, Outstanding Beginning Balance $ 0.15 $ 0.17
Options, Granted 0 0
Weighted Average Exercise Price, Granted $ 0 $ 0
Options, Exercised 0 (250,000)
Weighted Average Exercise Price, Exercised $ 0 $ 0.08
Options, Cancelled (300,446) (4,773,000)
Weighted Average Exercise Price, Cancelled $ 0.72 $ 0.26
Options, Outstanding ending balance 25,757,155 26,057,601
Weighted Average Exercise Price, Outstanding Ending Balance $ 0.14 $ 0.15
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Options and Warrants (Details - Options by exercise price per share) - Equity Option [Member] - $ / shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Shares, options outstanding 25,757,155 26,057,601 31,080,601
Life (Years), options outstanding 3 years 10 months 24 days    
Weighted average exercise price, options outstanding $ 0.14 $ 0.15 $ 0.17
Shares, options exercisable 25,757,155    
Weighted average exercise price, options exercisable $ 0.14    
$0.02 - $0.24 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Shares, options outstanding 22,055,551    
Life (Years), options outstanding 4 years 1 month 6 days    
Weighted average exercise price, options outstanding $ 0.10    
Shares, options exercisable 22,055,551    
Weighted average exercise price, options exercisable $ 0.10    
$0.25 - $0.49 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Shares, options outstanding 3,238,552    
Life (Years), options outstanding 2 years 8 months 12 days    
Weighted average exercise price, options outstanding $ 0.36    
Shares, options exercisable 3,238,552    
Weighted average exercise price, options exercisable $ 0.36    
$0.50 - $0.99 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Shares, options outstanding 463,052    
Life (Years), options outstanding 4 months 24 days    
Weighted average exercise price, options outstanding $ 0.85    
Shares, options exercisable 463,052    
Weighted average exercise price, options exercisable $ 0.85    
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Options and Warrants (Details - Warrant exercise price per share) - Warrant [Member] - $ / shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Warrants outstanding, beginning balance 20,314,153 19,977,149
Warrants outstanding, beginning balance $ 0.04 $ 0.04
Warrants granted 12,482,410 16,426,657
Weighted average exercise price, Granted $ 0.07 $ 0.04
Warrants exercised (1,383,327) (14,483,825)
Weighted average exercise price, Exercised $ 0.04 $ 0.04
Warrants Expired (13,459,997) (1,605,828)
Weighted average exercise price, Expired $ 0.04 $ 0.04
Warrants outstanding, ending balance 17,953,239 20,314,153
Weighted average exercise price, Outstanding ending balance $ 0.06 $ 0.04
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Options and Warrants (Details - Warrant exercise price per share) - Warrant [Member] - $ / shares
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Warrants outstanding 17,953,239 20,314,153 19,977,149
Life (Years), warrants outstanding 7 months 6 days    
Weighted average exercise price, warrants outstanding $ 0.06    
Warrants exercisable 17,919,906    
Weighted average exercise price, warrants exercisable $ 0.06    
$0.02 - $0.24 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Warrants outstanding 17,883,239    
Life (Years), warrants outstanding 7 months 6 days    
Weighted average exercise price, warrants outstanding $ 0.06    
Warrants exercisable 17,849,906    
Weighted average exercise price, warrants exercisable $ 0.06    
$0.25 - $0.49 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Warrants outstanding 0    
Weighted average exercise price, warrants outstanding $ 0    
Warrants exercisable 0    
Weighted average exercise price, warrants exercisable $ 0    
$0.50 - $1.00 [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Warrants outstanding 70,000    
Life (Years), warrants outstanding 3 months 18 days    
Weighted average exercise price, warrants outstanding $ 0.80    
Warrants exercisable 70,000    
Weighted average exercise price, warrants exercisable $ 0.80    
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock Options and Warrants (Details Narrative) - USD ($)
 1 Months Ended 7 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Equity Option [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock price     $ 0.06  
Aggregate intrinsic value of options outstanding     $ 115,000  
Unamortized compensation expense     0  
Warrant [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Aggregate intrinsic value of options outstanding     $ 145,000  
Warrants vested outstanding     17,919,906  
Warrants expected to vest     33,333  
Warrants granted     12,482,410 16,426,657
Weighted Average Exercise Price, warrants outstanding     $ 0.06  
Warrant [Member] | Consulting Agreement [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Warrants granted     766,662 2,016,662
Fair value of warrants granted     $ 35,000 $ 127,000
Risk free interest rate - minimum     0.73% 0.13%
Risk free interest rate - maximum     5.07% 4.49%
Volatility - minimum     182.00% 193.00%
Volatility - maximum     245.00% 245.00%
Expected dividend yield     0.00% 0.00%
Share based compensation expense     $ 37,000 $ 127,000
Warrant [Member] | Consulting Agreement [Member] | Minimum [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Weighted Average Exercise Price, warrants outstanding       $ 0.02
Expected life     1 year 2 years
Warrant [Member] | Consulting Agreement [Member] | Maximum [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Weighted Average Exercise Price, warrants outstanding       $ 0.09
Expected life     2 years 5 years
Warrant [Member] | Convertible Debt [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Warrants granted   11,715,748    
Weighted Average Exercise Price, warrants outstanding   $ 0.07    
Warrants granted 14,409,995      
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related Party Transactions (Details Narrative) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Related Party Transactions [Abstract]    
Accrued expenses related parties $ 6,000 $ 6,000
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies (Details - Commitments)
 12 Months Ended
Dec. 31, 2023
USD ($)
Other Commitments [Line Items]  
2024 $ 384,500
2025 187,500
2026 187,500
2027 187,500
2028 187,500
Total 1,134,500
Severance payable 197,000
Temple University License Agreements [Member]  
Other Commitments [Line Items]  
Annual maintenance fee 187,500
License Agreements [Member]  
Other Commitments [Line Items]  
2024 187,500
2025 187,500
2026 187,500
2027 187,500
2028 187,500
Total 937,500
Compensation Agreements [Member]  
Other Commitments [Line Items]  
2024 197,000
2025 0
2026 0
2027 0
2028 0
Total $ 197,000
EXCEL 56 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( %WB5@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " !=XE8][-Y%? K @ $0 &1O8U!R;W!S+V-O&ULS9)1 M2\,P$,>_BN2]O;;;Q(4N+XI/"H(#Q;>0W+:P)@W)2;MO;QJW#M$/(.0E=__\ M[G>05GFN^H OH?<8R&"\&6WG(E=^PPY$G@-$=4 K8YD2+C5W?;"2TC7LP4MU ME'N$IJINP2))+4G"!"S\3&2BU8JK@)+Z<,9K->/]9^@R3"O #BTZBE"7-3 Q M3?2GL6OA"IA@A,'&[P+JF9BK?V)S!]@Y.48SIX9A*(=%SJ4=:GA_?GK-ZQ;& M19).87H5#:>3QPV[3'Y;W#]L'YEHJF995.FLM_4=7ZWX&PO M=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$ M[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4 M\GA@V2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?+&A T%116F]?(+3E'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6 M:\?1TDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+ MTHMP' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3 M:W?=TXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ M %AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ W MQ-%,4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYK ME']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6? MR"VZY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^: M/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SCFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B" MP#E_+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F M.$KTL@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1 MN0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/ MPT.'>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,K MD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5; M\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;Z MEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX# M7N83+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1 M/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO M0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$% M @ 7>)6-S&VK%D!@ *B, !@ !X;"]W;W)K4&Q '$MD?&L3 XX3=T;;U(O3=EFQ#XQ$VT(DT:6H M7/[]CBZ6G( Z]H3J2V+).J_YB!3UZ'+Z*-5]M!9"DZ? #Z.SUEKKS=M.)W+6 M(N#1L=R($+Y92A5P#8MJU8DV2G W+0K\#K6L7B?@7M@:G:;KYFIT*F/M>Z&8 M*Q+%0<#5\[GPY>-9RVYM5UQ[J[5.5G1&IQN^$@NAOVSF"I8Z18KK!2*,/!D2 M)99GK;']=L+Z24&ZQ5=//$8[GTF"G2CX2E6P-:<)X%T(H FY)/,M3KB%R&KG!?!G2@-463Z+9)YQ1- MO!#.,6'V$:$6988&3?#R\48=$RLK/T&:PXH]Q-(\ANZA[^.[2"L8=/^:=E&6 M<&).2([$M]&&.^*L!8=:)-2#:(W>_&KWK'+EMM3^8D-"JFDC= JF+MFD,/&[*-/7YRL2$UR^Y'YEVQ00MJPG5 M*Z!ZA_73. QC[I-KL9%*F^#P'*UB(QM:59.M7[#U#QR#BL/I(IWMJ_GPK,K. M0\MJ @X*P,%A@'.A/.DF$R>!R=MXO.U)VDZ5E7,E6E^38K7IT!YT MC7AH95V\4F-L5!RV>-=BY24F SUZQ0-S#^)!?RW(Y=7E]?O;(S*[FAP;49MP M&+N4&!O7D!QU L-6P9"=@9@^D0_BV0B+1UF69=L6ZP_-7=J$V-BEV=BXFN2< M-_R)S%R ]9:>P]/S)3)^\<@N;5-K,&"T9^1MPGGL4GILW%9RWEGH2 4^D*(> MD86&F8A(128RA@Z'?I>N>5SCZ5=?C5Y>TE"6Z1Y923B5X-1@>T*_ :D*-:*E&%+>:CS+U M][4,,37:$\(LJ]WOG?2-?$VX$2W=B![D1M^$[[?O0YAGR$+P"&A=,HNBN (7 MS[R21M FS(B69D0/,J.OTH=3)5>9[2KCUI J\)H2(ED)$#Q*B[25+=M? M"U?IU&J^*-N3>"M,51.\JBYG*4+T0!'20F4WPI/+,;X%-W+BB56<3=@/+>V' M'F0_Z2 E$S@[KJ0R6OR>G"L9MKGC"(B!$#<+-/(VH3ZT5!]ZD/HL A 6QAA,*AK8\/^D-D#BQ6[["7DSF,LW$=FD^DU&<>NI^$*8ZRU M *ST7D'58Y$]>=6#LPG%8:7BL ,?84V]D(>.!^*:7EBEZRZ52F\4P&DR>XS\ M/:$W/]/#?Z8:OPD%8J4"L3V/N_(>GGHJ(+,+(]F>6T!]:N1J0GE8J3P,%Y0M M5]5-RSWEWX07PF7+BKSAP>;==DX^^F5^/#;>P<3CZM*6XL-P8=G2)A=>R3@U M$N,1'V5$QN$*G">YA\)];RE5Z'$C[$^UGL[.VPC)F3Y]22,B3G)W+GLQH5A; MO @R3E]_Z)2;9V^1?.*)*$3$%TLHM8[[, 95]F)&MJ#E)GVWX4YJ+8/TXUIP M5ZAD _A^*:7>+B0_4+P>,_H/4$L#!!0 ( %WB5B" 3,J\00 P3 8 M >&PO=V]R:W-H965T&ULK5AM3^,X$/XK5A:M[J1 XKR7 M+96@L-J5N-UJR]Y]-HFA%DF?[9:D73L!=/"!QNW,Y'G&GIDGF6XH M>^ KC 5XK,J:GSDK(9I3S^/Y"E>(G] &U_*7.\HJ).22W7N\81@5VJDJO<#W M$Z]"I'9F4_W=@LVFM!4EJ?&" =Y6%6)/%[BDFS,'.L]?_"#W*Z&^\&;3!MWC M)18_FP63*Z^+4I *UYS0&C!\=^:-5!4;BE]4(NOQ9GC M*T2XQ+E0(9#\6.,Y+DL52>+XM0OJ=/=4COO7S]$_:_*2S"WB>$[+?T@A5F=. MYH "WZ&V%#_HY@O>$8I5O)R67/\'FYVM[X"\Y8)6.V>)H"+U]A,][A*QYP"C M 8=@YQ"\UB'<.82:Z!:9IG6)!)I-&=T IJQE-'6A8^)]L[-XIV '7L.,:CD6?S1%? MV0ANO6+MI8I[/4M]^3?UUOO(32L8AOMF!YBB#E,TBFG!<(-( ?"C;#\<\?VML0'?AD[V(04F<(O59!!WW.&.1W'?4('*5T",C9MG%HBF%8R# M08Q)AS%Y(;>RIS/QI'.*?[6DD5U6N*#&P@8U,4!8D)I&R2#.M,.9OB*7PSE, MS1Q&)C+3"L;9(+:LPY:]JC^4!-V2D@B"[4TB>\\F\4[!#@A/.L*3T/4PM(TRP=@=@/6C@^:0^GPU[OL&(-3:QA8"D9BV&41<,]#O9#&(Y/X2W> MEW":@W0 IVDXCK,?NG!\ZLYI51&AFY ^Q3FMA3S=^B,-D= (M!5 M@=IO^43'50I<<.2?^#Z49<_ &I4M/@6R5G4+4UV-KQ!3^K$5*\K(O[AP03@) MW#A+W"B%^KB$:>+Z:>3ZD^39G'"NYH)6G:W@0EZH;HD$D$\:N+J5.O3Y844; MJ<>.PXYIW013C$@L<9;^7BD6NS3QTWB@4'K5 D3UL6SJ M.6J(K'(KW,SLU5#.ODD$P]\16TTE8DEO '2O/."+TJ.MVA()N2%C)]R4#L

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end XML 57 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 58 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 60 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 127 237 1 false 39 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://qsenergy.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://qsenergy.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://qsenergy.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://qsenergy.com/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT Sheet http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 995512 - Disclosure - Business and Summary of Significant Accounting Policies Sheet http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPolicies Business and Summary of Significant Accounting Policies Notes 9 false false R10.htm 995513 - Disclosure - Property and Equipment Sheet http://qsenergy.com/role/PropertyAndEquipment Property and Equipment Notes 10 false false R11.htm 995514 - Disclosure - Leases Sheet http://qsenergy.com/role/Leases Leases Notes 11 false false R12.htm 995515 - Disclosure - Convertible Notes Payable Notes http://qsenergy.com/role/ConvertibleNotesPayable Convertible Notes Payable Notes 12 false false R13.htm 995516 - Disclosure - PPP Loan Payable Sheet http://qsenergy.com/role/PppLoanPayable PPP Loan Payable Notes 13 false false R14.htm 995517 - Disclosure - Research and Development Sheet http://qsenergy.com/role/ResearchAndDevelopment Research and Development Notes 14 false false R15.htm 995518 - Disclosure - Income Taxes Sheet http://qsenergy.com/role/IncomeTaxes Income Taxes Notes 15 false false R16.htm 995519 - Disclosure - Common Stock Sheet http://qsenergy.com/role/CommonStock Common Stock Notes 16 false false R17.htm 995520 - Disclosure - Stock Options and Warrants Sheet http://qsenergy.com/role/StockOptionsAndWarrants Stock Options and Warrants Notes 17 false false R18.htm 995521 - Disclosure - Related Party Transactions Sheet http://qsenergy.com/role/RelatedPartyTransactions Related Party Transactions Notes 18 false false R19.htm 995522 - Disclosure - Commitments and Contingencies Sheet http://qsenergy.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 19 false false R20.htm 995523 - Disclosure - Subsequent Events Sheet http://qsenergy.com/role/SubsequentEvents Subsequent Events Notes 20 false false R21.htm 995524 - Disclosure - Business and Summary of Significant Accounting Policies (Policies) Sheet http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies Business and Summary of Significant Accounting Policies (Policies) Policies http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPolicies 21 false false R22.htm 995525 - Disclosure - Property and Equipment (Tables) Sheet http://qsenergy.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://qsenergy.com/role/PropertyAndEquipment 22 false false R23.htm 995526 - Disclosure - Convertible Notes Payable (Tables) Notes http://qsenergy.com/role/ConvertibleNotesPayableTables Convertible Notes Payable (Tables) Tables http://qsenergy.com/role/ConvertibleNotesPayable 23 false false R24.htm 995527 - Disclosure - Income Taxes (Tables) Sheet http://qsenergy.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://qsenergy.com/role/IncomeTaxes 24 false false R25.htm 995528 - Disclosure - Stock Options and Warrants (Tables) Sheet http://qsenergy.com/role/StockOptionsAndWarrantsTables Stock Options and Warrants (Tables) Tables http://qsenergy.com/role/StockOptionsAndWarrants 25 false false R26.htm 995529 - Disclosure - Commitments and Contingencies (Tables) Sheet http://qsenergy.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://qsenergy.com/role/CommitmentsAndContingencies 26 false false R27.htm 995530 - Disclosure - Business and Summary of Significant Accounting Policies (Details Narrative) Sheet http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative Business and Summary of Significant Accounting Policies (Details Narrative) Details http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies 27 false false R28.htm 995531 - Disclosure - Property and Equipment (Details) Sheet http://qsenergy.com/role/PropertyAndEquipmentDetails Property and Equipment (Details) Details http://qsenergy.com/role/PropertyAndEquipmentTables 28 false false R29.htm 995532 - Disclosure - Property and Equipment (Details Narrative) Sheet http://qsenergy.com/role/PropertyAndEquipmentDetailsNarrative Property and Equipment (Details Narrative) Details http://qsenergy.com/role/PropertyAndEquipmentTables 29 false false R30.htm 995533 - Disclosure - Leases (Details Narrative) Sheet http://qsenergy.com/role/LeasesDetailsNarrative Leases (Details Narrative) Details http://qsenergy.com/role/Leases 30 false false R31.htm 995534 - Disclosure - Convertible Notes Payable (Details) Notes http://qsenergy.com/role/ConvertibleNotesPayableDetails Convertible Notes Payable (Details) Details http://qsenergy.com/role/ConvertibleNotesPayableTables 31 false false R32.htm 995535 - Disclosure - Convertible Notes Payable (Details Narrative) Notes http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative Convertible Notes Payable (Details Narrative) Details http://qsenergy.com/role/ConvertibleNotesPayableTables 32 false false R33.htm 995536 - Disclosure - PPP Loan Payable (Details Narrative) Sheet http://qsenergy.com/role/PppLoanPayableDetailsNarrative PPP Loan Payable (Details Narrative) Details http://qsenergy.com/role/PppLoanPayable 33 false false R34.htm 995537 - Disclosure - Research and Development (Details Narrative) Sheet http://qsenergy.com/role/ResearchAndDevelopmentDetailsNarrative Research and Development (Details Narrative) Details http://qsenergy.com/role/ResearchAndDevelopment 34 false false R35.htm 995538 - Disclosure - Income Taxes (Details - Income tax reconciliation) Sheet http://qsenergy.com/role/IncomeTaxesDetails-IncomeTaxReconciliation Income Taxes (Details - Income tax reconciliation) Details http://qsenergy.com/role/IncomeTaxesTables 35 false false R36.htm 995539 - Disclosure - Income Taxes (Details - Deferred taxes) Sheet http://qsenergy.com/role/IncomeTaxesDetails-DeferredTaxes Income Taxes (Details - Deferred taxes) Details http://qsenergy.com/role/IncomeTaxesTables 36 false false R37.htm 995540 - Disclosure - Income Taxes (Details Narrative) Sheet http://qsenergy.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://qsenergy.com/role/IncomeTaxesTables 37 false false R38.htm 995541 - Disclosure - Common Stock (Details Narrative) Sheet http://qsenergy.com/role/CommonStockDetailsNarrative Common Stock (Details Narrative) Details http://qsenergy.com/role/CommonStock 38 false false R39.htm 995542 - Disclosure - Stock Options and Warrants (Details - Options outstanding) Sheet http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsOutstanding Stock Options and Warrants (Details - Options outstanding) Details http://qsenergy.com/role/StockOptionsAndWarrantsTables 39 false false R40.htm 995543 - Disclosure - Stock Options and Warrants (Details - Options by exercise price per share) Sheet http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare Stock Options and Warrants (Details - Options by exercise price per share) Details http://qsenergy.com/role/StockOptionsAndWarrantsTables 40 false false R41.htm 995544 - Disclosure - Stock Options and Warrants (Details - Warrant exercise price per share) Sheet http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShare Stock Options and Warrants (Details - Warrant exercise price per share) Details http://qsenergy.com/role/StockOptionsAndWarrantsTables 41 false false R42.htm 995545 - Disclosure - Stock Options and Warrants (Details - Warrant exercise price per share) Sheet http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure Stock Options and Warrants (Details - Warrant exercise price per share) Details http://qsenergy.com/role/StockOptionsAndWarrantsTables 42 false false R43.htm 995546 - Disclosure - Stock Options and Warrants (Details Narrative) Sheet http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative Stock Options and Warrants (Details Narrative) Details http://qsenergy.com/role/StockOptionsAndWarrantsTables 43 false false R44.htm 995547 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://qsenergy.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://qsenergy.com/role/RelatedPartyTransactions 44 false false R45.htm 995548 - Disclosure - Commitments and Contingencies (Details - Commitments) Sheet http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments Commitments and Contingencies (Details - Commitments) Details http://qsenergy.com/role/CommitmentsAndContingenciesTables 45 false false All Reports Book All Reports qsenergy_i10k-123123.htm qsep-20231231.xsd qsep-20231231_cal.xml qsep-20231231_def.xml qsep-20231231_lab.xml qsep-20231231_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 62 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "qsenergy_i10k-123123.htm": { "nsprefix": "qsep", "nsuri": "http://qsenergy.com/20231231", "dts": { "inline": { "local": [ "qsenergy_i10k-123123.htm" ] }, "schema": { "local": [ "qsep-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "qsep-20231231_cal.xml" ] }, "definitionLink": { "local": [ "qsep-20231231_def.xml" ] }, "labelLink": { "local": [ "qsep-20231231_lab.xml" ] }, "presentationLink": { "local": [ "qsep-20231231_pre.xml" ] } }, "keyStandard": 214, "keyCustom": 23, "axisStandard": 14, "axisCustom": 0, "memberStandard": 12, "memberCustom": 25, "hidden": { "total": 23, "http://fasb.org/us-gaap/2023": 17, "http://qsenergy.com/20231231": 2, "http://xbrl.sec.gov/dei/2023": 4 }, "contextCount": 127, "entityCount": 1, "segmentCount": 39, "elementCount": 455, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 459, "http://xbrl.sec.gov/dei/2023": 34, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://qsenergy.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R2": { "role": "http://qsenergy.com/role/ConsolidatedBalanceSheets", "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:Cash", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "unique": true } }, "R3": { "role": "http://qsenergy.com/role/ConsolidatedBalanceSheetsParenthetical", "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R4": { "role": "http://qsenergy.com/role/ConsolidatedStatementsOfOperations", "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OtherCostAndExpenseOperating", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "unique": true } }, "R5": { "role": "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit", "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R6": { "role": "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows", "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "unique": true } }, "R7": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true }, "uniqueAnchor": null }, "R8": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-10-012023-12-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-10-012023-12-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R9": { "role": "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPolicies", "longName": "995512 - Disclosure - Business and Summary of Significant Accounting Policies", "shortName": "Business and Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R10": { "role": "http://qsenergy.com/role/PropertyAndEquipment", "longName": "995513 - Disclosure - Property and Equipment", "shortName": "Property and Equipment", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R11": { "role": "http://qsenergy.com/role/Leases", "longName": "995514 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R12": { "role": "http://qsenergy.com/role/ConvertibleNotesPayable", "longName": "995515 - Disclosure - Convertible Notes Payable", "shortName": "Convertible Notes Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R13": { "role": "http://qsenergy.com/role/PppLoanPayable", "longName": "995516 - Disclosure - PPP Loan Payable", "shortName": "PPP Loan Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "qsep:PPPLoanPayableDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "qsep:PPPLoanPayableDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R14": { "role": "http://qsenergy.com/role/ResearchAndDevelopment", "longName": "995517 - Disclosure - Research and Development", "shortName": "Research and Development", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R15": { "role": "http://qsenergy.com/role/IncomeTaxes", "longName": "995518 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R16": { "role": "http://qsenergy.com/role/CommonStock", "longName": "995519 - Disclosure - Common Stock", "shortName": "Common Stock", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R17": { "role": "http://qsenergy.com/role/StockOptionsAndWarrants", "longName": "995520 - Disclosure - Stock Options and Warrants", "shortName": "Stock Options and Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R18": { "role": "http://qsenergy.com/role/RelatedPartyTransactions", "longName": "995521 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R19": { "role": "http://qsenergy.com/role/CommitmentsAndContingencies", "longName": "995522 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R20": { "role": "http://qsenergy.com/role/SubsequentEvents", "longName": "995523 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R21": { "role": "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies", "longName": "995524 - Disclosure - Business and Summary of Significant Accounting Policies (Policies)", "shortName": "Business and Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "qsep:GoingConcernPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "qsep:GoingConcernPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R22": { "role": "http://qsenergy.com/role/PropertyAndEquipmentTables", "longName": "995525 - Disclosure - Property and Equipment (Tables)", "shortName": "Property and Equipment (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R23": { "role": "http://qsenergy.com/role/ConvertibleNotesPayableTables", "longName": "995526 - Disclosure - Convertible Notes Payable (Tables)", "shortName": "Convertible Notes Payable (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ConvertibleDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ConvertibleDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R24": { "role": "http://qsenergy.com/role/IncomeTaxesTables", "longName": "995527 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R25": { "role": "http://qsenergy.com/role/StockOptionsAndWarrantsTables", "longName": "995528 - Disclosure - Stock Options and Warrants (Tables)", "shortName": "Stock Options and Warrants (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R26": { "role": "http://qsenergy.com/role/CommitmentsAndContingenciesTables", "longName": "995529 - Disclosure - Commitments and Contingencies (Tables)", "shortName": "Commitments and Contingencies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OtherCommitmentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:OtherCommitmentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R27": { "role": "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "995530 - Disclosure - Business and Summary of Significant Accounting Policies (Details Narrative)", "shortName": "Business and Summary of Significant Accounting Policies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:NotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "qsep:GoingConcernPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "unique": true } }, "R28": { "role": "http://qsenergy.com/role/PropertyAndEquipmentDetails", "longName": "995531 - Disclosure - Property and Equipment (Details)", "shortName": "Property and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R29": { "role": "http://qsenergy.com/role/PropertyAndEquipmentDetailsNarrative", "longName": "995532 - Disclosure - Property and Equipment (Details Narrative)", "shortName": "Property and Equipment (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R30": { "role": "http://qsenergy.com/role/LeasesDetailsNarrative", "longName": "995533 - Disclosure - Leases (Details Narrative)", "shortName": "Leases (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "From2022-11-012022-12-31", "name": "qsep:OperatingLeaseRightOfUseAssetWriteOff", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-11-012022-12-31", "name": "qsep:OperatingLeaseRightOfUseAssetWriteOff", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R31": { "role": "http://qsenergy.com/role/ConvertibleNotesPayableDetails", "longName": "995534 - Disclosure - Convertible Notes Payable (Details)", "shortName": "Convertible Notes Payable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ConvertibleDebtCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ConvertibleDebtCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R32": { "role": "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative", "longName": "995535 - Disclosure - Convertible Notes Payable (Details Narrative)", "shortName": "Convertible Notes Payable (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ConvertibleNotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DebtInstrumentConvertibleTermsOfConversionFeature", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "unique": true } }, "R33": { "role": "http://qsenergy.com/role/PppLoanPayableDetailsNarrative", "longName": "995536 - Disclosure - PPP Loan Payable (Details Narrative)", "shortName": "PPP Loan Payable (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:OtherNotesPayableCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2020-06-012020-06-30_custom_PPPLoanMember", "name": "us-gaap:ProceedsFromNotesPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "qsep:PPPLoanPayableDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "unique": true } }, "R34": { "role": "http://qsenergy.com/role/ResearchAndDevelopmentDetailsNarrative", "longName": "995537 - Disclosure - Research and Development (Details Narrative)", "shortName": "Research and Development (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ResearchAndDevelopmentExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_AOTPrototysMember", "name": "us-gaap:ResearchAndDevelopmentExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "unique": true } }, "R35": { "role": "http://qsenergy.com/role/IncomeTaxesDetails-IncomeTaxReconciliation", "longName": "995538 - Disclosure - Income Taxes (Details - Income tax reconciliation)", "shortName": "Income Taxes (Details - Income tax reconciliation)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R36": { "role": "http://qsenergy.com/role/IncomeTaxesDetails-DeferredTaxes", "longName": "995539 - Disclosure - Income Taxes (Details - Deferred taxes)", "shortName": "Income Taxes (Details - Deferred taxes)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R37": { "role": "http://qsenergy.com/role/IncomeTaxesDetailsNarrative", "longName": "995540 - Disclosure - Income Taxes (Details Narrative)", "shortName": "Income Taxes (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R38": { "role": "http://qsenergy.com/role/CommonStockDetailsNarrative", "longName": "995541 - Disclosure - Common Stock (Details Narrative)", "shortName": "Common Stock (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_ConvertibleNotesPayableMember75350406", "name": "us-gaap:DebtConversionConvertedInstrumentSharesIssued1", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_ConvertibleNotesPayableMember75350406", "name": "us-gaap:DebtConversionConvertedInstrumentSharesIssued1", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R39": { "role": "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsOutstanding", "longName": "995542 - Disclosure - Stock Options and Warrants (Details - Options outstanding)", "shortName": "Stock Options and Warrants (Details - Options outstanding)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_StockOptionMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_StockOptionMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "unique": true } }, "R40": { "role": "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare", "longName": "995543 - Disclosure - Stock Options and Warrants (Details - Options by exercise price per share)", "shortName": "Stock Options and Warrants (Details - Options by exercise price per share)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "AsOf2023-12-31_us-gaap_StockOptionMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_StockOptionMember", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "unique": true } }, "R41": { "role": "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShare", "longName": "995544 - Disclosure - Stock Options and Warrants (Details - Warrant exercise price per share)", "shortName": "Stock Options and Warrants (Details - Warrant exercise price per share)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "AsOf2022-12-31_us-gaap_WarrantMember", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_WarrantMember", "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "unique": true } }, "R42": { "role": "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure", "longName": "995545 - Disclosure - Stock Options and Warrants (Details - Warrant exercise price per share)", "shortName": "Stock Options and Warrants (Details - Warrant exercise price per share)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "AsOf2023-12-31_us-gaap_WarrantMember", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_us-gaap_WarrantMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "qsep:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansByExercisePriceRangeTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "unique": true } }, "R43": { "role": "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative", "longName": "995546 - Disclosure - Stock Options and Warrants (Details Narrative)", "shortName": "Stock Options and Warrants (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2023-12-31_us-gaap_StockOptionMember", "name": "us-gaap:SharePrice", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_us-gaap_StockOptionMember", "name": "us-gaap:SharePrice", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R44": { "role": "http://qsenergy.com/role/RelatedPartyTransactionsDetailsNarrative", "longName": "995547 - Disclosure - Related Party Transactions (Details Narrative)", "shortName": "Related Party Transactions (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "qsep:AccruedExpensesRelatedParties", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "qsep:AccruedExpensesRelatedParties", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } }, "R45": { "role": "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments", "longName": "995548 - Disclosure - Commitments and Contingencies (Details - Commitments)", "shortName": "Commitments and Contingencies (Details - Commitments)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:OtherCommitmentDueInNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:OtherCommitmentsTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:OtherCommitmentDueInNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:OtherCommitmentsTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "qsenergy_i10k-123123.htm", "first": true, "unique": true } } }, "tag": { "qsep_AOTPrototysMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "AOTPrototysMember", "presentation": [ "http://qsenergy.com/role/ResearchAndDevelopmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "A O T Prototys [Member]" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued expenses", "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets", "http://qsenergy.com/role/ResearchAndDevelopmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts payable-license agreements-past due", "verboseLabel": "Accounts payable - licensing agreement", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r16", "r467" ] }, "us-gaap_AccountsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r62", "r605" ] }, "qsep_AccruedExpensesRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "AccruedExpensesRelatedParties", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accrued expenses related parties" } } }, "auth_ref": [] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r43", "r119", "r362" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r527" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r70", "r467", "r608" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r282", "r283", "r284", "r381", "r577", "r578", "r579", "r592", "r609" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r533" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r533" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r533" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r533" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Warrants issued with convertible notes", "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature." } } }, "auth_ref": [ "r8", "r92", "r300" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Fair value of options and warrants issued as compensation", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r55", "r56", "r249" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Fair value of warrants issued as compensation", "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants." } } }, "auth_ref": [ "r8", "r45", "r92" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r497", "r509", "r519", "r545" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r500", "r512", "r522", "r548" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r533" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r540" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r504", "r513", "r523", "r540", "r549", "r553", "r561" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt discount amortization", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r4", "r59", "r77", "r223" ] }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCostsAndDiscounts", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of debt discount", "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r223", "r330", "r462", "r463", "r574" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r505" ] }, "qsep_AnnualMaintenanceFee": { "xbrltype": "monetaryItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "AnnualMaintenanceFee", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments" ], "lang": { "en-us": { "role": { "label": "Annual maintenance fee" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Antidilutive shares", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r161" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r34" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r34" ] }, "us-gaap_AssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetImpairmentCharges", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Asset impairment", "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill." } } }, "auth_ref": [ "r4", "r41" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r96", "r120", "r138", "r164", "r170", "r174", "r179", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r309", "r311", "r323", "r355", "r407", "r467", "r478", "r583", "r584", "r596" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r116", "r121", "r138", "r179", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r309", "r311", "r323", "r467", "r583", "r584", "r596" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r505" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r490", "r492", "r505" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r490", "r492", "r505" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r490", "r492", "r505" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price" } } }, "auth_ref": [ "r556" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r557" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r552" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r552" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r552" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r552" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r552" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r552" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsOutstanding", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure", "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r555" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r554" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r553" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r553" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Cash", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash", "verboseLabel": "Cash on Hand", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r104", "r357", "r382", "r402", "r467", "r478", "r571" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r29" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, beginning of period", "periodEndLabel": "Cash, end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r28", "r79", "r134" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r0", "r79" ] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Non-cash investing and financing activities" } } }, "auth_ref": [] }, "qsep_CashPaidDuringYearForAbstract": { "xbrltype": "stringItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "CashPaidDuringYearForAbstract", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash paid during the year for:" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r531" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShare" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants outstanding, beginning balance", "periodEndLabel": "Weighted average exercise price, Outstanding ending balance", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r243" ] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure" ], "lang": { "en-us": { "role": { "label": "Warrants exercisable", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r243" ] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure" ], "lang": { "en-us": { "role": { "periodStartLabel": "Warrants outstanding, beginning balance", "periodEndLabel": "Warrants outstanding, ending balance", "label": "Warrants outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r532" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r532" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r23", "r63", "r356", "r393" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r86", "r186", "r187", "r448", "r582" ] }, "us-gaap_CommonStockConvertibleConversionPriceIncrease": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockConvertibleConversionPriceIncrease", "presentation": [ "http://qsenergy.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Conversion price", "documentation": "Per share increase in conversion price of convertible common stock. Excludes change due to standard antidilution provision." } } }, "auth_ref": [ "r243" ] }, "qsep_CommonStockIssuedOnConversionOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "CommonStockIssuedOnConversionOfNotesPayable", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Common stock issued on conversion of notes payable" } } }, "auth_ref": [] }, "qsep_CommonStockIssuedOnConversionOfNotesPayableShares": { "xbrltype": "sharesItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "CommonStockIssuedOnConversionOfNotesPayableShares", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Common stock issued on conversion of notes payable, shares" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r469", "r470", "r471", "r473", "r474", "r475", "r476", "r577", "r578", "r592", "r607", "r609" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r69" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r69", "r394" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r69" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r8", "r69", "r394", "r413", "r609", "r610" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, $0.001 par value: 500,000,000 shares authorized, 392,586,471 and 376,074,096 shares issued and outstanding at December 31, 2023 and 2022, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r69", "r358", "r467" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r537" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r536" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r538" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r535" ] }, "qsep_CompensationAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "CompensationAgreementsMember", "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments" ], "lang": { "en-us": { "role": { "label": "Compensation Agreements [Member]" } } }, "auth_ref": [] }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationRelatedCostsPolicyTextBlock", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation", "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense." } } }, "auth_ref": [ "r51" ] }, "qsep_ConsultingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "ConsultingAgreementMember", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consulting Agreement [Member]" } } }, "auth_ref": [] }, "qsep_ConversionOfConvertibleNotesToCommonStockNet": { "xbrltype": "monetaryItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "ConversionOfConvertibleNotesToCommonStockNet", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of convertible notes to common stock, net" } } }, "auth_ref": [] }, "us-gaap_ConversionOfStockByUniqueDescriptionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockByUniqueDescriptionAxis", "presentation": [ "http://qsenergy.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock Conversion Description [Axis]", "documentation": "Information by description of stock conversions." } } }, "auth_ref": [ "r31", "r32", "r33" ] }, "us-gaap_ConversionOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockLineItems", "presentation": [ "http://qsenergy.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Conversion of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ConversionOfStockNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockNameDomain", "presentation": [ "http://qsenergy.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The unique name of a noncash or part noncash stock conversion." } } }, "auth_ref": [ "r31", "r32", "r33" ] }, "us-gaap_ConversionOfStockTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockTable", "presentation": [ "http://qsenergy.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Conversion of Stock [Table]", "documentation": "This table may be used to disclose all the information related to converting stock into another financial instrument(s) in a noncash (or part noncash) transaction. It may include a description sufficient information to understand the nature and purpose of the conversion, as well as the financial instruments converted from and to (for example, preferred, common, treasury, etc.) the amounts converted, the new shares issued, and the value of the new shares issued, if applicable. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r31", "r32", "r33" ] }, "us-gaap_ConvertibleDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtCurrent", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Convertible notes", "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r66" ] }, "us-gaap_ConvertibleDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtMember", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible Debt [Member]", "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock." } } }, "auth_ref": [ "r88", "r202", "r203", "r213", "r214", "r215", "r219", "r220", "r221", "r222", "r223", "r459", "r460", "r461", "r462", "r463" ] }, "us-gaap_ConvertibleDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtTableTextBlock", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableTables" ], "lang": { "en-us": { "role": { "label": "Schedule of convertible notes payable", "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount." } } }, "auth_ref": [] }, "qsep_ConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "ConvertibleNotesMember", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible Notes [Member]" } } }, "auth_ref": [] }, "us-gaap_ConvertibleNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleNotesPayable", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetails", "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Total outstanding debt, including $2,022,000 and $1,730,000 in default at December 31, 2023 and 2022, respectively", "verboseLabel": "Convertible notes payable", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder." } } }, "auth_ref": [ "r15", "r98", "r606" ] }, "us-gaap_ConvertibleNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleNotesPayableCurrent", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets", "http://qsenergy.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Convertible notes payable, net of discounts of $25,000 and $140,000, respectively: including $2,022,000 and $1,730,000, respectively, in default", "verboseLabel": "Total outstanding debt, net of unamortized debt discount", "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r18" ] }, "us-gaap_ConvertibleNotesPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleNotesPayableMember", "presentation": [ "http://qsenergy.com/role/CommonStockDetailsNarrative", "http://qsenergy.com/role/ConsolidatedBalanceSheetsParenthetical", "http://qsenergy.com/role/ConvertibleNotesPayableDetails", "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable [Member]", "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder." } } }, "auth_ref": [ "r66", "r97" ] }, "qsep_CorporateOfficeSpaceMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "CorporateOfficeSpaceMember", "presentation": [ "http://qsenergy.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Corporate Office Space [Member]" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionConvertedInstrumentAmount1", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Debt converted, amount converted", "label": "Debt Conversion, Converted Instrument, Amount", "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r31", "r33" ] }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionConvertedInstrumentSharesIssued1", "presentation": [ "http://qsenergy.com/role/CommonStockDetailsNarrative", "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt converted, shares issued", "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period." } } }, "auth_ref": [ "r31", "r33" ] }, "qsep_DebtConversionInterestAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "DebtConversionInterestAmount1", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt converted, interest converted" } } }, "auth_ref": [] }, "us-gaap_DebtConversionOriginalDebtAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtConversionOriginalDebtAmount1", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt converted, amount converted", "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r31", "r33" ] }, "us-gaap_DebtDefaultLongtermDebtAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDefaultLongtermDebtAmount", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheetsParenthetical", "http://qsenergy.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Convertible notes in default", "verboseLabel": "Debt default amount", "documentation": "Amount of outstanding long-term debt or borrowing associated with any securities or credit agreement for which there has been a default in principal, interest, sinking fund, or redemption provisions, or any breach of covenant that existed at the end of the period and subsequently has not been cured." } } }, "auth_ref": [ "r136" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayable" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Payable", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r87", "r136", "r201", "r207", "r208", "r209", "r210", "r211", "r212", "r217", "r224", "r225", "r227" ] }, "qsep_DebtDiscountMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "DebtDiscountMember", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Discount [Member]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r15", "r66", "r67", "r97", "r98", "r140", "r202", "r203", "r204", "r205", "r206", "r208", "r213", "r214", "r215", "r216", "r218", "r219", "r220", "r221", "r222", "r223", "r331", "r459", "r460", "r461", "r462", "r463", "r575" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Unamortized debt discount", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r15", "r98", "r228" ] }, "us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleTermsOfConversionFeature", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible notes terms", "documentation": "Description of conversion terms for debt instrument." } } }, "auth_ref": [ "r21", "r47", "r90", "r91" ] }, "us-gaap_DebtInstrumentDecreaseForgiveness": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentDecreaseForgiveness", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/PppLoanPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt instrument, decrease, forgiveness", "documentation": "Decrease for amounts of indebtedness forgiven by the holder of the debt instrument." } } }, "auth_ref": [ "r575" ] }, "us-gaap_DebtInstrumentIncreaseDecreaseForPeriodNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentIncreaseDecreaseForPeriodNet", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Increase in convertible notes", "documentation": "Net increase or decrease in the carrying amount of the debt instrument for the period." } } }, "auth_ref": [ "r575" ] }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateEffectivePercentage", "presentation": [ "http://qsenergy.com/role/PppLoanPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt interest rate", "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium." } } }, "auth_ref": [ "r20", "r60", "r229", "r331" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheetsParenthetical", "http://qsenergy.com/role/ConvertibleNotesPayableDetails", "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative", "http://qsenergy.com/role/PppLoanPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r140", "r202", "r203", "r204", "r205", "r206", "r208", "r213", "r214", "r215", "r216", "r218", "r219", "r220", "r221", "r222", "r223", "r226", "r331", "r459", "r460", "r461", "r462", "r463", "r575" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://qsenergy.com/role/PppLoanPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maturity date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r113", "r459", "r593" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r22", "r140", "r202", "r203", "r204", "r205", "r206", "r208", "r213", "r214", "r215", "r216", "r218", "r219", "r220", "r221", "r222", "r223", "r331", "r459", "r460", "r461", "r462", "r463", "r575" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheetsParenthetical", "http://qsenergy.com/role/ConvertibleNotesPayableDetails", "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative", "http://qsenergy.com/role/PppLoanPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r22", "r47", "r48", "r59", "r60", "r61", "r64", "r90", "r91", "r140", "r202", "r203", "r204", "r205", "r206", "r208", "r213", "r214", "r215", "r216", "r218", "r219", "r220", "r221", "r222", "r223", "r226", "r331", "r459", "r460", "r461", "r462", "r463", "r575" ] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/CommonStockDetailsNarrative", "http://qsenergy.com/role/ConsolidatedBalanceSheetsParenthetical", "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Discounts on convertible notes payable", "verboseLabel": "Unamortized debt discount", "terseLabel": "Unamortized discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r59", "r61", "r586" ] }, "qsep_DecreaseInDebtDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "DecreaseInDebtDiscount", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Decrease in debt discount" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/IncomeTaxesDetails-DeferredTaxes" ], "lang": { "en-us": { "role": { "label": "Total deferred taxes net of valuation allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r590" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/IncomeTaxesDetails-DeferredTaxes" ], "lang": { "en-us": { "role": { "label": "Net operating loss carry forwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r58", "r591" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/IncomeTaxesDetails-DeferredTaxes" ], "lang": { "en-us": { "role": { "negatedLabel": "Valuation allowance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r296" ] }, "us-gaap_DeferredTaxLiabilitiesDeferredExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesDeferredExpense", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/IncomeTaxesDetails-DeferredTaxes" ], "lang": { "en-us": { "role": { "negatedLabel": "Stock based compensation", "label": "Deferred Tax Liabilities, Deferred Expense", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from capitalized costs." } } }, "auth_ref": [ "r58", "r591" ] }, "us-gaap_DeferredTaxLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxLiabilitiesOther", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/IncomeTaxesDetails-DeferredTaxes" ], "lang": { "en-us": { "role": { "label": "Other temporary differences", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other." } } }, "auth_ref": [ "r58", "r591" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/PropertyAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation expense", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r4", "r42" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r4", "r42" ] }, "qsep_DisclosureLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "DisclosureLeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases" } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrants" ], "lang": { "en-us": { "role": { "label": "Stock Options and Warrants", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r247", "r251", "r278", "r279", "r281", "r466" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "qsep_DisclosurePppLoanPayableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "DisclosurePppLoanPayableAbstract", "lang": { "en-us": { "role": { "label": "Ppp Loan Payable" } } }, "auth_ref": [] }, "qsep_DiscountConvertedMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "DiscountConvertedMember", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Discount Converted [Member]" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r492" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r490", "r492", "r505" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r490", "r492", "r505", "r541" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r491" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r479" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r492" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r492" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r526" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r482" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net loss per common share, basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r129", "r146", "r147", "r148", "r149", "r150", "r154", "r156", "r158", "r159", "r160", "r162", "r321", "r322", "r352", "r365", "r455" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Net loss per common share, diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r129", "r146", "r147", "r148", "r149", "r150", "r156", "r158", "r159", "r160", "r162", "r321", "r322", "r352", "r365", "r455" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Loss per Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r34", "r35" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "presentation": [ "http://qsenergy.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Federal corporate tax rate", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates." } } }, "auth_ref": [ "r305", "r589" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unamortized compensation expense", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r280" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r485" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r481" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r481" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r569" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r481" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r566" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r505" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r481" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r481" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r481" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r481" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r567" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r8", "r114", "r125", "r126", "r127", "r141", "r142", "r143", "r145", "r151", "r153", "r163", "r180", "r181", "r244", "r282", "r283", "r284", "r301", "r302", "r313", "r314", "r315", "r316", "r317", "r318", "r320", "r324", "r325", "r326", "r327", "r328", "r329", "r336", "r369", "r370", "r371", "r381", "r435" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r534" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r497", "r509", "r519", "r545" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r494", "r506", "r516", "r542" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r540" ] }, "qsep_ExerciseOfOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "ExerciseOfOptionsMember", "presentation": [ "http://qsenergy.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise Of Options [Member]" } } }, "auth_ref": [] }, "qsep_ExerciseOfWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "ExerciseOfWarrantsMember", "presentation": [ "http://qsenergy.com/role/CommonStockDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise Of Warrants [Member]" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_ExtinguishmentOfDebtGainLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ExtinguishmentOfDebtGainLossNetOfTax", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 }, "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows", "http://qsenergy.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "PPP loan debt forgiveness", "negatedLabel": "Gain on partial forgiveness of PPP note payable", "documentation": "The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax." } } }, "auth_ref": [ "r46" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r6", "r14" ] }, "qsep_FairValueOfWarrantsGranted": { "xbrltype": "monetaryItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "FairValueOfWarrantsGranted", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of warrants granted" } } }, "auth_ref": [] }, "qsep_FairValueOfWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "FairValueOfWarrantsMember", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair Value Of Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r182", "r183", "r184", "r185", "r350", "r351" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r350" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r39", "r40" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r501", "r513", "r523", "r549" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r501", "r513", "r523", "r549" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r501", "r513", "r523", "r549" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r501", "r513", "r523", "r549" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r501", "r513", "r523", "r549" ] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://qsenergy.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_GainLossOnContractTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnContractTermination", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gain on lease cancellation", "documentation": "Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform." } } }, "auth_ref": [ "r81" ] }, "qsep_GainOnForgivenessOfPppLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "GainOnForgivenessOfPppLoan", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/PppLoanPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gain on forgiveness of PPP loan" } } }, "auth_ref": [] }, "qsep_GoingConcernPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "GoingConcernPolicyTextBlock", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Going Concern" } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r490", "r492", "r505" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment of Long-lived Assets", "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets." } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://qsenergy.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "verboseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r139", "r288", "r293", "r294", "r298", "r303", "r306", "r307", "r308", "r377" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://qsenergy.com/role/IncomeTaxesDetails-IncomeTaxReconciliation": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://qsenergy.com/role/IncomeTaxesDetails-IncomeTaxReconciliation" ], "lang": { "en-us": { "role": { "totalLabel": "Income tax provision", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r103", "r112", "r152", "r153", "r167", "r291", "r304", "r367" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Income Taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r124", "r289", "r290", "r294", "r295", "r297", "r299", "r375" ] }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "crdr": "debit", "calculation": { "http://qsenergy.com/role/IncomeTaxesDetails-IncomeTaxReconciliation": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://qsenergy.com/role/IncomeTaxesDetails-IncomeTaxReconciliation" ], "lang": { "en-us": { "role": { "label": "Valuation allowance", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r589" ] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "calculation": { "http://qsenergy.com/role/IncomeTaxesDetails-IncomeTaxReconciliation": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://qsenergy.com/role/IncomeTaxesDetails-IncomeTaxReconciliation" ], "lang": { "en-us": { "role": { "label": "Computed tax provision (benefit) at federal statutory rate (21%)", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r292" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r30" ] }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInterestPayableNet", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accrued interest expense", "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Operating lease liabilities", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r570", "r573" ] }, "us-gaap_IncreaseDecreaseInOtherAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherAccountsPayable", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accounts payable \u2013 license agreements", "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued expenses", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Operating lease right of use asset", "label": "Increase (Decrease) in Other Operating Assets", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r3" ] }, "qsep_IncreaseInDebtDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "IncreaseInDebtDiscount", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Increase in debt discount" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r504", "r513", "r523", "r540", "r549", "r553", "r561" ] }, "qsep_InflationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "InflationPolicyTextBlock", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Inflation" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r559" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r493", "r565" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r493", "r565" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r493", "r565" ] }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsFiniteLivedPolicy", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Patent Costs", "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets." } } }, "auth_ref": [ "r40", "r346", "r347", "r348", "r350", "r453" ] }, "us-gaap_InterestAndDebtExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndDebtExpense", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfOperations", "http://qsenergy.com/role/ResearchAndDevelopmentDetailsNarrative" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest and financing expense", "label": "Interest and financing expense", "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity." } } }, "auth_ref": [ "r7" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseDebt", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued interest", "label": "Interest Expense, Debt", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r77", "r221", "r230", "r462", "r463" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r130", "r132", "r133" ] }, "us-gaap_InterestPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPayableCurrent", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetails" ], "lang": { "en-us": { "role": { "label": "Accrued interest", "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r18" ] }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accrued interest on convertible notes payable", "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables." } } }, "auth_ref": [ "r62", "r605" ] }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Fair value of warrants issued as compensation", "label": "Issuance of Stock and Warrants for Services or Claims", "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims." } } }, "auth_ref": [ "r4" ] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://qsenergy.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r85" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Leases", "label": "Lessee, Leases [Policy Text Block]", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r335" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://qsenergy.com/role/Leases" ], "lang": { "en-us": { "role": { "verboseLabel": "Leases", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r332" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r17", "r138", "r179", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r310", "r311", "r312", "r323", "r392", "r456", "r478", "r583", "r596", "r597" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 deficit", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r74", "r99", "r360", "r467", "r576", "r580", "r594" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 DEFICIT" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r19", "r117", "r138", "r179", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r310", "r311", "r312", "r323", "r467", "r583", "r596", "r597" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "auth_ref": [] }, "qsep_LicenseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "LicenseAgreementsMember", "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments" ], "lang": { "en-us": { "role": { "label": "License Agreements [Member]" } } }, "auth_ref": [] }, "qsep_LicensingAgreementTerms": { "xbrltype": "stringItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "LicensingAgreementTerms", "presentation": [ "http://qsenergy.com/role/ResearchAndDevelopmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Temple licensing agreement terms" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheetsParenthetical", "http://qsenergy.com/role/ConvertibleNotesPayableDetails", "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative", "http://qsenergy.com/role/PppLoanPayableDetailsNarrative", "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r22" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheetsParenthetical", "http://qsenergy.com/role/ConvertibleNotesPayableDetails", "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative", "http://qsenergy.com/role/PppLoanPayableDetailsNarrative", "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r22", "r44" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://qsenergy.com/role/CommonStockDetailsNarrative", "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r188", "r189", "r190", "r191", "r246", "r345", "r368", "r384", "r385", "r442", "r443", "r444", "r445", "r446", "r449", "r450", "r458", "r464", "r465", "r468", "r585", "r598", "r599", "r600", "r601", "r602", "r603" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r532" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name" } } }, "auth_ref": [ "r532" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://qsenergy.com/role/CommonStockDetailsNarrative", "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r188", "r189", "r190", "r191", "r246", "r345", "r368", "r384", "r385", "r442", "r443", "r444", "r445", "r446", "r449", "r450", "r458", "r464", "r465", "r468", "r585", "r598", "r599", "r600", "r601", "r602", "r603" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r552" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r560" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r533" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r131" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r131" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "negatedLabel": "Cash flow from operations", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r79", "r80", "r81" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from Operating Activities" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://qsenergy.com/role/ConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows", "http://qsenergy.com/role/ConsolidatedStatementsOfOperations", "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net Loss", "label": "Net loss", "verboseLabel": "Net Income (Loss) Attributable to Parent", "negatedLabel": "Net loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r75", "r81", "r100", "r115", "r122", "r123", "r127", "r138", "r144", "r146", "r147", "r148", "r149", "r152", "r153", "r157", "r164", "r169", "r173", "r175", "r179", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r322", "r323", "r364", "r415", "r433", "r434", "r457", "r477", "r583" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recent Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r532" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r530" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r529" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r560" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r560" ] }, "us-gaap_NotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayable", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Notes payable", "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r15", "r98", "r606" ] }, "us-gaap_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OfficeEquipmentMember", "presentation": [ "http://qsenergy.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Office Equipment [Member]", "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine." } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r164", "r169", "r173", "r175", "r457" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseExpense", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments of lease liability", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r595" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating lease liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r334" ] }, "qsep_OperatingLeaseLiabilityWriteOff": { "xbrltype": "monetaryItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "OperatingLeaseLiabilityWriteOff", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating lease liability cancelled" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating lease right-of-use asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r333" ] }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amortization of right-of-use asset", "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease." } } }, "auth_ref": [ "r574" ] }, "qsep_OperatingLeaseRightOfUseAssetWriteOff": { "xbrltype": "monetaryItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "OperatingLeaseRightOfUseAssetWriteOff", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Right-of-use asset write off" } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net operating loss carryforward", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r57" ] }, "qsep_OptionPrice1Member": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "OptionPrice1Member", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare" ], "lang": { "en-us": { "role": { "label": "$0.02 - $0.24 [Member]" } } }, "auth_ref": [] }, "qsep_OptionPrice2Member": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "OptionPrice2Member", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare" ], "lang": { "en-us": { "role": { "label": "$0.25 - $0.49 [Member]" } } }, "auth_ref": [] }, "qsep_OptionPrice3Member": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "OptionPrice3Member", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare" ], "lang": { "en-us": { "role": { "label": "$0.50 - $0.99 [Member]" } } }, "auth_ref": [] }, "qsep_OriginalIssueDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "OriginalIssueDiscount", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Original issue discount" } } }, "auth_ref": [] }, "qsep_OriginalIssueDiscountMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "OriginalIssueDiscountMember", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Original Issue Discount [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherCommitment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitment", "crdr": "credit", "calculation": { "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Other Commitment", "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentDueInFifthYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentDueInFifthYear", "crdr": "credit", "calculation": { "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments": { "parentTag": "us-gaap_OtherCommitment", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments" ], "lang": { "en-us": { "role": { "label": "2028", "documentation": "Amount of commitment classified as other to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentDueInFourthYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentDueInFourthYear", "crdr": "credit", "calculation": { "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments": { "parentTag": "us-gaap_OtherCommitment", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments" ], "lang": { "en-us": { "role": { "label": "2027", "documentation": "Amount of commitment classified as other to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentDueInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentDueInNextTwelveMonths", "crdr": "credit", "calculation": { "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments": { "parentTag": "us-gaap_OtherCommitment", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments" ], "lang": { "en-us": { "role": { "label": "2024", "documentation": "Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentDueInSecondYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentDueInSecondYear", "crdr": "credit", "calculation": { "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments": { "parentTag": "us-gaap_OtherCommitment", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments" ], "lang": { "en-us": { "role": { "label": "2025", "documentation": "Amount of commitment classified as other to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentDueInThirdYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentDueInThirdYear", "crdr": "credit", "calculation": { "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments": { "parentTag": "us-gaap_OtherCommitment", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments" ], "lang": { "en-us": { "role": { "label": "2026", "documentation": "Amount of commitment classified as other to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsAxis", "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Axis]", "documentation": "Information by type of other commitment." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsDomain", "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments" ], "lang": { "en-us": { "role": { "documentation": "Other future obligation." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsLineItems", "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsTable", "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments" ], "lang": { "en-us": { "role": { "label": "Other Commitments [Table]", "documentation": "Disclosure of information about obligations resulting from other commitments." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCommitmentsTableTextBlock", "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of contractual commitments", "documentation": "Tabular disclosure of information about obligations resulting from other commitments." } } }, "auth_ref": [] }, "us-gaap_OtherCostAndExpenseOperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCostAndExpenseOperating", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating expenses", "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation." } } }, "auth_ref": [ "r76", "r366" ] }, "us-gaap_OtherNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNotesPayableCurrent", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets", "http://qsenergy.com/role/PppLoanPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "PPP Loan payable", "verboseLabel": "PPP loan payable", "documentation": "Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r18" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure Amount" } } }, "auth_ref": [ "r532" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r492" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r499", "r511", "r521", "r547" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r502", "r514", "r524", "r550" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r502", "r514", "r524", "r550" ] }, "qsep_PPPLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "PPPLoanMember", "presentation": [ "http://qsenergy.com/role/PppLoanPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "PPP Loan [Member]" } } }, "auth_ref": [] }, "qsep_PPPLoanPayableDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "PPPLoanPayableDisclosureTextBlock", "presentation": [ "http://qsenergy.com/role/PppLoanPayable" ], "lang": { "en-us": { "role": { "label": "PPP Loan Payable" } } }, "auth_ref": [] }, "qsep_PatentCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "PatentCostsMember", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Patent Costs [Member]" } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r528" ] }, "us-gaap_PaymentsForLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForLoans", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/PppLoanPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "PPP loan paid", "documentation": "Cash payments for and related to principal collection on loans related to operating activities." } } }, "auth_ref": [ "r2" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r78" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r531" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r531" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r530" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r533" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r529" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r486" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r487" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r572" ] }, "us-gaap_ProceedsFromConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromConvertibleDebt", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows", "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net proceeds from issuance of convertible notes and warrants", "verboseLabel": "Proceeds from convertible debt", "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r26" ] }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net proceeds from exercise of warrants and options", "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised." } } }, "auth_ref": [ "r1", "r13" ] }, "us-gaap_ProceedsFromNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromNotesPayable", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/PppLoanPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aggregate amount", "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r26" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://qsenergy.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r5" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://qsenergy.com/role/PropertyAndEquipment" ], "lang": { "en-us": { "role": { "label": "Property and Equipment", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r84", "r107", "r110", "r111" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r85", "r118", "r363" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://qsenergy.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets", "http://qsenergy.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r5", "r354", "r363", "r467" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Property and Equipment", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r5", "r107", "r110", "r361" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://qsenergy.com/role/PropertyAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "Schedule of property and equipment", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r5" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://qsenergy.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r85" ] }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertySubjectToOrAvailableForOperatingLeaseAxis", "presentation": [ "http://qsenergy.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Property Subject to or Available for Operating Lease [Axis]", "documentation": "Information by property that could be leased or is available for lease." } } }, "auth_ref": [ "r102" ] }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertySubjectToOrAvailableForOperatingLeaseDomain", "presentation": [ "http://qsenergy.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "A descriptive title of whether the property is subject to or available for operating lease." } } }, "auth_ref": [ "r102" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r528" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r528" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://qsenergy.com/role/CommonStockDetailsNarrative", "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r188", "r189", "r190", "r191", "r245", "r246", "r274", "r275", "r276", "r344", "r345", "r368", "r384", "r385", "r442", "r443", "r444", "r445", "r446", "r449", "r450", "r458", "r464", "r465", "r468", "r471", "r581", "r585", "r599", "r600", "r601", "r602", "r603" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://qsenergy.com/role/CommonStockDetailsNarrative", "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "auth_ref": [ "r188", "r189", "r190", "r191", "r245", "r246", "r274", "r275", "r276", "r344", "r345", "r368", "r384", "r385", "r442", "r443", "r444", "r445", "r446", "r449", "r450", "r458", "r464", "r465", "r468", "r471", "r581", "r585", "r599", "r600", "r601", "r602", "r603" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r494", "r506", "r516", "r542" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://qsenergy.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r337", "r338", "r339", "r340", "r341", "r378", "r379", "r380", "r418", "r419", "r420", "r439", "r441" ] }, "qsep_RelativeFairValueOfWarrantsAssociatedWithIssuedConvertibleNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "RelativeFairValueOfWarrantsAssociatedWithIssuedConvertibleNotes", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Relative fair value of warrants associated with issued convertible notes" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfNotesPayable", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Principal payment on PPP loan payable", "label": "Repayments of Notes Payable", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r27" ] }, "us-gaap_ResearchAndDevelopmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentAbstract", "lang": { "en-us": { "role": { "label": "Research and Development [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis", "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments", "http://qsenergy.com/role/ResearchAndDevelopmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]", "documentation": "Information by form of arrangement related to research and development." } } }, "auth_ref": [ "r287", "r588" ] }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems", "presentation": [ "http://qsenergy.com/role/ResearchAndDevelopmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r287", "r588" ] }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain", "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments", "http://qsenergy.com/role/ResearchAndDevelopmentDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others." } } }, "auth_ref": [ "r287", "r588" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://qsenergy.com/role/ConsolidatedStatementsOfOperations", "http://qsenergy.com/role/ResearchAndDevelopmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Research and development expenses", "verboseLabel": "Research and development costs", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r65", "r286", "r604" ] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Research and Development Costs", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r285" ] }, "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock", "presentation": [ "http://qsenergy.com/role/ResearchAndDevelopment" ], "lang": { "en-us": { "role": { "label": "Research and Development", "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period." } } }, "auth_ref": [ "r101", "r287" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r495", "r507", "r517", "r543" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r496", "r508", "r518", "r544" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r503", "r515", "r525", "r551" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r71", "r92", "r359", "r372", "r373", "r376", "r395", "r467" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r114", "r141", "r142", "r143", "r145", "r151", "r153", "r180", "r181", "r282", "r283", "r284", "r301", "r302", "r313", "r315", "r316", "r318", "r320", "r369", "r371", "r381", "r609" ] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r416", "r451", "r454" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfOperations", "http://qsenergy.com/role/ResearchAndDevelopmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r128", "r138", "r165", "r166", "r168", "r171", "r172", "r176", "r177", "r178", "r179", "r192", "r193", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r323", "r353", "r583" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r560" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r560" ] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://qsenergy.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of deferred income taxes", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r95" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://qsenergy.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of reconciliation of income taxes", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r94" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r39", "r40", "r350" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://qsenergy.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable", "presentation": [ "http://qsenergy.com/role/ResearchAndDevelopmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]", "documentation": "A schedule reflecting the terms of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements." } } }, "auth_ref": [ "r287", "r588" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsOutstanding", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure", "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r248", "r250", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277" ] }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of options outstanding by per share price", "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms." } } }, "auth_ref": [ "r50" ] }, "qsep_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansByExercisePriceRangeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansByExercisePriceRangeTextBlock", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of warrants outstanding by per share price" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsTables" ], "lang": { "en-us": { "role": { "label": "Stock options outstanding", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r11", "r12", "r52" ] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of warrants activity", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r49" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r480" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r484" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r483" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r488" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share based compensation expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r3" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShare" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, Expired", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r268" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants granted", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r266" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShare" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, Granted", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r266" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure", "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, warrants outstanding", "verboseLabel": "Weighted Average Exercise Price, warrants outstanding", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r263", "r264" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure" ], "lang": { "en-us": { "role": { "label": "Life (Years), warrants outstanding", "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r93" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants vested outstanding", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r267" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShare" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, Exercised", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r267" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected dividend yield", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r275" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Volatility - maximum", "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Volatility - minimum", "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Risk free interest rate - maximum", "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Risk free interest rate - minimum", "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsOutstanding", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure", "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r248", "r250", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShare" ], "lang": { "en-us": { "role": { "negatedLabel": "Warrants exercised", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "documentation": "Number of non-option equity instruments exercised by participants." } } }, "auth_ref": [ "r9" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShare" ], "lang": { "en-us": { "role": { "negatedLabel": "Warrants Expired", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations", "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed." } } }, "auth_ref": [ "r10" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsOutstanding" ], "lang": { "en-us": { "role": { "negatedLabel": "Options, Cancelled", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired." } } }, "auth_ref": [ "r587" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsOutstanding" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Cancelled", "documentation": "Weighted average price of options that were either forfeited or expired." } } }, "auth_ref": [ "r587" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsOutstanding" ], "lang": { "en-us": { "role": { "label": "Options, Granted", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r259" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aggregate intrinsic value of options outstanding", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r50" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsOutstanding" ], "lang": { "en-us": { "role": { "periodStartLabel": "Options, Outstanding beginning balance", "periodEndLabel": "Options, Outstanding ending balance", "label": "Shares, options outstanding", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r255", "r256" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsOutstanding" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Exercise Price, Outstanding Beginning Balance", "periodEndLabel": "Weighted Average Exercise Price, Outstanding Ending Balance", "label": "Weighted average exercise price, options outstanding", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r255", "r256" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare" ], "lang": { "en-us": { "role": { "label": "Shares, options exercisable", "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r272" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, options exercisable", "verboseLabel": "Weighted average exercise price, warrants exercisable", "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r271" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsOutstanding", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure", "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsOutstanding" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Exercised", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r260" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsOutstanding" ], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price, Granted", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r259" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure" ], "lang": { "en-us": { "role": { "label": "Exercise Price Range [Axis]", "documentation": "Information by range of option prices pertaining to options granted." } } }, "auth_ref": [ "r53" ] }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "auth_ref": [ "r54" ] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Aggregate intrinsic value of options outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding", "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected life", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r273" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare" ], "lang": { "en-us": { "role": { "label": "Life (Years), options outstanding", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r93" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance, shares", "periodEndLabel": "Ending balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Business and Summary of Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r82", "r135" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r489" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r8", "r25", "r114", "r125", "r126", "r127", "r141", "r142", "r143", "r145", "r151", "r153", "r163", "r180", "r181", "r244", "r282", "r283", "r284", "r301", "r302", "r313", "r314", "r315", "r316", "r317", "r318", "r320", "r324", "r325", "r326", "r327", "r328", "r329", "r336", "r369", "r370", "r371", "r381", "r435" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://qsenergy.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r141", "r142", "r143", "r163", "r349", "r374", "r383", "r386", "r387", "r388", "r389", "r390", "r391", "r394", "r397", "r398", "r399", "r400", "r401", "r403", "r404", "r405", "r406", "r408", "r409", "r410", "r411", "r412", "r414", "r416", "r417", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r435", "r472" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://qsenergy.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r141", "r142", "r143", "r163", "r349", "r374", "r383", "r386", "r387", "r388", "r389", "r390", "r391", "r394", "r397", "r398", "r399", "r400", "r401", "r403", "r404", "r405", "r406", "r408", "r409", "r410", "r411", "r412", "r414", "r416", "r417", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r435", "r472" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r498", "r510", "r520", "r546" ] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Common stock issued on exercise of warrants, shares", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r8", "r24", "r47", "r92", "r218" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsOutstanding" ], "lang": { "en-us": { "role": { "label": "Common stock issued on exercise of options, shares", "negatedLabel": "Options, Exercised", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r8", "r68", "r69", "r92", "r260" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Common stock issued on exercise of warrants", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r8", "r25", "r92" ] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "label": "Common stock issued on exercise of options", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r8", "r25", "r92" ] }, "us-gaap_StockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockOptionMember", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsByExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-OptionsOutstanding", "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Option [Member]", "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)." } } }, "auth_ref": [ "r471" ] }, "qsep_StockOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "StockOptionsMember", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock Options [Member]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://qsenergy.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://qsenergy.com/role/ConsolidatedBalanceSheets", "http://qsenergy.com/role/ConsolidatedStatementsOfStockholdersDeficit" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 deficit", "periodStartLabel": "Beginning balance, value", "periodEndLabel": "Ending balance, value", "negatedLabel": "Stockholders' deficit", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r69", "r72", "r73", "r83", "r396", "r413", "r436", "r437", "r467", "r478", "r576", "r580", "r594", "r609" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://qsenergy.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 deficit" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://qsenergy.com/role/CommonStock" ], "lang": { "en-us": { "role": { "label": "Common Stock", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r89", "r137", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r244", "r319", "r438", "r440", "r447" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://qsenergy.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r342", "r343" ] }, "us-gaap_SupplementalCashFlowElementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowElementsAbstract", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Supplemental disclosures of cash flow information" } } }, "auth_ref": [] }, "us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalUnemploymentBenefitsSeveranceBenefits", "crdr": "credit", "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments" ], "lang": { "en-us": { "role": { "label": "Severance payable", "documentation": "Liability for amount due employees, in addition to wages and any other money that employers owe employees, when their employment ends through a layoff or other termination. For example, a company may provide involuntarily terminated employees with a lump sum payment equal to one week's salary for every year of employment." } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r539" ] }, "qsep_TempleUniversityLicenseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "TempleUniversityLicenseAgreementsMember", "presentation": [ "http://qsenergy.com/role/CommitmentsAndContingenciesDetails-Commitments", "http://qsenergy.com/role/ResearchAndDevelopmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Temple University License Agreements [Member]", "documentation": "Temple university license agreements." } } }, "auth_ref": [] }, "qsep_TestingEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "TestingEquipmentMember", "presentation": [ "http://qsenergy.com/role/PropertyAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Testing Equipment [Member]" } } }, "auth_ref": [] }, "qsep_TomballTexasOfficesMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "TomballTexasOfficesMember", "presentation": [ "http://qsenergy.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tomball Texas Offices [Member]" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r531" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r538" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransactionDomain", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative", "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Agreement between buyer and seller for the exchange of financial instruments." } } }, "auth_ref": [ "r452" ] }, "us-gaap_TransactionTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransactionTypeAxis", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative", "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Transaction Type [Axis]", "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments." } } }, "auth_ref": [ "r452" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r562" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r563" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r561" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r561" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Aggregate Available" } } }, "auth_ref": [ "r564" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r562" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r558" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r36", "r37", "r38", "r105", "r106", "r108", "r109" ] }, "qsep_Warrant1Member": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "Warrant1Member", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "$0.02 - $0.24 [Member]", "label": "$0.02 - $0.24 [Member] [Default Label]" } } }, "auth_ref": [] }, "qsep_Warrant2Member": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "Warrant2Member", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "$0.25 - $0.49 [Member]", "label": "$0.25 - $0.49 [Member] [Default Label]" } } }, "auth_ref": [] }, "qsep_Warrant3Member": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "Warrant3Member", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure" ], "lang": { "en-us": { "role": { "label": "$0.50 - $1.00 [Member]" } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShare", "http://qsenergy.com/role/StockOptionsAndWarrantsDetails-WarrantExercisePricePerShareDisclosure", "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r469", "r470", "r473", "r474", "r475", "r476" ] }, "qsep_WarrantsExpectedToVest": { "xbrltype": "sharesItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "WarrantsExpectedToVest", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants expected to vest" } } }, "auth_ref": [] }, "qsep_WarrantsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "WarrantsIssued", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants issued, shares" } } }, "auth_ref": [] }, "qsep_WarrantsIssuedShares": { "xbrltype": "sharesItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "WarrantsIssuedShares", "presentation": [ "http://qsenergy.com/role/StockOptionsAndWarrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrants granted", "label": "WarrantsIssuedShares" } } }, "auth_ref": [] }, "qsep_WarrantsIssuedValue": { "xbrltype": "monetaryItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "WarrantsIssuedValue", "crdr": "debit", "presentation": [ "http://qsenergy.com/role/ConvertibleNotesPayableDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants issued, value" } } }, "auth_ref": [] }, "qsep_WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://qsenergy.com/20231231", "localname": "WarrantsMember", "presentation": [ "http://qsenergy.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average common shares outstanding, diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r155", "r160" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://qsenergy.com/role/ConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average common shares outstanding, basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r154", "r160" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://qsenergy.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r568" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "835", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(2)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(4)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-2" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(b),(f(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-10" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "985", "SubTopic": "730", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//985-730/tableOfContent" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-4" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "51", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-51" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r452": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r453": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r454": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r455": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r456": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r457": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r458": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r459": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r460": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r461": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r462": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r463": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r464": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r465": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r466": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r468": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r469": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r471": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r474": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r475": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r476": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r477": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r478": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r479": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r480": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r481": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r483": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r485": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r486": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r487": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r488": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r489": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r490": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r491": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r492": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r493": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r494": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r495": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r496": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r497": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r498": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r499": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r500": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r501": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r502": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r503": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r504": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r505": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r506": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r507": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r508": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r509": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r510": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r511": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r512": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r513": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r514": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r515": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r516": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r517": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r518": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r519": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r520": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r521": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r522": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r523": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r524": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r525": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r526": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r528": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r529": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r530": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r531": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r532": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r533": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r534": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r535": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r536": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r537": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r538": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r539": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r540": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r541": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r542": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r543": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r544": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r545": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r546": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r547": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r548": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r549": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r550": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r551": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r552": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r553": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r554": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r555": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r556": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r557": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r558": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r559": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r560": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r561": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r562": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r563": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r564": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r565": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r566": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r567": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r568": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r569": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r570": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r571": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r572": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r573": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r574": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r575": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r576": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r577": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r578": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r579": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r580": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r581": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r582": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r583": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r584": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r585": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r586": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r587": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r588": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "730", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1" }, "r589": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r590": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r591": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r592": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r593": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r594": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r595": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4" }, "r596": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r597": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r598": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r599": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r600": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r601": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r602": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r603": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r604": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r605": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r606": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r607": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r608": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r609": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r610": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 63 0001683168-24-002236-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-24-002236-xbrl.zip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�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qsenergy_i10k-123123_htm.xml IDEA: XBRL DOCUMENT 0001103795 2023-01-01 2023-12-31 0001103795 2023-12-31 0001103795 2024-04-01 0001103795 2023-10-01 2023-12-31 0001103795 2022-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2023-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2022-12-31 0001103795 2022-01-01 2022-12-31 0001103795 us-gaap:CommonStockMember 2021-12-31 0001103795 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001103795 us-gaap:RetainedEarningsMember 2021-12-31 0001103795 2021-12-31 0001103795 us-gaap:CommonStockMember 2022-12-31 0001103795 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001103795 us-gaap:RetainedEarningsMember 2022-12-31 0001103795 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001103795 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001103795 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001103795 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001103795 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001103795 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001103795 us-gaap:CommonStockMember 2023-12-31 0001103795 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001103795 us-gaap:RetainedEarningsMember 2023-12-31 0001103795 qsep:PatentCostsMember 2023-01-01 2023-12-31 0001103795 qsep:PatentCostsMember 2022-01-01 2022-12-31 0001103795 qsep:StockOptionsMember 2023-01-01 2023-12-31 0001103795 qsep:StockOptionsMember 2022-01-01 2022-12-31 0001103795 qsep:WarrantsMember 2023-01-01 2023-12-31 0001103795 qsep:WarrantsMember 2022-01-01 2022-12-31 0001103795 qsep:ConvertibleNotesMember 2023-01-01 2023-12-31 0001103795 qsep:ConvertibleNotesMember 2022-01-01 2022-12-31 0001103795 us-gaap:OfficeEquipmentMember 2023-12-31 0001103795 us-gaap:OfficeEquipmentMember 2022-12-31 0001103795 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001103795 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001103795 qsep:TestingEquipmentMember 2023-12-31 0001103795 qsep:TestingEquipmentMember 2022-12-31 0001103795 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001103795 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001103795 qsep:CorporateOfficeSpaceMember 2021-06-30 0001103795 qsep:CorporateOfficeSpaceMember 2021-12-31 0001103795 qsep:CorporateOfficeSpaceMember 2022-12-31 0001103795 qsep:CorporateOfficeSpaceMember 2022-01-01 2022-12-31 0001103795 2022-11-01 2022-12-31 0001103795 qsep:TomballTexasOfficesMember 2023-12-31 0001103795 qsep:ConvertibleNotesMember 2021-12-31 0001103795 qsep:ConvertibleNotesMember 2022-01-01 2022-12-31 0001103795 qsep:ConvertibleNotesMember 2022-12-31 0001103795 qsep:ConvertibleNotesMember 2023-01-01 2023-12-31 0001103795 qsep:ConvertibleNotesMember 2023-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2021-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-12-31 0001103795 qsep:DebtDiscountMember 2021-12-31 0001103795 qsep:DebtDiscountMember 2022-01-01 2022-12-31 0001103795 qsep:DebtDiscountMember qsep:FairValueOfWarrantsMember 2022-01-01 2022-12-31 0001103795 qsep:DebtDiscountMember qsep:OriginalIssueDiscountMember 2022-01-01 2022-12-31 0001103795 qsep:DebtDiscountMember qsep:DiscountConvertedMember 2022-01-01 2022-12-31 0001103795 qsep:DebtDiscountMember 2022-12-31 0001103795 qsep:DebtDiscountMember 2023-01-01 2023-12-31 0001103795 qsep:DebtDiscountMember qsep:FairValueOfWarrantsMember 2023-01-01 2023-12-31 0001103795 qsep:DebtDiscountMember qsep:OriginalIssueDiscountMember 2023-01-01 2023-12-31 0001103795 qsep:DebtDiscountMember qsep:DiscountConvertedMember 2023-01-01 2023-12-31 0001103795 qsep:DebtDiscountMember 2023-12-31 0001103795 qsep:PPPLoanMember 2020-06-01 2020-06-30 0001103795 qsep:PPPLoanMember 2020-06-30 0001103795 qsep:PPPLoanMember 2021-12-31 0001103795 qsep:PPPLoanMember 2022-01-01 2022-12-31 0001103795 qsep:PPPLoanMember 2022-12-31 0001103795 qsep:PPPLoanMember 2023-01-01 2023-12-31 0001103795 qsep:PPPLoanMember 2023-12-31 0001103795 qsep:AOTPrototysMember 2023-01-01 2023-12-31 0001103795 qsep:AOTPrototysMember 2022-01-01 2022-12-31 0001103795 qsep:TempleUniversityLicenseAgreementsMember 2023-01-01 2023-12-31 0001103795 qsep:TempleUniversityLicenseAgreementsMember 2022-01-01 2022-12-31 0001103795 qsep:TempleUniversityLicenseAgreementsMember 2023-12-31 0001103795 qsep:TempleUniversityLicenseAgreementsMember 2022-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-12-31 0001103795 srt:MinimumMember us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-12-31 0001103795 srt:MaximumMember us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2023-12-31 0001103795 qsep:ExerciseOfWarrantsMember 2023-01-01 2023-12-31 0001103795 srt:MinimumMember qsep:ExerciseOfWarrantsMember 2023-01-01 2023-12-31 0001103795 srt:MaximumMember qsep:ExerciseOfWarrantsMember 2023-01-01 2023-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001103795 srt:MinimumMember us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001103795 srt:MaximumMember us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001103795 us-gaap:ConvertibleNotesPayableMember 2022-12-31 0001103795 qsep:ExerciseOfWarrantsMember 2022-01-01 2022-12-31 0001103795 srt:MinimumMember qsep:ExerciseOfWarrantsMember 2022-01-01 2022-12-31 0001103795 srt:MaximumMember qsep:ExerciseOfWarrantsMember 2022-01-01 2022-12-31 0001103795 qsep:ExerciseOfOptionsMember 2022-01-01 2022-12-31 0001103795 us-gaap:StockOptionMember 2021-12-31 0001103795 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001103795 us-gaap:StockOptionMember 2022-12-31 0001103795 us-gaap:StockOptionMember 2023-01-01 2023-12-31 0001103795 us-gaap:StockOptionMember 2023-12-31 0001103795 us-gaap:WarrantMember 2023-12-31 0001103795 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001103795 us-gaap:WarrantMember us-gaap:ConvertibleDebtMember 2023-03-01 2023-09-30 0001103795 us-gaap:WarrantMember us-gaap:ConvertibleDebtMember 2023-09-30 0001103795 us-gaap:WarrantMember qsep:ConsultingAgreementMember 2023-01-01 2023-12-31 0001103795 srt:MinimumMember us-gaap:WarrantMember qsep:ConsultingAgreementMember 2023-01-01 2023-12-31 0001103795 srt:MaximumMember us-gaap:WarrantMember qsep:ConsultingAgreementMember 2023-01-01 2023-12-31 0001103795 us-gaap:WarrantMember us-gaap:ConvertibleDebtMember 2022-09-01 2022-09-30 0001103795 us-gaap:WarrantMember qsep:ConsultingAgreementMember 2022-01-01 2022-12-31 0001103795 srt:MinimumMember us-gaap:WarrantMember qsep:ConsultingAgreementMember 2022-12-31 0001103795 srt:MaximumMember us-gaap:WarrantMember qsep:ConsultingAgreementMember 2022-12-31 0001103795 srt:MinimumMember us-gaap:WarrantMember qsep:ConsultingAgreementMember 2022-01-01 2022-12-31 0001103795 srt:MaximumMember us-gaap:WarrantMember qsep:ConsultingAgreementMember 2022-01-01 2022-12-31 0001103795 us-gaap:StockOptionMember qsep:OptionPrice1Member 2023-12-31 0001103795 us-gaap:StockOptionMember qsep:OptionPrice1Member 2023-01-01 2023-12-31 0001103795 us-gaap:StockOptionMember qsep:OptionPrice2Member 2023-12-31 0001103795 us-gaap:StockOptionMember qsep:OptionPrice2Member 2023-01-01 2023-12-31 0001103795 us-gaap:StockOptionMember qsep:OptionPrice3Member 2023-12-31 0001103795 us-gaap:StockOptionMember qsep:OptionPrice3Member 2023-01-01 2023-12-31 0001103795 us-gaap:WarrantMember 2021-12-31 0001103795 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001103795 us-gaap:WarrantMember 2022-12-31 0001103795 us-gaap:WarrantMember qsep:Warrant1Member 2023-12-31 0001103795 us-gaap:WarrantMember qsep:Warrant1Member 2023-01-01 2023-12-31 0001103795 us-gaap:WarrantMember qsep:Warrant2Member 2023-12-31 0001103795 us-gaap:WarrantMember qsep:Warrant3Member 2023-12-31 0001103795 us-gaap:WarrantMember qsep:Warrant3Member 2023-01-01 2023-12-31 0001103795 qsep:LicenseAgreementsMember 2023-12-31 0001103795 qsep:CompensationAgreementsMember 2023-12-31 iso4217:USD shares iso4217:USD shares pure false 2023 FY 0001103795 10-K true 2023-12-31 --12-31 false 0-29185 QS ENERGY, INC. NV 52-2088326 23902 FM 2978 Tomball TX 77375 775 300-7647 No No Yes Yes Non-accelerated Filer true false false false false 21268000 397931803 false false false false 572 Weinberg & Company, P.A. Los Angeles, California 70000 133000 12000 19000 82000 152000 2000 6000 84000 158000 2198000 1962000 972000 946000 25000 140000 2022000 1730000 2101000 1865000 57000 75000 5328000 4848000 5328000 4848000 0.001 0.001 500000000 500000000 392586471 392586471 376074096 376074096 392587 376075 119729413 119075925 -125366000 -124142000 -5244000 -4690000 84000 158000 0 0 688000 765000 203000 486000 -891000 -1251000 0 63000 333000 360000 -1224000 -1548000 -0.00 -0.00 -0.00 -0.00 385561786 385561786 361790243 361790243 355300222 355301 118065699 -122594000 -4173000 6040049 6040 52960 59000 283000 283000 14483825 14484 527516 542000 127000 127000 250000 250 19750 20000 -1548000 -1548000 376074096 376075 119075925 -124142000 -4690000 15129048 15129 334871 350000 231000 231000 1383327 1383 50617 52000 37000 37000 -1224000 -1224000 392586471 392587 119729413 -125366000 -5244000 -1224000 -1548000 37000 127000 103000 149000 182000 162000 4000 4000 -0 63000 -0 -143000 -7000 5000 26000 16000 236000 236000 0 -144000 -629000 -923000 -0 1000 0 -1000 532000 393000 52000 562000 18000 12000 566000 943000 -63000 19000 133000 114000 70000 133000 0 0 1600 1600 350000 59000 231000 283000 <p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_z6HvOKojURng" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 34px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_823_z38DVGBJwoc4">Business and Summary of Significant Accounting Policies</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">QS Energy, Inc. (“QS Energy”, “Company”) was incorporated on February 18, 1998, as a Nevada Corporation under the name Mandalay Capital Corporation. The Company changed its name to Save the World Air, Inc. on February 11, 1999. Effective August 11, 2015, the Company changed its name to QS Energy, Inc.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">QS Energy develops and seeks to commercialize energy efficiency technologies that assist in meeting increasing global energy demands, improving the economics of oil transport, and reducing greenhouse gas emissions. The Company’s intellectual properties include a portfolio of domestic and international patents, a substantial portion of which have been developed in conjunction with and exclusively licensed from Temple University of Philadelphia, PA (“Temple”). QS Energy’s primary technology is called Applied Oil Technology (AOT), a commercial-grade crude oil pipeline transportation flow-assurance product.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84B_ecustom--GoingConcernPolicyTextBlock_z2ACmybHNF17" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_860_ztueDtRPrTD7">Going Concern</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the twelve-months ended December 31, 2023, the Company incurred a net loss of $<span id="xdx_907_eus-gaap--NetIncomeLoss_iN_di_c20230101__20231231_zlgfKeeSqB0d" title="Net loss">1,224,000</span>, used cash in operations of $<span id="xdx_90E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20230101__20231231_zEihBSI3I2kd" title="Cash flow from operations">629,000</span> and had a stockholders’ deficit of $<span id="xdx_90E_eus-gaap--StockholdersEquity_iNI_pp0p0_di_c20231231_zC5eBxPnbNh5" title="Stockholders' deficit">5,244,000</span> as of December 31, 2023. In addition, as of December 31, 2023, thirty-eight notes payable with an aggregate balance of $<span id="xdx_903_eus-gaap--NotesPayable_pp0p0_c20231231_z0PRXOqeOSpa" title="Notes payable">2,022,000</span> and certain obligations to a former officer are past due. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">At December 31, 2023, the Company had cash on hand in the amount of $<span id="xdx_901_eus-gaap--Cash_pp0p0_c20231231_zBRVvMxMAEB1" title="Cash on Hand">70,000</span>. Management estimates that the current cash on hand will be sufficient to continue operations through April 2024. The AOT product is still in development and testing and has transitioned from laboratory testing to initial demonstration and continued testing in advance of our goal of seeking commercial acceptance and adoption by the upstream and midstream pipeline marketplace. QS Energy’s efforts in the foregoing regard have been substantially hampered by a lack of capital. The Company should be able to continue its efforts to commercialize its AOT product during 2024 only if sufficient capital is raised to do so. The Company can provide no assurances in its ability to raise the capital needed to continue efforts in 2024, or that any such capital will be available to it on acceptable terms and conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Management is currently seeking additional funds, primarily through the issuance of debt and equity securities for cash to operate our business, including without limitation the expenses it will incur in connection with the license agreements with Temple; costs associated with product development and commercialization of the AOT technologies; costs to manufacture and ship the products; costs to design and implement an effective system of internal controls and disclosure controls and procedures; costs of maintaining our status as a public company by filing periodic reports with the SEC and costs required to protect our intellectual property. In addition, as discussed below, the Company has substantial contractual commitments, including without limitation salaries to our executive officers pursuant to employment agreements, and certain payments to a former officer and consulting fees, during the remainder of 2024 and beyond.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders in case of equity financing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_841_ecustom--InflationPolicyTextBlock_zFnlRP2MPkZc" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_866_zbe8GqNX6L31">Inflation</span> </span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Macroeconomic factors such as inflation, rising interest rates, governmental responses there to and possible recession caused thereby also add significant uncertainty to our operations and possible effects to the amount and type of financing available to the Company in the future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b> </b></p> <p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z0Ugdq2X4E03" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><b><span style="text-decoration: underline"><span id="xdx_863_z0lDJaK4JJA6">Basis of Presentation</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in; background-color: white">The accompanying consolidated financial statements and related notes include activities of the Company and have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in; background-color: white">The consolidated financial statements include the accounts of QS Energy Inc. and its wholly owned subsidiaries, QS Energy Pool, Inc. and STWA Asia Pte. Limited. Intercompany transactions and balances have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b> </b></p> <p id="xdx_842_eus-gaap--UseOfEstimates_z31oVcG0jsJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_866_zUmHRnVXGDfd">Use of Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates include those related to assumptions used in valuing the issuance of convertible notes and the corresponding debt discount, assumptions used in valuing equity instruments issued for services, the realizability of deferred tax assets and the related valuation allowance, accruals for potential liabilities, and assumptions used in the determination of the Company’s liquidity. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b> </b></p> <p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_z2jNyBO0OBo1" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_860_zKsHROp1A0Ee">Revenue Recognition</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Under its business plan, the Company anticipates the leasing of its primary technology. The Company will recognize lease revenue ratably over the life of the lease upon commencement of the lease. Revenue on future product sales will be recognized in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606, <i>Revenue from Contracts with Customers</i>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zhruR4Lbdi6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><b><span style="text-decoration: underline"><span id="xdx_865_z3b0SynxtKx1">Cash</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Cash consists of demand deposits with banks. The Company holds no cash equivalents as of December 31, 2023 and 2022, respectively. The Company maintains its cash with domestic financial institutions. At times, cash balances may exceed federally insured limits of $250,000 per depositor at each financial institution. The Company believes that no significant concentration of credit risk exists with respect to these cash balances because of its assessment of the creditworthiness and financial viability of the financial institutions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zQSLleHvu2zb" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_862_zO5bssskrqMl">Property and Equipment</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method based on the estimated useful lives of the assets, generally ranging from three to ten years. Expenditures for major renewals and improvements that extend the useful lives of property and equipment are capitalized. Expenditures for repairs and maintenance are charged to expense as incurred. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the lease term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84D_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zHsLKojb1Op2" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><b><span style="text-decoration: underline"><span id="xdx_861_zYi3Bh8DLLza">Impairment of Long-lived Assets</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Our long-lived assets, such as property and equipment, are reviewed for impairment at least annually, or when events and circumstances indicate that depreciable or amortizable long-lived assets might be impaired and the undiscounted cash flows estimated to be generated by those assets are less than the carrying amount of those assets. When specific assets are determined to be unrecoverable, the cost basis of the asset is reduced to reflect the current value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">We use various assumptions in determining the current fair value of these assets, including future expected cash flows and discount rates, as well as other fair value measures. Our impairment loss calculations require us to apply judgment in estimating future cash flows, including forecasting useful lives of the assets and selecting the discount rate that reflects the risk inherent in future cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">If actual results are not consistent with our assumptions and judgments used in estimating future cash flows and asset fair values, we may be exposed to future impairment losses that could be material to our results. Based upon management’s annual review, <span id="xdx_904_eus-gaap--AssetImpairmentCharges_pp0p0_do_c20220101__20221231_zhEA7QEEi1vg" title="Asset impairment"><span id="xdx_906_eus-gaap--AssetImpairmentCharges_pp0p0_do_c20230101__20231231_zpJtJPuI0Hf6" title="Asset impairment">no</span></span> impairments were recorded for the years ended December 31, 2023 and 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84B_eus-gaap--LesseeLeasesPolicyTextBlock_zC3QP3PJBTH" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_86B_zSthQ75SBbhk">Leases</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The Company accounts for its leases in accordance with the guidance of ASC 842, <i>Leases.</i> The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments (see Note 3).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_zrJSfhBsIUFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_862_zvUshj1xBCCj">Income Taxes</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The Company follows the asset and liability method of accounting for income taxes. The Company recognizes deferred tax assets and liabilities to reflect the estimated future tax effects, calculated at anticipated future tax rates, of future deductible or taxable amounts attributable to events that have been recognized on a cumulative basis in the financial statements. A valuation allowance related to a deferred tax asset is recorded when it is more likely than not that some portion of the deferred tax asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_z7Yz1G49wpBe" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_865_zzKV6zoCfgq1">Research and Development Costs</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Research and development expenses relate primarily to the development, design, testing of preproduction prototypes and models, compensation, and consulting fees, and are expensed as incurred. Total research and development costs recorded during the years ended December 31, 2023 and 2022, amounted to $<span id="xdx_901_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20230101__20231231_zZxRT4g7ujca" title="Research and development costs">203,000</span> and $<span id="xdx_903_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20220101__20221231_zMIEUEWBNTYj" title="Research and development costs">486,000</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.5in"> </p> <p id="xdx_844_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zBfXSOulxWC4" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_861_zd5yq3ZfHzk8">Patent Costs</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Patent costs consist of patent-related legal and filing fees. Due to the uncertainty associated with the successful development of our AOT product, all patent costs are expensed as incurred. During the years ended December 31, 2023 and 2022, patent costs were $<span id="xdx_901_eus-gaap--OperatingExpenses_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentCostsMember_zJmdUKrJOAK9" title="Operating expenses">30,000</span> and $<span id="xdx_90C_eus-gaap--OperatingExpenses_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentCostsMember_zVUDr3kr6sVe" title="Operating expenses">13,000</span>, respectively, and were included as part of operating expenses in the accompanying consolidated statements of operations. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b> </b></p> <p id="xdx_848_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zCNr6nGQtXik" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_862_z36ZHxZKpvRi">Stock-Based Compensation</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock-based payments to officers, directors, employees, and consultants by measuring the cost of services received in exchange for equity awards utilizing the grant date fair value of the awards, with the cost recognized as compensation expense on the straight-line basis in the Company’s financial statements over the vesting period of the awards.  Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The fair value of the Company's stock options and warrants grant is estimated using the Black-Scholes Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or warrants, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes Option Pricing model could materially affect compensation expense recorded in future periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b> </b></p> <p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zALzDGjpV8ua" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_86B_zsZQJd4esQF6">Fair Value of Financial Instruments</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Accounting standards require certain assets and liabilities to be reported at fair value in the financial statements and provide a framework for establishing that fair value. Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, the Company considers the principal or most advantageous market in which it transacts and considers assumptions that market participants would use when pricing the asset or liability. The framework for determining fair value is based on a hierarchy that prioritizes the inputs and valuation techniques used to measure fair value:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Level 1—Quoted prices in active markets for identical assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Level 2—Inputs, other than the quoted prices in active markets, are observable either directly or indirectly.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Level 3—Unobservable inputs based on the Company’s assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The Company is required to use observable market data if such data is available without undue cost and effort.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The carrying amounts for cash, accounts payable, accrued expenses and convertible notes payable approximate their fair value due to the short-term nature of such instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">  </p> <p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zBizDsuRpBLi" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_863_zTPFnIoYsKQa">Loss per Share</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution, using the treasury stock method that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the loss of the Company. In computing diluted loss per share, the treasury stock method assumes that outstanding options and warrants are exercised, and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">For the years ended December 31, 2023 and 2022, the dilutive impact of outstanding stock options of <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zoAyl8czGj6h" title="Antidilutive shares">25,757,155</span> shares and <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zBGw0KnuM9sl" title="Antidilutive shares">26,057,601</span> shares; outstanding warrants of <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_zDSaCOQbZfN9" title="Antidilutive shares">17,953,239</span> shares and <span id="xdx_90C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_zOouo7YvTd8e" title="Antidilutive shares">20,314,153</span> shares; and notes convertible into approximately <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zrJtOeEtLDta" title="Antidilutive shares">34,716,235</span> and <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zRYLeZVHpAW1" title="Antidilutive shares">35,138,466</span> shares of our common stock, respectively, have been excluded because their impact on the loss per share is anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z8rTasltQQ7c" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_862_ziaDQiwmqLHd">Recent Accounting Pronouncements</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statement presentation or disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06). ASU 2020-06 simplifies the accounting for convertible debt by eliminating the beneficial conversion and cash conversion accounting models. Upon adoption of ASU 2020-06, convertible debt proceeds, unless issued with a substantial premium or an embedded conversion feature that is not clearly and closely related to the host contract, will no longer be allocated between debt and equity components. This modification will reduce the issue discount and result in less non-cash interest expense in financial statements. ASU 2020-06 also updates the earnings per share calculation and requires entities to assume share settlement when the convertible debt can be settled in cash or shares. ASU 2020-06 will be effective January 1, 2024, and a cumulative-effect adjustment to the opening balance of retained earnings is required upon adoption. Early adoption is permitted, but no earlier than January 1, 2021, including interim periods within that year. The adoption of ASU 2020-06 is not expected to have any impact on the Company’s consolidated financial statement presentation or disclosures subsequent to its adoption, with any effect being largely dependent on the composition and terms of outstanding financial instruments at the time of adoption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84B_ecustom--GoingConcernPolicyTextBlock_z2ACmybHNF17" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_860_ztueDtRPrTD7">Going Concern</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, during the twelve-months ended December 31, 2023, the Company incurred a net loss of $<span id="xdx_907_eus-gaap--NetIncomeLoss_iN_di_c20230101__20231231_zlgfKeeSqB0d" title="Net loss">1,224,000</span>, used cash in operations of $<span id="xdx_90E_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pp0p0_di_c20230101__20231231_zEihBSI3I2kd" title="Cash flow from operations">629,000</span> and had a stockholders’ deficit of $<span id="xdx_90E_eus-gaap--StockholdersEquity_iNI_pp0p0_di_c20231231_zC5eBxPnbNh5" title="Stockholders' deficit">5,244,000</span> as of December 31, 2023. In addition, as of December 31, 2023, thirty-eight notes payable with an aggregate balance of $<span id="xdx_903_eus-gaap--NotesPayable_pp0p0_c20231231_z0PRXOqeOSpa" title="Notes payable">2,022,000</span> and certain obligations to a former officer are past due. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">At December 31, 2023, the Company had cash on hand in the amount of $<span id="xdx_901_eus-gaap--Cash_pp0p0_c20231231_zBRVvMxMAEB1" title="Cash on Hand">70,000</span>. Management estimates that the current cash on hand will be sufficient to continue operations through April 2024. The AOT product is still in development and testing and has transitioned from laboratory testing to initial demonstration and continued testing in advance of our goal of seeking commercial acceptance and adoption by the upstream and midstream pipeline marketplace. QS Energy’s efforts in the foregoing regard have been substantially hampered by a lack of capital. The Company should be able to continue its efforts to commercialize its AOT product during 2024 only if sufficient capital is raised to do so. The Company can provide no assurances in its ability to raise the capital needed to continue efforts in 2024, or that any such capital will be available to it on acceptable terms and conditions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Management is currently seeking additional funds, primarily through the issuance of debt and equity securities for cash to operate our business, including without limitation the expenses it will incur in connection with the license agreements with Temple; costs associated with product development and commercialization of the AOT technologies; costs to manufacture and ship the products; costs to design and implement an effective system of internal controls and disclosure controls and procedures; costs of maintaining our status as a public company by filing periodic reports with the SEC and costs required to protect our intellectual property. In addition, as discussed below, the Company has substantial contractual commitments, including without limitation salaries to our executive officers pursuant to employment agreements, and certain payments to a former officer and consulting fees, during the remainder of 2024 and beyond.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders in case of equity financing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> -1224000 -629000 -5244000 2022000 70000 <p id="xdx_841_ecustom--InflationPolicyTextBlock_zFnlRP2MPkZc" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_866_zbe8GqNX6L31">Inflation</span> </span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Macroeconomic factors such as inflation, rising interest rates, governmental responses there to and possible recession caused thereby also add significant uncertainty to our operations and possible effects to the amount and type of financing available to the Company in the future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b> </b></p> <p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z0Ugdq2X4E03" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><b><span style="text-decoration: underline"><span id="xdx_863_z0lDJaK4JJA6">Basis of Presentation</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in; background-color: white">The accompanying consolidated financial statements and related notes include activities of the Company and have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in; background-color: white">The consolidated financial statements include the accounts of QS Energy Inc. and its wholly owned subsidiaries, QS Energy Pool, Inc. and STWA Asia Pte. Limited. Intercompany transactions and balances have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b> </b></p> <p id="xdx_842_eus-gaap--UseOfEstimates_z31oVcG0jsJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_866_zUmHRnVXGDfd">Use of Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates include those related to assumptions used in valuing the issuance of convertible notes and the corresponding debt discount, assumptions used in valuing equity instruments issued for services, the realizability of deferred tax assets and the related valuation allowance, accruals for potential liabilities, and assumptions used in the determination of the Company’s liquidity. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b> </b></p> <p id="xdx_84B_eus-gaap--RevenueRecognitionPolicyTextBlock_z2jNyBO0OBo1" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_860_zKsHROp1A0Ee">Revenue Recognition</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Under its business plan, the Company anticipates the leasing of its primary technology. The Company will recognize lease revenue ratably over the life of the lease upon commencement of the lease. Revenue on future product sales will be recognized in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 606, <i>Revenue from Contracts with Customers</i>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zhruR4Lbdi6k" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><b><span style="text-decoration: underline"><span id="xdx_865_z3b0SynxtKx1">Cash</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Cash consists of demand deposits with banks. The Company holds no cash equivalents as of December 31, 2023 and 2022, respectively. The Company maintains its cash with domestic financial institutions. At times, cash balances may exceed federally insured limits of $250,000 per depositor at each financial institution. The Company believes that no significant concentration of credit risk exists with respect to these cash balances because of its assessment of the creditworthiness and financial viability of the financial institutions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p> <p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zQSLleHvu2zb" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_862_zO5bssskrqMl">Property and Equipment</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method based on the estimated useful lives of the assets, generally ranging from three to ten years. Expenditures for major renewals and improvements that extend the useful lives of property and equipment are capitalized. Expenditures for repairs and maintenance are charged to expense as incurred. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated useful life of the asset or the lease term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84D_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_zHsLKojb1Op2" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><b><span style="text-decoration: underline"><span id="xdx_861_zYi3Bh8DLLza">Impairment of Long-lived Assets</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Our long-lived assets, such as property and equipment, are reviewed for impairment at least annually, or when events and circumstances indicate that depreciable or amortizable long-lived assets might be impaired and the undiscounted cash flows estimated to be generated by those assets are less than the carrying amount of those assets. When specific assets are determined to be unrecoverable, the cost basis of the asset is reduced to reflect the current value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">We use various assumptions in determining the current fair value of these assets, including future expected cash flows and discount rates, as well as other fair value measures. Our impairment loss calculations require us to apply judgment in estimating future cash flows, including forecasting useful lives of the assets and selecting the discount rate that reflects the risk inherent in future cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">If actual results are not consistent with our assumptions and judgments used in estimating future cash flows and asset fair values, we may be exposed to future impairment losses that could be material to our results. Based upon management’s annual review, <span id="xdx_904_eus-gaap--AssetImpairmentCharges_pp0p0_do_c20220101__20221231_zhEA7QEEi1vg" title="Asset impairment"><span id="xdx_906_eus-gaap--AssetImpairmentCharges_pp0p0_do_c20230101__20231231_zpJtJPuI0Hf6" title="Asset impairment">no</span></span> impairments were recorded for the years ended December 31, 2023 and 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> 0 0 <p id="xdx_84B_eus-gaap--LesseeLeasesPolicyTextBlock_zC3QP3PJBTH" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_86B_zSthQ75SBbhk">Leases</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The Company accounts for its leases in accordance with the guidance of ASC 842, <i>Leases.</i> The Company determines whether a contract is, or contains, a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset during the lease term, and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at lease commencement based upon the estimated present value of unpaid lease payments over the lease term. The Company uses its incremental borrowing rate based on the information available at lease commencement in determining the present value of unpaid lease payments (see Note 3).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_zrJSfhBsIUFc" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_862_zvUshj1xBCCj">Income Taxes</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The Company follows the asset and liability method of accounting for income taxes. The Company recognizes deferred tax assets and liabilities to reflect the estimated future tax effects, calculated at anticipated future tax rates, of future deductible or taxable amounts attributable to events that have been recognized on a cumulative basis in the financial statements. A valuation allowance related to a deferred tax asset is recorded when it is more likely than not that some portion of the deferred tax asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84F_eus-gaap--ResearchAndDevelopmentExpensePolicy_z7Yz1G49wpBe" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_865_zzKV6zoCfgq1">Research and Development Costs</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Research and development expenses relate primarily to the development, design, testing of preproduction prototypes and models, compensation, and consulting fees, and are expensed as incurred. Total research and development costs recorded during the years ended December 31, 2023 and 2022, amounted to $<span id="xdx_901_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20230101__20231231_zZxRT4g7ujca" title="Research and development costs">203,000</span> and $<span id="xdx_903_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20220101__20221231_zMIEUEWBNTYj" title="Research and development costs">486,000</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.5in"> </p> 203000 486000 <p id="xdx_844_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zBfXSOulxWC4" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_861_zd5yq3ZfHzk8">Patent Costs</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Patent costs consist of patent-related legal and filing fees. Due to the uncertainty associated with the successful development of our AOT product, all patent costs are expensed as incurred. During the years ended December 31, 2023 and 2022, patent costs were $<span id="xdx_901_eus-gaap--OperatingExpenses_pp0p0_c20230101__20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentCostsMember_zJmdUKrJOAK9" title="Operating expenses">30,000</span> and $<span id="xdx_90C_eus-gaap--OperatingExpenses_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentCostsMember_zVUDr3kr6sVe" title="Operating expenses">13,000</span>, respectively, and were included as part of operating expenses in the accompanying consolidated statements of operations. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b> </b></p> 30000 13000 <p id="xdx_848_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zCNr6nGQtXik" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_862_z36ZHxZKpvRi">Stock-Based Compensation</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock-based payments to officers, directors, employees, and consultants by measuring the cost of services received in exchange for equity awards utilizing the grant date fair value of the awards, with the cost recognized as compensation expense on the straight-line basis in the Company’s financial statements over the vesting period of the awards.  Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The fair value of the Company's stock options and warrants grant is estimated using the Black-Scholes Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or warrants, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes Option Pricing model could materially affect compensation expense recorded in future periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b> </b></p> <p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zALzDGjpV8ua" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_86B_zsZQJd4esQF6">Fair Value of Financial Instruments</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Accounting standards require certain assets and liabilities to be reported at fair value in the financial statements and provide a framework for establishing that fair value. Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, the Company considers the principal or most advantageous market in which it transacts and considers assumptions that market participants would use when pricing the asset or liability. The framework for determining fair value is based on a hierarchy that prioritizes the inputs and valuation techniques used to measure fair value:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Level 1—Quoted prices in active markets for identical assets or liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Level 2—Inputs, other than the quoted prices in active markets, are observable either directly or indirectly.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Level 3—Unobservable inputs based on the Company’s assumptions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The Company is required to use observable market data if such data is available without undue cost and effort.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The carrying amounts for cash, accounts payable, accrued expenses and convertible notes payable approximate their fair value due to the short-term nature of such instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">  </p> <p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zBizDsuRpBLi" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_863_zTPFnIoYsKQa">Loss per Share</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution, using the treasury stock method that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the loss of the Company. In computing diluted loss per share, the treasury stock method assumes that outstanding options and warrants are exercised, and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">For the years ended December 31, 2023 and 2022, the dilutive impact of outstanding stock options of <span id="xdx_903_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zoAyl8czGj6h" title="Antidilutive shares">25,757,155</span> shares and <span id="xdx_906_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--StockOptionsMember_zBGw0KnuM9sl" title="Antidilutive shares">26,057,601</span> shares; outstanding warrants of <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_zDSaCOQbZfN9" title="Antidilutive shares">17,953,239</span> shares and <span id="xdx_90C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_zOouo7YvTd8e" title="Antidilutive shares">20,314,153</span> shares; and notes convertible into approximately <span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20230101__20231231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zrJtOeEtLDta" title="Antidilutive shares">34,716,235</span> and <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--ConvertibleNotesMember_zRYLeZVHpAW1" title="Antidilutive shares">35,138,466</span> shares of our common stock, respectively, have been excluded because their impact on the loss per share is anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> 25757155 26057601 17953239 20314153 34716235 35138466 <p id="xdx_841_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z8rTasltQQ7c" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_862_ziaDQiwmqLHd">Recent Accounting Pronouncements</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statement presentation or disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06). ASU 2020-06 simplifies the accounting for convertible debt by eliminating the beneficial conversion and cash conversion accounting models. Upon adoption of ASU 2020-06, convertible debt proceeds, unless issued with a substantial premium or an embedded conversion feature that is not clearly and closely related to the host contract, will no longer be allocated between debt and equity components. This modification will reduce the issue discount and result in less non-cash interest expense in financial statements. ASU 2020-06 also updates the earnings per share calculation and requires entities to assume share settlement when the convertible debt can be settled in cash or shares. ASU 2020-06 will be effective January 1, 2024, and a cumulative-effect adjustment to the opening balance of retained earnings is required upon adoption. Early adoption is permitted, but no earlier than January 1, 2021, including interim periods within that year. The adoption of ASU 2020-06 is not expected to have any impact on the Company’s consolidated financial statement presentation or disclosures subsequent to its adoption, with any effect being largely dependent on the composition and terms of outstanding financial instruments at the time of adoption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zYZioWGY0dA" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 34px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_823_z9Exjmpi8fCg">Property and Equipment</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">At December 31, 2023 and 2022, property and equipment consists of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_z56n5dKg8pA4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BF_zr6qZoveT0wf" style="display: none">Schedule of property and equipment</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Office equipment</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zKTTFJ5Ctj24" style="width: 13%; text-align: right" title="Property and equipment, gross">35,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zlI9TK5PpJJk" style="width: 13%; text-align: right">35,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and fixtures</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zMPNRwZRADW9" style="text-align: right">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zL5hvlTVjDn2" style="text-align: right">5,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Testing equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TestingEquipmentMember_z8v9jZzcIXoh" style="text-align: right">37,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TestingEquipmentMember_z3ItDCUnZJcf" style="text-align: right">37,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Leasehold Improvements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zBNEOZhol7p1" style="border-bottom: Black 1pt solid; text-align: right">25,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zWGwpLTtJQAh" style="border-bottom: Black 1pt solid; text-align: right">25,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Subtotal</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231_z3lo0AeGQlDj" style="text-align: right">102,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_zC993JNILCc6" style="text-align: right">102,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20231231_zhlzxh7JBEE7" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(100,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_zrqi4cbhunDe" style="border-bottom: Black 1pt solid; text-align: right">(96,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20231231_zKepHZdioxH7" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">2,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_z30GslUCmQC3" style="border-bottom: Black 2.5pt double; text-align: right">6,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Depreciation expense for the years ended December 31, 2023 and 2022 was $<span id="xdx_903_eus-gaap--Depreciation_pp0p0_c20230101__20231231_zUnCC1i4BSje" title="Depreciation expense">4,000</span> and $<span id="xdx_907_eus-gaap--Depreciation_pp0p0_c20220101__20221231_zhGugol5UoJ6" title="Depreciation expense">4,000</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--PropertyPlantAndEquipmentTextBlock_z56n5dKg8pA4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BF_zr6qZoveT0wf" style="display: none">Schedule of property and equipment</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Office equipment</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zKTTFJ5Ctj24" style="width: 13%; text-align: right" title="Property and equipment, gross">35,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zlI9TK5PpJJk" style="width: 13%; text-align: right">35,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture and fixtures</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zMPNRwZRADW9" style="text-align: right">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zL5hvlTVjDn2" style="text-align: right">5,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Testing equipment</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TestingEquipmentMember_z8v9jZzcIXoh" style="text-align: right">37,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TestingEquipmentMember_z3ItDCUnZJcf" style="text-align: right">37,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Leasehold Improvements</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zBNEOZhol7p1" style="border-bottom: Black 1pt solid; text-align: right">25,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zWGwpLTtJQAh" style="border-bottom: Black 1pt solid; text-align: right">25,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Subtotal</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20231231_z3lo0AeGQlDj" style="text-align: right">102,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_zC993JNILCc6" style="text-align: right">102,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20231231_zhlzxh7JBEE7" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(100,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_zrqi4cbhunDe" style="border-bottom: Black 1pt solid; text-align: right">(96,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20231231_zKepHZdioxH7" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">2,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_z30GslUCmQC3" style="border-bottom: Black 2.5pt double; text-align: right">6,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 35000 35000 5000 5000 37000 37000 25000 25000 102000 102000 100000 96000 2000 6000 4000 4000 <p id="xdx_80B_eus-gaap--LesseeOperatingLeasesTextBlock_zn036qnRX0j6" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 34px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_828_zs2blzIyAuza">Leases</span> </b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">In June 2021, the Company commenced a lease for its corporate office space under an operating lease agreement, and recorded an operating lease right-of-use asset and the related operating lease liability of $<span id="xdx_903_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20210630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--CorporateOfficeSpaceMember_zmsIQ9wIhlsj" title="Operating lease right-of-use asset"><span id="xdx_90E_eus-gaap--OperatingLeaseLiability_iI_c20210630__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--CorporateOfficeSpaceMember_ziHbKDAo2Ksa" title="Operating lease liability">165,000</span></span>. At December 31, 2021, the balance of right-of-use asset was $<span id="xdx_900_eus-gaap--OperatingLeaseRightOfUseAsset_iI_c20211231__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--CorporateOfficeSpaceMember_zKYKia3hzJxf" title="Operating lease right-of-use asset">143,000</span> and the balance of the lease liability was $<span id="xdx_905_eus-gaap--OperatingLeaseLiability_iI_c20221231__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--CorporateOfficeSpaceMember_zEGU521A7Hnk" title="Operating lease liability">144,000</span>. During 2022, the Company amortized $<span id="xdx_906_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_c20220101__20221231__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--CorporateOfficeSpaceMember_zEczj7Y00Tp7" title="Amortization of right-of-use asset">33,000</span> of the right-of-use asset and paid $<span id="xdx_90B_eus-gaap--OperatingLeaseExpense_c20220101__20221231__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--CorporateOfficeSpaceMember_z7obBAdMzJ64" title="Payments of lease liability">32,000</span> of the lease liability. On October 31, 2022, the Company entered into a lease amendment with the lessor of the space to terminate the lease and be released from lease obligation. The Company accounted for the cancellation of the lease by writing off the right-of-use asset of $<span id="xdx_908_ecustom--OperatingLeaseRightOfUseAssetWriteOff_c20221101__20221231_zjEnrk0BAyq3" title="Right-of-use asset write off">110,000</span> and cancelling the operating lease liability of $<span id="xdx_90E_ecustom--OperatingLeaseLiabilityWriteOff_c20221101__20221231_zdmTIygcxJY7" title="Operating lease liability cancelled">112,000</span>, which resulted in the gain on lease cancellation of $<span id="xdx_908_eus-gaap--GainLossOnContractTermination_c20220101__20221231__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--CorporateOfficeSpaceMember_zTY4a3fyEYw6" title="Gain on lease cancellation">2,000</span> which is recorded in operating expense on the accompany consolidated statements of operations for the year ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="text-decoration: underline">Lease with former related party </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The Company’s former executive offices were formally located in Tomball, Texas and was leased for $5,000 per month under a month-to-month lease from JBL Energy Partners (“JBL”). JBL was an entity owned by Jason Lane, former Director and Chairman of the Board of the Company who resigned in April 2021, and the lease was terminated in April 2021 in connection with the resignation of Mr. Lane. As of December 31, 2023, the balance payable to JBL Energy Partners was $<span id="xdx_904_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20231231__us-gaap--PropertySubjectToOrAvailableForOperatingLeaseAxis__custom--TomballTexasOfficesMember_ztWn0M23Vt1b">19,000 </span>and is included as part of accounts payable and accrued expenses in the accompanying consolidated balance sheets. Commencing May 1, 2021, the Company agreed to continue to lease a portion of the Tomball facility from the new landlord on a month-to-month basis at $1,000 per month. The Company also rents a storage facility on a month-to-month basis for $250 per month.</p> 165000 165000 143000 144000 33000 32000 110000 112000 2000 19000 <p id="xdx_808_eus-gaap--DebtDisclosureTextBlock_zdRwxNgSvMF8" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 34px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82F_zvzZqFjdrcjd">Convertible Notes Payable</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"></p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ConvertibleDebtTableTextBlock_zvJIHr7pSbK5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Convertible Notes Payable (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8B2_zgYJYl7U1Mfd" style="display: none">Schedule of convertible notes payable</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_49A_20231231_zL1RpulSk6S2" style="text-align: center"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_493_20221231_z3mRDKEZ60Z9" style="text-align: center"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleDebtCurrent_iI_maCzEzh_zniTXhkJlRAf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Convertible notes</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,332,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,393,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InterestPayableCurrent_iI_maCzEzh_zLwVoMyr6Ve4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accrued interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">794,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">612,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--ConvertibleNotesPayable_iI_zFhlJnTmNsR1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Total outstanding debt, including $<span id="xdx_900_eus-gaap--DebtDefaultLongtermDebtAmount_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zfpinLpLZ421" title="Debt default amount">2,022,000</span> and $<span id="xdx_907_eus-gaap--DebtDefaultLongtermDebtAmount_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zaQ3LDfWDm32" title="Debt default amount">1,730,000</span> in default at December 31, 2023 and 2022, respectively</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,126,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,005,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DebtInstrumentCarryingAmount_iNI_di_zqbN3HW5aLN7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Unamortized debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(25,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(140,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--ConvertibleNotesPayableCurrent_iI_z8VNCpPVEhI4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total outstanding debt, net of unamortized debt discount</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,101,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,865,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="text-decoration: underline">Convertible notes</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">At December 31, 2021, convertible notes payable totaled $<span id="xdx_908_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_zKBPo524e6se" title="Convertible notes payable">1,137,000</span>. During the year ended December 31, 2022, the Company issued convertible promissory notes in the aggregate of $<span id="xdx_90F_eus-gaap--DebtInstrumentIncreaseDecreaseForPeriodNet_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_zJeAzz3DJ0A8" title="Increase in convertible notes">432,000</span> for cash proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_zGBldE7oBRZk" title="Proceeds from convertible debt">393,000</span>, net of OID of $<span id="xdx_902_ecustom--OriginalIssueDiscount_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_z0gWQ8g66d4a">39,000</span>. The notes are unsecured, with a 10% original issue discount, mature in twelve months from issuance, and are convertible into 14,409,995 shares of the Company’s common stock at $0.03 per share. In addition, the Company granted the note holders warrants to purchase <span id="xdx_90C_ecustom--WarrantsIssued_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_zC7sNCIg2DI1" title="Warrants issued, shares">14,409,995</span> shares of the Company’s common stock with a relative value of $<span id="xdx_901_ecustom--WarrantsIssuedValue_iI_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_z6gFRJ7DYfte" title="Warrants issued, value">283,000</span>. The warrants are fully vested, and expire one year from the date of issuance. The Company determined the fair value of the warrants by using a Black-Scholes option pricing model, with the following assumptions: expected term of 1.0 year, stock price of $0.09, exercise price of $0.04, volatility of 212%, risk-free rate of 4.05%, and no forfeiture rate. Also during 2022, convertible notes of $<span id="xdx_90B_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_zA19xNkxETB2" title="Debt converted, amount converted">176,000</span> and accrued interest of $<span id="xdx_909_ecustom--DebtConversionInterestAmount1_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_z0P7yfDmiVe2" title="Debt converted, interest converted">2,000</span>, net of unamortized discount of $<span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_zVvJ5VSSnXNl" title="Unamortized discount">119,000</span>, were converted into <span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_zrIG3nAxEcU6" title="Debt converted, shares issued">6,040,049</span> shares of common stock. At December 31, 2022, total outstanding convertible notes payable totaled $<span id="xdx_907_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_zu930hgpPjr7" title="Convertible notes payable">1,393,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">During the year ended December 31, 2023, the Company issued convertible promissory notes in the aggregate of $<span id="xdx_908_eus-gaap--DebtInstrumentIncreaseDecreaseForPeriodNet_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_zjxYOoClmkqj">585,000</span> for cash proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_zkFIbMCpZWP4">532,000</span>, net of OID of $<span id="xdx_90B_ecustom--OriginalIssueDiscount_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_zhos75ipWE15" title="Original issue discount">53,000</span>. The notes are unsecured, with a 10% original issue discount, mature in twelve months from issuance, and are convertible into 11,715,748 shares of the Company’s common stock at $0.05 per share. In addition, the Company granted the note holders warrants to purchase <span id="xdx_900_ecustom--WarrantsIssued_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_zz2wgOGuult7" title="Warrants issued, shares">11,715,748</span> shares of the Company’s common stock with a relative fair value of $<span id="xdx_904_ecustom--WarrantsIssuedValue_iI_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_z4QakIGvK4Qe" title="Warrants issued, value">231,000</span>. The warrants are fully vested and expire one year from the date of issuance. The Company determined the fair value of the warrants by using a Black-Scholes option pricing model, with the following assumptions: expected term of 1.0 year, stock price of $0.06 to $0.07, exercise price of $0.07, volatility of 169% to 206%, risk-free rate of 4.64% to 5.46%, and no forfeiture rate. Also during 2023, convertible notes of $<span id="xdx_90B_eus-gaap--DebtConversionOriginalDebtAmount1_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_zq48rJGtROC4">646,000</span>, net of unamortized discount of $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_zMunMEEwXqp7">296,000</span>, were converted into <span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_zmiqy2uM4U5f">15,129,048</span> shares of common stock. At December 31, 2023, total outstanding convertible notes payable totaled $<span id="xdx_90B_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_ziNaeRU3Bj3" title="Convertible notes payable">1,332,000</span>. <span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleTermsOfConversionFeature_c20230101__20231231_zALAGjvjqn22" title="Convertible notes terms">As of December 31, 2023, convertible notes payable and accrued interest are convertible into 34,716,235 shares of common stock at conversion rates ranging from $0.02 to $0.48 per share.</span> As of December 31, 2023, a total of 38 convertible notes and accrued interest in the aggregate of $2,022,000 have reached maturity and are past due. The Company is currently in negotiations with these noteholders to settle these past due notes payable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="text-decoration: underline">Accrued interest </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">At December 31, 2021, accrued interest on convertible notes payable totaled $<span id="xdx_90C_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zBd7GqisfwBf" title="Accrued interest on convertible notes payable">435,000</span>. During the year ended December 31, 2022, accrued interest of $<span id="xdx_90E_eus-gaap--InterestExpenseDebt_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z2SFzXb4X4uk" title="Accrued interest">162,000</span> was recorded, and accrued interest of $<span id="xdx_909_ecustom--DebtConversionInterestAmount1_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotesMember_zI41YediJxNb" title="Debt converted, interest converted">2,000</span> was converted into shares of common stock. At December 31, 2022, accrued interest on convertible notes payable totaled $<span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zJSW1wwm9evb" title="Accrued interest on convertible notes payable">612,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">During the year ended December 31, 2023, accrued interest of $<span id="xdx_909_eus-gaap--InterestExpenseDebt_pp0p0_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zEha5ufz53V7" title="Accrued interest">182,000</span> was recorded. At December 31, 2023, accrued interest on convertible notes payable totaled $<span id="xdx_908_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z6wSIcCGijEf" title="Accrued interest on convertible notes payable">794,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="text-decoration: underline">Debt discount </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">At December 31, 2021, the unamortized debt discount was $<span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember_zg4rS5XGBw22" title="Unamortized debt discount">86,000</span>. During the year ended December 31, 2022, debt discount of $<span id="xdx_908_ecustom--IncreaseInDebtDiscount_pp0p0_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember_zwJ7ehU6tpWe" title="Increase in debt discount">322,000</span> was recorded for the relative fair value of warrants of $<span id="xdx_908_ecustom--IncreaseInDebtDiscount_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--TransactionTypeAxis__custom--FairValueOfWarrantsMember_z9LxqOWBLQ69" title="Increase in debt discount">283,000</span> and OID of $<span id="xdx_90C_ecustom--IncreaseInDebtDiscount_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--TransactionTypeAxis__custom--OriginalIssueDiscountMember_zAA10pMLdsse" title="Increase in debt discount">39,000</span>, debt discount amortization of $<span id="xdx_90C_eus-gaap--AmortizationOfDebtDiscountPremium_c20220101__20221231_zlgyCGeMaaQg" title="Debt discount amortization">149,000</span> was recorded, and $<span id="xdx_90D_ecustom--DecreaseInDebtDiscount_c20220101__20221231__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--TransactionTypeAxis__custom--DiscountConvertedMember_zCKhbhOIcX42">119,000</span> of debt discount was removed and included in the carrying amount of related convertible notes payable that were converted into shares of common stock. At December 31, 2022, the unamortized debt discount was $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20221231__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember_z7lAUe6sc02h">140,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">During the year ended December 31, 2023, debt discount of $<span id="xdx_90B_ecustom--IncreaseInDebtDiscount_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember_zbwVi3ynepPf" title="Increase in debt discount">284,000</span> was recorded for the relative fair value of warrants of $<span id="xdx_908_ecustom--IncreaseInDebtDiscount_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--TransactionTypeAxis__custom--FairValueOfWarrantsMember_zAaUAuI4d654" title="Increase in debt discount">231,000</span> and OID of $<span id="xdx_903_ecustom--IncreaseInDebtDiscount_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--TransactionTypeAxis__custom--OriginalIssueDiscountMember_z9q0MLO1AtV4" title="Increase in debt discount">53,000</span>, debt discount amortization of $<span id="xdx_90D_eus-gaap--AmortizationOfDebtDiscountPremium_c20230101__20231231_zTIgEL5DI8tc" title="Debt discount amortization">103,000</span> was recorded, and $<span id="xdx_907_ecustom--DecreaseInDebtDiscount_c20230101__20231231__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember__us-gaap--TransactionTypeAxis__custom--DiscountConvertedMember_zFmE7bcRtKCe" title="Decrease in debt discount">296,000</span> of debt discount was removed and included in the carrying amount of related convertible notes payable that were converted into shares of common stock. At December 31, 2023, the unamortized debt discount was $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20231231__us-gaap--DebtInstrumentAxis__custom--DebtDiscountMember_zTjQVrdRXyYk" title="Unamortized debt discount">25,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ConvertibleDebtTableTextBlock_zvJIHr7pSbK5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Convertible Notes Payable (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8B2_zgYJYl7U1Mfd" style="display: none">Schedule of convertible notes payable</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_49A_20231231_zL1RpulSk6S2" style="text-align: center"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_493_20221231_z3mRDKEZ60Z9" style="text-align: center"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleDebtCurrent_iI_maCzEzh_zniTXhkJlRAf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Convertible notes</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,332,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,393,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InterestPayableCurrent_iI_maCzEzh_zLwVoMyr6Ve4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Accrued interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">794,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">612,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--ConvertibleNotesPayable_iI_zFhlJnTmNsR1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 10pt; text-align: left">Total outstanding debt, including $<span id="xdx_900_eus-gaap--DebtDefaultLongtermDebtAmount_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zfpinLpLZ421" title="Debt default amount">2,022,000</span> and $<span id="xdx_907_eus-gaap--DebtDefaultLongtermDebtAmount_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zaQ3LDfWDm32" title="Debt default amount">1,730,000</span> in default at December 31, 2023 and 2022, respectively</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,126,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,005,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DebtInstrumentCarryingAmount_iNI_di_zqbN3HW5aLN7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Unamortized debt discount</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(25,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(140,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--ConvertibleNotesPayableCurrent_iI_z8VNCpPVEhI4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total outstanding debt, net of unamortized debt discount</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,101,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,865,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1332000 1393000 794000 612000 2022000 1730000 2126000 2005000 25000 140000 2101000 1865000 1137000 432000 393000 39000 14409995 283000 176000 2000 119000 6040049 1393000 585000 532000 53000 11715748 231000 646000 296000 15129048 1332000 As of December 31, 2023, convertible notes payable and accrued interest are convertible into 34,716,235 shares of common stock at conversion rates ranging from $0.02 to $0.48 per share. 435000 162000 2000 612000 182000 794000 86000 322000 283000 39000 149000 119000 140000 284000 231000 53000 103000 296000 25000 <p id="xdx_80D_ecustom--PPPLoanPayableDisclosureTextBlock_zd8kcvMjqCG4" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 34px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82E_zvPHXbCDMTaf">PPP Loan Payable</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">In June 2020, the Company was granted a loan (the “PPP loan”) from Cadence Bank in the aggregate amount of $<span id="xdx_906_eus-gaap--ProceedsFromNotesPayable_pp0p0_c20200601__20200630__us-gaap--LongtermDebtTypeAxis__custom--PPPLoanMember_zMzAeTM6h6G9" title="Aggregate amount">151,000</span>, pursuant to the Paycheck Protection Program (the “PPP”) under the CARES Act.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The PPP loan agreement matures on <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_dd_c20200601__20200630__us-gaap--LongtermDebtTypeAxis__custom--PPPLoanMember_zZ41RxQNzxZ3" title="Maturity date">June 18, 2025</span>, bears interest at a rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_dp_c20200630__us-gaap--LongtermDebtTypeAxis__custom--PPPLoanMember_zUJrnSGfvSHh" title="Debt interest rate">1</span>% per annum, and is unsecured and guaranteed by the U.S. Small Business Administration (“SBA”). The Company applied ASC 470, Debt, to account for the PPP loan. The PPP loan may be prepaid at any time prior to maturity with no prepayment penalties. Funds from the PPP loan may only be used for qualifying expenses as described in the CARES Act, including qualifying payroll costs, qualifying group health care benefits, qualifying rent and debt obligations, and qualifying utilities. Management believes the entire loan amount has been used for qualifying expenses and all of the conditions outlined in the PPP loan program were adhered to by the Company. Under the terms of the PPP, certain amounts of the loan may be forgiven if they are used for qualifying expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">At December 31, 2021, the balance of the PPP loan was $<span id="xdx_905_eus-gaap--OtherNotesPayableCurrent_iI_pp0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--PPPLoanMember_zkpXtdbulCn3" title="PPP loan payable">151,000</span>. During the year ended December 31, 2022, the Company received notice that $<span id="xdx_90E_eus-gaap--DebtInstrumentDecreaseForgiveness_pp0p0_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--PPPLoanMember_zPbhFSHMJWYi" title="Debt instrument, decrease, forgiveness">63,000</span> of the loan was forgiven, and recognized a gain on forgiveness of PPP loan of $<span id="xdx_901_ecustom--GainOnForgivenessOfPppLoan_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--PPPLoanMember_ziisRMSIyrb" title="Gain on forgiveness of PPP loan">63,000</span>. During 2022, the Company paid $<span id="xdx_90A_eus-gaap--PaymentsForLoans_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--PPPLoanMember_zTGpb3uvRHZd" title="PPP loan paid">12,000</span> of principal, and at December 31, 2022, the balance of the PPP loan was $<span id="xdx_907_eus-gaap--OtherNotesPayableCurrent_iI_pp0p0_c20221231__us-gaap--LongtermDebtTypeAxis__custom--PPPLoanMember_zhdVSOb7cWG7" title="PPP loan payable">75,000</span>. During the year ended December 31, 2023, the Company paid $<span id="xdx_905_eus-gaap--PaymentsForLoans_c20230101__20231231__us-gaap--LongtermDebtTypeAxis__custom--PPPLoanMember_zZNxXCNGvxz9" title="PPP loan paid">18,000</span> of principal on the PPP loan, and at December 31, 2023, the balance of the PPP loan was $<span id="xdx_908_eus-gaap--OtherNotesPayableCurrent_iI_pp0p0_c20231231__us-gaap--LongtermDebtTypeAxis__custom--PPPLoanMember_z96zu4K7kt76" title="PPP loan payable">57,000</span>. The terms of the PPP loan provide for customary events of default including, among other things, payment defaults, breach of representations and warranties, and insolvency events. The Company was in compliance with the terms of the PPP loan as of December 31, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> 151000 2025-06-18 0.01 151000 63000 63000 12000 75000 18000 57000 <p id="xdx_80D_eus-gaap--ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_zyJlnuKlxjU2" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 34px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_823_z6pUUa7BQsA5">Research and Development</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The Company constructs, develops and tests the AOT technology with internal resources and through the assistance of various third-party entities. Costs incurred and expensed include fees such as license fees, purchase of test equipment, viscometers, SCADA systems, computer equipment, direct costs related to AOT equipment manufacture and installation, payroll and other related equipment and various logistical expenses for the purposes of evaluating and testing the Company’s AOT prototypes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Costs incurred for research and development are expensed as incurred. Purchased materials that do not have an alternative future use are also expensed. Furthermore, costs incurred in the construction of prototypes with no certainty of any alternative future use and established commercial uses are also expensed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">For the years ended December 31, 2023 and 2022, our research and development expenses were $<span id="xdx_900_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20230101__20231231_zbMVQxIcnin2" title="Research and development expenses">203,000</span> and $<span id="xdx_90E_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20220101__20221231_zKFfjt8cEsO4" title="Research and development expenses">486,000</span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><b><span style="text-decoration: underline">AOT Prototypes</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">During the years ended December 31, 2023 and 2022, the Company incurred total expenses of $<span id="xdx_90E_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20230101__20231231__us-gaap--ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis__custom--AOTPrototysMember_zyFUHTKpENz1" title="Research and development expenses">14,000</span> and $<span id="xdx_90F_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20220101__20221231__us-gaap--ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis__custom--AOTPrototysMember_zVP98GHdBbq1" title="Research and development expenses">298,000</span>, respectively, in the manufacture and testing of the AOT prototype equipment. These expenses have been reflected as part of Research and Development expenses on the accompanying consolidated statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><b><span style="text-decoration: underline">Temple University Licensing Agreement-amount past due </span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">On August 1, 2011, the Company and Temple University (“Temple”) entered into two (2) Exclusive License Agreements (collectively, the “License Agreements”) relating to Temple’s patent applications, patents and technical information pertaining to technology associated with an electric and/or magnetic field assisted fuel injector system (the “First Temple License”), and to technology to reduce crude oil viscosity (the “Second Temple License”). The License Agreements are exclusive, and the territory licensed to the Company is worldwide and replace previously issued License Agreements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Pursuant to the two licensing agreements, the Company paid Temple a non-refundable license maintenance fee of $300,000, and agreed to pay (i) annual maintenance fees of $187,500; (ii) royalty fee ranging from 4% up to 7% from revenues generated from the licensing agreements; and (iii) 25% of all revenues generated from sub-licensees to secure or maintain the sub-license or option thereon. The term of the licenses commenced in August 2011 and will expire upon expiration of the patents. The agreements can also be terminated by either party upon notification under terms of the licensing agreements or if the Company ceases the development of the patent or fails to commercialize the patent rights.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Total expenses recognized during each twelve-month period ended December 31, 2023 and 2022 pursuant to these two License Agreements amounted to $<span id="xdx_90F_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20230101__20231231__us-gaap--ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis__custom--TempleUniversityLicenseAgreementsMember_zBbzIV7bQpv2"><span id="xdx_90D_eus-gaap--ResearchAndDevelopmentExpense_pp0p0_c20220101__20221231__us-gaap--ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis__custom--TempleUniversityLicenseAgreementsMember_zixC8oGJ33hh">188,000</span></span> and has been reflected in Research and Development expenses on the accompanying consolidated statements of operations. In the twelve-month periods ended December 31, 2023 and 2022, the Company also recognized penalty interest on past-due balances of $<span id="xdx_908_eus-gaap--InterestAndDebtExpense_pp0p0_c20230101__20231231__us-gaap--ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis__custom--TempleUniversityLicenseAgreementsMember_zfYqQGMCHfBf" title="Interest and financing expense">48,000</span> and $<span id="xdx_903_eus-gaap--InterestAndDebtExpense_pp0p0_c20220101__20221231__us-gaap--ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis__custom--TempleUniversityLicenseAgreementsMember_zkpnj0Q4S4Il" title="Interest and financing expense">48,000</span>, respectively, which is included as part of interest and financing expense in the accompanying consolidated statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">As of December 31, 2023 and 2022, total unpaid fees due to Temple pursuant to these agreements are $<span id="xdx_900_eus-gaap--AccountsPayableCurrent_pp0p0_c20231231__us-gaap--ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis__custom--TempleUniversityLicenseAgreementsMember_zGKbJ0yiBQl1" title="Accounts payable - licensing agreement">2,198,000</span> and $<span id="xdx_90D_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20221231__us-gaap--ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis__custom--TempleUniversityLicenseAgreementsMember_zIbcMjwv8FZa" title="Accounts payable - licensing agreement">1,962,000</span>, respectively, which are included as part of Accounts Payable – license agreements in the accompanying consolidated balance sheets. <span id="xdx_905_ecustom--LicensingAgreementTerms_pp0p0_c20230101__20231231__us-gaap--ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis__custom--TempleUniversityLicenseAgreementsMember_zG3jmjlwBQOh" title="Temple licensing agreement terms">With regards to the unpaid fees to Temple, a total of $135,000 are deferred until such time the Company achieves a revenue milestone of $835,000 or upon termination of the licensing agreements and the remaining $2,063,000 are deemed past due. The Company is currently in discussions with Temple to settle or cure the past due balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><span id="xdx_903_eus-gaap--Revenues_do_c20230101__20231231_zQjrXy9VVjO3"><span id="xdx_902_eus-gaap--Revenues_do_c20220101__20221231_zz6a1CT435g2">No</span></span> revenues were earned from the two License Agreements during the year ended December 31, 2023 and 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> 203000 486000 14000 298000 188000 188000 48000 48000 2198000 1962000 With regards to the unpaid fees to Temple, a total of $135,000 are deferred until such time the Company achieves a revenue milestone of $835,000 or upon termination of the licensing agreements and the remaining $2,063,000 are deemed past due. The Company is currently in discussions with Temple to settle or cure the past due balance. 0 0 <p id="xdx_80C_eus-gaap--IncomeTaxDisclosureTextBlock_ziIuPn8ztKcf" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82E_zP5Z3OVDw216">Income Taxes</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The Company did not provide for any Federal and State income tax for the years ended December 31, 2023 and 2022 due to the Company’s net losses. A reconciliation of income taxes with the amounts computed at the statutory federal rate follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEuu8qfaRpsc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Income tax reconciliation)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BD_zDasrmiNVOE2" style="display: none">Schedule of reconciliation of income taxes</span> </td><td> </td> <td colspan="2" id="xdx_498_20230101__20231231_zccEYIP27udl" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_498_20220101__20221231_zjRyRXVeSDS5" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzUek_z4HZePgsvWKf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Computed tax provision (benefit) at federal statutory rate (21%)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(70,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(167,000</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzUek_zgPmXplaXxLc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">70,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">167,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--IncomeTaxExpenseBenefit_iT_d0_mtITEBzUek_zzzm4TcEKVda" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Income tax provision</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zaAKLHVlaFEa" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The deferred tax assets and deferred tax liabilities recorded on the balance sheet are as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zFcmbwMdTa8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Deferred taxes)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BC_zYDwVYUaLaW7" style="display: none">Schedule of deferred income taxes</span> </td><td> </td> <td colspan="2" id="xdx_494_20231231_zDkQM2BwY6Ne" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49F_20221231_z5FtMHUpRxW1" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Net operating loss carry forwards</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">12,698,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">13,124,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesDeferredExpense_iNI_pp0p0_di_zhSlnjMcDeB" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stock based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(27,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesOther_iI_pp0p0_zsf7NNvhuRA4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Other temporary differences</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(57,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">35,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_zHtr6O4GI0xj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(12,633,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(13,132,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_d0_zEvJnZVUmEWf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total deferred taxes net of valuation allowance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zosk18xbNLkf" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">As of December 31, 2023, the Company had net operating losses available for carry forward for state and federal tax purposes of approximately $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_pn6n6_c20231231_z70MPrpFsdz7" title="Net operating loss carryforward">60</span> million expiring through 2044. These carry forward benefits will be subject to annual limitations due to the ownership change limitations imposed by the Internal Revenue Code and similar state provisions. The annual limitation, if imposed, may result in the expiration of net operating losses before utilization.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">As of December 31, 2023, the Company recorded a valuation allowance of $12,633,000 for its deferred tax assets since the Company believes that such assets did not meet the more likely than not criteria to be recoverable through projected future profitable operations in the foreseeable future. This valuation is based on the federal corporate tax rate of <span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_dp_c20230101__20231231_zhDAxEV6JFR1" title="Federal corporate tax rate">21</span>%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Effective January 1, 2007, the Company adopted FASB guidance that addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under this guidance, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The FASB also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. As of December 31, 2023 and 2022, the Company does not have a liability for unrecognized tax benefits.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The Company files income tax returns in the U.S. federal jurisdiction and the State of Texas. The Company is subject to U.S. federal or state income tax examinations by tax authorities for years after 2002. During the periods open to examination, the Company has net operating loss and tax credit carry forwards for U.S. federal and state tax purposes that have attributes from closed periods. Since these net operating losses and tax credit carry forwards may be utilized in future periods, they remain subject to examination. The Company’s policy is to record interest and penalties on uncertain tax provisions as income tax expense. As of December 31, 2023, the Company has no accrued interest or penalties related to uncertain tax positions. The Company believes that it has not taken any uncertain tax positions that would impact its consolidated financial statements as of December 31, 2023 and 2022. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zEuu8qfaRpsc" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Income tax reconciliation)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BD_zDasrmiNVOE2" style="display: none">Schedule of reconciliation of income taxes</span> </td><td> </td> <td colspan="2" id="xdx_498_20230101__20231231_zccEYIP27udl" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_498_20220101__20221231_zjRyRXVeSDS5" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzUek_z4HZePgsvWKf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Computed tax provision (benefit) at federal statutory rate (21%)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(70,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(167,000</td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzUek_zgPmXplaXxLc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">70,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">167,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--IncomeTaxExpenseBenefit_iT_d0_mtITEBzUek_zzzm4TcEKVda" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Income tax provision</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> -70000 -167000 70000 167000 0 0 <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zFcmbwMdTa8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Income Taxes (Details - Deferred taxes)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BC_zYDwVYUaLaW7" style="display: none">Schedule of deferred income taxes</span> </td><td> </td> <td colspan="2" id="xdx_494_20231231_zDkQM2BwY6Ne" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49F_20221231_z5FtMHUpRxW1" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Net operating loss carry forwards</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">12,698,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">13,124,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxLiabilitiesDeferredExpense_iNI_pp0p0_di_zhSlnjMcDeB" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stock based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(8,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(27,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesOther_iI_pp0p0_zsf7NNvhuRA4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Other temporary differences</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(57,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">35,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_zHtr6O4GI0xj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(12,633,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(13,132,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsNet_iI_pp0p0_d0_zEvJnZVUmEWf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Total deferred taxes net of valuation allowance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 12698000 13124000 8000 27000 -57000 35000 12633000 13132000 0 0 60000000 0.21 <p id="xdx_807_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zg6HL5cFjin3" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 34px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_827_z90r8BsVExIf">Common Stock</span> </b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><b><span style="text-decoration: underline">Year Ending December 31, 2023</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">During the year ended December 31, 2023, the Company issued an aggregate of 16,512,375 shares of its common stock as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20230101__20231231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__us-gaap--ConvertibleNotesPayableMember_zRaPFR9bfAW4" title="Debt converted, shares issued">15,129,048</span> shares of its common stock upon the conversion of $<span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20230101__20231231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__us-gaap--ConvertibleNotesPayableMember_zu8DYnq3lhtb" title="Debt converted, amount converted">646,000</span> in convertible notes at $<span id="xdx_902_eus-gaap--CommonStockConvertibleConversionPriceIncrease_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--ConversionOfStockByUniqueDescriptionAxis__us-gaap--ConvertibleNotesPayableMember_zZ4e3g9Va6B3" title="Conversion price">0.03</span> to $<span id="xdx_903_eus-gaap--CommonStockConvertibleConversionPriceIncrease_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--ConversionOfStockByUniqueDescriptionAxis__us-gaap--ConvertibleNotesPayableMember_z4s4wBiXOXne" title="Conversion price">0.05</span> per share, net of unamortized discount of $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_pp0p0_c20231231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__us-gaap--ConvertibleNotesPayableMember_z4OVtDbrIHPb" title="Unamortized discount">296,000</span>.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20230101__20231231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--ExerciseOfWarrantsMember_zD9WTZ4yibB6" title="Debt converted, shares issued">1,383,327</span> shares of its common stock upon the exercise of warrants of $<span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20230101__20231231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--ExerciseOfWarrantsMember_z4qnZ1QbKlP2" title="Debt converted, amount converted">52,000</span>, at $<span id="xdx_90C_eus-gaap--CommonStockConvertibleConversionPriceIncrease_c20230101__20231231__srt--RangeAxis__srt--MinimumMember__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--ExerciseOfWarrantsMember_z3CPqXWs1711" title="Conversion price">0.02</span> to $<span id="xdx_908_eus-gaap--CommonStockConvertibleConversionPriceIncrease_c20230101__20231231__srt--RangeAxis__srt--MaximumMember__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--ExerciseOfWarrantsMember_zic3Es0EnTZi" title="Conversion price">0.04</span> per share.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><b><span style="text-decoration: underline">Year Ending December 31, 2022</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">During the year ended December 31, 2022, the Company issued an aggregate of 20,773,874 shares of its common stock as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220101__20221231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__us-gaap--ConvertibleNotesPayableMember_z1seLaHkEXP9" title="Debt converted, shares issued">6,040,049</span> shares of its common stock upon the conversion of $<span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20220101__20221231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__us-gaap--ConvertibleNotesPayableMember_zlBqGPEVFKK9" title="Debt converted, amount converted">178,000</span> in convertible notes at $<span id="xdx_90A_eus-gaap--CommonStockConvertibleConversionPriceIncrease_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--ConversionOfStockByUniqueDescriptionAxis__us-gaap--ConvertibleNotesPayableMember_zObGlSt3uUHf" title="Conversion price">0.02</span> to $<span id="xdx_90F_eus-gaap--CommonStockConvertibleConversionPriceIncrease_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ConversionOfStockByUniqueDescriptionAxis__us-gaap--ConvertibleNotesPayableMember_zniLCAyADLp1" title="Conversion price">0.03</span> per share, net of unamortized discount of $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20221231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__us-gaap--ConvertibleNotesPayableMember_z9UYfNhSLJNh" title="Unamortized discount">119,000</span>.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220101__20221231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--ExerciseOfWarrantsMember_zD3P8giPobo2" title="Debt converted, shares issued">14,483,825</span> shares of its common stock upon the exercise of warrants of $<span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20220101__20221231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--ExerciseOfWarrantsMember_zalcx5JyZdUh" title="Debt converted, amount converted">542,000</span>, at $$<span id="xdx_901_eus-gaap--CommonStockConvertibleConversionPriceIncrease_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--ExerciseOfWarrantsMember_zx7JIjQw71C4" title="Conversion price">0.03</span> to $<span id="xdx_904_eus-gaap--CommonStockConvertibleConversionPriceIncrease_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--ExerciseOfWarrantsMember_z81vYvq1oZYd" title="Conversion price">0.04</span> per share.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220101__20221231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--ExerciseOfOptionsMember_zpEFuuX4nTCh" title="Debt converted, shares issued">250,000</span> shares of its common stock upon the exercise of options of $<span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20220101__20221231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--ExerciseOfOptionsMember_zEaZfcFQ2Oui" title="Debt converted, amount converted">20,000</span>, at $<span id="xdx_90C_eus-gaap--CommonStockConvertibleConversionPriceIncrease_c20220101__20221231__us-gaap--ConversionOfStockByUniqueDescriptionAxis__custom--ExerciseOfOptionsMember_zZEBFvxOR6yf" title="Conversion price">0.08</span> per share.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> 15129048 646000 0.03 0.05 296000 1383327 52000 0.02 0.04 6040049 178000 0.02 0.03 119000 14483825 542000 0.03 0.04 250000 20000 0.08 <p id="xdx_80C_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zBfIZZtRd4C2" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 34px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82C_zVkwIdtlcWI1">Stock Options and Warrants</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The Company periodically issues stock options and warrants to employees and non-employees in capital raising transactions, for services and for financing costs. Options and warrants vest and expire according to terms established at the grant date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><b><span style="text-decoration: underline">Options</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">Employee options vest according to the terms of the specific grant and expire from 5 to 10 years from date of grant. The weighted average, remaining contractual life of employee and non-employee options outstanding at December 31, 2023 was 3.9 years. Stock option activity for the period January 1, 2022 to December 31, 2023, was as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"></p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zbX0dovs2wPb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Options and Warrants (Details - Options outstanding)"> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8B4_zYyYUBlBbQ38" style="display: none">Stock options outstanding</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><b>Weighted Avg.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><b>Exercise Price</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%">Options outstanding, December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z2Zjy5SXFjbk" style="width: 13%; text-align: right" title="Options, Outstanding beginning balance">31,080,601</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_znDG7JPHDE1g" style="width: 13%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning Balance">0.17</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWmfnAQ3r4V3" style="text-align: right" title="Options, Granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zGJpRX1s2Nhb" style="text-align: right" title="Weighted Average Exercise Price, Granted">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Options exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zedKEbmYAIkc" style="text-align: right" title="Options, Exercised">(250,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zoRf3OAd75Y5" style="text-align: right" title="Weighted Average Exercise Price, Exercised">0.08</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Options cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zsm7xgwcH9ub" style="border-bottom: Black 1pt solid; text-align: right" title="Options, Cancelled">(4,773,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z3a515zxmyG" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Cancelled">0.26</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Options outstanding, December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zzIfNKW77myl" style="text-align: right" title="Options, Outstanding beginning balance">26,057,601</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zX9N7GxwxEUc" style="text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning Balance">0.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zu5Rr8NrmKNh" style="text-align: right" title="Options, Granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z40uK9iuHHz8" style="text-align: right" title="Weighted Average Exercise Price, Granted">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Options exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDQqOqGoWqGj" style="text-align: right" title="Options, Exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z5WX9lAfgpE1" style="text-align: right" title="Weighted Average Exercise Price, Exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Options cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z6h1HAuPw9Ui" style="border-bottom: Black 1pt solid; text-align: right" title="Options, Cancelled">(300,446</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zIcMBGHMToO" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Cancelled">0.72</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Options outstanding, December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zAVvX1o79bu8" style="border-bottom: Black 2.5pt double; text-align: right" title="Options, Outstanding ending balance">25,757,155</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zdV9peXZHQ78" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending Balance">0.14</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zjduu0YF4ZYc" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The weighted average exercise prices, remaining contractual lives for options granted, exercisable, and expected to vest as of December 31, 2023, were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">As of December 31, 2023, the market price of the Company’s stock was $<span id="xdx_907_eus-gaap--SharePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zg7k5ECEKEEh" title="Stock price">0.06</span> per share. At December 31, 2023 the aggregate intrinsic value of the options outstanding was $<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zqhZR0XoCaQ2" title="Aggregate intrinsic value of options outstanding">115,000</span>. Future unamortized compensation expense on the unvested outstanding options at December 31, 2023 is $<span id="xdx_907_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zcM9uK3uKjb8" title="Unamortized compensation expense">0</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zgTXKnQUB6B8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Options and Warrants (Details - Options by exercise price per share)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BA_zKlbMGHBd45k" style="display: none">Schedule of options outstanding by per share price</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Outstanding Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercisable Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Option <br/>Exercise Price <br/>Per Share</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Life <br/> (Years)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise Price</p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise Price</p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 20%; text-align: center">$0.02 - $0.24</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice1Member_zFRlJq9XO4Lg" style="width: 13%; text-align: right" title="Shares, options outstanding">22,055,551</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 15%; text-align: center"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice1Member_ziwjRbv1qiAh" title="Life (Years), options outstanding">4.1</span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice1Member_zst2azlXMq8d" style="width: 13%; text-align: right" title="Weighted average exercise price, options outstanding">0.10</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice1Member_zBcF6A5rkC4c" style="width: 13%; text-align: right" title="Shares, options exercisable">22,055,551</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice1Member_zlKVTeZdr8Q5" style="width: 13%; text-align: right" title="Weighted average exercise price, options exercisable">0.10</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">$0.25 - $0.49</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice2Member_zRkCOpIQGvoc" style="text-align: right" title="Shares, options outstanding">3,238,552</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice2Member_z9L3a2iUce0a" title="Life (Years), options outstanding">2.7</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice2Member_zuZLTdODkIhg" style="text-align: right" title="Weighted average exercise price, options outstanding">0.36</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice2Member_zbcP1rnl2VRh" style="text-align: right" title="Shares, options exercisable">3,238,552</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice2Member_zlVcPLuPNBn5" style="text-align: right" title="Weighted average exercise price, options exercisable">0.36</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-bottom: 1pt">$0.50 - $0.99</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice3Member_z5Ird2wDFZv4" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, options outstanding">463,052</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice3Member_zcrfmNErjILj" title="Life (Years), options outstanding">0.4</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice3Member_zxOxyie4HCPc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, options outstanding">0.85</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice3Member_zU0qnZ2PgJh1" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, options exercisable">463,052</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice3Member_zz6kryUfMeaf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, options exercisable">0.85</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zVPfVfLSK4Fa" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, options outstanding">25,757,155</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z5v2LFEfxwq5" title="Life (Years), options outstanding">3.9</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zGCzpNm2SxH8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, options outstanding">0.14</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z6WUF5rf2mQe" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, options exercisable">25,757,155</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zu0kcy2EQii7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, options exercisable">0.14</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zJUejTfA4Vh4" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-indent: 0.5in"><b><span style="text-decoration: underline">Year Ending December 31, 2023</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in; text-align: justify">During the year ended December 31, 2023 did not issue options to employees, officers or members of the Board of Directors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><b><span style="text-decoration: underline">Year Ending December 31, 2022</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in; text-align: justify">During the year ended December 31, 2022, the Company did not issue options to employees, officers or members of the Board of Directors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><b><span style="text-decoration: underline">Warrants</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The following table summarizes certain information about the Company’s stock purchase warrants.</p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zIpRXTx87i33" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Options and Warrants (Details - Warrant exercise price per share)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B7_z9T7Q3yReLr5" style="display: none">Schedule of warrants activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><b>Weighted Avg.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><b>Exercise Price</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%">Warrants outstanding, December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zgNBUgZcDaL" style="width: 13%; text-align: right" title="Warrants outstanding, beginning balance">19,977,149</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zkSTf9ukSFgf" style="width: 13%; text-align: right" title="Weighted average exercise price, Outstanding beginning balance">0.04</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_znfygAxglH2h" style="text-align: right" title="Warrants granted">16,426,657</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zUN9Ptb7UO8l" style="text-align: right" title="Weighted average exercise price, Granted">0.04</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Warrants exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zL5Efwr23LF4" style="text-align: right" title="Warrants exercised">(14,483,825</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zb7bdjWgIi3h" style="text-align: right" title="Weighted average exercise price, Exercised">0.04</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Warrants expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zNcH5C2Rkic4" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants Expired">(1,605,828</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zwb8x1U3biGj" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Expired">0.04</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Warrants outstanding, December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zxY6e2euKxy3" style="text-align: right" title="Warrants outstanding, beginning balance">20,314,153</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zq0Blj4EqEc9" style="text-align: right" title="Warrants outstanding, beginning balance">0.04</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zA2A3GyOabW7" style="text-align: right" title="Warrants granted">12,482,410</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zBLRmLwQxKUc" style="text-align: right" title="Weighted average exercise price, Granted">0.07</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Warrants exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z3JXzrIwu7ob" style="text-align: right" title="Warrants exercised">(1,383,327</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zfRFqEMy1q07" style="text-align: right" title="Weighted average exercise price, Exercised">0.04</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Warrants expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z6xRjUc0xy7i" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants Expired">(13,459,997</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zSEhJQOfGq0h" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Expired">0.04</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Warrants outstanding, December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z5tGignL7ORb" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending balance">17,953,239</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zcXHFrMHNKzc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Outstanding ending balance">0.06</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zLK3w5lOdUnj" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> At December 31, 2023 the price of the Company’s common stock was $0.06 per share and the aggregate intrinsic value of the warrants outstanding was $<span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_pp0p0_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zpTPmUtg2dsl" title="Aggregate intrinsic value of options outstanding">145,000</span>. As of December 31, 2023, <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zTUNEfnmUZRg" title="Warrants vested outstanding">17,919,906</span> warrants were fully vested and <span id="xdx_90B_ecustom--WarrantsExpectedToVest_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zglMRZ23xEjk" title="Warrants expected to vest">33,333</span> warrants vest in January 2024.</p> <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansByExercisePriceRangeTextBlock_zUNoLFchyaW" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Options and Warrants (Details - Warrant exercise price per share)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B9_zyiBiTNuPj17" style="display: none">Schedule of warrants outstanding by per share price</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Outstanding Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercisable Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Warrant <br/>Exercise Price <br/>Per Share</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Life <br/> (Years)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise Price</p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise Price</p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 20%; text-align: center">$0.02 - $0.24</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant1Member_zGJqHt9Tph1h" style="width: 13%; text-align: right" title="Warrants outstanding">17,883,239</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 15%; text-align: center"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant1Member_z0DSmmoTKSSd" title="Life (Years), warrants outstanding">0.6</span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant1Member_zrjcZN1hj3s4" style="width: 13%; text-align: right" title="Weighted average exercise price, warrants outstanding">0.06</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant1Member_z0WHjj48UCwa" style="width: 13%; text-align: right" title="Warrants exercisable">17,849,906</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant1Member_z8f61c7ha2Ze" style="width: 13%; text-align: right" title="Weighted average exercise price, warrants exercisable">0.06</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">$0.25 - $0.49</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_d0_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant2Member_zen30UYVxIfi" style="text-align: right" title="Warrants outstanding">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">–</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iI_d0_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant2Member_zwgulI4nuRz6" style="text-align: right" title="Weighted average exercise price, warrants outstanding">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_d0_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant2Member_zp6qNq92uTtg" style="text-align: right" title="Warrants exercisable">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_d0_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant2Member_ztXY1vLg8JK5" style="text-align: right" title="Weighted average exercise price, warrants exercisable">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-bottom: 1pt">$0.50 - $1.00</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant3Member_zLJGyCQU3Qs7" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants outstanding">70,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant3Member_zK1Crt8WqPy1" title="Life (Years), warrants outstanding">0.3</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant3Member_zx4k6Eaxdz65" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, warrants outstanding">0.80</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant3Member_zZXL0fGuIWHf" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercisable">70,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant3Member_zHlev7cceUFc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, warrants exercisable">0.80</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zP0gh2JkAsZ5" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding">17,953,239</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zs04oeUzq1Nl" title="Life (Years), warrants outstanding">0.6</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zHlPvQTsTKej" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, warrants outstanding">0.06</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zQmjYuocf3kl" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable">17,919,906</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z7v1srWP8P4l" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, warrants exercisable">0.06</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zLjN4j09aXke" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline">Year Ending December 31, 2023</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March through September 2023, pursuant to terms of convertible notes issued, the Company granted warrants to purchase <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230301__20230930__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zU0atB6aLIme" title="Warrants granted">11,715,748</span> shares of common stock with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20230930__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z9Tyu3KiTSif" title="Weighted Average Exercise Price, warrants outstanding">0.07</span> per share, vesting immediately upon grant and expiring one year from the date of grant.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January through December 2023, pursuant to terms of consulting agreements, the Company granted warrants to purchase <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_ztqGPFQfM414" title="Warrants granted">766,662</span> shares of common stock with an exercise price of $0.03 to $0.13 per share, vesting up to one month from the date of grant and expiring one to two years from the date of grant. Total fair value of these options at grant date was approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_905_ecustom--FairValueOfWarrantsGranted_pp0p0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zyPP2PqATtFj" title="Fair value of warrants granted">35,000</span> determined using the Black-Scholes Option Pricing model with the following assumptions: life of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember__srt--RangeAxis__srt--MinimumMember_zqIjqTWbTivc" title="Expected life">1</span> to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember__srt--RangeAxis__srt--MaximumMember_zj2GkB80duTe" title="Expected life">2</span> years; risk free interest rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zjEhRKOS9Qy" title="Risk free interest rate - minimum">0.73</span>% to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zQ9W2cGFxvQi" title="Risk free interest rate - maximum">5.07</span>%; volatility of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zLZ5omU72uI9" title="Volatility - minimum">182</span>% to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zaDWEbcuBAB1" title="Volatility - maximum">245</span>%; and dividend yield of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_znpPIHp5a6i8" title="Expected dividend yield">0</span>%. During the year ended December 31, 2023, the Company recognized compensation expense of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_90C_eus-gaap--ShareBasedCompensation_pp0p0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zsYMFTJVPkF3" title="Share based compensation expense">37,000</span> based on the fair value of the warrants that vested.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline">Year Ending December 31, 2022</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2022, pursuant to terms of convertible notes issued, the Company granted warrants to purchase <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_90A_ecustom--WarrantsIssuedShares_c20220901__20220930__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zD8SfPJJIFCj" title="Warrants granted">14,409,995</span> shares of common stock with an exercise price of $0.04 per share, vesting immediately upon grant and expiring one year from the date of grant.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January through December 2022, pursuant to terms of consulting agreements, the Company granted warrants to purchase <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zrtyc48Y1Jy4" title="Warrants granted">2,016,662</span> shares of common stock with an exercise price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zrXodXjqo3U6" title="Weighted Average Exercise Price, warrants outstanding">0.02</span> to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zCKNqS0cbpQe" title="Weighted Average Exercise Price, warrants outstanding">0.09</span> per share, vesting up to one month from the date of grant and expiring two to five years from the date of grant. Total fair value of these options at grant date was approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_903_ecustom--FairValueOfWarrantsGranted_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zrkOTqvtkyuj" title="Fair value of warrants granted">127,000</span> determined using the Black-Scholes Option Pricing model with the following assumptions: life of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember__srt--RangeAxis__srt--MinimumMember_zVwDYV1JVxMf" title="Expected life">2</span> to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember__srt--RangeAxis__srt--MaximumMember_zKgxHdou6097" title="Expected life">5</span> years; risk free interest rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zGxHL4jLQky2" title="Risk free interest rate - minimum">0.13</span>% to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zD6vbppi0dVc" title="Risk free interest rate - maximum">4.49</span>%; volatility of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zNzYDKKDIAog" title="Volatility - minimum">193</span>% to <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zmtAKK1ddADh" title="Volatility - maximum">245</span>%; and dividend yield of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_zDrGSwLjdv7k" title="Expected dividend yield">0</span>%. During the year ended December 31, 2022, the Company recognized compensation expense of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFN0b2NrIE9wdGlvbnMgYW5kIFdhcnJhbnRzIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_90F_eus-gaap--ShareBasedCompensation_pp0p0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--TransactionTypeAxis__custom--ConsultingAgreementMember_z0QvV3AGPUP7" title="Share based compensation expense">127,000</span> based on the fair value of the warrants that vested.</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89C_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zbX0dovs2wPb" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Options and Warrants (Details - Options outstanding)"> <tr style="vertical-align: bottom"> <td style="text-align: left; padding-bottom: 1pt"><span id="xdx_8B4_zYyYUBlBbQ38" style="display: none">Stock options outstanding</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><b>Weighted Avg.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><b>Exercise Price</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%">Options outstanding, December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z2Zjy5SXFjbk" style="width: 13%; text-align: right" title="Options, Outstanding beginning balance">31,080,601</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_znDG7JPHDE1g" style="width: 13%; text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning Balance">0.17</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zWmfnAQ3r4V3" style="text-align: right" title="Options, Granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zGJpRX1s2Nhb" style="text-align: right" title="Weighted Average Exercise Price, Granted">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Options exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zedKEbmYAIkc" style="text-align: right" title="Options, Exercised">(250,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zoRf3OAd75Y5" style="text-align: right" title="Weighted Average Exercise Price, Exercised">0.08</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Options cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zsm7xgwcH9ub" style="border-bottom: Black 1pt solid; text-align: right" title="Options, Cancelled">(4,773,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z3a515zxmyG" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Cancelled">0.26</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Options outstanding, December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zzIfNKW77myl" style="text-align: right" title="Options, Outstanding beginning balance">26,057,601</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zX9N7GxwxEUc" style="text-align: right" title="Weighted Average Exercise Price, Outstanding Beginning Balance">0.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zu5Rr8NrmKNh" style="text-align: right" title="Options, Granted">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z40uK9iuHHz8" style="text-align: right" title="Weighted Average Exercise Price, Granted">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Options exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDQqOqGoWqGj" style="text-align: right" title="Options, Exercised">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z5WX9lAfgpE1" style="text-align: right" title="Weighted Average Exercise Price, Exercised">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Options cancelled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z6h1HAuPw9Ui" style="border-bottom: Black 1pt solid; text-align: right" title="Options, Cancelled">(300,446</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zIcMBGHMToO" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Cancelled">0.72</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Options outstanding, December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zAVvX1o79bu8" style="border-bottom: Black 2.5pt double; text-align: right" title="Options, Outstanding ending balance">25,757,155</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zdV9peXZHQ78" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding Ending Balance">0.14</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 31080601 0.17 0 0 250000 0.08 4773000 0.26 26057601 0.15 0 0 -0 0 300446 0.72 25757155 0.14 0.06 115000 0 <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_zgTXKnQUB6B8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Options and Warrants (Details - Options by exercise price per share)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8BA_zKlbMGHBd45k" style="display: none">Schedule of options outstanding by per share price</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Outstanding Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercisable Options</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Option <br/>Exercise Price <br/>Per Share</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Life <br/> (Years)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise Price</p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise Price</p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 20%; text-align: center">$0.02 - $0.24</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice1Member_zFRlJq9XO4Lg" style="width: 13%; text-align: right" title="Shares, options outstanding">22,055,551</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 15%; text-align: center"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice1Member_ziwjRbv1qiAh" title="Life (Years), options outstanding">4.1</span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice1Member_zst2azlXMq8d" style="width: 13%; text-align: right" title="Weighted average exercise price, options outstanding">0.10</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice1Member_zBcF6A5rkC4c" style="width: 13%; text-align: right" title="Shares, options exercisable">22,055,551</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice1Member_zlKVTeZdr8Q5" style="width: 13%; text-align: right" title="Weighted average exercise price, options exercisable">0.10</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">$0.25 - $0.49</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice2Member_zRkCOpIQGvoc" style="text-align: right" title="Shares, options outstanding">3,238,552</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice2Member_z9L3a2iUce0a" title="Life (Years), options outstanding">2.7</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice2Member_zuZLTdODkIhg" style="text-align: right" title="Weighted average exercise price, options outstanding">0.36</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice2Member_zbcP1rnl2VRh" style="text-align: right" title="Shares, options exercisable">3,238,552</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice2Member_zlVcPLuPNBn5" style="text-align: right" title="Weighted average exercise price, options exercisable">0.36</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-bottom: 1pt">$0.50 - $0.99</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice3Member_z5Ird2wDFZv4" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, options outstanding">463,052</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice3Member_zcrfmNErjILj" title="Life (Years), options outstanding">0.4</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice3Member_zxOxyie4HCPc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, options outstanding">0.85</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice3Member_zU0qnZ2PgJh1" style="border-bottom: Black 1pt solid; text-align: right" title="Shares, options exercisable">463,052</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--OptionPrice3Member_zz6kryUfMeaf" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, options exercisable">0.85</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zVPfVfLSK4Fa" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, options outstanding">25,757,155</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z5v2LFEfxwq5" title="Life (Years), options outstanding">3.9</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zGCzpNm2SxH8" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, options outstanding">0.14</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z6WUF5rf2mQe" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, options exercisable">25,757,155</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zu0kcy2EQii7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, options exercisable">0.14</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 22055551 P4Y1M6D 0.10 22055551 0.10 3238552 P2Y8M12D 0.36 3238552 0.36 463052 P0Y4M24D 0.85 463052 0.85 25757155 P3Y10M24D 0.14 25757155 0.14 <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zIpRXTx87i33" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Options and Warrants (Details - Warrant exercise price per share)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B7_z9T7Q3yReLr5" style="display: none">Schedule of warrants activity</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><b>Weighted Avg.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><b>Exercise Price</b></p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%">Warrants outstanding, December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zgNBUgZcDaL" style="width: 13%; text-align: right" title="Warrants outstanding, beginning balance">19,977,149</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zkSTf9ukSFgf" style="width: 13%; text-align: right" title="Weighted average exercise price, Outstanding beginning balance">0.04</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_znfygAxglH2h" style="text-align: right" title="Warrants granted">16,426,657</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zUN9Ptb7UO8l" style="text-align: right" title="Weighted average exercise price, Granted">0.04</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Warrants exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zL5Efwr23LF4" style="text-align: right" title="Warrants exercised">(14,483,825</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zb7bdjWgIi3h" style="text-align: right" title="Weighted average exercise price, Exercised">0.04</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Warrants expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zNcH5C2Rkic4" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants Expired">(1,605,828</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zwb8x1U3biGj" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Expired">0.04</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Warrants outstanding, December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zxY6e2euKxy3" style="text-align: right" title="Warrants outstanding, beginning balance">20,314,153</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zq0Blj4EqEc9" style="text-align: right" title="Warrants outstanding, beginning balance">0.04</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zA2A3GyOabW7" style="text-align: right" title="Warrants granted">12,482,410</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zBLRmLwQxKUc" style="text-align: right" title="Weighted average exercise price, Granted">0.07</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Warrants exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z3JXzrIwu7ob" style="text-align: right" title="Warrants exercised">(1,383,327</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zfRFqEMy1q07" style="text-align: right" title="Weighted average exercise price, Exercised">0.04</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Warrants expired</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z6xRjUc0xy7i" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants Expired">(13,459,997</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zSEhJQOfGq0h" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, Expired">0.04</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt">Warrants outstanding, December 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z5tGignL7ORb" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding, ending balance">17,953,239</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zcXHFrMHNKzc" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Outstanding ending balance">0.06</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 19977149 0.04 16426657 0.04 14483825 0.04 1605828 0.04 20314153 0.04 12482410 0.07 1383327 0.04 13459997 0.04 17953239 0.06 145000 17919906 33333 <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantPlansByExercisePriceRangeTextBlock_zUNoLFchyaW" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Options and Warrants (Details - Warrant exercise price per share)"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span id="xdx_8B9_zyiBiTNuPj17" style="display: none">Schedule of warrants outstanding by per share price</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Outstanding Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercisable Warrants</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Warrant <br/>Exercise Price <br/>Per Share</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: center">Life <br/> (Years)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise Price</p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Weighted</p> <p style="margin-top: 0; margin-bottom: 0">Average</p> <p style="margin-top: 0; margin-bottom: 0">Exercise Price</p></td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 20%; text-align: center">$0.02 - $0.24</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant1Member_zGJqHt9Tph1h" style="width: 13%; text-align: right" title="Warrants outstanding">17,883,239</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 15%; text-align: center"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant1Member_z0DSmmoTKSSd" title="Life (Years), warrants outstanding">0.6</span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant1Member_zrjcZN1hj3s4" style="width: 13%; text-align: right" title="Weighted average exercise price, warrants outstanding">0.06</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant1Member_z0WHjj48UCwa" style="width: 13%; text-align: right" title="Warrants exercisable">17,849,906</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant1Member_z8f61c7ha2Ze" style="width: 13%; text-align: right" title="Weighted average exercise price, warrants exercisable">0.06</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">$0.25 - $0.49</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_d0_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant2Member_zen30UYVxIfi" style="text-align: right" title="Warrants outstanding">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">–</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iI_d0_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant2Member_zwgulI4nuRz6" style="text-align: right" title="Weighted average exercise price, warrants outstanding">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_d0_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant2Member_zp6qNq92uTtg" style="text-align: right" title="Warrants exercisable">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_d0_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant2Member_ztXY1vLg8JK5" style="text-align: right" title="Weighted average exercise price, warrants exercisable">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-bottom: 1pt">$0.50 - $1.00</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant3Member_zLJGyCQU3Qs7" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants outstanding">70,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant3Member_zK1Crt8WqPy1" title="Life (Years), warrants outstanding">0.3</span></td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant3Member_zx4k6Eaxdz65" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, warrants outstanding">0.80</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant3Member_zZXL0fGuIWHf" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants exercisable">70,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Warrant3Member_zHlev7cceUFc" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, warrants exercisable">0.80</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zP0gh2JkAsZ5" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants outstanding">17,953,239</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zs04oeUzq1Nl" title="Life (Years), warrants outstanding">0.6</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zHlPvQTsTKej" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, warrants outstanding">0.06</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zQmjYuocf3kl" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants exercisable">17,919,906</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20231231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z7v1srWP8P4l" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, warrants exercisable">0.06</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 17883239 P0Y7M6D 0.06 17849906 0.06 0 0 0 0 70000 P0Y3M18D 0.80 70000 0.80 17953239 P0Y7M6D 0.06 17919906 0.06 11715748 0.07 766662 35000 P1Y P2Y 0.0073 0.0507 1.82 2.45 0 37000 14409995 2016662 0.02 0.09 127000 P2Y P5Y 0.0013 0.0449 1.93 2.45 0 127000 <p id="xdx_806_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zxKnkMsYSRy7" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 34px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82B_z63ccVITiL2f">Related Party Transactions</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline">Accrued Expenses – Related Party</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">As of December 31, 2023 and 2022, total accrued expenses – related parties amounted to $<span id="xdx_904_ecustom--AccruedExpensesRelatedParties_iI_c20231231_zcYYvamOBfa6" title="Accrued expenses related parties">6,000</span> and $<span id="xdx_90F_ecustom--AccruedExpensesRelatedParties_iI_c20221231_zr209055NyQ3" title="Accrued expenses related parties">6,000</span> and are included in accrued expense on the accompany consolidated balance sheet. The accrued expenses – related parties consisted of unused vacation of officers, unreimbursed out-of-pocket expenses incurred by officers, and unpaid board and committee fees to members of the Company’s Board of Directors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"></p> 6000 6000 <p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zAqqijOXlqBd" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 34px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_822_zRfQFo6VxzB5">Commitments and Contingencies</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">We are involved in certain legal proceedings that arise from time to time in the ordinary course of our business. Except for income tax contingencies, we record accruals for contingencies to the extent that our management concludes that the occurrence is probable and that the related amounts of loss can be reasonably estimated. Legal expenses associated with the contingency are expensed as incurred. There is no current or pending litigation of any significance with the exception of the matters that have arisen under, and are being handled in, the normal course of business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt 0.5in"><b><span style="text-decoration: underline">Contractual Commitments</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">The Company’s contractual commitments for future periods, licensing agreements and minimum guaranteed compensation payments as described in the following table and associated footnotes:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"></p> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--OtherCommitmentsTableTextBlock_zemGkFPlVckj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details - Commitments)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B1_zf7plbkTqAZd" style="display: none">Schedule of contractual commitments</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20231231__us-gaap--OtherCommitmentsAxis__custom--LicenseAgreementsMember_zcGbEWpUWv4d" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20231231__us-gaap--OtherCommitmentsAxis__custom--CompensationAgreementsMember_zmEcoQ32sCke" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20231231_zAW7WucSDRud" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Year ending <br/> December 31,</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">License<br/> Agreements (1)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Compensation <br/> Agreements (2)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total <br/> Obligations</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_405_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_pp0p0_maOCzXwt_z7RDZRdIPLKf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: center">2024</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">187,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">197,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">384,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherCommitmentDueInSecondYear_iI_pp0p0_d0_maOCzXwt_zjsZ496Yvtcb" style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187,500</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OtherCommitmentDueInThirdYear_iI_pp0p0_d0_maOCzXwt_zJSocxhVqhqf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187,500</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OtherCommitmentDueInFourthYear_iI_pp0p0_d0_maOCzXwt_zXptSCnAfV64" style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187,500</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherCommitmentDueInFifthYear_iI_pp0p0_d0_maOCzXwt_zYcQuuiDAaUj" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-bottom: 1pt">2028</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">187,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">187,500</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OtherCommitment_iTI_pp0p0_mtOCzXwt_zH0x2vv590Ac" style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">937,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">197,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,134,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify">Consists of license maintenance fees to Temple University in the amount of $<span id="xdx_906_ecustom--AnnualMaintenanceFee_pp0p0_c20230101__20231231__us-gaap--ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis__custom--TempleUniversityLicenseAgreementsMember_zSjt8keKV6L6" title="Annual maintenance fee">187,500</span> paid annually through the life of the underlying patents or until otherwise terminated by either party (see Note 6).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"></p></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of certain contractually provided benefits to a former executive officer pursuant to a severance agreement and amendments thereto. The balance due as of December 31, 2023, of $<span id="xdx_90A_eus-gaap--SupplementalUnemploymentBenefitsSeveranceBenefits_pp0p0_c20231231_zP51VIhlX8Sc" title="Severance payable">197,000</span> is included as part of Accounts payable and accrued expenses in the accompanying consolidated balance sheets, of which the total amount is in arrears. The former executive officer disputes the amount identified in the above table, claiming the above amount is less than the amount to which he believes he is owed. Absent an agreement to settle the dispute, and in the event the former executive officer elects to initiate litigation regarding the dispute, including claims for interest and penalties to which the former executive officer believes he is entitled, the Company has reserved, and if necessary and appropriate will assert, all factual and legal defenses, counter-claims, rights, and remedies it may have in any such suit.</span></td></tr> </table> <p id="xdx_8A8_zt5wYnA73B29" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--OtherCommitmentsTableTextBlock_zemGkFPlVckj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Commitments and Contingencies (Details - Commitments)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B1_zf7plbkTqAZd" style="display: none">Schedule of contractual commitments</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20231231__us-gaap--OtherCommitmentsAxis__custom--LicenseAgreementsMember_zcGbEWpUWv4d" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20231231__us-gaap--OtherCommitmentsAxis__custom--CompensationAgreementsMember_zmEcoQ32sCke" style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20231231_zAW7WucSDRud" style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Year ending <br/> December 31,</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">License<br/> Agreements (1)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Compensation <br/> Agreements (2)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total <br/> Obligations</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_405_eus-gaap--OtherCommitmentDueInNextTwelveMonths_iI_pp0p0_maOCzXwt_z7RDZRdIPLKf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 49%; text-align: center">2024</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">187,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">197,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">384,500</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherCommitmentDueInSecondYear_iI_pp0p0_d0_maOCzXwt_zjsZ496Yvtcb" style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187,500</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OtherCommitmentDueInThirdYear_iI_pp0p0_d0_maOCzXwt_zJSocxhVqhqf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187,500</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OtherCommitmentDueInFourthYear_iI_pp0p0_d0_maOCzXwt_zXptSCnAfV64" style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">187,500</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherCommitmentDueInFifthYear_iI_pp0p0_d0_maOCzXwt_zYcQuuiDAaUj" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: center; padding-bottom: 1pt">2028</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">187,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">187,500</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OtherCommitment_iTI_pp0p0_mtOCzXwt_zH0x2vv590Ac" style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">937,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">197,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,134,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify">Consists of license maintenance fees to Temple University in the amount of $<span id="xdx_906_ecustom--AnnualMaintenanceFee_pp0p0_c20230101__20231231__us-gaap--ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis__custom--TempleUniversityLicenseAgreementsMember_zSjt8keKV6L6" title="Annual maintenance fee">187,500</span> paid annually through the life of the underlying patents or until otherwise terminated by either party (see Note 6).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"></p></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of certain contractually provided benefits to a former executive officer pursuant to a severance agreement and amendments thereto. The balance due as of December 31, 2023, of $<span id="xdx_90A_eus-gaap--SupplementalUnemploymentBenefitsSeveranceBenefits_pp0p0_c20231231_zP51VIhlX8Sc" title="Severance payable">197,000</span> is included as part of Accounts payable and accrued expenses in the accompanying consolidated balance sheets, of which the total amount is in arrears. The former executive officer disputes the amount identified in the above table, claiming the above amount is less than the amount to which he believes he is owed. Absent an agreement to settle the dispute, and in the event the former executive officer elects to initiate litigation regarding the dispute, including claims for interest and penalties to which the former executive officer believes he is entitled, the Company has reserved, and if necessary and appropriate will assert, all factual and legal defenses, counter-claims, rights, and remedies it may have in any such suit.</span></td></tr> </table> 187500 197000 384500 187500 0 187500 187500 0 187500 187500 0 187500 187500 0 187500 937500 197000 1134500 187500 197000 <p id="xdx_807_eus-gaap--SubsequentEventsTextBlock_zZ2zXWsyAMI7" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_826_zItNmaobue96">Subsequent Events</span> </b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in">In January through March 2024, pursuant to terms of a consulting agreement, the Company granted warrants to purchase 99,999 shares of common stock with an exercise price of $0.05 to $0.07 per share, vesting one month from grant and expiring two years from the date of grant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In January through March 2024, the Company issued convertible promissory notes in the aggregate of $199,000 for cash proceeds of $181,000, net of OID $18,000. The notes are unsecured, have an implied interest rate of 10%, mature in twelve months from issuance, and are convertible into 3,980,900 shares of the Company’s common stock at $0.05 per share. In addition, the Company granted the note holders warrants to purchase 3,980,900 shares of the Company’s common stock at $0.07 per share. The warrants are fully vested and expire one year from the date of issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In February 2024, the Company issued 133,333 shares of its common stock upon the exercise of warrants for proceeds of $4,000 at an exercise price of $0.03 to $0.04 per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In February through March 2024, the Company issued 3,212,000 shares of its common stock upon the conversion of notes payable at a conversion price of $0.05 per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In March 2024, pursuant to terms of a consulting agreement, the Company issued 2,000,000 shares of its common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p>